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ABSTRACT 
On the basis of neuropathological, neurochemical, genetic, and clinical profile 
studies on patients, distinct forms of dementia, such as dementia with Lewy 
bodies (DLB), have been distinguished which were originally thought to be 
Alzheimer's disease (AD). Dementia with Lewy bodies is probably the second 
most common form of dementia in the elderly. In this thesis, a well characterised 
and investigated cohort of DLB and AD patients were compared to non-demented 
elderly controls in order to establish profiles of cognitive decline in these groups. 
Initially, comprehensively matched experimental groups were compared using the 
Cambridge Neuropsychological Test Automated Battery (CANTAB). The DLB 
group was less impaired than the AD group on a test of visual pattern recognition 
memory. However, the DLB group performed worse on a number of cognitive 
tests. 
Comparison of larger, carefully matched, experimental groups using the Cognitive 
Drug Research Computerised Assessment Battery (CDR) also revealed differences 
in the profile of cognitive impairment in DLB and AD. The DLB group showed 
more marked deficits in attentional abilities than the AD group. In particular, the 
DLB group were unable to sustain attention. Conversely, the DLB group were less 
impaired on a test of visual secondary recognition memory than the AD group. 
Further division of the DLB group into cases with and without persistent visual 
hallucinations revealed distinct patterns of cognitive impairment in these two 
groups. Generally, DLB cases with persistent visual hallucinations showed greater 
attentional and spatial working memory deficits than the DLB cases without 
persistent visual hallucinations. 
A final study compared decline in cognitive function over 1 year in DLB, AD and 
control groups. Similar rates of cognitive decline were identified in a number of 
cognitive domains in AD and DLB groups. In addition, disproportionate decline in 
the ability to sustain attention was identified in the DLB group. 
A comparative model relating known neuropsychological, neurochemical, and 
neuropathological features of DLB and AD was proposed. 
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Chapter 1: 
Introduction 
1.1 General Introduction 
Improved social, economic, medical and nutritional circumstances, as well as 
falling birth rates, especially in developed countries, have led to radical changes in 
demographic profiles with an increasingly aged population. The number of people 
over retirement age has increased dramatically over the past 20 years so that 
already one in six of the population now falls into this category. The estimated 9.5 
million retirement pensioners in the UK outnumber children of school age 
(Central Statistical Office, 1984). Dementia is primarily a disease of the elderly 
and has consequently become 'one of the most pervasive social health problems of 
our generation' (Royal College of Physicians Committee on Geriatrics, 198 1). 
Dementia affects approximately 5% of the population over 65 years old and this 
figure rises to 22% in those over 80 years old (Kay et al, 1970). 
Dementia describes a specific group of illnesses characterised by chronic 
irreversible and progressive deterioration of intellectual function based on primary 
neuronal disturbances. The three most common forms of dementia in the elderly 
are Alzheimer's disease, dementia with Lewy bodies and vascular dementia (Perry, 
R. et al, 1990). 
Cerebral dysfunction is central to problems created by these progressive 
neurodegenerative diseases, and has a major impact on the ability of an individual 
to lead an independent lifestyle and places an enormous social, psychological, and 
economic burden on the sufferer themselves, their carers and relatives, and on 
state welfare services. 
James Cowle Pritchard (18 3 5) first described a syndrome of 'forgetfulness of 
recent impressions, while the memory retains a relatively firm hold of ideas laid 
up in the recesses from times long past' some 70 years prior to Alois Alzheimer's 
(1907) neuropathological description of a case of essentially the same disease 
with an earlier onset. Forgetfulness, namely mnemonic dysfunction, is widely 
reported as the hallmark for the diagnosis of dementia (American Psychiatric 
Association, Committee on Nomenclature and Statistics, 1987), or as a prominent 
early symptom of Alzheimer's disease (AD) (Sjorgen, 1952; Katzman et al, 1975). 
'Alzheimer's' has become a title synonymous with pathological memory loss in 
the elderly. 
Lishman (1978) attempted to define dementia as 'an acquired global impairment 
of intellect, memory and personality ... without impairment of 
consciousness ... almost always of long duration, and usually progressive'. This 
appears indeed to be true towards the end stages of the dementing process. 
However, more recently many researchers have described a great degree of 
heterogeneity in the neuropsychological deficits seen in patients with dementia; 
implying differential damage to brain areas and neurotransmitter systems. 
Dementia with Lewy bodies (DLB) is one form of dementia that accounts for at 
least some of the heterogeneity seen in 'AD'. It was almost a century after James 
Parkinson first described a case of Parkinson's disease (PD) that F. H. Lewy first 
described Lewy bodies in the substantia nigra of patients with PD 1912. The 
presence of Lewy bodies in the substantia nigra remains the defining 
neuropathological. marker in PD. The techniques used for staining Lewy bodies 
meant that only Lewy bodies in subcortical. nuclei were identified. The 
development of anti-ubiquitin immunocytohistochernistry facilitated the 
identification of Lewy bodies in cortical regions (e. g. Kosaka et al, 1976). Several 
independent groups have reported incidence rates of between 12% and 35% of 
Lewy bodies in the brains of dementia sufferers coming to autopsy. The 
relationship between the Lewy body and the pathogenesis of dementia has 
stimulated a great deal of research interest, yet remains unresolved. 
Clinical diagnostic criteria have been published which describe the clinical 
syndrome associated with cortical LB pathology (McKeith et al 1 992c; Byrne et 
al, 199 1; McKeith et al, 1996a). Moreover, McKeith et al (I 994b) have 
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demonstrated that the majority of DLB cases were previously misdiagnosed as 
either possible or probable AD using NINCDS-ARDRA criteria. Such a 
misdiagnosis prevents patients with DLB receiving optimal treatment, notably 
with respect to neuroleptic medication (DLB patients show a high rate of severe 
sensitivity associated with reduced life expectancy). In addition, misdiagnosis of 
DLB is also potentially a major confounder of research results. 
Dementia with Lewy bodies appears to represent a common, neurodegenerative 
process with neuropathological, genetic, neurochemical, psychological and non- 
cognitive characteristics which both overlap and are independent of those 
observed in Alzheimer's and Parkinson's disease. A comprehensive review of 
literature describing the current nosological status of DLB with respect to AD and 
PD is provided. The length of this introduction is testimony to the emerging 
acceptance and research interest in DLB as a major cause of morbidity in the 
elderly. An understanding of neuropathological, neurochemical, neuropsychiatric, 
genetic, and psychological features of DLB is essential if the neuropsychological 
profile of DLB is to be effectively elucidated. 
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1.2 Neuropathology of dementia with Lewy bodies. 
1.2.1 Historical background and introduction. 
Although Friederich Lewy first described cytoplasmic inclusions, now known as 
'Lewy bodies' (LB), in the dorsal motor nucleus of the vagus and the nucleus 
basalis of Meynert in Parkinson's disease in 1912, it was in 1919 when Tretiakoff 
detected the presence of Lewy bodies in the substantia nigra of Parkinson's disease 
cases that the name 'Lewy body' became firmly established. The presence of 
Lewy bodies in the substantia nigra remains the definitive pathological marker for 
Parkinson's disease. The topographical distribution of Lewy bodies was 
established using conventional haernotoxylin and eosin (H&E) stains, and was 
thought to be primarily restricted to subcortical areas. Traditional H&E staining 
techniques proved poor discriminators of cortical Lewy bodies (see Figure 1.1 a). 
The development (Kuzuhara et al, 1988) of immunohistochemical techniques 
using antibodies to ubiquitin, a neuronal protein found in Lewy bodies, established 
that Lewy bodies were more widely distributed in many cortical areas of the brains 
of dementia patients than previously thought (see Figure 1.1 b). The discovery of 
these so called 'cortical Lewy bodies' has led in the last ten years to an explosion 
of interest and debate about the role Lewy bodies play in the pathogenesis of 
dementia, and the relationship with pathological markers more traditionally 
associated with Alzheimer's disease. 
An understanding of the reported neuropathological changes is central to the 
comprehension of the problem facing researchers attempting to characterise 
dementia with Lewy bodies and its relationship to Alzheimer's disease and 
Parkinson's disease. As many forms of dementia are ultimately defined by 
neuropathological change, diagnoses made without histopathological confirmation 
can only be tentative. Moreover, the differences between the different sites and 
type of neuropathological change enlighten our understanding of brain - behaviour 
relationships. Finally, detailed neuropathological work may unravel the different 
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aetiologies of various dementia syndromes and open up possible avenues for 
therapeutic intervention. 
1.2.2 Functional biology of Lewy bodies, senile plaques and neurofibrillary 
tangles. 
1.2. 'ale bodies, LeM neurites and associated biochemical 
markers. 
Lewy bodies (LB) are eosinophilic, intracytoplasmic, inclusion bodies which are 
found in a diversity of locations including cholinergic and monoaminergic neurons 
of the brain-stem, diencephalon, basal forebrain, autonomic ganglia and cerebral 
cortex (Gibb, 1989b; Fearnley et al, 1994). Lewy bodies are generally rounded and 
may show a multilocular or fusiform. outline (see Figures 1.1 a; 1.1 b). Numerous 
authors have described two distinctive morphological types depending on their 
topographical location (Perry, R. et al, 1990; Kosaka, 1989; Lowe, 1994). 
Classical brain-stem Lewy bodies are rounded, eosinophilic, intracytoplasmic 
inclusions with a hyaline core and a pale-staining peripheral halo and are typically 
found in the substantia nigra and locus coeruleus. Cortical Lewy bodies generally 
do not have a distinct peripheral halo. De la Fuente-Fernandez et al (1996) suggest 
that these differences reflect topographically distinct aspects of the same structure 
rather than different aetiologic or pathogenic factors. Other neuropathological 
markers in dementia with Lewy bodies are the so called 'pale bodies', which are 
thought to be precursors of Lewy bodies (Dale et al, 1992; Hayashida et al, 1993). 
Neurofilament proteins have been found by a number of groups to be an important 
constituent of Lewy bodies (Goldman et al, 1983; Galloway et al, 1988; Pollanen 
et al, 1992). These neurofilament proteins are phosphorylated and truncated by 
proteolysis (Bancher et al, 1989; Schmidt et al, 1991). Lewy bodies also contain 
several compounds (including ubiquitin, ubiquitin carboxyl-terminal hydrolase, 
multicatalystic protease, and cc B crystalin) that represent one form of a more 
generalised pathological phenomenon. Other forms include: Crooke's hyaline, 
Mallory's hyaline and Rosenthal fibres (Lowe et al, 1988), all of which contain 
ubiquitin, crystalin and filament inclusions. Ubiquitin plays an important part in 
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the targeting of damaged or abnormal proteins for proteolysis. The fact that Lewy 
bodies contain several enzymes associated with the ubiquitin-mediated proteolytic 
pathways suggests that Lewy bodies are cytoprotective responses, and may be 
structural rearrangements to eliminate damaged cellular elements (See Figure 1-2). 
Lewy bodies do not in general contain Tau' protein, and this may be used to 
distinguish cortical Lewy bodies from small spherical tangles. 
Figure 1.2: Functional biology of ubiquitin intermediate filament inclusions 
(adLapted from Lowe et al, 1996) 
Chronic deleterious stimulus 
Genetic factors 
Elements of cell stress 
response 
Intermediate filaments 
-did 144 Kinases 
4B crystallin 
Collapse into inclusion 
Ubiquitin system 
PGP9.5 lplr, --- 1.4 , Proteasome 
I Lysosomal and cytoplasmic proteolysis I 
'Lewy neurites' depict ubiquitin-immunoreactive neuritic degeneration, a distinct 
process seen in Lewy body disorders. They are found in the substantia nigra, the 
CA2/3 regions of the hippocampus, the nucleus basalis of Meynert, and the dorsal 
vagus nerve. Lowe et al (1996) suggest that this particular type of neuritic 
degeneration should be regarded as a distinct part of the Lewy body phenomenon. 
1 Tau proteins are the basic components of paired helical filaments (PHF), the ultrastructural units 
of cytoskeletal neurofibrillary degeneration. Tau proteins are responsible for the polymerisation of 
microtubules in the neurons, and are an important factor in the maintenance of axonal transport. In 
AD, Tau proteins which accumulate within the neurons are abnormally phosphorylated. 
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Figure 1. la: Shows a cortical Lewy body (arrow) found within a neuron located in 
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1.2.2.2 Senile Plaques. 
Senile plaques are structurally complex lesions accumulating in the cerebral cortex 
in both pathological states and normal ageing, the development of which remains 
partially understood. They are round or ovoid structures, 15-200 ýtm in diameter 
(see Figure 1.1 c). Most, if not all, senile plaques start as primarily non-filamentous 
amorphous aggregates of the P-amyloid protein. Such 'diffuse' P-amyloid 
depositions gradually become increasingly fibrillar and acquire the classical 
features of amyloid plaques: a central core of amyloid material surrounded by a 
peripheral rim of dystrophic neurites. These 'mature' P-amyloid plaques bind with 
certain histochernical dyes (thioflavin and Congo red). Associated with mature P- 
amyloid plaques are dystrophic axonal and dendritic Processes which lie close to, 
or immediately next to, the fibrous amyloid deposit. The mature plaques show 
activated microglia associated with the central amyloid deposit and the 
distinguishing fibrous astrocytes rimming the plaque. Mature plaques might 
represent 'burnt out plaques', as they are thought to be at the latter stage of their 
evolution. 
The ratio of differing types of amyloid plaques has received relatively little 
attention. However, work in Newcastle suggests there is a relative preponderance 
of the mature type in Alzheimer's disease (Perry, R. et al, 1986). Gentleman et al 
(1992) have also demonstrated the density and ratio of diffuse and mature plaques 
to be equivalent in AD and DLB. 
1.2.2.3 Neurofibrillqry tangles. 
In the large majority of Alzheimer's disease cases, senile plaques are accompanied 
by neurofibrillary tangles (NFT). Neurofibrillary tangles are abnormal filamentous 
accumulations in the cytoplasm of neurons. The structure of neurofibrillary tangles 
have been identified by electron microscopy to reveal masses of paired, helically 
wound filaments intermixed with straight filaments (see Figure 1.1 c). 
Neuroanatornical studies have suggested that neurofibrillary tangles are often 
located in cells whose axons project to the sites of neuritic plaques; however this 
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is not an absolute prerequisite for their location. Archicortical regions appear to be 
more susceptible to neurofibrillary tangle formation than neocortical regions in 
terms of both density and proportions of neurons involved. This is true for both 
Alzheimer's disease and normal ageing. Specific subcortical nuclei appear to be 
particularly prone to neurofibrillary tangle formation, most notably the 
serotenergic dorsal raphe nucleus (Hirano, 1962). Neurofibrillary tangles also 
show a predilection for somatostatin and enkephalin neurons (Roberts et al, 1985). 
Neurofibrillary tangles occur without senile plaques in a number of aetiologically 
diverse disorders including: sub-acute sclerosing panencephalitis, Kuf s disease, 
and Hallervorden- Spatz disease. Terry et al (1987) also demonstrated Alzheimer's 
disease cases with plentiful senile plaques but minimal or no neurofibrillary 
tangles. Thus the interaction between senile plaques and neurofibrillary tangles is 
not a simple one, indeed Selkoe (1994) is one of several who suggest that 
neurofibrillary tangles may well be non-specific markers of certain kinds of 
neuronal insult. 
1.2.3 The nosological status of dementia with Lewy bodies: The necessity for 
a unitary title and 'gold standard' criteria for pathological diagnosis. 
1.2.3.1 Introduction. 
Primary Lewy body syndromes, such as Parkinson's disease, have Lewy body 
pathology which is believed to be the fundamental to the pathogenesis of the 
disease, whilst 'coincidental' Lewy body diseases are thought to show Lewy body 
formation in the presence of other primary pathological processes. Perhaps the 
most important coincidental association is that proposed by some between 
Alzheimer's disease pathology and Lewy body pathology. 
The relationship between Lewy body and Alzheimer's disease pathology remains 
unclear. In attempts at clarification, American neuropathologists generally cite 
criteria for the diagnosis of Alzheimer's disease based principally on senile plaque 
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counts (Mirra et al, 1991; Khachaturian, 1985). Senile plaques are not uncommon 
in dementia with Lewy bodies cases, hence plaque only based neuropathological 
criteria incorporate many Lewy body cases and thus imply Alzheimer's disease 
with a 'Lewy body' flavouring (Hansen et al, 1990). However, criteria which 
include both plaque and neurofibrillary tangle counts exclude most cases with 
Lewy bodies. Indeed it is suggested by some that the Alzheimer's pathology in 
Lewy body disease is incidental and represents normal ageing processes (e. g. 
Dickson et al, 1989). These differing interpretations are reflected in the number of 
different titles awarded prior to the adoption of the consensus title 'dementia with 
Lewy bodies' in 1996. 
1.2.3.2 Diffuse LeM body disease (DLBj)). 
In 1980, Kosaka proposed Lewy body disease (LBD) as a disease entity and 
classified it into three forms reflecting the topographical distribution of Lewy 
bodies in cerebral tissue. He studied 55 cases of Parkinson's disease and 
distinguished three types of dementia associated with Parkinson's disease. 
Brain-stem type LBD showed a predilection for Lewy body formation in brain- 
stem and diencephalic nuclei, but very few, or none, were evident in the cerebral 
cortex or the basal ganglia. The 'Alzheimer type' pathology was in accordance 
with norms for the ages of the patients. Brain-stem type DLB was identical to 
Parkinson's disease and the four cases reported did not develop symptoms 
typically associated with a cortical dementia. 
In Diffuse LBD four patients suffered a progressive dementia, with or without 
parkinsonism, and showed numerous Lewy bodies distributed in the brain-stem 
and diencephalic nuclei as well as the cerebral cortex and basal ganglia. Senile 
plaques were present in all cases, and neurofibrillary tangles were also present in 
some cases. 
Transitional type LBD represents an intermediary between diffuse and brain-stem 
type LBD and might fall under a clinical description of Parkinson's disease plus 
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dementia. These cases show numerous Lewy bodies in the brain-stem and 
diencephalon and although Lewy bodies were present in the cortex, there were less 
than is seen in diffuse type. 
Table 1.1: Classifications and titles used to describe LeM body disorders 
* Lewy body disease (LBD) (Kosaka et al, 1984) 
" Group A: Diffuse type 
" Group B: Transitional type 
" Group C: Brain-stem type 
e Diffuse Lewy body disease (DLBD) (Yoshimura, 1983) 
e Diffuse Lewy body disease (DLBD) (Kosaka, 1990) 
9 Common form (cDLBD) 
o Pure form (pDLBD) 
* Diffuse cortical Lewy body disease (Gibb et al, 1989) 
9 (Lewy body dementia) 
e Senile dementia of the Lewy body type (SDLT) (Perry et al, 1990) 
e Lewy body variant of Alzheimer's disease (LBVAD) (Hansen et al, 1990) 
e Cerebral type Lewy body disease (Kosaka et al, 1996) 
e Dementia with Lewy bodies (Consensus Term: McKeith et al, 1996) 
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Kosaka (1990) reviewed 37 Japanese autopsy cases with DLBD, and then repeated 
the analysis in 1993 with an increased cohort of 44 cases. Based on this work he 
divided DLBD into two forms,, common and pure, based on the neuroPathologic 
findings of whether many concomitant senile plaques and/or neurofibrillary 
tangles were present. In common DLBD (cDLBD) (n=33) the most manifest 
presenting symptom was memory disturbance (55%), whilst parkinsonian 
symptoms represented only 18% of presenting symptomatology. Common DLBD 
cases showed numerous senile plaques and neurofibrillary tangles, pathological 
markers traditionally associated with Alzheimer's disease and to a lesser extent in 
normal ageing. Cortical Lewy bodies were found mainly in the small neurons in 
the deeper cortical layers, mainly in the temporal, frontal and insular cortices 
although all lobes were involved to some extent. Moderate to severe densities of 
senile plaques were found in all cases. Neurofibrillary tangles were found to be 
widely present in 65% of the cases and all the remaining cases (bar one) showed 
neurofibrillary tangles restricted to the hippocampus and parahippocampal gyrus. 
The final case showed very little neurofibrillary tangle pathology, although there 
were numerous senile plaques present. 
Kosaka also described II cases of the pure form DLBD (pDLBD) in which by far 
the most common presenting symptom was parkinsonism (8 1 %) with 2 cases 
(19%) presenting with psychotic phenomena. The cases with pDLBD appear to 
have an earlier age of onset than cDLBD (Mean = 38.9 years vs. 68.5 years in 
cDLBD) with one case reported in a 14 year old! The clinical diagnosis was 
generally atypical juvenile Parkinson's disease with profound dementia towards 
the end stage. Lewy bodies were distributed widely in the central nervous system, 
however there were no cortical senile plaques or neurofibrillary tangles found. In 7 
of the cases mild neurofibrillary tangle pathology was found in hippocampal and 
parahippocampal regions. 
Very recently (Kosaka et al, 1996b) described yet another type of LBD, 'cerebral 
type of Lewy body disease'. He described the case of a male who started 
becoming forgetful at 77 years, and showed a progressive cortical dementia with 
delirious episodes until he died aged 79 years. Notably he showed no 
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parkinsonism. Neuropathological examination showed no degeneration in the 
substantia nigra or locus coeruleus and only rare Lewy bodies in other brain-stem 
nuclei. There were, however, as many cortical Lewy bodies as have been 
previously seen in DLBD. Kosaka et al. suggest that in this 'cerebral type Lewy 
body disease' the development of cortical Pathology precedes that of Parkinson's 
disease pathology, which might explain why cortical dementia precedes 
parkinsonism in many cases where cortical Lewy bodies are abundant. 
1.2.3.3 The Leya body variant of Alzheimer's disease (LBVAD). 
Fbrstl et al (1993) reported 8 cases of Lewy body dementia from a cohort of 65 
patients collected during a prospective study of clinically diagnosed Alzheimer's 
disease. These were compared with eight patients matched for age and sex from 
the same study with pathologically confirmed Alzheimer's disease. The 
Alzheimer's disease pathology in the group with Lewy bodies was less severe than 
in the Alzheimer's disease group without Lewy bodies. Other distinguishing 
features of the Alzheimer's disease cases with Lewy bodies included: the incidence 
of parkinsonian features, greater frontal cerebral atrophy on Computerised 
Tomography (CT) scans, and a greater loss of neurons in the nucleus basalis of 
Meynert and the substantia nigra. However, Fbrstl et al reported that the LBV 
cases in their sample were not clinically different from the cases without Lewy 
bodies, except for an increased risk of rigidity developing during the course of the 
illness. 
Hansen et al (1990) suggested the title of 'Lewy body variant of Alzheimer's 
disease' (LBVAD) reflecting their proposition that DLBD is in fact Alzheimer's 
disease with incidental Lewy body disease. They examined brains from 36 
clinically diagnosed and pathologically confirmed cases of Alzheimer's disease. 
They found thirteen contained cortical and subcortical Lewy bodies. They argue 
that the LBVAD patients represent a neuropathologically distinct subset of 
Alzheimer's disease for three main reasons: i) all LBV cases fulfilled criteria for 
the neuropathological diagnosis of Alzheimer's disease (Khachaturian, 1985); ii) 
senile plaque counts in the hippocampus were equivalent in LBV and Alzheimer's 
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disease; iii) the gross morphological changes seen in LBV and Alzheimer's disease 
groups were similar. Hansen, however, argues that LBV are a distinct subset of 
Alzheimer's disease based on: i) the presence of Lewy bodies in LBV brains, and 
the universal lack of Lewy bodies in Alzheimer's disease brains; ii) the subcortical 
cell loss was much greater in LBV (particularly locus coeruleus, substantia nigra, 
and substantia inominata) than in Alzheimer's disease. 
The relationship between senile plaques and Lewy bodies in the cortex was further 
examined by Hansen et al (1993). They examined 147 consecutive cases of 
neuropathologically confirmed Alzheimer's disease, and found a minority (25%) 
to have 'plaque-only' Alzheimer's disease, whilst a majority had both senile 
plaques and neurofibrillary tangles. Twenty eight percent of the total sample were 
shown to be LBV, and these were further delineated to show 66% were 'plaque- 
only' Alzheimer's disease and 33% were plaque and tangle Alzheimer's disease. 
Of the plaque-only cases, 75% were found to be LBV, whilst only 25% were 
found to be Alzheimer's disease cases. Hansen suggests that plaque-only 
Alzheimer's disease is usually the Lewy body variant and vice-versa. 
Alzheimer's disease pathology commences and progresses insidiously, with 
diffuse plaques in the neocortex evolving to neuritic forms lacking paired helical 
filaments, and eventually to Tau-positive dense cored neuritic plaques 
accompanied by neurofibrillary tangles. Hansen et al (1994) used the highly 
consistent medial temporal lobe neurofibrillary pathology (Braak & Braak, 1991) 
to grade Alzheimer's disease changes in LBV (see Figure 1.3). 
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Figure 1.3: The extent of AD neurofibrillaiy pathology in four different disease 
categories assessed using a modified Braak and Braak Staging Scheme. (Adapte 
from Hansen et al, 1996) 
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Using the 6 stage Braak & Braak protocol, they found that LBV usually had 
Alzheimer's disease pathology classified in the III / IV (limbic) stage, whilst 
Alzheimer's disease is usually classified in stages V/ VI (isocortical), and normal 
ageing either does not register (0) or reaches only stage I (transentorhinal) in the 
classification. Hansen et al suggest that stage III / IV correspond 'nicely' to the 
plaque-only Alzheimer's disease and achieve CERAD-probable Alzheimer's 
disease. 
Hansen employed diagnostic criteria from the National Institute on Ageing 
(Khachaturian, 1985) and the Consortium to Establish a Registry for Alzheimer's 
Disease (CERAD) (Mirra et al, 1991). Both of these sets of criteria emphasise the 
role of senile plaques for making diagnoses, and out of the 71 Lewy body 
dementia brains the group received in the previous 10 years, most (nearly 90%) of 
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DLBD qualify as either possible or probable Alzheimer's disease. 
More recently, Hansen et al (1996) have demonstrated the impact of specific 
pathological diagnostic criteria for Alzheimer's disease. They applied plaque based 
criteria, as well as plaque and tangle based criteria, to a collection of post mortern 
brains obtained from 58 Alzheimer's disease cases, 58 dementia with Lewy bodies 
cases, and 10 non-demented elderly controls. Their findings demonstrate that the 
proportion of mixed Lewy body disease and Alzheimer's disease (LBVAD), 
compared to pure forms of Lewy body disease (DLBD) is highly dependent on the 
utilisation of neurofibrillary tangles as a diagnostic marker for Alzheimer's 
disease. Using plaque based criteria 91% were LBVAD and only 9% were DLBD- 
In contrast, when plaque and tangle based criteria are employed, this relationship 
changes to 3 4% LBVAD and 66% DLBD. Indeed, Dickson et al (1992) suggest 
that beta-amyloid deposition may be a relatively non-specific manifestation of a 
number of disorders, and that the distinguishing feature between Alzheimer's 
disease and DLBD may well be the presence of neurofibrillary tangles. Arguments 
about the nosological status of dementia with Lewy bodies are entwined with the 
use of differing neuropathological criteria. 
The different interpretations by Kosaka and colleagues (1984), Hansen and 
colleagues (1990), and F6rstl and colleagues (1993) not only show different 
interpretations of the neuropathology of Lewy body disease, but also strongly 
represent sampling extremes. The Japanese sample was taken from cases with a 
primary clinical diagnosis of Parkinson's disease, whilst the early samples used by 
Hansen et al and F6rstI et al were restricted to clinically diagnosed and 
neuropathologically confirmed cases of Alzheimer's disease. Although both 
Alzheimer's disease and particularly Parkinson's disease are the two disorders 
most strongly associated with Lewy bodies, to obtain a more complete 
comprehension of the Lewy body disease spectrum it is certainly necessary to 
extend sampling beyond pathologically confirmed Alzheimer's disease cases 
(Hansen et al., 1990; 1993) or clinically diagnosed Alzheimer's disease cases 
(F6rstl et al., 1993). There is a somewhat tautological argument suggesting that 
Lewy body disease is a variant of Alzheimer's disease, when selection bias 
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requires at least clinical if not neuropathological diagnosis of Alzheimer's disease. 
Employing the LBV of AD nosology is likely to omit many cases of Lewy body 
disease who do not present with typical Alzheimer's disease symptornatology or 
even more restrictively with typical Alzheimer's disease pathology. 
In contrast, Kosaka and colleagues use a sample biased towards a population with 
Parkinson's disease, in whom the Lewy body-related cognitive impairment is 
unlikely to be representative of a more general population of dementia patients. 
Cases of Lewy body disease without extrapyramidal symptoms as a major 
symptom are more likely to be excluded. Kosaka and colleagues suggest a 
nosological spectrum of Lewy body disease which is able to explain the various 
clinical manifestations of dementia associated with the presence of Lewy bodies. 
Hansen and colleagues restrict the nosological status of Lewy body disease to 
within the heterogeneity of Alzheimer's disease. Hansen and colleagues omit cases 
where there are no Alzheimer's disease-like changes, which Kosaka suggests 
might represent upwards of 30% of DLBD cases. Understanding of the true nature 
of the Lewy body disease spectrum of diseases requires sampling which is not 
biased to a particular established clinicopathological entity and is representative of 
a clinical population of dementia patients. 
1.2.3.4 Senile dementia of the LeM body lype (SDLT) -A distinct 
neuropathological entily. 
Perry, R. et al (1990) proposed the term 'senile dementia of the Lewy body type' 
(SDLT) an appellation adopted by other researchers in Newcastle (McKeith et al, 
1992c) which corresponds to transitional DLBD proposed by Kosaka and 
colleagues. They found that neither the clinical or neuropathological features of 
the disease were typical of Parkinson's disease or Alzheimer's disease, and 
suggested a distinct neurodegenerative disorder, part of the Lewy body disease 
spectrum, in which mental symptoms predominate over motor disabilities. Thus 
they suggest that SDLT is a form of dementia distinct from Alzheimer's disease 
and Parkinson's disease, but with some of the neuropathological markers of both; 
that is to say; SDLT occupies a central point on a three category spectrum with 
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Alzheimer's disease and Parkinson's disease occupying either end. 
1.2.3.5 Consensus critf-ja for the neurovathological diagnosis of dementia with 
Lewy bodies (DLB). 
In October 1995, many of the key contributors to this neuropathological debate 
attended the 'International Workshop on Dementia with Lewy bodies'. 
Discussions were held throughout the pathology workshop as to the utility of 
producing neuropathological. criteria. The consensus term 'dementia with Lewy 
bodies' was adopted by both pathologists and clinically based researchers alike. 
The aim was to allow different groups to publish work based on a unitary 
diagnostic schedule enabling direct comparison of findings from different groups. 
The criteria provide guidelines for regional brain sampling, evaluation of Lewy 
body distribution and density, and diagnostic rating protocol (see Table 1-2). 
Table 1.2: Pathological features associated with DLB (adapted from McKeith et 
al, 1996a). 
II Essential for diagnosis of DLB 
Lewy bodies 
2 Associated but not essential 
Lewy-related neurites. 
Plaques (all morphological types). 
Neurofibrillary tangles. 
Regional neuronal loss - especially brain-stem (substantia nigra and locus 
coeruleus) and Meynert Nucleus. 
The criteria propose several additions to CERAD protocols for neuropathological 
assessment, including neocortical, limbic, and paralimbic areas. The cortical Lewy 
body density is assessed using a semi-quantitative scale as follows: 
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Table 1.3: Consensus semi -quantitative measurement of Len body denLity Ladapted from McKeith et al, 1996a). 
Score count (LB/area) 
00 
1 up to 5 
3 >5 
The criteria also recommend that Lewy body count scores are totalled to give a 
final score and anatomical distribution (see Table 1.4). 
Table 1.4: Total LeM body scores providing overall index of Leya body 
pathology (adapted from McKeith et al, 1996a) 
Category Transentorhinal Cingulate Temporal Frontal Parietal Total 
Brainstern 0-1 0-1 0 0 0 0-2 
Predominant 
'Limbic' t 0-3 0-3 0-1 0-1 0-1 3-10 
(Transitional) 
Neocortical 1-3 1-3 1-3 1-3 1-3 11-15 
Limbic category: neocortical involvement should not exceed a score of I in more than one lobe. 
Scores higher than I- generally indicate neocortical category. 
The role of Alzheimer's disease pathology in dementia with Lewy bodies was not 
agreed, the focus being on establishing a common protocol for investigating 
neuropatho logical lesions in dementia with Lewy bodies. 
1.2.3.6 Do LeM bodies cause the dem. entia in DLB?. 
The role of different pathological lesions in the genesis of cognitive deficits in 
DLB remains somewhat uncertain. In DLB cases with Lewy body and 'Alzheimer 
type' pathological changes, several authors have suggested that Lewy bodies play 
a significant role in the pathogenesis of cognitive impairment (Lennox et al, 
1989b; Samuel et al, 1996; Hansen et al, 1990; 1993). 
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Hansen et al (1990; 1993) have demonstrated a similar degree of cognitive 
impairment in LBV and AD cases despite less severe 'Alzheimer type' 
pathological changes in the LBV group. Samuel et al (1996) found a significant 
correlation between Lewy body counts in the cingulate and superior temporal 
cortex and the degree of cognitive impairment assessed using the Mini Mental 
State Examination (MMSE), however, Lewy body counts in the mid-frontal or 
inferior parietal regions did not correlate with the degree of cognitive impairment. 
Perry, R. et al (1990) failed to find a correlation between the degree of cognitive 
impairment and Lewy body counts in the limbic cortex. These studies are 
restricted by the use of the relatively insensitive and mnemonically biased MMSE. 
In addition, the design of these studies means that the correlation is between 
pathological burden at death and cognitive performance measured some time 
previously. 
The most convincing evidence is provided by Kosaka et al (1984), who describe 
pathologically confirmed cases of pure, diffuse Lewy body disease (PDLBD) in 
which Lewy bodies appear to be sufficient to produce a primary dementia 
syndrome in the absence of significant 'Alzheimer type' pathology (Hely et al, 
1996). Thus, although Lewy bodies appear to contribute to the dementia seen in 
DLB, methodological restrictions prevent the determination of the relative 
contributions of Lewy bodies, senile plaques, and neurofibrillary tangles to the 
dementia in DLB. 
1.2.3.7 QLtoskeletal distinctions between AD and DLB. 
In AD the major cytoskeletal abnormalities appear to be in the altered assembly of 
the protein Tau which is associated with microtubules. Markers of this 
abnormality, namely paired helical filaments and hyper-phosphorylated Tau 
associated with neurofibrillary tangle formation, were found to be similar in DLB 
to levels found in PD and controls. Levels of PHF and neurofibrillary tangles 
were found to be twenty times greater in AD cases than controls, I'D cases, and 
DLB cases (Harrington et al, 1994). 
19 
In contrast, the primary cytoskeletal abnormality In DLB appears to be associated 
with neurofilaments. Carter et al (1996) indicate that detailed ultrastructural 
analysis of both cortical and subcortical Lewy bodies shows that they consist of 
neurofilament-like fibrils. Bergeron et al (1996) suggest that Lewy body 
neurofilaments undergo normal assembly but subsequently undergo 
phosphorylation, proteolysis and cross-linking. Thus, the primary pathological 
markers in AD and DLB appear to be distinct at a molecular level. 
1.2.3.8 SummaKy and conclusions. 
Consensus terminology has now been agreed and published (McKeith et al, 
1996a), but underlying debates about the nosological status of dementia with 
Lewy bodies remain unresolved. Criteria for the neuropathological diagnosis of 
Alzheimer's disease may require reformulation in the light of recent autopsy 
studies,, which consistently suggest Lewy body disorders represent 10-30% of all 
cases of dementia coming to autopsy. Continued application of these now 
apparently outdated criteria in tautological arguments about the nosology of Lewy 
body disease fails to progress understanding of the neuropathological features of 
dementia both with and without Lewy bodies. Indeed, American 
neuropathological criteria for the diagnosis of AD are currently under review, and 
future criteria will place a greater emphasis on neurofibrillary tangle pathology. 
Several authors have also strongly suggested that Lewy bodies contribute to the 
pathogenesis of dementia in DLB, although this subject requires further 
consideration. In addition, AD and DLB appear to show distinct patterns of 
disruption to cytoskeletal structures. Lowe et al (1996) suggest that the association 
of Lewy bodies and Alzheimer's neuropathological changes is a reflection of the 
interplay of several factors common to AD and PD (see Figure 1.4). 
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; ociation between cortical LeM bodies and Alzheimer 
pathology (adante from Lowe et al, 1996) 
Lewy body Alzheimer's 
risk factors risk factors 
Mostly Several 
unknown 
known 
: dementia with cortical Lewy bodies 
associated with Alzheimer pathology represents the 
intersection of two sets of risk factors 
Similarly, Hansen and colleagues in the San Diego group have employed a useful 
construct to summarise the status of DLB with respect to the pathological changes 
of I'D and AD. In a recent paper they describe the LBV of AD as.... 
4 ... a neurodegenerative 
hybrid separate and distinct from AD and PD but with 
clinical and neuropathological features of both. By analogy, just as a mule is 
neither a horse nor a donkey, despite being composed of nothing other than horse 
or donkey, so too is LBV a 'different animal' than AD or PD, despite sharing 
features with both. ' 
(Samuel et al, 1996). 
It is to be hoped, however, that the DLB construct does not share the evolutionary 
limitations of the mule! 
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1.3 The clinical syndrome of dementia with Lewy bodies: 
comparison with Alzheimer's disease and Parkinson's disease. 
1.3.1 Clinical features of dementia with Lewy bodies. 
1.3.1.1 Introduction. 
With improved understanding, it has become increasingly apparent that there is 
substantial heterogeneity within the boundaries of a diagnosis of Alzheimer's 
disease. On the basis of retrospective and prospective, clinical and pathological, 
genetic, and psychological studies of patients, distinct forms of dementia are now 
being delineated which were originally thought to be Alzheimer's disease. 
Dementia with Lewy bodies is one such form of dementia and is thought to be one 
of the most common forms of dementia in the elderly. Dementia with Lewy bodies 
may represent up to 24% of clinically diagnosed, senile dementia cases (Shergill et 
al, 1994; Ballard et al, 1993), although post-mortem studies generally suggest 
prevalence rates of between 12 % and 20% (Forno et al, 1993; Byrne et al, 1989; 
Joachim et al. 1988; Dickson et al, 1989; Perry, R. et al, 1990; Hansen et al, 
1990). Whatever the exact figure, dementia with Lewy bodies represents a major 
cause of morbidity in the elderly. 
In-vivo distinctions between dementia with Lewy bodies, Parkinson's disease , and 
Alzheimer's disease are made difficult by considerable overlap between the 
clinical syndromes. Nonetheless, there are a number of clinical features which 
distinguish dementia with Lewy bodies, Parkinson's disease, and Alzheimer's 
disease. These are reviewed below and have become the basis of clinical 
diagnostic criteria for the diagnosis of dementia with Lewy bodies (Byrne et al, 
1991; McKeith et al, 1992c; 1996a). 
Retrospective and prospective clinicopathological studies have examined the 
clinical syndrome of dementia with Lewy bodies. There are a number of 
remarkable mental state symptoms which are strongly associated with the 
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presence of Lewy bodies in the cortex. These include fluctuating cognitive 
impairment, a high incidence of psychotic features, increased risk of depression, 
and extrapyramidal symptoms worsened by the administration of neuroleptics. 
In a review2of 80 dementia cases reaching post mortern in Newcastle, in which 
50% had classical Alzheimer's disease pathology and 20% had Lewy bodies in the 
cortex and brain-stem, McKeith et al (1992c) compared mental state symptoms in 
dementia with Lewy bodies and SDAT (see Table 1.5) 
Table 1.5: Comparison of mental state symptoms in Alzheimer's disease and 
dementia with Leya bodies (% of cases) (adapted from McKeith et al, 1992c). 
...... ... ... 
SDLT SDAT SDLT SDAT 
Fluctuating cognitive impairment 81.0 10.8tt 86.0 18.9tt 
Clouding of consciousness 38.1 8.1tt 81.0 13.5tt 
Visual Hallucinations 33.3 8.1t 47.6 16.2tt 
Auditory Hallucinations 14.3 2.7 19.0 2.7t 
Paranoid delusions 47.6 8.1 tt 57.1 10.8tt 
Depression (Total) 38.1 16.2t 38.1 21.6t 
Depression (Major) 14.3 Ot 14.3 5.4 
Depression (Minor) 23.8 16.2 23.8 16.2 
tp<0.05, ttp<0.01.. 0.001 
2 Retrospective case note review is frequently used in c linicopatho logical studies of dementia. 
There are, however, a number of limitations to this type of study. No matter how comprehensively 
compiled, case notes are limited by the fact that they are likely to omit clinical data (possibly 
deemed not relevant at the time of compilation) or contain diagnostic inferences. Studies based in 
Newcastle reduce this effect by the use of uniform assessment procedures in psychogeriatric units. 
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1.3.1. s of cognitive function. 
A fluctuating level of cognitive impairment is found in the majority of dementia 
with Lewy bodies cases, when other causes such as delirium, medication toxicity, 
or concurrent illness are excluded. McKeith and colleagues (I 992c) estimated 
around 86% of SDLT cases to display fluctuations in the level of cognitive 
impairment throughout the course of the illness (see Table 1.6 for review). 
Ballard et al (1993) found 16 out of 58 patients who were assessed at a day 
hospital for probable dementia fulfilled a somewhat limited study definition for 
idiopathic clouding of consciousness. The identification of idiopathic clouding of 
consciousness required a positive response to the question 'Are there episodes 
lasting days or weeks when his/her thinking seems quite clear and then becomes 
muddled? '. Fourteen out of sixteen (87.5%) of those patients who were identified 
with idiopathic clouding of consciousness also fulfilled McKeith criteria for 
SDLT. Ballard and colleagues found that by selecting their patients on the basis 
only of idiopathic clouding of consciousness they identified similar clinical 
symptomatology as McKeith et al (1 992c). 
McKeith et al (I 992c) describe fluctuating cognitive impairment as essential for a 
diagnosis of DLB, and idiopathic clouding of consciousness as a feature 
supportive of a diagnosis of DLB. Fluctuating cognitive impairment is identified 
by changeable scores on formal psychometric testing or variable performance in 
daily living skills. Idiopathic clouding of consciousness is described as observable 
phasic drowsiness without need to resort to more sensitive methods of 
assessment. This distinction may be somewhat arbitrary as fluctuation also 
includes and, indeed may be based on, pronounced variations in attention and 
alertness (idiopathic clouding of consciousness). 
The Consensus criteria (McKeith et al, 1996a) reflect the development of the 
construct of 'fluctuation' to acknowledge this relationship by including 
'fluctuating cognition with pronounced variations in attention and alertness' as a 
core diagnostic feature. Thus, the distinction between idiopathic clouding of 
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consciousness and fluctuating cognitive impairment may only represent differing 
manifestations of a similar underlying psychopathology. 
Identification of episodes of clouding of consciousness may require more sensitive 
methods of assessment than simple observation, as initially proposed by McKeith 
et al (I 992c). There have been subsequent suggestions that patients might show 
short term increases in arousal in response to environmental stimuli (McKeith et 
al, 1996a), which would confound formal psychometric assessment scores. 
Identifying fluctuating levels of impairment is hindered by problems defining, 
quantifying, and distinguishing fluctuating levels of cognitive impairment and 
altered levels of consciousness. These difficulties become particularly apparent in 
the late stages of dementia when fluctuation may become indistinguishable from 
the severe cognitive impairment. In addition, the utility of formal psychometric 
assessment in end-stage dementia is restricted. 
Methodological problems in the operational identification and classification of 
'fluctuating cognitive impairment' are reflected in the relative paucity of studies 
which attempt to address this issue. Evidence from studies which do address the 
issue demonstrate significantly greater fluctuations in attention / alertness, formal 
psychometric testing and daily living skills in DLB than AD patients. In addition, 
altered levels of consciousness are consistent with neuropathological findings 
implicating disruption of the ascending reticular-activating system (ARAS) and 
associated nuclei (particularly in brain-stem nuclei, and cholinergic neurons in 
nucleus basalis of Meynert) in DLB. 
1.3.1.3 Psychosis in dementia. 
Psychosis is associated with patient and carer stress, as well as a reduced ability to 
live independently (Steele et al, 1990). Psychotic symptoms, and more 
specifically, visual hallucinations are a common feature in cases of dementia 
associated with Lewy bodies (see Table 1.8 for review). Prevalence rates have 
varied from between 13% (Byme et al, 1989) and 80% (McKeith et al, 1992c). As 
would be expected, lower prevalence rates are found in clinical populations 
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associated with neurological services than those with psychiatric services. 
Preliminary data from a series of 72 patients enrolled in the Newcastle prospective 
study of SDLT includes data from 42 SDLT cases (see Table 1.7) (Ballard et al, in 
press). These data suggest visual and auditory hallucinations, as well as delusions, 
occur more frequently in DLB and AD. Ballard et al found the content of the 
hallucinations in dementia with Lewy bodies and Alzheimer's disease to be 
similar. The most common themes were circumscribed hallucinations involving 
animals, objects and people. 
Ala et al, (1997) also found that the presence of hallucinations at presentation 
helped distinguish Lewy body dementia and Alzheimer's disease; however they 
suggested this may not be a particularly sensitive as they were reported for less 
than half of the patients with LBD. 
Table 1.7: Comparative prevalence of non-cognitive symptoms at baseline 
assessment in 42 DLB and 30 AD cases matched for severily of dementia from the 
Newcastle Prospective Study of Memojy Disorders (adapted from Ballard et al, in 
Press). 
Visual hallucinations 1 92.9% 1 26.7% 1y 
Auditory hallucinations 57.1% 10.0% Y 
Delusions 59.5% 20.0% y 
19% 10.0% NS Major depression 
I dysthymia 
2 or more falls i 38.1% 1 30.0% 1 iI NS 
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McShane et al (1996) examined 98 patients with dementia of whom 58 were 
followed up to autopsy. They demonstrated that hallucinations starting within 
three years of the onset of dementia were associated with Lewy body pathology as 
well as reduced life expectancy. In particular, recurrent hallucinations were 
strongly associated with cortical Lewy body pathology. McShane et al (1995) 
provide an operationalised definition of 'persistent' hallucinations as: 'the 
occurrence of hallucinations on more than 5 of the previous 28 days assessed at 
two consecutive visits spaced 4 months apart'. The link between persistent 
hallucinations was studied in a cohort of 51 cases; only 2 of 6 cases with persistent 
hallucinations did not have Lewy bodies at post mortem, whilst 4 out of 9 LBD 
cases had persistent hallucinations. Those with 'fleeting' hallucinations were no 
more likely to have LBD than cases without hallucinations (McShane et al, 1996). 
Thus, it appears that not only is there an increased prevalence of hallucinations in 
DLB, but the persistency of these hallucinations means that they tend to dominate 
the clinical picture. Although poor vision may contribute to the intensity of visual 
hallucinations, it is not thought to contribute to the frequency; hence persistent 
hallucinations appear to be a manifestation of LBD. 
McKeith et al (I 992c) include 'visual and/or auditory hallucinations that are 
usually accompanied by paranoid delusions' as a supportive, but not essential, 
clinical feature for the diagnosis of DLB. Indeed, in studies which include 
assessment of delusion there is generally an increased prevalence in DLB 
compared to AD (McKeith et al, (I 994b); Ballard et al, (1993), however, this 
finding was not supported by Galasko et al (I 996a), Byrne et al (1989), or Klatka 
et al (1996). The most commonly described are delusions of reference (the 
negative interpretation of remarks which are neutral). The delusions in Lewy body 
disease appear to be similar to those seen in Alzheimer's disease but distinct from 
those seen in Parkinson's disease which tend to be less complex (Ballard et al, 
1996a). 
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1.2.1.4 NgimIgntic sensitivily. 
Dementia with Lewy bodies cases have an increased prevalence and persistency of 
psychotic symptomatology. Moreover, they also show severe sensitivity to the 
extrapyramidal side effects of neuroleptic medication (McKeith et al, 1992a). 
McKeith et al (I 992b) described a characteristic pattern of neuroleptic sensitivity 
of initial sedation, followed by the sudden onset of rigidity, postural instability and 
falls. This is accompanied by increased confusion and decreased fluid and food 
intake. Death is usually due to the complications of reduced mobility and fluid 
intake. This occurred in 57% of 14 LBD and 54% of 16 LBD patients receiving 
neuroleptic medication (McKeith et al, 1992b). Neuroleptic treated LBD cases 
showed an increased mortality risk of 2.7 six months after presentation to services. 
McKeith et al (I 992b) also described differences in life expectancy between 
neuroleptic treated and neuroleptic naive dementia with Lewy bodies cases, with 
the mean survival time for neuroleptic treated cases as 7.4 months as opposed to 
28.5 months in cases not treated with neuroleptics. 
The United Kingdom Committee on the Safety of Medicines (CSM, 1994) sent a 
circular indicting that when neuroleptics were to be employed with elderly patients 
with dementia, very low doses should be titrated against the clinical state, and 
extra care should also be taken in cases with symptoms suggestive of dementia 
with Lewy bodies. Neuroleptic sensitivity in cases of dementia associated with 
Lewy bodies is not a ubiquitous finding, McShane et al (1996) failed to find an 
increased risk of neuroleptic sensitivity in dementia associated with Lewy body 
disease within a year of starting neuroleptics. McShane and colleagues did 
however describe an increased rate of cognitive decline in male patients receiving 
neuroleptics, although this association was not apparent in women. 
A possible explanation for this increased sensitivity is the loss of brain-stem 
doparninergic neurons in the substantia nigra of DLB cases. This loss is generally 
reported to be approximately 60% (Perry, E. et al, 199 1), and lies just below the 
symptomatic threshold of 70% depletion. Thus, the administration of any drugs 
reducing the availability of dopamine is likely to induce parkinsonian like 
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symptoms (see Section 1.4.3). 
1.3.1.5 Affective disturbance. 
Depression is the only mood disorder to have been systematically studied in DLB- 
Given the increasing quantity of evidence suggesting pathology in the locus 
coeruleus is associated with depression in both AD and PD, it would seem logical 
to suggest an increased incidence of depression in DLB where numerous Lewy 
bodies are found in the locus coeruleus. A number of studies have identified a 
higher prevalence of depression in DLB than AD (see Table 1.9). McKeith et al 
(1992c) describe higher prevalence rates of major depression at presentation in 
DLB then AD cases. Ballard et al (1993) found 7 out of a series of 16 patients 
with idiopathic clouding of consciousness fulfilled criteria for the diagnosis of 
depression based on the Cambridge assessment of Mental Disorders in the Elderly 
(CAMDEX) schedule. Fourteen of these sixteen also fulfilled McKeith criteria for 
the diagnosis of DLB, although neuropathological diagnoses were not available. 
Klatka et al (1996) retrospectively assessed the frequency of depression in 28 
DLBD, 58 AD, and 26 PD cases. Depression was more common in the DLBD 
(5 0.0%) than AD (13.8 %) groups, but was equivalently common in PD (5 7.7%) 
and DLBD. The authors do not comment on the relative frequencies of depression 
in AD and PD groups. 
Most studies have reported a similar incidence and prevalence of depression in 
DLB and AD (e. g. Ballard et al, 1996a; Hansen et al, 1990). The prevalence rate 
of DSM-IIIR major depression was reported as 15% in a series of 42 cases of 
SDLT from the Newcastle prospective study of memory disorders (Ballard et al, 
1995). This is very similar to the majority of neuropathological studies, which all 
find prevalence rates of DSM-IIIR (American Psychiatric Association, 1994) 
major depression of around 15%. 
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Studies which employ less strict criteria for a diagnosis of depression (e. g. Ballard 
et al, 1993, Klatka et al, 1996) identify more depression in DLB than AD; whilst 
those using the stricter DSM-IIIR criteria generally find dementia rates to be 
equivalent in the two syndromes (e. g. Galasko et al, 1996a). These findings raise 
the possibility that depressive symptoms are more prevalent in DLB than AD, but 
may not be severe enough to satisfy DSM-IIIR criteria. 
1.3.1.6 Movement disorder and DLB. 
Disorders of movement, similar to those seen in PD, are common in DLB. Indeed, 
DLB may present with either cognitive or extrapyramidal symptomatology (EPS). 
Criteria for diagnosing DLB ante-mortem all include the presence of EPS as a 
useful discriminator between DLB and AD. There remains, however, some 
discrepancy over the prevalence; some authors report over 70% of DLB cases 
qualifying for a secondary diagnosis of PD at some stage during the illness (Gibb 
et al, 1989a; Byrne et al, 1989; Kosaka, 1990; & McKeith at al, 1994b) and most 
of the motor features of PD have been described in DLB, whilst others report only 
mild EPS in DL13 (Perry, R. et al, 1990; Fbrstl et al, 1993; & Hansen et al, 1990). 
Moreover, there is little agreement about the type of parkinsonian syndrome in 
DLB. Crystal et al (1990) describe an akinetic-rigid syndrome without rest tremor, 
whilst Byrne et al (1989) describe resting tremor in up to 66% of cases. Once 
again, such discrepancy is likely to reflect different study design and sampling 
methodologies. Comparative study of EPS in DLB and idiopathic PD may help in 
ante-mortem diagnosis especially in those DLB cases presenting with motor 
symptoms. In a similar way, careful comparison of neuropsychological 
performance in DLB patients presenting with cognitive symptoms and AD 
patients, is likely to aid early differentiation. 
Recently, Gnanalingham. et al (1997) assessed EPS in 16 patients with Lewy body 
dementia, 15 with PD, 25 with AD, and 22 control subjects, using the motor 
section of the Unified Parkinson's Disease Rating Scale (UPDRS) (Lang et al, 
1989). Both Pl) and LB dementia had significantly greater overall motor 
impairment than AD cases; furthermore, LB dementia patients scored significantly 
33 
higher total scores (38.3) on the UPDRS scale than PD patients (29-5). Ninety- 
four percent of LB dementia cases qualified for a secondary diagnosis of PD. LB 
dementia patients showed significantly more rigidity than PD cases. EPS items 
assessed in the motor section of the UPDRS failed to discriminate the PD and LB 
dementia, with the exception of resting tremor, which was seen in a greater 
proportion of patients with PD (93%) than LB dementia (50%). The PD group 
showed significantly greater left/right asymmetry of motor signs than other 
groups, but similar upper/lower limb asymmetry to other groups. 
A retrospective review of case notes revealed a subgroup of patients with 
sufficient clinical details about the onset of the clinical symptoms of parkinsonism 
to enable comparison in II PD and 12 LB dementia cases. There were no 
differences between PD and LB dementia in terms of tremor, rigidity, 
bradykinesia, or upper/lower limb asymmetry. However, PD cases showed greater 
(100%) left/right asymmetry than LB dementia cases (42%). Gnanalinghain and 
colleagues conclude that the motor disability is consistent with the doparninergic 
dysfunction in the brain stem in DLB, however, the subtle differences in the nature 
of the EPS between LB dementia and PD may be of little use for the clinical 
differentiation of the two disorders. 
Louis et al (1996) reviewed prospective and retrospective clinical data on a large 
series of pathologically diagnosed cases of PD (n=34) and common form DLBD 
(n=3 1). They found the DLBD group to have an older age of onset (67.9 years) 
than PD cases (62.0 years). Rest tremor was present in significantly more PD 
cases (85%) than DLBD cases (55%); whilst myoclonus was more common in 
DLBD (18.5%) than PD (0%). There were no differences in rigidity, bradykinesia, 
dystonia, or gaze palsies. Data also suggest clinical response to levodopa might be 
more common (p=0.059) in PD (100%) than DLBD (70%). The occurrence of any 
one of four clinical features (myoclonus, absence of rest tremor, no response to 
levodopa, or no perceived need to treat with I-dopa) was 10 times more likely in 
DLBD than PD. The sensitivity of these features to discriminate PD and DLBD 
was moderate (66.7%), but showed a better specificity and positive predictive 
value (85.7%). These must be interpreted with caution, as the population 
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examined was not representative of a clinical population, as participants were 
recruited only from a movement disorders clinic. 
Hansen et al (1990) compared 9 LBV and 9 AD cases with pathological 
confirmation of the clinical diagnosis. Several differences were identified between 
the groups in terms of the neurological findings. Essential tremor (although not 
considered to be a parkinsonian action tremor), masked faces, bradykinesia and 
nuchal rigidity were found more commonly in LBV cases than AD cases. 
Parkinsonian features were generally more mild in AD than LBV, although a mild 
limitation in upward gaze was more common in the AD group. The LBV cases did 
not show parkinsonian features typical of PD such as flexed posture or 
parkinsonian tremor. Hansen concludes that the parkinsonian features are typical 
of early stage idiopathic PD which corresponds to the relatively mild degree of 
loss of pigmented neurons in the substantia nigra. LBV cases met clinical and 
pathological diagnostic criteria for AD, and as such are of limited applicability to 
the range of Lewy body disorders. 
The studies presented above represent the most detailed assessment of movement 
disorders in DLB; however, they fail to show clinically useful or easily 
theoretically interpretable differences between the groups investigated. Subtle 
differences in extrapyramidal symptoms between PD and DLB are unlikely to 
prove useful in the clinical differentiation of the two disorders. Differentiation of 
DLB and PD with dementia is an under investigated area in with respect to the 
movement disorder, mental state symptoms, and cognitive functioning. 
Nonetheless, the occurrence of extrapyramidal symptoms has been shown to be a 
useful discriminator of AD and DLB and is included in all sets of diagnostic 
criteria (see Appendices 1,11, & III). 
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1.3.1.7 Criteria for the clinical diaiznosis of dementia with Lewv bodies 
DLB is identifiable during life. Different profiles of mental state symptoms and 
neuropsychological performance (see Section 1.5) are testimony to the 
possibilities for accurate clinical diagnosis. The ability to distinguish DLB from 
AD and PD in vivo provides benefits not only for research (especially trials of 
possible treatments), but also for routine clinical practice. Early recognition of 
DLB cases aids the differential management of the disorder, particularly with 
respect to administration of neuroleptic medication, and the provision of care by 
professionals and carers. 
Diagnostic criteria are employed differently by researchers and clinicians. The 
primary aim of diagnosis for researchers is one of accuracy (high diagnostic 
specificity), even if this is achieved at the expense of the exclusion of some 
patients, who do in fact have the disease. Clinicians, however, require simple and 
robust tools which should be sufficiently broad to alert clinicians to the possibility 
of DLB, even in more atypical cases (high diagnostic sensitivity). Both researchers 
and clinicians benefit from diagnostic tools which are sensitive and specific to 
DLB. 
Criteria proposed by groups in Nottingham (Byrne et al, 1991) (see Appendix 1) 
and Newcastle (McKeith et al, 1992c) (see Appendix II) were developed on the 
basis of retrospective case note analysis. Both sets of criteria acknowledge the 
importance of fluctuating confusion for the identification of DLB; however, 
neither provides an adequate formalised method of assessing fluctuation (McKeith 
et al. 1996a; Mega et al, 1996). Although both criteria comprise generally similar 
features, there are a number of subtle differences which merit discussion. The 
Nottingham criteria follow the NINCDS-ARDRA 
3 model by suggesting 
diagnostic categories of probable and possible LBD, whilst the Newcastle criteria 
only suggest a single category of SDLT. In addition, the Newcastle criteria are 
3 National Institute of Neurological and Communicative Disorders and Stroke in conjunction with 
the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) proposed clinical 
criteria for the diagnosis of AD (McKhann et al, 
1984). 
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based on symptoms at presentation, whilst the Nottingham criteria are based on 
the occurrence of symptoms throughout the course of the illness. For example, the 
Nottingham criteria require the presence of extrapyramidal symptoms for a 
diagnosis of LBD to be made. However, only 9% of 21 SDLT cases from the 
Newcastle cohort had extrapyramidal symptoms at presentation, although this 
figure eventually increased to 74% of cases. The Newcastle criteria do not 
therefore include extrapyramidal symptoms as a feature essential for the diagnosis 
of SDLT. 
The Nottingham and the Newcastle criteria were retrospectively applied to the 
case notes of a consecutive series of patients with a diagnosis of dementia, who 
were referred to old age psychiatry services over a one year period (Shergill et al, 
1994). The study examined whether the retrospectively applied criteria produced 
similar prevalence rates of DLB to those rates identified in post-mortem studies 
Shergill and colleagues employed logistic regression analysis to identify features 
from each set of criteria that were most likely to differentiate between DLB and 
other dementias. 
McKeith et al criteria identified 26.3% of a cohort of 114 cases to have SDLT; 
whilst Byrne et al criteria identified 7% probable LBD and 17% possible LBD. 
These rates are similar to those found in post-mortem series. Shergill et al 
conclude, however, that the two sets of criteria identify somewhat different 
groups. McKeith et al criteria focus on hallucinations, neuroleptic sensitivity, and 
fluctuating impairment and consciousness, whilst the Byrne et al criteria focus 
more on the dementia of PD. This may reflect the samples employed by the two 
groups, as McKeith et al recruited from old age psychiatry services, and Byrne et 
al recruited from medical, neurological and psychiatric services. Shergill et al 
(1994) might overestimate the utility of the Byrne et al criteria in making an early 
differential diagnosis of DLB, as case notes were reviewed not just prior and 
subsequent to the patients' presentation to the medical services, but throughout the 
course of the illness. 
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McKeith et al (I 994b) reviewed how the Newcastle criteria would classify a series 
of case histories of patients with autopsy confirmed SDLT and thus provide a 
measure of predictive validity. A range of diagnostic criteria were applied to a 
series of patients who suffered from dementia and who had received post mortem 
diagnosis. The series included 20 SDLT, 21 AD, and 9 Multi-Infarct Dementia 
(MID) cases. Cases with a neuropathological diagnosis of SDLT were commonly 
misdiagnosed as MID (35% of SDLT cases had a Hachinski score of greater than 
7), or AD (50% of SDLT met current NINCDS-ARDRA criteria for possible AD, 
and 35% met DSM-III-R criteria for AD). If these cases of misdiagnosis are 
totalled, then it is evident that the majority of SDLT cases might be misdiagnosed 
using the most widely employed diagnostic systems, and may represent a major 
confound of previous research into AD. 
McKeith et al (I 994a) also investigated the predictive validity and inter-rater 
reliability of the Newcastle criteria on the same series of SDLT, AD and MID 
cases reviewed in the McKeith et al (I 994b) study. Four clinicians retrospectively 
reviewed the case notes of the 50 cases and provided a diagnosis for each case. 
Raters one and two were experienced senior clinicians who were specialists in old 
age psychiatry, rater three was a clinician with higher training in old age 
psychiatry, and rater four was a psychiatrist not experienced with a demented 
elderly population. The effect of rater experience in the ability to diagnose SDLT 
was noted (see Table 1.10). 
Table 1.10: Sensitivity and specificily of clinical diagnosis of SDLT amongst four 
Raters using Newcastle criteria (McKeith et al, 1992c) (adapted from McKeith et 
al (1994a). 
Sensitivity Specificity 
Rater (true positive rate) (true negative rate) 
One 85.0 97.0 
Two 90.0 90.0 
Three 65.0 97.0 
Four 55.0 97.0 
Mean 73.75 95.0 
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The sensitivity values (sensitivity is the proportion of true positives that are 
correctly identified by the criteria) ranged from 55 to 90% and are comparable 
with those found in AD using NINCDS-ADRDA criteria (46-92%) (Kukull et al, 
1990), for pure MID (70 to 80%) and mixed AD / MID (17 to 50%) (Chui et al, 
1992). The high specificity (specificity is the proportion of true negatives 
identified by the criteria) rates of between 90 and 97% suggest that the clinical 
syndrome of SDLT, as identified by the Newcastle criteria, is not frequently seen 
in MID or AD cases. More detailed appraisal of individual items on the diagnostic 
criteria revealed an apparent lack of clear guidance to less experienced clinicians 
about the identification of a fluctuating course of illness in SDLT cases. 
Nonetheless, McKeith et al (I 994b) demonstrate that SDLT may be distinguished 
with a degree of diagnostic accuracy comparable to AD and MID in a clinical 
population. However, at this stage the criteria await prospective evaluation. 
In November 1995, the first international meeting to bring together clinicians and 
researchers from the main centres studying DLB was held in Newcastle, England. 
Similar to the consensus guidelines for the neuropathological. sampling and 
diagnosis of DLB, clinicians agreed clinical diagnostic criteria following 
workshops lasting two days. These criteria (see Appendix III) were published in a 
major j ournal the following year (McKeith et al, 1996a) as a refinement of the 
previous Newcastle and Nottingham criteria. The criteria note the need to review 
current diagnostic criteria for AD, PD, and SDLT and acknowledge that DLB may 
present as, primarily, a neuropsychiatric syndrome, or in cases which follow a 
primary diagnosis of PD (although this should be within a1 year period). 
The consensus criteria maintain the central feature of progressive mental 
impairment. However, this was broadened to include tests of memory retrieval as 
well as the impairments in acquisition and consolidation associated with AD. 
Furthermore, attentional and visuo-spatial dysfunction were included as these are 
thought to be particularly impaired in SDLT. Early memory impairment is not 
necessary for a diagnosis of DLB, although severe memory impairment is likely 
with disease progression. 
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In addition, the criteria require at least one of the following for a clinical diagnosis 
of DLB: fluctuation, visual hallucinations, or motor parkinsonism. Problems, 
previously associated with operationalising 'fluctuation', were addressed by the 
provision of detailed guidelines for identifying fluctuation. Fluctuation was not 
required as a mandatory feature of DLB as had been previously suggested 
(McKeith et al, 1992c), but was retained as a core diagnostic feature with 
considerable diagnostic weight. 
Visual hallucinations were also included as a core feature for the diagnosis of 
DLB, as they are the only psychotic symptom to reliably distinguish it from AD. 
McKeith et al (1996a) suggest that it is the persistence of visual hallucinations that 
enable DLB to be distinguished from other forms of dementia and systemic illness 
(e. g. delirium) where the perceptual disturbances are usually episodic and 
transient. 
Motor symptoms of parkinsonism were the third core feature of DLB. Rigidity and 
bradykinesia were identified as the parkinsonian symptoms most likely to 
distinguish SDLT. Onset of motor and cognitive symptoms may vary. However, 
the onset of extrapyramidal symptoms and mental symptoms should occur within 
aI year period for a primary diagnosis of DLB to be made. To help distinguish 
DLB from PD, responsiveness to L-dopa was not included as necessary to the 
diagnosis of DLB. If the extrapyramidal motor symptoms occur late on in the 
dementing illness, then they are deemed as supportive, but not specific to a 
diagnosis of DLB, as extrapyramidal motor symptoms also occur late on in a 
number of dementing processes. The motor symptoms associated with dementia 
are distinguished from neuroleptic-induced parkinsonism by their persistence after 
withdrawal of neuroleptic medication. 
A number of clinical features were included in the consensus criteria as supportive 
of, but not core to, the diagnosis of DLB. These include repeated falls, syncope, or 
transient losses of consciousness, neuroleptic sensitivity, or systematised 
delusions and hallucinations not in the visual modality. In addition, clinical 
features which might be employed to exclude a diagnosis of DLB in the evaluation 
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dementia patients include: the identification of stroke disease, physical illness, or 
other brain disorder. These features may be present in some cases of DLB, as 
concomitant 1 Inesses are not uncommon in dementia. 
The formulation, reliability, and validity of the proposed consensus criteria were 
evaluated by Mega et al (1996) who compared the reliability of five neurologists 
to identify the clinical features of DLB (see Table 1.11). 
Table 1.11: Inter-rater reliabilily for components of the three clinical criteria 
amongst five raters (ada-pted from Mega et al, 1996) 
% Agreement Kappa score 
Signs and Symptoms Mean (range) Mean 
Delusions 92(88-100) 0.82 
- ----- ---- - ------- CogwheýEhpg 84(76-92) 0.68 
Hallucinations 80(68-92) 0.59 
Rigidity 78 (6 8-8 8) 0.52 
Bradykinesia 74 (64-80)--, 
--0.46 
. 
Unexplained falls 74(64-80) 0.46 
Changing consciousness 71 (64-84) 0.27 
Neuroleptic sensitiyýý 66(36-88) 0.45 
Episodic confusion 66(48-80) 0.36 
Fluctuating ADL 60(40-80) 0.25 
(activities of daily living) 
Fluctuatijjg ýýeýrformance 8 ((ý3 2-8 0.25 
According to Mega et al (1996), the attempts to operationalise fluctuations in a 
clinical setting would appear to have had limited success, as this remains the 
feature with the lowest agreement amongst raters. Mega et al attempt to quantify 
fluctuations as variability in MMSE scores of greater than 5 points over three 
administrations in a six-month period, which is based on half of the patients in 
their study with consensus DLB meeting this criterion. The other half of 
consensus DLB cases do not meet this criterion, but do show fluctuations in either 
attention or word list memory. Mega et al conclude that the criteria require further 
refinement of the fluctuation criterion to facilitate their application in the clinical 
setting. Mega et al (1996) suggest an improvement in diagnostic sensitivity 
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afforded by the increased emphasis placed on extrapyramidal symptoms in the 
consensus criteria. 
Despite being an early indicator of possible refinements to the consensus criteria, 
the Mega et al (1996) study is limited by a number of factors. Firstly, the study has 
a very small and poorly defined sample of only 24 dementia cases. These cases 
were apparently biased towards a neuropsychiatric population, as most received a 
clinical diagnosis of AD. This bias is likely to improve the differentiation of DLB 
from AD by the presence of extrapyramidal motor symptoms. However, this 
would not be appropriate for a more representative population, including patients 
presenting with primarily motor symptoms. Secondly, the study design was a 
retrospective case note analysis and is thus limited by factors previously described. 
Ballard et al (I 997b) assessed a cohort of 72 dementia patients using standardised 
assessments, as well as operationalised definitions, to diagnose non-cognitive 
symptoms in a series of 42 SDLT and 30 AD cases. Although Ballard and 
colleagues do not directly address the question of validity of the consensus 
clinical criteria, their findings support the changes in diagnostic criteria made in 
the consensus criteria. Moreover, Ballard et al suggest that the core features, 
included in the recent consensus criteria, remain useful in distinguishing the two 
disorders after one year follow-up. 
In summary, early diagnostic criteria were published by groups in Nottingham 
(Byrne et al, 199 1) and Newcastle (McKeith et al, 1992c). Continuing research 
and discussion has lead to refinements to these criteria and the publication of 
consensus criteria for the antemortem diagnosis of DLB (McKeith et al, 1996a). 
The consensus criteria await substantive validation with a representative cohort of 
psychiatric and neurological patients who are prospectively evaluated and receive 
post mortem evaluation. Such a study is currently underway in Newcastle upon 
Tyne. Nonetheless, experienced clinicians are able to make a differential diagnosis 
of DLB with a similar specificity and sensitivity to that seen in AD (McKeith et al, 
1994a; 1994b). Improvements in the clinical diagnosis of DLB also require 
revisions of clinical diagnostic criteria for AD, PD and MID. 
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1.3.1. riclusions. 
Dementia with Lewy bodies represent a major form of dementia in the elderly. 
Early differential diagnosis is essential if therapeutic intervention is to be 
maximised. Operationalised criteria for the clinical diagnosis of DLB have been 
developed following a series of retrospective and prospective studies. One feature 
which is essential for a diagnosis of DLB is a progressive cognitive decline of 
sufficient magnitude to interfere with normal social or occupational function. 
Unlike AD, early cognitive decline is not always associated with short term 
memory loss, indeed, attentional and visuo-spatial dysfunction may be early 
indicators of DLB. 
Clinical symptoms which have been identified in the literature as strongly 
associated with a diagnosis of DLB are included in the consensus criteria as core 
features; whilst clinical symptoms which are associated with DLB, but less 
persuasively, are included as supportive features. Core clinical symptoms 
associated with DLB include: fluctuating cognition, visual hallucinations, and 
spontaneous extrapyramidal motor symptoms. Clinical symptoms supportive of 
DLB include: repeated falls, syncope, transient losses of consciousness, 
neuroleptic sensitivity, systernatised delusions, and hallucinations in non-visual 
modalities. Early diagnostic criteria have been shown to be useful in the 
differential diagnosis of DLB, however, the more recent consensus criteria await 
substantial prospective validation in a representative population. 
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1.3.2 Genetics of dementia with DLB- 
Aivo-protein E). 
Apolipoprotein E (ApoE) is a polymorphic secretary glycoprotein expressed by a 
wide variety of tissues in mammals, particularly the liver and the brain (Mahley, 
1988). ApoE is involved in the mobilisation and distribution of cholesterol and 
other lipids which would be insoluble in aqueous solutions such as the blood, and 
is expressed during neuronal growth and after injury. The brain produces about 
20% of the body's ApoE and this glycoprotein is a major (4-5%) component of the 
cerebro-spinal fluid. The main neural cells responsible for the production of ApoE 
are astrocytes and macrophages. 
There are three major isoforms of ApoE (E2, E3, and E4) that are the product of 
three alleles (e2, e3, and e4), which are co-dominantly expressed in humans and 
determine 6 different ApoE phenotypes. These alleles are encoded for by a single 
gene (ApoE) which is located on the long arm of chromosome 19. The distribution 
of ApoE phenotypes varies between populations. However, in the general 
Caucasian population, e3 is the most common allele with an approximate 
frequency of 0.78, whereas the e4 allele has a relative frequency of 0.14 
(Davignon et al, 1988). 
There are several indicators that ApoE is associated with the pathogenesis of AD. 
Firstly, Diedrich et al (199 1) demonstrated increased levels of ApoE e4 
messenger ribo-nucleic acid (mRNA) in AD compared to controls. Secondly, 
apolipoprotein has immunohistochemical associations with both senile plaques 
and neurofibrillary tangles (Wisniewski et al, 1992). Thirdly, it has been suggested 
that ApoE is able to bind and transport P-amyloid in cerebrospinal fluid in a 
manner that prevents paired helical filament formation (Wisniewski et al, 1993). 
Lastly, The presence of the e4 allele is associated with both late-onset familial and 
sporadic AD, suggesting that e4 may be a risk factor for AD, although the 
observation that AD can occur in persons without the allele is consistent with the 
heterogeneity of AD (Saunders et al, 1993). 
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1.3.2.2 The role of apolipoprotein in the pathogenesis of DLB. 
The role of apolipoprotein genotype in DLB has received considerable research 
interest (Betard et al, 1994; Harrington et al, 1994; Galasko et al, 1994; Benjamin 
et al, 1995; Hardy et al, 1994, Arai et al, 1994; Katzman et al, 1995; Lippa et al, 
1995; Martinoli et al. 1995; Olichney et al, 1996). 
Betard et al (1994) describe increased e4 allele frequency in presenile and senile 
AD cases, in AD cases with LB pathology, and in AD with evidence of 
cerebrovascular disease, when compared with cases of vascular dementia from the 
same cohort. The increased relative frequency of e4 allele in LBD cases suggests 
that the aetiology of LBD may be somehow linked to AD. Betard and colleagues 
suggest that LBD may share a common underlying genetic susceptibility factor 
with AD, or have a different genetic causal origin that is enhanced by ApoE 
susceptibility. 
Harrington et al, (1994) studied ApoE allele distribution in autopsy confirmed 
AD, SDLT, PD, Huntingdon's disease (HD), and controls with and without 
coronary complications. There was increased frequency of the ApoE e4 allele in 
SDLT (0.365), and AD (0.328) as compared to controls (0.147), PD cases (0.098), 
or HD cases (0.17 1). They found a 1.8 fold increase of P-amyloid protein in AD as 
compared with controls. Notably, the levels in SDLT were intermediate between 
those in AD and controls. AD was associated with a 20 fold increase in Tau 
pathology compared to controls. However, despite possessing increased e4 allele 
frequencies there was no significant Tau pathology in SDLT. Harrington and 
colleagues suggest that defective Tau processing is most strongly associated with 
AD, and that overrepresentation of the ApoE e4 allele is important in the 
formation of P-amyloid plaques, but plays little role in the formation of Tau 
pathology. This somewhat contradicts immunohistochemical findings from 
Wisniewski et al 0 993), who suggest apolipoprotein is associated with both 
plaques and tangles. 
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Galasko et al, (1994) determined ApoE genotypes in 122 dementia cases who had 
come to autopsy. Their study investigated 74 cases of AD, 40 cases with LBV, and 
8 with DLBD. They demonstrated increased ApoE e4 allele prevalence in both 
AD (3 9.6%) and LBV (29.0%) but not in DLBD (6%) when compared to 1000 
controls taken from a study by Menzel et al. (1983). They suggest these findings 
indicate that ApoE e4 is associated with AD lesions, but not with Lewy bodies. 
The increased level of ApoE e4 in LBV cases suggests a link between some forms 
of DLB and AD. Although cases where both Lewy bodies and AD type changes 
are present show higher frequencies of ApoE e4, the relationship between LB 
formation and ApoE e4 frequency does not appear to be causal, as 8 DLBD cases 
without AD changes show a similar ApoE e4 allele frequency to that seen in 
controls. 
Hardy et al (1994) also found elevated ApoE e4 allele frequencies in AD and 
SDLT compared to both PD and controls. ApoE e4 allele frequencies in SDLT 
were intermediate between AD and controls. SDLT cases include cases with LB 
pathology alone, as well as with concomitant AD type pathology, which might 
provide some explanation for the intermediate frequency. They suggest that SDLT 
represents the co-occurrence of AD and PD. 
Lippa et al (1995) investigated whether ApoE genotype affected neuropathology 
in LBD by investigating ApoE genotypes, P-amyloid and LB density in different 
brain regions, the intensity of ubiquitin-positive neurites, vacuolar change, nigral 
pathology, amyloid angiopathy, and subpial amyloid deposition. They found a 
relationship between ApoE genotype and P-amyloid deposition such that the 
e3/e3 LBD cases showed a lower density of P-amyloid density than other 
genotypes. Interestingly, the mean number of P-amyloid plaques was greater in e2 
than e4 groups, which appears contradictory to the finding that possession of 
ApoE e2 alleles is protective against AD. The CA2-3 neuritic degeneration was 
greater in cases with the e4/e4 allele than those with the e3/e3 allele. Lippa and 
colleagues suggest that although ApoE genotype does have an impact on the 
pathological burden in LBD, it is neither necessary or sufficient to account for 
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either P-amyloid formation or the motor and cognitive changes seen in LBD 
patients. 
Martinoli et al (1995) determined the frequency of ApoE alleles in cases with 
pathologically confirmed AD, PD, DLBD, AD with concomitant PD pathology, 
demented PD cases with or without concomitant AD pathology and in cases of 
schizophrenia with a progressive dementia. Only the AD group showed increased 
ApoE e4 allele frequency compared to control, although this might have been 
more to do with small group sizes than with real distinctions. 
Olichney et al (1996) performed a retrospective genetic-neuropathologic study to 
determine the relationship between ApoE genotype and neuropathologic lesions in 
AD and LBV. Their study of 127 neuropathologically diagnosed cases (AD n=84; 
LBV n=43) found the ApoE e4 allele to be strongly associated with increased 
amyloid deposition, but not with NFTs, in both AD and LBV. 
The finding that ApoE e4 allele frequency is associated with senile plaque burden 
is not ubiquitous. Arai et al (1994) described ApoE e4 allele frequency in a small 
series of cases, clinically and pathologically diagnosed as DLBD, 5 of which were 
diagnosed as having concomitant AD. ApoE e4 allele frequency was elevated in 
DLBD cases with (50%) and without (40%) concomitant AD pathology. Arai and 
colleagues imply that ApoE is a risk factor for LB dementias, and that both DLBD 
and AD may share a common pathogenic mechanism driven by the ApoE gene. 
Caution should be exercised in the interpretation of these results due to the very 
small sample size. 
Benjamin et al. (1995) investigated 45 AD, 28 SDLT, and 46 control who had 
pathological confirmation of their clinical diagnosis. ApoE e4 allele frequency 
was significantly elevated in both SDLT and AD groups with a parallel reduction 
in ApoE e3 frequencies. Benjamin found no significant association between SP 
density and NFT density in the neocortex and ApoE allele dose in SDLT or AD, 
which lends no support to the hypothesis that ApoE promotes P-amyloid 
deposition, particularly via the e4 allele. They suggest that ApoE may play a role 
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in initiating the P-amyloid deposition cascade, but the subsequent degree of 
deposition is dependent on a self-sustaining mechanism with P-amyloid self- 
assembling on the initial framework. 
The role of ApoE alleles in the pathogenesis of dementia syndromes remains 
somewhat enigmatic, especially with respect to DLB- The only certainties are that 
increased ApoE e4 frequency is the most potent genetic risk factor known for AD, 
and that increased frequency is also associated with earlier onset (Saunders et al, 
1993). Although ApoE e4 allele frequency appears to be increased in DLB, the 
exact role of ApoE allele expression in the pathogenesis of DLB remains 
somewhat unclear. Whilst the majority of evidence suggests that the increased 
ApoE e4 frequency in DLB are associated with the senile plaque burden (Betard et 
al, 1994; Harrington et al, 1994; Galasko et al, 1994; Benjamin et al, 1995; Lippa 
et al, 1995; Martinoli et al, 1995; Olichney et al, 1996), some studies have failed 
to identify a link between senile plaque burden and ApoE allele frequency 
(Benjamin et al, 1995; Arai et al, 1994). Moreover, the frequency of the ApoE e4 
allele has not been reported to be increased in other amyloid-forming diseases 
such as Creutzfeldt-Jacob disease and familial amyloidotic neuropathy (Saunders 
et al, 1993). Although some cases of DLB may share the genetic risk factor 
associated with elevated ApoE e4 frequency, this appears to be only for cases 
associated with senile plaque formation. ApoE e4 allele frequencies appear not to 
be elevated in pure DLBD cases and in PD, thus, the e4 allele does not appear to 
be associated with LB burden in cases without concomitant AD changes. 
Whether, e4 alleles might play a role in the pathogenesis of Lewy bodies in DLB 
with concomitant AD changes remains unclear, and is central to the nosological 
status of DLB. It may be the changes in the abnormal processing of Tau, rather 
than P-amyloid deposition in senile plaques, which is associated with the clinical, 
pathological, and immunohistochemical factors that distinguish AD from both 
DLB and normal ageing. 
The presence of the ApoE e4 allele is neither sufficient or necessary to cause AD, 
indeed the only firm conclusion to be drawn is that it affects the age of onset of 
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AD (Roses, 1995). There is no evidence that ApoE e4 allele frequency affects the 
age of onset of PD, however, it remains to be determined whether it affects the age 
of onset of DLB. 
1.3.2.3 Cylochrome P450 2D6 Genetic Polymorphism. 
It has been proposed that alleles of CYP2D6, one of the P450 monooxygenases, 
are associated with the metabolic degradation of MPTP (I -methyl-4-phenyl- 
1,2,3,6-tetrahydropyridine) and tetrahydroisoquinoline which are toxins known to 
be capable of inducing lesions to produce parkinsonism. The CYP2D6 allele has 
several common alleles. The most common (wild type) allele is present in most 
individuals and ethnic groups. The 'A' and '13' variant alleles are associated with 
reduced debrisoquine hydroxylase activity. Armstrong et al, (1992) reported an 
association between the CYP2D6 '13' allele and PD. In a larger series, Smith et al 
(1992) failed to report the increased frequency of '13' alleles. In fact Smith and 
colleagues reported an increased (1.8 times) 'A' allele frequency in PD. Kondo et 
al (199 1) found that having two mutant alleles (they investigated only 'A' and 'B') 
was 2.4 times more frequent in PD. Saitoh et al (1995) described an increased 
frequency of the '13' allele in DLB. 
Bordet et al (1994) investigated genetic polymorphism of the cytochrome P450 
2D6 gene in idiopathic Parkinson's disease (IPD) and DLBD. They failed to 
establish a relationship between CYP2D6 impairment and neuropathological 
lesion diffusion in lPD and DLBD cases. However, their study was unable to 
exclude involvement of neuronal expression of CYP2D6 due to complex 
neuroanatomical regional differences in the expression of CYP2D6 in lPD and 
DLBD. 
1.3.2.4 Summga. 
Increased ApoE e4 allele frequencies are observed in DLB cases, this appears to 
be associated with senile plaque burden. ApoE e4 allele frequencies do not appear 
to be increased in pure DLBD cases or in PD. Thus, ApoE e4 allele frequencies do 
not appear to be associated with Lewy body formation without concomitant senile 
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plaque formation. Mutations of the CYP2D6 gene appear to act as susceptibility 
factors for PD as well as DLB. There are evidently further genes to be delineated 
which describe the relationship between PD and DLB, especially those which 
determine the topographical distribution of Lewy body pathology. Whether the 
complex nature of the genetic interactions between DLB, AD, and PD will 
eventually prove to be useful in the clinical diagnosis of DLB remains to be 
ascertained. 
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1.3.3 Macroscopic and neuroimaging features of Alzheimer's disease, 
Parkinson's disease, and dementia with Lewy bodies. 
On a gross macroscopic level, Alzheimer's disease is accompanied by widespread 
cortical atrophy and associated increase in ventricular size (Perry, R. et al, 1982). 
However, considerable atrophy can be found in the brains of Patients with non- 
dementing conditions (Tomlinson, 1980) and, furthermore, there may be as much 
as a 20% overlap between pathological and non-pathological atrophy. A similar 
pattern for brain weight is observed (Terry & Katzman., 1983). 
Neuroimaging data for Alzheimer's disease suggest the medial temporal lobe to 
demonstrate the most consistent changes, and indeed Jobst and colleagues (1995) 
suggest a simple measure of atrophy in the medial temporal lobe by computed 
tomography as a useful diagnostic tool for identifying Alzheimer's disease in life. 
Neuroimaging has not yet been able to show any specific discriminatory indices 
between Alzheimer's disease and dementia with Lewy bodies. Macroscopic 
features do not at present provide a peripheral marker or diagnostic test to identify 
and discriminate between the two disorders. 
Parkinson's disease patients also show cortical atrophy, particularly in the frontal 
lobes (Cummings et al, 1983). However, as the course of Parkinson's disease is 
relatively easily distinguishable from Alzheimer's disease and dementia with 
Lewy bodies, the implications for use as a clinical diagnostic tool are rather 
limited. There are, however, interesting implications for the subclassification of 
Parkinson's disease as a 'subcortical' dementia. 
Patients with vascular dementia can usually be identified without recourse to 
specialised imaging. A background of cerebrovascular risk factors, and in 
particular hypertension, a history of stroke like events and stepwise deterioration, 
focal motor and sensory signs, early urinary disturbance and patchy cognitive 
deficits are all indicative of vascular pathology (Hachinski et al, 1975). However, 
infarcts lead to cell death and a characteristic alteration of density of 
representation on both CT scan and MRI, making identification of vascular 
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involvement in dementia relatively simple to distinguish. Evidence of significant 
infarcts are included as a feature to exclude a diagnosis of DLB in the consensus 
criteria (McKeith et al, 1996a). Furthermore, a sizeable proportion of cases who 
show multiple infarcts in-vivo, display coexistent Alzheimer's disease pathology 
post mortem. This condition called mixed dementia, adds a pitfall to the use of 
neuroirnaging techniques as a clinical diagnostic tool, although it is commonly 
used as an aid to clinical diagnosis 
Crystal et al, (1990) suggest that electroencephalogram measures might be useful 
in distinguishing dementia with Lewy bodies and Alzheimer's disease. They found 
that four out of six patients with Lewy body disease had abnormal EEGs showing 
background slowing and bursts of frontal 2-4 Hz activity when only mildly 
demented, and comment that EEG changes in Alzheimer's disease patients tend to 
be relatively less severe. Although similar non-specific changes have been 
reported by Gibb et al (I 989a) these findings await validation and clarification in a 
larger cohort. 
Neuroirnaging in DLB is an under researched area which awaits systematic 
investigation with large cohorts of patients. Whether this reveals distinctions 
between AD and DLB which are of sufficient magnitude to aid in the differential 
diagnosis of the two disorders remains to be elucidated. 
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1.4 Neurochemical dysfunction in dementia with Lewy bodiesq 
comparisons with Alzheimer's disease and Parkinson's disease. 
1.4.1 introduction. 
That neurochernical alterations underlie many of the cognitive and clinical 
problems seen in AD is well documented especially with respect to cholinergic 
dysfunction in AD (e. g. Perry, E. 1978). The interaction between the topography 
and extent of neurochernical and neuropathological deficits in DLB is less well 
documented. There is, however, a significant emergent literature to suggest 
neurochemical distinctions from both PD and AD, but with common features of 
both. The prevalence of clinical symptoms in DLB reflects neurochemical 
dysfunction unique to DLB. 
1.4.2 Cholinergic systems in DLB. 
1.4.2.1 The cholinergic hypotheses revisited. 
The disproportionate disturbance in cholinergic function seen in AD was implied 
at the same time by a number of teams in the 1970's (Davies et al, 1976; Perry, E. 
et al, 1977). A reduction in the enzyme choline acetyltransferase (ChAT), was 
described in AD. ChAT levels are typically reduced by 50% (30-90%) in cortical 
areas, but remained relatively preserved in the brainstem, thalamus, pre and post- 
central gyrus, occipital cortex, and cerebellum (Davies et al, 1978). Whitehouse et 
al (198 1) showed marked loss of the nucleus basalis of Meynert neurons, the 
nucleus projecting to most cholinergic neurons in the cortex, in AD. The 
subsequent cortical cholinergic dysfunction and reductions in ChAT are attributed 
to pathology of the nucleus basalis of Meynert. 
The discovery of cholinergic dysfunction in AD led to much of the cognitive 
impairment of the disease being attributed to loss of this transmitter, giving rise to 
the so called 'cholinergic hypotheses'. This is supported by other human and 
animal, experimental and clinical, psychopharmacological investigations. Human 
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psychopharmacological investigations have demonstrated that a profile of 
cognitive changes similar to AD can be induced in healthy volunteers by 
administration of anticholinergic agents such as scopolamine. These effects are 
reversed by the administration of physostigmine which enhances cholinergic 
functioning by inhibiting cholinesterase breakdown of acetylcholine (Wesnes et al, 
1983a, 1994,1988a; 1988b; Drachman, 1977). Alzheimer's disease cases are also 
more sensitive to the administration of anticholinergic treatments than non- 
demented elderly (Sunderland et al, 1985). In addition, cortical ChAT is reduced 
in autopsy and biopsy samples, and the ChAT levels correlate with the degree of 
cognitive impairment (Perry, E. et al, 1978; Sims et al, 1983). 
The status of cholinergic receptors in diseases of the human brain associated with 
cholinergic dysfunction in the cortex is of interest, particularly with respect to 
putative cholinergic therapy. There remains a great deal of interest in drugs which 
aim to alleviate AD symptoms by enhancing cholinergic function. Although a 
number of cholinesterase inhibitors are now licensed, results to date have been 
somewhat disappointing. In the trial of Eagger et al, (199 1) only about I in 3 'AD' 
patients showed a clinically significant response in terms of improvements in 
MMSE scores to the administration of tetrahydroaminoacridine (THA; Tacrine). 
Interestingly, most responders in this trial who have reached autopsy have shown 
Lewy bodies, as well as very dramatically reduced cholinergic activities. Not all 
studies have, however, demonstrated such an improved rate of response in DLB 
cases to THA (Wilcock et al, 1994). These findings suggest that DLB may 
represent a subset of clinically identifiable dementia patients who respond to 
cholinergic therapy. 
1.4.2.2 Cholin (ChAT) aCtivily. 
Perry, E. et al (I 990a: 1990b; 1994) described cholinergic and dopaminergic 
activities in SDLT, AD and PD in post mortem tissue. SDLT cases showed even 
greater reductions in the cortical cholinergic enzyme choline acetyltransferase 
(ChAT) than AD cases which is consistent with previous findings in DLBD 
(Dickson et al, 1987). Neocortical ChAT was more profoundly reduced in SDLT 
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cases with hallucinations (80% reduction) compared to those without 
hallucinations (50% reduction). There was a strong correlation between choline 
acetyltransferase levels and mental test scores (Blessed et al, 1968), as measured 
shortly before death. Indeed, this correlation is considerably greater than the 
correlation (0.52) between cholinergic loss and mental test score previously 
described in a series of 16 AD cases (Perry, E. et al, 1978). Langlais et al, (1993) 
have also demonstrated significantly depleted neocortical ChAT activity in the 
LBV cases compared to the pure AD cases, and also suggest that this is related to 
degeneration of the nucleus basalis of Meynert. 
Topographical distinctions between ChAT depletion in SDLT and AD have been 
demonstrated (Perry, E. et al, 1994). Archicortical cholinergic dysfunction has 
been shown to be more severe in AD then DLB (Perry, E. et al, 1994) which 
contrasts the more severe cholinergic dysfunction in many neocortical areas in 
DLB (Perry, E. et al, 1990a; 1990b; Langlais et al, 1993). The mechanism by 
which Lewy body pathology preferentially affects the nucleus basalis of Meynert 
which provides cholinergic innervation to the neocortex, and senile plaque and 
neurofibrillary tangle formation primarily affect pathways projecting from the 
septal area to archicortical structures remains unclear. Perry and colleagues did not 
find an association between the topographical variations in the degree of 
cholinergic enzyme loss and prevalence of Lewy bodies in the cortex. 
Nonetheless, Perry, E. et al (1994) suggest the 'pathological processes which 
contribute to degeneration of cholinergic neurons in the nucleus basalis of 
Meynert and the development of widespread cerebral Lewy body formation are 
likely to be linked'. 
1.4.2.3 Muscarinic receptor alterations in DLB. 
In AD muscarinic receptors are generally not reported to undergo major changes 
in their overall population, the ratio of subtypes (MI or M2) of receptor, or the 
agonist affinity states, although M2 receptor binding is generally moderately 
reduced. In PD, however, cortical muscarinic receptors (particularly MI) actually 
increase in number (Nordberg et al, 1985). Similarly, Perry, E. et al, (1990b) have 
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demonstrated increases in cortical muscarinic receptors in SDLT. In all cortical 
areas investigated, (temporal, parietal and occipital) there were increases in the Mi 
receptors in PD and SDLT, but not AD. There is relative sparing, and increased 
binding, of the M, muscarinic receptors in SDLT. The M, muscarinic receptors 
are thought to be primarily post-synaptic. This finding has important implications 
for therapeutic treatments, as it may be indicative of a capacity of intrinsic 
cholinoceptive neurons in the cortex to compensate for cholinergic denervation. 
This is less apparent in AD, where in particular M2 but also Mi , muscarinic sites 
are reduced in end-stage AD. Perry and colleagues postulate that neurofibrillary 
tangles, which are sparse in SDLT, may affect the ability of M, receptors to up- 
regulate (Perry, E. et al, 1990b). 
1.4.2.4 Nicotinic receptor alterations in DLB. 
Central nicotinic receptors have been consistently found to be reduced in numbers 
by approximately 50% in AD, and PD (Perry, E. et al, 1987; Nordberg et al, 
1988). Perry, E. et al (1995a) studied high-affinity nicotine binding in brain 
regions most severely affected by AD and PD type pathology in AD, PD and 
SDLT cases. In the midbrain, significant reductions in the density of nicotinic 
binding in the pars compacta of the substantia nigra were described in PD and 
Lewy body dementia. Reduction in nicotinic receptor binding is thought to parallel 
the degeneration of doparninergic neurons in this region, as there is 
neurophysiological evidence that cholinergic neurons control striatal doparnine 
metabolism via the cholinergic input to the pars compacta (Hemandez-Lopez et al, 
1992). 
A selective vulnerability of doparninergic neurons in I'D such that the lateral 
portion of the pars compacta is more severely affected than the medial portion has 
been demonstrated, and is paralleled in Lewy body dementia (Agid et al, 1993). In 
SDLT the loss of nicotinic receptor binding in the substantia nigra pars compacta 
exceeds the reduction in dopaminergic neuron number. The selective vulnerability 
of doparninergic neurons and alterations in nicotinic binding in PD and SDLT are 
anatomically consistent with a degree of overlapping neurochernical pathology. 
56 
The extensive receptor compared to neuron loss in Lewy body dementia raises the 
possibility that nicotinic receptor attenuation precedes cell death in PD. This, 
combined with the finding that smoking appears to be protective against PD, and 
that administration of nicotine increases the density of nicotinic binding (in 
smoking and experimental animals), may have important implications for the 
mechanism of cell death in PD. On this basis, DLB may be part of a spectrum of 
Lewy body diseases including PD, and may represent a less advanced form of PD. 
The more extensive cortical pathology in AD compared to Lewy body dementia, 
especially in terms of tangle formation, is reflected in greater receptor loss in AD. 
Indeed, temporal lobe acetylcholine disruption appears to differentiate AD and 
DLB. In AD, temporal cortex nicotinic binding is diminished due to a greater 
nicotinic receptor loss in the temporal cortex than is observed in Lewy body 
dementia. In neocortical areas, a relationship has been described between the 
decreasing nicotinic receptor binding and increasing density of senile plaques in 
neocortical areas. However, the reductions in the hippocampus and ad acent 
cortex in AD do not appear to precisely parallel the areas of highest plaque 
density. Moreover, DLB cases show a greater reduction in choline 
acetlytransferase in the temporal neocortex, despite the nicotinic binding sites 
being less disrupted (Perry, E. et al, 1990a; 1990b; 1994). 
Relatively selective reductions of nicotinic binding in the subicular complex and 
parahippocampal gyrus in have been demonstrated in AD, but not Lewy body 
dementia (Perry, E. et al, 1994). Thus, although the parahippocampal gyrus is one 
of the most affected areas in LBD in terms of Lewy body density, this is not 
reflected in terms of nicotinic receptor abnormalities. The disruption of the 
perforant path (with projections from the entorhinal cortex to the dentate) seen in 
AD, but not Lewy body dementia, may account for the relatively greater memory 
loss often reported in AD. 
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1.4.3 Monoaminergic Function in AD, SDLT, and PD. 
1.4.3.1 Dopamine in dementia with Leya bodies. 
SDLT shares with PD a significant (although less extensive) loss of dopamine 
from the caudate nucleus, which correlates with a less severe reduction in 
substantia nigra pigmented neurons and the severity of the extrapyramidal 
movement disorder (Perry, E. et al, 1990b). In the neostriatum (caudate nucleus), 
loss of dopamine and increased homovanillic acid (HVA) : dopamine ratio 
correlates with the loss of substantia nigra neurons in Lewy body dementia but not 
PD, despite the greater loss of neurons and dopamine and the higher dopamine 
turnover ratio in PD. Marshall et al (1994) indicate that unlike AD, in which the 
dopaminergic system is relatively spared, or PD, in which the turnover of 
doparnine in the caudate is higher than normal, despite considerable loss of nigral 
doparnine-containing neurons, DLB cases exhibit changes in the dopamine 
metabolism in the caudate nucleus that suggest abnormalities of dopamine 
synthesis or storage. Unpublished results (Marshall et al, 1994) suggest that whilst 
the putamen is more affected than the caudate in PD, the reverse is true in Lewy 
body dementia. Nigrostriatal pathology may, then differ both quantitatively and 
qualitatively in Lewy body dementia and PD (Marshall et al, 1994). 
Langlais et al (1993) showed the LBV cases to have severe reductions in several 
biochemical markers of dopamine activity in the caudate that closely resemble PD. 
However, neocortical monoamines, indolamines and their metabolites showed no 
significant difference between LBV, AD, and controls. In the LBV brains, 
dopamine levels were reduced to 5% of the control value in the putamen, and to 
19% of the control group in caudate. Previous studies have also shown the loss of 
doparnine in typical PD to be also greater in the putamen than caudate. This 
contrasts with findings of Perry and co-workers and unpublished findings of 
Marshall et al, who found loss of dopamine in the caudate to be greater than the 
putamen (Perry, E. et al, 1993; Marshall et al, 1994). A significant reduction of 
tyrosine hydroxylase (TYR-OH) was observed in the putamen of the LBV cases 
(Langlais et al, 1993), which is consistent with functional disruption of the nigral 
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cells and terminals. Reductions in 5-HT and metabolites in both the caudate and 
putamen of the LBV cases were similar to those seen in typical PD brains. Despite 
the severe loss of dopaminergic innervation to the basal ganglia, extrapyramidal 
symptoms were relatively mild compared to PD cases. Langlais and colleagues 
suggest this might be explained by the significant reduction in cholinergic activity 
in the caudate of the LBV cases, as some theories of the pathophysiological basis 
of PD implicate a dopamine : ACh imbalance (Hornykiewicz et al, 1993). 
Possibly related to the moderate reduction in dopamine levels in SDLT, is the 
observation that 64% of cases treated with dopaminergic blocking, neuroleptic 
drugs show severe extrapyramidal symptoms associated with high morbidity 
(McKeith et al, 1992b). Piggot et al (1994) measured dopamine and its 
metabolites and receptors in post-mortern brain specimens of 19 Lewy body 
disease cases. They compared Lewy body disease without neuroleptic exposure 
(n=6) to Lewy body disease groups exposed to neuroleptics who had either shown 
adverse reactions (n=9) or no adverse reaction (n=4). The findings suggest that 
severe neuroleptic reactions are associated with a failure to up-regulate D2 
receptors. In untreated PD, where substantia nigra neuron density and 
doparninergic input to the striaturn are reduced, striatal D2 receptor binding is up- 
regulated, at least in the early stages of the disease. In the Lewy body dementia 
group with severe neuroleptic reactions, substantia nigra neuron density was 
significantly reduced, but there was no compensatory rise in striatal D2receptors. 
They suggest caution in the administration of neuroleptics. 
1.4.4 Serotonin in dementia with Lewy bodies. 
Measurements of serotenergic activity such as 5-hydroxyindoacetic acid 
(5HIAA) : 5-HT turnover ratios have suggested relative hyperactivity of the 
serotenergic neurotransmission in DLB (Perry, E. et al, 1993b). Despite the 
relative serotonergic hyperactivity, individual measures of this transmitter and 
metabolite are generally lower in Lewy body dementia compared to other groups. 
This is suggestive of dorsal raphe system dysfunction and that compensatory 
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hyperactivity has occurred in cortical projections of surviving neurons (Perry, E. et 
al, 1993b). 
1.4.5 The psychopharmacological basis of psychosis in DLB. 
An increased prevalence of psychotic symptoms in DLB compared to other 
common forms of dementia has been described by a number of groups (Alai et al, 
1997; Hely et al, 1996; McShane et al, 1996; Galasko et al, 1995; Shergill et al, 
1994; McKeith et al, 1992c; Gibb et al, 1987). Initial retrospective studies 
identified an increased incidence of hallucinations in DLB (57%). However, with 
the increased attention of clinicians, this incidence has risen to 80% in DLB 
compared to 20% in AD, in a larger, prospectively assessed and autopsy 
confirmed series (Perry, E. et al, 1996). The raised incidence of hallucinations 
observed has encouraged neurochernists to investigate the relationship between 
neurotransmitter systems and the occurrence of psychosis in dementia. 
In a series of studies, Perry and co-workers have suggested a role for cortical 
cholinergic systems in the pathogenesis of psychosis in DLB. This is primarily 
based on three research findings: 
1. Neocortical cholinergic deficits are more extensive in hallucinating compared 
to non-hallucinating cases of DLB (Perry, E. et al, 1990a); 
2. There is reduced neocortical cholinergic activity, and increased incidence of 
psychosis in DLB compared to AD cases (Perry, E. et al, 1996); 
3. Drugs with anticholinergic properties such as scopolamine induced 
hallucinations in normal individuals which are qualitatively similar to those 
seen in DLB cases (Perry, E. et al, 1995b). 
Furthermore, Perry, E. et al (1993) have distinguished the Lewy body dementia 
group with hallucinations from other categories by an increase in the 5HIAA : 5- 
HT turnover ratio measured in the frontal cortex, and by the serotenergic (5-HIAA 
or 5-HIAA : 5-HT) : cholinergic (ChAT) ratio in frontal and temporal cortex. The 
evidence of relative serotonergic hyperactivity and hypo-cholinergic activities on 
hallucinating Lewy body dementia cases is compatible with the 
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psychopharmacological effects of drugs active on these systems. Further evidence 
of relative serotenergic hyperactivity is provided by Cheng et al (199 1) who 
demonstrated that although SDLT subgroups do not differ from each other in 
terms of senile plaque, neurofibrillary tangle, or Lewy body density, 5-HT2 
binding in the deep cortical layers in SDLT cases with hallucinations is preserved; 
whilst in SDLT cases without hallucinations a marked deficit was recorded. 
The temporal cortex may be involved in the pathogenesis of hallucinations, since 
it has connections with the hippocampus, amygdala and other cortical areas 
associated with sensory information processing. It has also been reported that 
patients with lesions in specific areas of the temporal cortex experience visual and 
or auditory hallucinations (Crosby et al, 1962). The possibility of a 
neurotransmitter imbalance in critical temporal lobe areas in SDLT may indicate a 
putative substrate for the high prevalence of perceptual disturbances seen in this 
group. 
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1.4.6 Summary. 
Although there are a number of groups who have described distinctions in 
neurochemical alterations in AD, DLB, and PD, the neurochemistry of DLB 
remains relatively under-investigated. Studies reviewed above suggest that DLB 
cases share some of the neurochernical features characteristic of AD and 
idiopathic PD, i. e., loss of neocortical ChAT and basal ganglia dopamine. 
However, DLB appears to be different from pure AD cases in the degree of ChAT 
loss in the neocortex and the extent of AD pathological markers. Equally, DLB 
appears distinct from I'D in the loss of cholinergic biochemical markers in basal 
ganglia, and the relatively mild extrapyramidal symptoms. The severe loss of 
dopamine in the basal ganglia of PD cases distinguishes them from SDLT in 
which basal ganglia dopamine loss is relatively mild. In addition, an imbalance 
between depleted cholinergic activity and relative monoaminergic hyperactivity 
may underlie the increased prevalence of psychotic symptoms in DLB- 
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1.5 Neuropsychology of dementia with Lewy bodies. 
1.5.1 Introduction. 
Neuropsychology is the branch of science which attempts to elucidate the 
relationship between behaviour and the structure and function of the nervous 
system. Organic changes in brain structure lead to observable alterations in 
cognitive ftinction. Until relatively recently. the dementias have received little 
attention from neuropsychologists. The global nature of the cognitive impairment 
renders interpretation of performance difficult and places severe restrictions on the 
sophistication of tasks which can be undertaken. In addition, approaches with 
essentially anatomical models of brain-behaviour relationships have difficulty in 
interpreting behavioural changes due to diffuse damage. 
Despite these pragmatic difficulties, the past decade has seen a very rapid increase 
of research interest in dementia. Neuropsychologists have been a core part of these 
efforts, and are not only advancing knowledge about the nature of the 
psychological deficits of patients with dementia but are interpreting the 
behavioural implications of advances made in other areas. 
It has been demonstrated that aetiologically distinct forms of dementia show 
characteristic patterns of neuropathological changes. The aspects of cognition 
predominantly disrupted vary between aetiologically distinct forms of dementia. 
Neuropsychological characterisation of the nature of the cognitive decline seen in 
DLB has been somewhat hampered by generally small sample sizes, the use of 
different clinical diagnostic criteria, and variations in study design. 
The main question for neuropsychologists investigating DLB is whether the 
cognitive decline seen in DLB has a distinct nature and course which will enable 
the condition to be distinguished from other forms of dementia, both 
quantitatively and qualitatively. Although quantitative differences between the 
different forms of dementia under investigation are of great interest, they may 
prove to be an artefact of procedures used to match dementia groups. Qualitative 
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distinctions in the neuropsychological performance of dementia groups are 
important, as they are unlikely to simply reflect imperfect matching procedures. 
However, the most powerful evidence of distinct profiles of cognitive impairment 
comes from double-dissociation of performance between groups, as such a finding 
cannot be attributed to a failure to adequately match groups. Furthermore, distinct 
profiles of neuropsychological performance may highlight subtle, but important, 
differences in sites of neurodegeneration in DLB and AD, which add further 
support to the nosological status of DLB as a distinct entity. 
This section presents a review of neuropsychological investigations of DLB, and 
is divided into four subsections based upon the type of study employed by the 
investigators. A single case report with biopsy-confirmed Lewy body disease is 
presented as an example of the cognitive decline seen in DLB. The second section 
covers retrospective studies based on cases coming to autopsy whose WAIS-R are 
subsequently reviewed. This technique is useful in the respect that cases have 
autopsy confirmation of the disease state, but is limited by inconsistencies in the 
collection of information during life. 
To overcome the problems of inconsistent data collection associated with 
retrospective studies, prospective studies use standardised assessment procedures. 
The third section reviews prospective studies where cases have received autopsy 
confirmation of the disease state. Autopsy-confirmed, prospective studies are the 
most Powerful design for examining aetiologically distinct forms of dementia, but 
require considerable resources. 
The fourth section reviews prospective studies which employ clinical criteria for 
the diagnosis of DLB (Byrne et al, 199 1; McKeith et al, 1992c; 1996a) and AD 
(McKhann et al, 1984). The good predictive validity of these criteria (McKeith et 
al, 1994a; Mega et al, 1997) enables researchers to accurately predict underlying 
neuropathological status without the need for autopsy confirmation of the 
diagnosis (although autopsy confirmation remains desirable). 
A number of neuropsychological tests are referenced in the review. A brief 
description of the procedure, and cognitive functions assessed can be found in 
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Appendix IV. These descriptions are not intended to be comprehensive and are 
included to inform the reader of the primary cognitive areas assessed by each test 
and the procedures for test administration. 
The terminology describing DLB (see Section 1.2.3) employed by the original 
investigators is retained in this review, as the distinctions in clinical and 
neuropathological. status associated with each term have important implications 
for the neuropsychological characterisation of DLB. 
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1.5.2 Single Case Review Studies. 
Wagner et al (1996) provide a detailed review of a 60 year old man with biopsy- 
proven Lewy body disease, who was followed over a 24 month period. During the 
patient's illness he underwent four neuropsychological examinations (6,10,12, 
and 14 months) which revealed an atypical, rapidly progressive dementia. 
Psychomotor speed, as measured by the digit symbol substitution (WAIS - R, 
Wechsler, 198 1) and Trails A (Retain et al, 1985) tests, was affected early in the 
course, a finding not common in AD cases. Immediate and delayed verbal and 
figural memory (Russell, 1988) were weak throughout the course, although 
Wagner & Bachman suggest that the focal progressive disturbance seen in AD 
was absent. This was "ecologically" substantiated by findings from the Memory 
and Behaviour Checklist (Teri et al, 1992), which suggested that deficits in day to 
day memory were not the prominent symptom. The prominent symptoms were 
identified as behavioural dyscontrol and hallucinatory episodes. Wagner et al 
found orientation and information questions (Wechsler, 1987) to be relatively 
preserved throughout the course of the disease. The patient presented with motor 
symptoms (which were rapidly followed by cognitive symptoms) and showed 
perseverative motor behaviour on both the Behavioural Dyscontrol Scale (Gigsby 
et al, 1992) and a test of perseverative graphic motor responding (Goodglass et al, 
1983). Language initially included occasional paraphrasic errors in speech, and 
evolved to frequent semantic paraphrasic errors. 
Wagner et al (1996) suggest this approach 'uniquely contributes to the 
understanding of the syndrome expression of DLBD by providing a detailed, 
prospective clinical and serial neuropsychological, description of a biopsy-proven 
case'. This case review provides a good example of the type of cognitive deficits 
associated with DLB. However, single case studies are relatively insensitive in 
characterising neuropsychological dysfunction in aetiologically different disorders. 
More substantial comparative studies are presented in the following sections. 
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1.5.3 Retrospective neuropsychological studies of dementia with Lewy bodies 
-a review. 
The studies described are subject to the same limitations that apply to all 
retrospective studies described previously (Footnote 2; Section 1 . 3.1 - I). 
In one of the first studies to describe clinical and cognitive symptoms, Gibb et al 
(1987) described four LBD cases from a retrospective study of idiopathic 
Parkinson's disease with severe dementia and a parkinsonian syndrome. At 
autopsy two of the cases showed significant, concomitant Alzheimer's disease 
pathology and two did not. Three of the four cases showed mild dysphasia or 
confrontation naming deficits, and one was impaired on the digit span, block 
design and object assembly sub-tests from the Wechsler Adult Intelligence Scale - 
Revised (WAIS - R). The participants in the Gibb et al study did not receive 
standardised assessment, and thus, comparisons between cases is difficult. 
Furthermore, no control group was included, which precluded comparison with 
other forms of dementia. Implications from the neuropsychological aspects 
represent a series of four single case studies and should be interpreted as 
principally descriptive. 
A more substantial retrospective study by Byrne et al (1989) investigated 15 
DLBD cases, using retrospective case-note analysis to examine clinical features. 
All cases were pathologically confirmed DLBD with varying degrees of AD 
pathology. Most cases underwent prospective clinical evaluation as part of a 
continuing study of dementia in old age which included: the mental status 
questionnaire; the Mini Mental State Examination (MMSE; Folstein et al, 1975); a 
more detailed psychometric evaluation using the Clifton Assessment Procedure 
for the Elderly (CAPE); and the WAIS - R. 
All cases showed impairment of mnemonic function. However, case 2 showed a 
mild impairment, which was attributed as secondary to severe depressive 
symptoms. Of the cases able to complete more detailed neuropsychological 
investigations, 8 out of 9 showed marked dysphasia, 9 out of 9 cases demonstrated 
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dyscalculia, and 8 out of 8 cases showed visuo-constructional and ideornotor 
dyspraxia. Conclusions drawn from this study about whether these deficits are 
different from those seen in AD are speculative due to the lack of an appropriate 
group for comparison. 
A larger retrospective study, which included an AD group, was described by 
McKeith et al (I 992c). Twenty-one patients with autopsy-verified SDLT and 37 
autopsy verified AD cases were reviewed. Although the AD and SDLT groups 
were matched for age and gender, the SDLT group was less impaired on the 
Blessed Information Memory Concentration (IMC) test (Blessed, 1968) than the 
AD group. Comparison of the recall component of the IMC test revealed the 
SDLT cases to be less impaired than the AD cases. 
Although a large cohort of AD cases was included in this study for comparison, 
interpretation of the findings is hampered by another methodological problem - 
SDLT and AD cases were not matched for 'overall' severity of cognitive 
impairment. The reported differences in recall ability may reflect a later stage of 
dementia in AD than SDLT, rather than the proposed preservation of recall ability. 
This assertion is supported by data from the study, which indicated SDLT cases 
had a significantly shorter duration of illness at presentation. 
The three retrospective studies presented describe cases of LBD, DLBD, and 
SDLT. As has been previously discussed (Section 1.2.3), these different 
nosological titles reflect samples of DLB cases recruited from subtly different, 
clinical populations, and this is hence reflected in the neuropathological 
degeneration seen at autopsy. This limits the compatibility of the results for 
comparative interpretation. Nonetheless, there is some suggestion that in DLB 
visuo-spatial ability is impaired; that there is disruption of normal speech; and 
there are prominent problems with arithmetic (Gibb et al, 1987; Byrne et al, 1989). 
Whether these deficits are relatively more severe than those seen in AD and PD 
was not addressed by these studies. The nature and the relative severity of the 
mnemonic impairment associated with DLB are also equivocal. Byrrie and 
colleagues identified mnemonic impairment in DLB. However, they did not have a 
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comparison group. McKeith and colleagues suggest recall to be less impaired in 
DLB than AD cases, however, this may just be an artefact of inadequately 
matched groups. 
1.5.4 Prospective neuropsychological studies of dementia with Lewy bodies. 
1.5.4.1 Autopsy Confirmed Studies of dementia with LeM bodies. 
F6rstI et al (1993) compared 8 LBV cases with 8 patients with AD who had histo- 
pathological confirmation of diagnosis. The LBV and AD cases were matched for 
age, gender, and duration of illness. They used the Mini Mental State Examination 
(MMSE) (Folstein et al, 1975) and the CAMCOG schedule (Roth et al, 1986) to 
compare cognitive functioning in the two groups. A summary of these findings is 
presented in Table 1.12. 
Table 1.12: A comparison of means (± SD) of neurospsychologiCal findings i 
eight patients with Alzheimer and concomitant Leýyy body lype pathology, an 
eight age and gender matched -patients without concomitant Leya body patholog 
(Adapted from F6rstl et al, (1993)) 
Mini Mental State 
Examination (MMSE) 9.8(6.7) 7.5(9.1) 
i (max. 30) 
CAMCOG Total Score 26.6(19.1) 23.0(18.9) 
(max. 107) 
CAMCOG Subsections: 
Language 9.1(9.4) 10.6(8.6) 
(max. 21) 
Praxis 3.5(4.3) 3.9(3.4) 
(max. 12) 
Memory 
(Max. 27) 
2.5(2.1) 2.8(2.4) 
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Analysis revealed no differences either in the total scores assessed using either the 
MMSE or CAMCOG, or in scores from subsections of the CAMCOG schedule. 
Unfortunately, the cohort investigated by F6rstl and colleagues had MMSE scores 
of less than 10. The low average MMSE scores indicate that both patient groups 
fall into the 'severe' dementia category. The usefulness of psychometric testing on 
groups with such severe cognitive impairment is dubious, as tools may become 
insensitive in the latter stages of cognitive decline (Lezak et al, 1983). 
At the Alzheimer's Disease Research Centre, San Diego, Hansen et al (1990) 
carried out a detailed, comparative, neuropsychological investigation of dementia 
associated with Lewy bodies. Thirty-six clinically diagnosed and pathologically 
confirmed cases of Alzheimer's disease were examined which included a group of 
13 cases with cortical and sub-cortical Lewy bodies. The Alzheimer's disease and 
LBV groups were matched for age, gender and level of education. Matching for 
overall degree of cognitive impairment used the Blessed Information Memory 
Concentration test. 
All patients completed a neuropsychological test battery which included: the Digit 
Span, Vocabulary and Arithmetic sub-tests from the Wechsler Adult intelligence 
Scale - Revised (WAIS-R) (Wechsler, 198 1); the Block Design sub-tests of the 
Wechsler Intelligence Scale for Children - Revised (WISC - R; Wechsler, 1974); 
an adapted version of the Visual Reproduction Test (Russell, 1975) a 30 item 
version of the Boston Naming test (Kaplan et al, 1978); a selective reminding test 
(Buschke-Fuld, 1974); and the letter and category fluency tests (Benton, 1968). 
The median scores achieved by LBV and Alzheimer's disease groups on each 
neuropsychological test are presented in Table 1.13. 
Although matched for overall severity of cognitive decline using the Blessed IMC 
Test, the groups showed different patterns of cognitive decline on tests assessing 
specific aspects of cognitive function. Both groups performed equivalently on 
tests of episodic memory (both verbal - Buschke Selective Reminding Test, and 
non-verbal - Visual Reproduction Test); on some tests of language and memory 
(Boston Naming Test, Category Fluency Test, writing from dictation, and 
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Vocabulary Sub-tests of the WAIS-R); on a test of motor sequencing (Luria-3- 
Step); and problem solving (Arithmetic sub-test of the WAIS-R). 
Table 1.13: Matched i4roups of 9 LBV and 9 AD subjects: Neuropsychological 
examination (median scores). Taken from Hansen et al, Neurology 1990; 40: 1-8. 
(nl/n2)* LBV AD pt 
Attention 
Digit Span Sub-tests (WAIS-R) (7/6) 10.00 14.00 0.02 
Language and semantic memory 
Boston Naming Test (30 items) (9/9) 17.00 15.00 N. S. 
Letter Fluency Test (F, A, S) (9/9) 6.00 17.00 0.02 
Category Fluency Test (9/9) 9.00 14.00 N. S. 
(animals, fruits, vegetables) 
Vocabulary Sub-test (WAIS-R) (7/6) 34.00 44.50 N. S. 
Error on writing from dictation (9/9) 5/9 0/8 0.02 
Visuo-spatial Processing 
Block Design Sub-test (WISC-R) (8/8) 0.00 15.00 0.02 
Copy-a-Cross Test (7/6) 4.00 1.50 0.03 
Visuospatial Reproduction Test (Copy) (7/7) 2.00 12.50 N. S. 
Episodic Memory 
Buschke-Fuld Selective Reminding Test (7/6) 13.00 14.00 N. S. 
Visual Reproduction Test (7/6) 19.1% 32.3% 
N. S. 
(0-sec delay; % of copy) 
Conceptualisation/problem solving 
Similarities Sub-test (WAIS-R) (7/6) 2.00 9.00 0.04 
Arithmetic Sub-test (WAIS-R) (7/6) 4.00 6.50 N. S. 
Motor Sequencingtt 
Error on Luria-3-Step, (9/9) 8/9 8/9 N. S. 
* nl = LBV; n2 = AD 
tp value based on Mann-Whitney U test. 
tt Item from neurologic examination (proportion of subjects producing errors) 
In addition to the deficits seen, which are typical of AD, the LBV group also 
showed especially poor performance in tests thought to be severely disrupted in 
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sub-cortical dementia. LBV cases performed significantly worse on the digit span 
Test, which assesses aspects of working memory and auditory attention. The two 
groups also showed differences in performance on the Verbal Fluency Test. 
Although LBV and AD groups performed equivalently on the category fluency 
task, the LBV group performed significantly worse on the Letter fluency task. The 
general and severe decrease in verbal fluency in LBV cases is similar to that 
described in sub-cortical dementia, and contrasts with the pattern typically 
observed in AD, where there are greater problems generating words from semantic 
categories than words beginning with a particular letter. The LBV group also 
showed severe visuo-spatial deficits as measured by the block-design sub-test, and 
were also significantly more impaired on a test of conceptualisation - the 
similarities sub-test of the WAIS-R. 
Hansen et al (1990) demonstrated differences in the neuropsychological profile of 
LBV and AD groups. Although the LBV group has many of the cognitive deficits 
associated with AD, many cognitive deficits previously observed in disease states 
with sub-cortical pathological changes were also recorded in the LBV group. As 
the distinctions in neuropsychological performance were observed between 
relatively small AD and LBV groups, the magnitude of the neuropsychological 
differences between groups must have been relatively large. These data suggest 
that LBV and AD might be readily discriminated by neuropsychological 
examination. However, the small number of cases examined and their method of 
selection (all LBV cases met criteria for the clinical and neuropathological 
diagnosis of AD and therefore represent only a subgroup of DLB cases) limits the 
applicability of the findings to a more clinically representative dementia 
population. 
In addition, although cases were matched for severity of global cognitive 
impairment, the LBV cases showed at least equivalent impairment in all tests 
administered, and significantly greater impairment on tests of working memory; 
visuo-spatial ability; conceptualisation and language. Although the dementia in 
LBV cases might possibly affect a broader range of cognitive functions than in 
AD, a more consistent explanation would be that groups were inadequately 
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matched for the overall degree of cognitive impairment. The Blessed IMC Test 
(used to match dementia groups for overall severity of cognitive impairment) Is 
strongly mnemonically biased and will thus, primarily, match dementia groups for 
the degree of mnemonic dysfunction. Thus, an a priori assumption has been made 
that the relative mnemonic dysfunction in each dementia group is equivalent. 
Hansen and colleagues also matched LBV and AD cases for the interval between 
time of testing and death. However, this further assumes the duration of LBV and 
AD to be equivalent. There is some evidence that LBV cases have a shorter 
duration of illness (Byme et al, 1989; Hansen et al, 1989), especially when 
administered neuroleptic medication (McKeith et al, 1992b). 
Assuming that DLB is a more rapidly progressive dementia, then at equal times 
prior to death the LBV cases might be less cognitively impaired than the AD 
cases. Hansen et al, however, suggest a more severe global cognitive impairment 
in the LBV cases at equal time prior to death. These findings highlight the 
difficulties associated with matching patients for duration of illness prior to death, 
especially when the duration of the illness may not be equivalent. 
Distinct profiles of cognitive impairment in different types of dementia may only 
be established by systematic investigations using patient groups matched for 
global cognitive impairment. Such matching of groups continues to pose massive 
methodological problems. 
Although the quantitative differences between LBV and AD cases reported by 
Hansen and colleagues should be interpreted with a degree of caution, due to 
matching problems, there are a number of qualitative differences which imply 
distinct patterns of cognitive impairment in DLB and AD. These differences are 
interesting when viewed within the framework of 'sub-cortical' and 'cortical' 
dementia described by Cummings (1986). The classic example of a 'cortical 
dementia' is AD, which is classically characterised by: prominent amnesia; 
deficits in language, semantic knowledge (aphasia), abstract reasoning and other 
4executive' functioning; as well as visuo-spatial, and constructional abilities. 
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Parkinson's disease and Huntingdon's disease are classically ascribed as 'sub- 
cortical' dementia. The 'sub-cortical' dementias typically show a less pronounced 
memory deficit attributed to retrieval problems, which contrasts the ineffective 
consolidation and rapid forgetting associated with 'cortical' dementia. In addition, 
bradykinesia; bradyphrenia; attentional dysfunction; problem solving deficits; as 
well as visuo-perceptual, constructional and arithmetic deficits are thought typical 
of 'sub-cortical' dementia. 
Hansen and colleagues (1996) revisited their 1990 study from the perspective of 
the 'cortical' - 'sub-cortical' framework. They suggested that LBV represents the 
(superimposition of cortical and sub-cortical neuropsychological impairments' and 
suggested 'the neuropsychological features of cortical and sub-cortical dementia in 
the LBV patients is consistent with the distribution of neuropathological changes 
in the brains of these patients'. LBV and AD groups show similar impairments on 
tests assessing 'cortical' functions, namely memory and confrontation naming, 
whilst LBV cases were more severely impaired in cases assessing 'sub-cortical' 
functioning such as attentional, verbal fluency and visuo-spatial tasks. 
To further explore the influence of sub-cortical pathology in the genesis of the 
cognitive deficits associated with LBV, (Connor et al, in Press) compared the 
performance of 23 patients with autopsy confirmed LBV and 23 patients with 
autopsy confirmed AD. The AD and LBV patients were pair-matched for their 
overall level of cognitive function using MMSE and total Mattis Dementia Rating 
Scale scores (DRS; Mattis, 1976). Patient groups were also matched for age, and 
years of education. 
The Mattis DRS is a standardised 144-point mental status examination with a cut 
off of 131/2 for separating normal from impaired subjects. The DRS consists of 
five subscales which assess attention (37 points), initiation/perseveration (37 
points), construction (6 points), conceptualisation (39 points) and memory (25 
points). Connor and colleagues also compared AD and LBV cases on the 
subsections of the MMSE. 
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The performance of the AD and LBV groups on subsections of the DRS were 
shown to be distinct. AD cases showed more marked impairment on the memory 
subscale. There were no group differences in terms of the attention, construction, 
and conceptualisation sub-tests. A more detailed examination of the subscores in 
the memory subscale reveal the AD group scored significantly lower on the 
orientation items, a test of free recall. On a second test of free recall the AD group 
were marginally (p<0.06) more impaired than the LBV group. The two tests of 
free recall of sentences are different in that the first is standard to the DRS, whilst 
the second is self-generated. There was no difference in performance between the 
two groups on tests of word and design recognition memory. These findings 
represent quantitative, but not qualitative, differences between the AD and LBV 
groups. Both groups performed better on the recognition tasks than they did on the 
recall tasks. However, the LBV group did not show the dramatic improvement 
usually seen with recognition testing over free recall testing associated with the 
access difficulties of 'sub-cortical' dementia. 
In contrast, LBV cases showed more severe impairment on the initiation / 
perseveration sub-scale. More detailed analysis revealed that, although the mean 
scores of LBV patients were lower than those of the AD group for each item 
(fluency for supermarket items, fluency for clothing items, verbal repetition, 
double alternating movements, and grapho-motor), this only achieved significance 
for the fluency for clothing items. There was no significant difference, however, 
for the other test of semantic proficiency - the fluency for supen-narket items. 
Performance on the graphornotor component failed to discriminate the two groups. 
However, a significantly greater proportion of the LBV cases failed to complete 
the most difficult component of the task, which involved switching between 
drawing "sawtooth" and "rampart" designs. Performance on the 
initiation/perseveration subscale of the DRS failed to reveal consistent or readily 
theoretically interpretable differences between the AD and LBV groups. 
Connors et al subdivided the cases into those that were mildly to moderately 
demented (DRS total scores between 125 and 106) and those that were moderately 
to severely demented (DRS total score between 106 and 80). For the mild to 
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moderately impaired group, the findings were similar to the findings for the 
overall group comparisons. However, the LBV group was also significantly more 
impaired on the construction subscale which requires patients to copy geometric 
de signs. The comparison between the moderately to severely demented LBV and 
AD groups revealed exactly the same distinctions found for the overall group 
comparisons, namely that the LBV were more impaired on the 
initiation/perseveration subscale, but less impaired than the AD group on the 
memory subscale. There was no difference between the AD and LBV groups on 
the construction subscale. The absence of the difference in performance in the 
moderate-severe group appears to be primarily due to worse performance in the 
moderate-severe AD group. Tests of visuo-constructional abilities may be 
discriminatory only at early stages of the disease process. Interestingly, the 
graphomotor section of the initiation/perseveration subscale was significantly 
more impaired in LBV than AD groups. This is considered to be a test of 
constructional and executive abilities and was more impaired in the LBV than the 
AD group, whatever the overall DRS scores. 
A discriminant function analysis derived from a linear discriminant function 
analysis comparing the DRS subscale scores of AD and HD patients was 
performed to investigate whether the performances of the LBV and AD groups 
were indicative of cortical or sub-cortical dementia. Cases classified as "cortical" 
included 23 AD cases (74%) and 9 LBV cases (40%). LBV cases classified as 
66cortical" were not significantly different in terms of the demographic factors or 
level of dementia. The LBV cases identified as "cortical" by the discriminant 
function analysis showed an increased burden of neurofibrillary tangles, largely in 
the medial temporal lobe. This was shown at autopsy by higher Braak & Braak 
staging than those who were classified as "sub-cortical". When Connor and 
colleagues applied a discriminant function analysis adjusted to incorporate the 
findings of their current study, only the memory and initiation/perseveration 
subscales were maintained as discriminant between the two diseases. These two 
variables alone were able to correctly classify 78% of the LBV patients and 74% 
of the AD patients. This is consistent with the notion that LBV patients are more 
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likely to manifest a sub-cortical-like pattern on the DRS compared with LBV 
patients. 
Comparisons of performance of the LBV and AD groups on the subscales of the 
MMSE revealed a pattern similar to that seen previously when comparing AD and 
HD groups. LBV performed worse than the AD patients on the memory 
registration and writing items, whereas the AD group performed worse on the free 
recall and orientation items. Again the pattern of deficits is consistent with the 
hypothesis that that sub-cortical pathology significantly influences the cognitive 
performance of the LBV group, and Lewy body burden affects the profile of 
cognitive impairment seen in LBV. 
The validity of a 'sub-cortical - cortical' framework is, however, somewhat 
uncertain, and a number of objections have been raised about the distinction (Hart 
et al, 1996). The distinction is undermined by neuropathological evidence of 'sub- 
cortical' damage in 'cortical' dementia and vice-versa. Furthermore, not all AD 
patients show pronounced disturbance of language on clinical evaluation. This is 
especially true of older patients with AD, in whom pathological change tends to be 
restricted to the cortex. Whilst linguistic deficits are more characteristic of 
younger patients in whom pathological damage is more likely to affect sub- 
cortical structures. 
Samuel et al (1996) investigated how neuropathological burden influenced 
cognitive deficits in LBV and AD. They remark that it is difficult to account for 
the equivalent dementia severity in LBV and AD in terms of the neuropathological 
changes typical of AD. In LBV cases neurofibrillary tangle counts are not 
significantly higher, and may even be lower in the temporal lobe (Hansen et al, 
1990; Masliah et al, 1993). Neurofibrillary tangle pathology correlates fairly 
strongly with declining mental status in AD. However, senile plaque density does 
not correlate well with dementia severity (Terry et al, 1987; Arriagada et al, 1992; 
Bierer et al, 1995). Thus neocortical neuron loss does not seem to correlate well 
with dementia severity in LBV. Sub-cortical neuron loss in LBV is equivalent to, 
or greater than that seen in AD. Several authors have found equivalent or greater 
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loss of the magnocellular neurons in the nucleus basalis of Meynert (e. g. Hansen 
et al, 1990). Samuel and colleagues tested the hypothesis that neuronal function is 
compromised by the presence of Lewy bodies in the neocortex and elsewhere, 
with a consequent impairment of similar magnitude to that seen in AD despite a 
lighter burden of AD pathology in LBV. 
Fourteen LBV and 12 AD cases who had equivalent age at death, gender 
proportions, disease duration, education, and time lapsed between last assessment 
and death,, were assessed using the MMSE, the Blessed IMC test, and the Mattis 
Dementia Rating Scale. The authors found the mean neuropsychological test 
scores to be similar in each of the three mental status measures. They did not, 
however, present any subsection breakdown of the neuropsychological 
assessment. In LBV cases, the neuropsychological test scores did not approach 
correlation with neocortical neurofibrillary tangles counts. Whilst in AD 
neurofibrillary tangle counts in several areas correlated significantly with mental 
status. Senile plaque counts did not correlate significantly with 
neuropsychological test scores in either LBV or AD. In the LBV cases, the 
relationship between mental status and Lewy body counts were in the anticipated 
direction, and most achieved significance. Thus, it appears that neocortical Lewy 
body counts, or neurodegenerative processes associated with their formation, are 
related to dementia severity. 
Data from the previous three studies suggest that Lewy bodies contribute 
significantly to the cognitive impairment in DLB. Hansen et al (1990) and Connor 
et al (In Press) both suggest that a profile of neuropsychological deficits which has 
aspects of both 'cortical' and 'sub-cortical' dementia. The Lewy body pathological 
burden is most concentrated in sub-cortical brain regions (e. g. Substantia Nigra), 
and Samuel et al (1996) have demonstrated that Lewy body pathology correlates 
with cognitive impairment in LBV cases, and yet appears relatively independent of 
the pathological markers typically associated with AD. 
The study by Connor and colleagues may be more readily interpreted than the 
Hansen et al (1990) study, as the authors effectively matched LBV and AD groups 
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for the global severity of dementia. The findings suggest that mnemonic 
performance is less impaired in LBV than AD cases, and subsequently the use of 
brief, mnemonically biased matching tools such as the MMSE and IMC test, are 
of little use for matching LBV and AD patients for overall severity of dementia. 
Both studies, however, suggest a distinct profile of cognitive impairment in LBV 
cases. All the autopsy confirmed studies of psychological functioning have 
included LBV cases which must fulfil clinical and neuropathological criteria for 
inclusion in the study. As previously discussed in the neuroPathology section, this 
nomenclature is somewhat exclusive of patients with Lewy body disease without 
significant concomitant AD type pathology. This nomenclature appears weak 
especially in the light of the findings of Samuel et al (1996) which imply typical 
AD pathology does not correlate significantly with the cognitive decline in LBV. 
A more logical nomenclature might be the Alzheimer's disease variant of Lewy 
body disease, which acknowledges the primary cause of the dementia as the Lewy 
body. 
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1.5.4.2 NeurODsvchological studies of clinically identified dementia with LeM 
bodies. 
As previously described (see Section 1.3.1.7), clinical criteria for the diagnosis of 
dementia with Lewy bodies have been established (Byrne et al, 199 1; McKeith et 
al, 1992c; 1996a). These are generally based on the comparative, retrospective 
evaluation of neurological and neuropsychiatric findings in autopsy verified cases. 
Operational criteria for diagnosing dementia with Lewy bodies are currently 
undergoing evaluation in Newcastle upon Tyne, England. However, preliminary 
reports suggest them to be relatively specific (true negative rate of 95%) and 
sensitive (true positive rate 74%) (McKeith et al, 1994b; Mega et al, 1996). These 
criteria allow investigators to identify individuals with DLB pre-mortem, and 
provide the opportunity to study neuropsychological features of the disorder 
prospectively. The results of these studies should, however, be accepted 
tentatively in the absence of autopsy confirmation of the disease, or indication that 
diagnosis is accurate within an experimental group. 
In a series of studies reported by Sahgal and colleagues, (Sahgal et al, 1992a; 
1992b; 1992c; 1995; Galloway et al, 1992) computerised assessment procedures 
were used to investigate neuropsychological function in clinically identified cases 
of SDLT and AD. The Cambridge Neuropsychological Test Automated Battery 
(CANTAB) uses experimental neuropsychological models to investigate the 
neuroanatornical basis of cognitive deficits in different disorders, and has been 
employed in a number of patient populations including both I'D and AD (see 
Sahakian et al, 1988, Owen et al, 1992; 1993). The battery focuses on non-verbal 
memory (spatial and non-spatial), attention and planning ability. A brief 
description of the constituent tests of CANTAB is included here; a more detailed 
review is provided elsewhere (see Chapter 3). Many of the tests were developed 
from animal lesion studies where circumscribed lesions can be made and thus 
poor performance in tests can be attributed to precise anatomical locations. This 
approach links neuropathological deficits to cognitive deficits, which can be 
measured in-vivo. Care must be taken when interpreting results from such an 
approach. The diffuse neuropathological changes evident in the later stages of 
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dementia are difficult to relate to discrete lesion studies in animals, and findings 
may be the result of damage to a number of areas and not simply attributable to 
specific nuclei or groups of neurons. Nonetheless, CANTAB has proved to be 
useful in the investigation of mild to moderately demented patients (e. g. Sahakian 
et al, 1988; Sahgal et al, 1991). 
Sahgal and colleagues compared 10 AD cases diagnosed according to McKhann 
criteria, 10 SDLT cases diagnosed according to McKeith criteria and 16 elderly 
healthy controls. The number of patients completing different sections of 
CANTAB varied. The two spatial tests groups included 9 AD and 10 SDLT, and 
in the four non-spatial tasks the groups included 10 AD and 7 SDLT cases. Patient 
groups were matched for age and stage of dementia using the MMSE and the 
Clinical Dementia Rating scale (Hughes et al, 1982). Patient groups were also 
matched for pre-morbid abilities using the National Adult Reading Test (NART) 
(Nelson, 1982), in which they performed significantly worse than the control 
group. Patient groups were also matched for performance on the Kendrick Object 
Learning Test (KOLT) and the Kendrick Digit Copying Test (KDCT) (Kendrick, 
1985). However, both dementia groups performed Worse on both the KOLT and 
KDCT tests than the control group. Motor screening revealed the SDLT group to 
be significantly slower than the SDAT and control groups; the SDAT and control 
groups were not significantly different from each other. 
In a test of pattern recognition memory (which assesses temporal lobe function) 
(see Owen et al, 1993 for review), a list of 12 abstract line patterns is presented, 
each pattern appearing for 3 seconds. Each stimulus pattern is subsequently 
represented alongside a novel stimulus pattern, and the participant is required to 
point to the pattern previously displayed. Both AD and SDLT groups performed 
worse (in both accuracy and speed) than controls, but there were no differences 
between the patient groups. Both patient groups performed at, or near, chance on 
the pattern recognition task, which may reflect floor effects. Thus, the pattern 
recognition test was unable to discriminate the two types of dementia, although it 
is demonstrably sensitive to changes in dementia. 
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In the simultaneous and delayed matching to sample task (MTS) (a test of 
temporal lobe function), participants are to memorise a sample abstract dot pattern 
required on a given trial. Then, the sample stimulus must be selected from four 
choice patterns presented to the participant. The choice patterns are presented 
either with the sample pattern or following varying delays (0,4 and 12 seconds). 
Both AD and SDLT groups were impaired at simultaneous presentation relative to 
controls, implying a non-specific problem such as visuo-perceptual or attentional 
deficits, or a failure to comprehend the test. Despite the fact that SDLT cases 
showed lower accuracy than the AD group at simultaneous MTS, this difference 
did not reach significance, implying the groups to have equivalent non-specific 
impairment on the MTS task. 
In delayed MTS, both patient groups were less accurate than controls and, in 
addition, the SDLT group were less accurate than the AD group. Response 
latencies for the patient groups were impaired with respect to control, but not with 
respect to each other. Differences in general responsiveness cannot account for the 
group difference in performance accuracy. 
Spatial memory was assessed using a computerised version of the Corsi block- 
tapping test. This task assesses spatial span and is sensitive to right hippocampal 
damage (Milner, 1971). Participants are required to point to boxes in the order in 
which they change colour. The control group was able to successfully complete 
significantly longer pointing sequences than the patients groups, although there 
was no difference between the patient groups. 
In a task described as Pattern-Location Paired Associates (CLPA), which is a test 
of conditional leaming and is sensitive to damage to frontal and temporal lobe 
structures and circuitry, participants are required to remember the spatial location 
in which a particular pattern is located. Patient groups performed significantly 
worse on this task than the control group. Moreover, SDLT patients performed 
significantly worse than AD cases. 
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Spatial working memory was assessed using a task requiring efficient search 
strategies to find tokens hidden behind a number of boxes. This test is especially 
sensitive to damage to frontal lobe structures. Performance is measured in terms of 
the time taken to respond, as well as the pattern of responses made. By also 
examining the type of errors made, a numerical index for the efficiency of the 
strategy employed was calculated. In general the SDLT group made more errors 
than the AD group who in turn were worse than control. An analysis of the 
strategy employed by the different groups suggested no differences between the 
patient and control groups. Poor performance on the spatial working memory task 
was not due to poor strategy, nor due to a worse spatial memory. 
Visual search matching to sample (VSMTS) is a test of focal attentional ability, 
which is sensitive to damage to fronto-striatal circuitry (see Sahgal, 1996). 
Participants are required to depress a hand-switch to reveal the sample stimulus in 
the centre of the screen, which is followed 2 seconds later by the presentation of 
the choice stimuli around the periphery of the screen. The number of choice 
stimuli varies (1,2,4, or 8). The participant must point to the choice stimulus 
which is the same as the sample stimulus. The task is similar to the simultaneous 
presentation MTS task, except that the spatial arrangement of the choice stimuli is 
different, and in addition, the number of choice stimuli vary. Control and SDAT 
groups performed at similar levels, however, the SDLT group performed 
significantly worse than both other groups. 
The intra- and extra-dimensional (ID-ED) set-shifting is a computerised analogue 
of the Wisconsin card sorting test, and is sensitive to frontal lobe dysfunction task 
(see Downes et al, 1989). The ID-ED task measures aspects of attentional 
processing , 
including selective perception, and the ability to shift attentional set 
from one focus to another. The task involves 9 successive stages, and the 
participant only progresses to the next stage upon completing 8 successive correct 
responses. If this criterion is not achieved within 50 trials, the task is terminated. 
Both dementing groups were significantly impaired compared to control. 
Although the dementia groups performance did not differ, a trend (p=0.057) 
towards worse performance in the DLB group was observed. 
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As both pattern recognition and matching to sample tasks are disrupted by 
temporal cortical lesions, Sahgal and colleague suggest that there is degeneration 
of temporal lobe structure in both SDLT and AD. They also suggest that the 
impairment in the DLB group, even at relatively short delays in the matching to 
sample task, reflects severe degeneration of hippocampal and other temporal lobe 
structures early in the course of DLB. Sahgal and colleagues support the 
suggestion of early damage to hippocampal structures early in both AD and 
SDLT, with data from the spatial span task which show both patient groups to be 
impaired with respect to controls. 
Group differences in the CLPA task showed the SDLT group to be more severely 
impaired than the AD group, who in turn performed worse than controls. This 
might reflect relatively severe degeneration of medial temporal and perhaps 
frontal lobe structures. Sahgal et al suggest that the evidence from the spatial 
working memory (SWM) task lead to a similar conclusion. Although both patient 
groups were capable of forming a search strategy, inspection of errors showed that 
SDLT patients made more errors. Other non-specific factors might be considered 
to explain the poor performance of SDLT cases in the SWM task, such as the 
inability of SDLT cases to sustain attentional resources over the period of time 
required to complete the task (approximately 25 minutes). 
The two tasks sensitive to attentional dysfunction, namely the visual search 
matching to sample (VSMTS) and attentional. set-shifting (ED/ID) paradigm, 
provide evidence of qualitative differences between the patient groups. On the 
VSMTS task the AD group performed at, or around, the same level as controls, 
whilst SDLT cases performed significantly worse. Sahgal and colleagues suggest 
that 'focal' attentional ability is more severely affected in SDLT than AD, and 
attribute this to substantia nigra degeneration (Sahgal et al, 1992a; Downes et al, 
1989). Data from the attentional set shifting task (ED/ID) task are more difficult to 
interpret. Although both patient groups were impaired with respect to controls, 
there were no significant overall differences. Nonetheless, Sahgal et al (I 992a) 
demonstrated a trend (p=0.057) towards worse performance by the SDLT 
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compared to the AD group when required to make intra-dimensional shifts of 
attention. Attentional performance appears to be significantly more affected in 
SDLT than in AD. A review of the results of Sahgal and colleagues series of 
studies is presented in Table 1.14. 
Table 1.14: Summqa of main outcome measures from CANTAB 
neuropsyC Ological investigation of SDLT and AD cases (ada-pted from Sahgal e 
al, 1992a; 1992b; 1992c; 1995; Galloway et al, 1992) 
Spatial recognition 
_(percent 
correct) 
Pattern recognition 
(percent correct) 
Delayed matching to sample 
(percent correct) 
Conditional learning paired associates 
(total trials) 
Spatial working memory 
(number of errors) 
Visual search matching to sample 
(percent correct) 
_ 
Intra / Extra-dimensional set shifting: 
Simple rule learning 
(percent correct) 
_ 
Reversal learning 
(stage of task completed) 
(ý = worse performance; ýý = markedly worse performance; ý= severely disrupted 
performance); (Perfon-nance is described relative to control group). 
Sahgal and colleagues have described both quantitative and qualitative differences 
between SDLT and AD groups using sophisticated neuropsychological paradigms. 
Mnemonic function (both working and long term) and visuo-spatial skills are 
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equally, or more greatly, impaired in SDLT than in AD, and there are qualitative 
differences in attentional function in AD and SDLT. How mnemonic, visuo- 
spatial and attentional dysfunction contribute to performance of tests of cognitive 
function remains difficult to delineate. The use of computerised 
neuropsychological assessment tools represents a considerable advance, especially 
for the assessment of attentional and mnemonic function, which require the 
accurate temporal and spatial control of stimuli. Furthermore, the standardised 
presentation of tests encourages high inter-rater reliability. 
There are, however, a number of methodological problems common to most 
studies comparing distinct forms of dementia. Firstly, diagnoses are prospective 
and await post-mortem confirmation. However, the Newcastle research group has 
been shown to have high sensitivity (74%) and specificity (95%) in the clinical 
diagnosis of SDLT and AD (McKeith et al, 1994b). Secondly, the MMSE which 
was used to match for global levels of cognitive impairment, has been criticised 
for a bias towards mnemonic dysfunction. Indeed, attentional, visuo-spatial, and, 
particularly, visuo-perceptual deficits are not comprehensively assessed by the 
MMSE. It has become apparent that all of these aspects of cognitive function are 
relevant for matching DLB and AD groups. The lack of a comprehensive 
matching tool for SDLT and AD groups cases suggests that the equivalently poor 
or worse performance of the SDLT group on all tests might reflect a more 
advanced dementia in the SDLT group. 
Matching patient groups for pre-morbid IQ on the basis of NART scores also 
requires consideration. The NART verbal IQ score correlates strongly with degree 
of cognitive impairment in dementia (O'Carroll, 1995), although this may be 
particularly apparent only at the later stages of dementia (Fromm et al, 1991). 
A number of authors have prospectively investigated cognitive decline in SDLT 
using the CAMCOG schedule (Roth et al, 1986). Ballard et al (1996b) 
investigated cognitive decline in a series of 124 patients with DSM-111-R 
diagnosed dementia. Which included 55 cases of probable AD, 33 possible AD, 
20 vascular dementia (Val)), and 12 SDLT- Patients were assessed using a 
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standardised battery of schedules including the Geriatric Mental State Schedule 
(Copeland et al, 1976), the History and Aetiology Schedule (Dewey et al, 1992), 
the CAMCOG schedule (Roth et al, 1986; Hooper et al, 1993), the Cornell 
Depression Scale (Alexopoulos et al, 1988), and for the assessment of psychotic 
symptoms, the Bums Symptom Checklist (Ballard et al, 1995). Of the 89 cases 
followed up after one year, 76 completed repeat CAMCOG profiles, these 
included 53 AD, 14 VaD, and 7 SDLT. 
There was no difference between groups in terms of severity of dementia at 
presentation, as measured by total CAMCOG scores, although stepwise logistic 
regression analysis revealed differences between groups on subsections of the 
CAMCOG schedule. The VaD group had significantly better recent memory and 
visual memory than AD. The SDLT group also had significantly better recent 
memory than the AD group, as well as significantly better visual memory than 
patients with Val). Linear regression analysis was undertaken on a number of 
variables including: female sex; age at onset; age at assessment; Comell 
depression score; deafness; years of education; and the presence of one or more 
psychotic symptoms. The only variable associated with CAMCOG scores at onset 
was that male patients had better total scores on the CAMCOG schedule than 
female patients. 
At I Year follow-up, decline in CAMCOG scores for the AD and VaD groups 
were similar (13.2 & 13.5 points respectively). The SDLT group trended towards a 
more rapid rate of decline (27.0 points) compared to AD and VaD groups (p=0.05 
& p=0.07 respectively). Unfortunately only 7 (out of the original 12) SDLT cases 
completed follow-up CAMCOG assessment. None of the variables assessed in the 
linear regression were associated with a greater rate of cognitive decline. In the 
CAMCOG schedule, there were no differences between AD and VaD cases in 
deterioration in subsections of the CAMCOG. SDLT cases showed greater decline 
in verbal fluency than both AD and VaD groups, which is consistent with the 
findings of Sahgal and colleagues who suggest greater frontal lobe types of 
dysfunction in SDLT than AD. The SDLT group also showed a greater 
deterioration in remote memory than the VaD group. 
87 
These data are taken from a relatively large cohort of dementia sufferers, although 
the number of SDLT cases at I year follow up is relatively small- This is the first 
longitudinal study directly demonstrating a more rapid rate of cognitive decline in 
SDLT than AD or VaD. The study does not, however, address the link between 
neuroleptic medication and an increased rate of decline which has previously been 
suggested in SDLT (McKeith et al. 1992b; McShane et al. 1996), and there is no 
neuropathological. confirmation of diagnostic accuracy for any of the cohort. 
More recently, Walker et al (1997) compared performance of AD and Lewy body 
disease (LBD) patients on sub-tests of the CAMCOG schedule. They examined 17 
LBD patients diagnosed according to McKeith criteria (McKeith et al, 1992c) and 
17 AD patients diagnosed according to NINCDS-ADRDA criteria (McKhann et 
al, 1984), who were attending a memory clinic. Patients also completed the 
MMSE, the behavioural part of the Clifton Assessment Procedure for the Elderly 
(CAPE; Pattie et al, 1979), a 15 item version of the Geriatric Depression Scale 
(GDS; Yesavage, 1988) and the Clinical Dementia Rating schedule. The 
CAMCOG scores were grouped according to Richards et al (1995). Patient groups 
were matched in terms of age; gender; years of education; length of illness; and 
Clinical Dementia Rating. Formal assessment revealed no differences between 
LBD and AD groups on the CAPE, GDS, MMSE or total CAMCOG scores. 
Statistical analysis revealed differences between the patient groups in scores for 
subsections of the CAMCOG. The LBD group were less severely impaired than 
the AD group on the recall subsection. This section requires the participant to 
recall a name and address, and the names of three objects presented to them 
earlier on in the schedule. In contrast, the AD group were more impaired than the 
DLB group on the visuo-spatial praxis subsection. This section requires the 
participant to copy a number of items (pentagon, spiral design, 3-D house), as well 
as spontaneously drawing a clock with the hands showing ten past eleven. Walker 
and colleagues suggested that poor performance on the visuo-spatial task is 
unlikely to be related to motor dysfunction, as most of the LBD patients had only 
very mild motor symptoms and, cognitive dysfunction is thought to be largely 
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independent of motor disability in the early stages of Parkinson's disease (Cooper 
et al, 1991). 
Unlike Hansen et al (1990), Walker and colleagues did not find any group 
differences in verbal fluency. However, the CAMCOG schedule only assesses 
category fluency, which was found to be only marginally impaired in the Hansen 
et al study. Letter fluency, found to be more impaired in LBV than AD (Hansen et 
al, 1990), is not assessed in the standard CAMCOG schedule. Similar to the study 
by Ballard et al (I 996b), Walker and colleagues demonstrated less severe memory 
impairment in LBD patients. In addition, Walker et al described more severe 
deficits in visuo-spatial-praxis in LBD, which were not evident in the Ballard et al 
study. 
In probably the most comprehensive neuropsychological study of LBD to date, 
Gnanalingham et al (1997) compared motor and cognitive function in 16 patients 
with LBD, 15 patients with Parkinson's disease, 25 patients with AD, and 22 
control subjects. There was no difference in age, sex, years of education, and 
social class between groups. The only significant difference was found in 
Parkinson's disease cases who had a longer duration of illness than the AD group 
(means 9.2 and 3.7 years respectively). 
Psychiatric assessment included the MMSE, the Clinical Dementia Rating Scale, 
and the Cornell Scale for Depression in Dementia (CSDD). As expected, controls 
were less demented than patient groups measured using MMSE scores. 
Comparisons of MMSE scores between patient groups showed AD (mean 13.4) 
and LBD (mean 12.5) groups to be equivalently impaired, but both groups were 
more severely impaired than the Parkinson's disease group (mean 24.1). Scores 
from the CSDD indicated LBD cases to have the highest prevalence of depression, 
scoring significantly higher than both the control and other patient groups. 
Parkinson's disease and AD groups were scored equivalently for the depression 
rating, although they showed a higher prevalence of depression than the control 
group. 
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Neurological assessment included the Unified Parkinson's Disease Rating Scale 
(UPDRS; Lang et al, 1989). Isolated extrapyramidal symptoms (EPS) were 
identified as a score of greater than one on any subsection of the UPDRS, and 
were recorded for 18% of controls, 72% of AD patients, 100% of LBD patients, 
and 100% of Parkinson's disease patients. Patients meeting Hughes et al (1992) 
criteria for parkinsonism included 12% of the AD cases, 94% of the LBD cases, 
and 100% of the Parkinson's disease cases. None of the controls were found to 
have extrapyramidal symptoms sufficient to warrant a diagnosis of Parkinson's 
disease. Both PD and LB dementia had significantly greater overall motor 
impairment, measured using total UPDRS scores, than AD and control cases. 
Furthermore, LBD patients scored significantly higher total scores (38.3) on the 
UPDRS scale than PD patients (29.5). Ninety-four percent of LB dementia cases 
qualified for a secondary diagnosis of PD. LB dementia patients showed 
significantly more rigidity then PD cases. EPS items assessed in the motor section 
of the UPDRS failed to discriminate the PD and LB dementia, with the exception 
of resting tremor, which was seen in a greater proportion of patients with PD 
(93%) than LB dementia (50%). The PD group showed significantly greater 
left/right asymmetry of motor signs than other groups, but similar upper/lower 
limb asymmetry to other groups. 
Bradykinesia was also assessed by requiring participants to tap two keys situated 
20 cm apart, as many times as possible in 30 seconds (Merello et al, 1994). The 
LBD, PD, and AD groups performed significantly worse than the controls on the 
tapping test. The LBD group were selectively more bradykinetic than the other 
patient groups. Walking was also quantitatively assessed, by requiring the patient 
to rise from an armless chair, walk 6 metres, return and then sit down. Time taken 
and number of steps were multiplied to produce an index of walking ability in 
'step-seconds'. Both LBD and PD groups performed worse on this walking test 
than AD or controls, taking more steps, longer to complete the test, and more 
overall 'step-seconds'. 
Neuropsychological tests were administered to characterise the cognitive profile of 
LBD cases and to identify characteristics which might distinguish LBD from PD 
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and, in particular, AD. Findings from the neuropsychological. assessment are 
presented in Table 1.15, and a simplified comparison of group performance is 
included in Table 1.16. 
The MMSE failed to distinguish LBD and AD, either in terms of the overall 
scores, or the subsections which make up the task. On the digit span sub-test of 
the WAIS-R (Wechsler, 1981), AD and LBD groups were similarly impaired with 
respect to each other, but performed worse than both control and PD groups. On 
the verbal and category fluency tests (Benton et al, 1968), there was a similar 
pattern of performance with all patient groups impaired with respect to controls, 
but AD and LBD groups were also impaired with respect to the PD group. The 
Nelson Card Sort Test (Nelson, 1976) assess the patients' ability to develop new 
concepts and shift sets, and has been shown to be sensitive to frontal lobe 
dysfunction. Performance on this test was somewhat varied, but overall analysis of 
the components suggest the LBD and especially the AD groups performed less 
well than controls. Thus, LBD and AD cases were not distinguished by tests of 
digit span, verbal or category fluency, motor sequencing, or the Nelson card sort 
test. 
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Table 1.15: Comparison of neuropsychological findings between controls (n=22), 
-LLa 
13) and LBD (n-- 16) (adapted from Gnanalingham et al, 1997 
Controls AD PD LBD 
Digit span 
Forward 6.2(0.3) 4.2 (0.4) ** 6.1(0.4) II** 3.7(0.5) 
Reverse 4.0(0.3) 2.2 (0.4) ** 4.2 (0.5) tt 2.1 (0.4) 11 
Verbal fluency 32.1 (3) 9.2 (2) ** 21.0 (5) tt* 8.3 (2) 11 
(total words for letters 
Sý A5 F) 
Category fluency 14.1 (1) 5.1 (1) 10.9 (2) 4.9 (1) 
(animals in I min) 
Motor sequencing tasks 0(0-1) 2.5(0-4) 0(0-3.5) 4(0-4) 
(median) 
Nelson card sort 
Categories 5.0(0.5) 1.9(0.4) 4.1 (0.8) t 2.7 (1.1) 
Total errors 12.2(2) 25.2 (2) 17.7(5) 22.0 (5) 
Perseverative errors 5.2 (1) 17.7 (3) 12.9(4) 11.2(6) 
% Perseverative errors 29.4(4) 58.9 (6) 36.0 (11) 46.4(15) 
Clock draw test 
Draw part 8.2(0.2) 3.7 (0.5) 6.2 (0.7) 2.4 (0.4) 
Copy part 9.6 (o. 1) 5.5 (0.7) 
AA 7.1 (0.8) 
At* 2.4 (0.6) tf 1 
Values are means (± SEM) junless otherwise stated) 
Post-hoc comparisons *p<0.05; **p<0.01 v controls. 
tP<0.05; ttp<0.01 v AD. *P<0.05; 
ttp<0.0 Iv PD. 'ý'P<0.05; 'ýýP<0.0 Iv corresponding score for draw part of Clock Face Test. 
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Table 1.16: Simplified comparison of performance on neuropsychological tests 
Best ...................................................... Worst 
Performance 
Digit span 
Forward & Reverse Con= PD) >>{AD= DLB 
Verbal fluency Con > PD >> {AD = LBDJ 
(total words for letters 
S, A, F) 
Category fluency Con > PD >> f AD = LBDJ 
(animals in I min) 
Motor sequencing Con > PD >> JAD = LBD) 
tasks (median) 
Nelson card sort 
Categories Con > LBD; Con >> AD; Con = PD; PD > AD; LBD = AD; 
PD = LBD. 
Total errors Con = PD; Con > AD; Con >> LBD; AD = LBD = PD 
Perseverative errors Con >> AD, Con = PD = LBD; AD = PD = LBD 
% Perseverative Con > AD; Con = PD = LBD; AD = PD = LBD. 
errors 
Clock draw test 
Draw part Con > PD > {AD = LBDJ 
Copy part Con > PD > AD >> LBD 
represents significantly better performance on a test and not the absolute scores for the test. 
p<0.05; '>>' p<0.01 
'Con' = Controls 
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The Clock Face Test (Libon et al, 1993) examines executive and visuo-spatial 
functioning, and is split into two halves - draw and copy. In the draw part of the 
Clock Face Test, participants are required to spontaneously draw a clock face with 
the hands pointing to ten past eleven (as in the CAMCOG schedule); whilst in the 
copy part, participants are required to copy a correctly drawn clock face. Patients 
were tested after an overnight drug free period to minimise the effect medication 
might have on the test scores. Analysis of results included the UPDRS scores as 
covariates to partial out effects due to poor motor performance on this task, and 
CSDD scores as covariates to eliminate the potentially confounding influence of 
depression on performance. On the draw part of the task, AD and LBD groups 
were equivalently impaired, and significantly more impaired than both PD and 
control groups. The PD group was also impaired with respect to the control group. 
For the copy part of the test, the pattern of impairment was different with 
particularly severe impairment to the LBD group who were more impaired than all 
of the other groups. AD and PD groups were equivalently impaired and performed 
less well than controls. The LBD patients were the only group not to show 
significant improvement in performance in the copy versus draw sections. As 
medication, depression and motor difficulties have been investigated and 
eliminated as potential causes of the differential impairment in cognitive function, 
the described differences in performance appear to reflect distinct patterns of 
cognitive impairment between the patient groups. 
Gnanalinghan and colleagues considered the clock-draw task in more detail. They 
employed the construct that a 'draw' score greater than the 'copy' score equated to 
a diagnosis of LBD. This showed high specificity (98%), positive predictive value 
(the probability of a clinically diagnosed patient having pathological confirmation 
of the disease state) (80%) and negative predictive value (82%), but low 
sensitivity (25%) and misidentification rates (18%). Despite the relatively low 
sensitivity of the test, patients who perform worse on the "draw" than the "copy" 
subsections of the clock drawing test are very likely to have LBD. Indeed, only 
one PD case tested positive for LBD according to the clock drawing test. The poor 
performance on tests of visuo-spatial functioning has previously been noted by 
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Hansen and colleagues (1990), Walker et al (1997), Sahgal et al (I 992a; 1992b; 
1992c). 
There are, however, inconsistencies between the Gnanalingham et al study of LBD 
cases and the series of autopsy confin-ned cases of LBV studied by Hansen et al 
(1990). Hansen and colleagues found LBV cases to be more severely impaired on 
the digit span and verbal fluency tests than AD cases, which was not replicated by 
Gnanalingharn and colleagues. Furthermore, the observation that AD cases are, if 
anything, more impaired than LBD cases on the Card Sort task is contrary to the 
findings of Sahgal et al (1992a; 1992b; 1992c), who employed a computerised 
version of the test paradigm (ED / ID shift) and found a tendency for SDLT cases 
to be more impaired than AD cases. 
The study by Gnanalingham and colleagues provides further evidence that, 
although AD and LBD patients have similar impairments in a number of 
neuropsychological tests, there are both quantitative and qualitative differences 
between the groups. Neuronal degeneration and subsequent depletion of 
acetylcholine in the nucleus basalis of Meynert has been strongly linked to 
impairment of visuo-spatial attentional function (Everitt & Robbins, 1997), which 
may underpin the severe visuo-spatial problems demonstrated by Gnanalingham 
and colleagues in LBD. 
1.5.5 Summary. 
The studies reviewed above are testimony to the increased research interest in 
DLB. Studies have identified both qualitative and quantitative differences between 
DLB and AD. Early studies, which were constrained by methodological problems, 
have provided a basis for the continuing study of the psychology of DLB by larger 
prospective studies with groups of carefully matched dementia patients. 
Mnemonic function has been extensively described in DLB- Most, but not all, 
studies indicate equivalent or worse performance of AD cases compared to DLB 
cases on tests assessing memory. Attention has received relatively little interest 
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from researchers investigating DLB- Some studies have cited the ability to repeat a 
string of numbers as evidence of more impaired attentional performance in DLB 
patients (e. g. Hansen et al, 1990). However, more systematic investigation of 
attentional function has been aided by the use of computerised assessment 
techniques. In the only study to date to employ such paradigms, Sahgal and 
colleagues have demonstrated both quantitative and qualitative differences in the 
ability of SDLT cases to focus visuo-spatial attention. 
A number of studies have also suggested that visuo-spatial and constructional 
ability is particularly severely affected in DLB cases. Indeed, Gnanalingham et al 
(1997) suggest that qualitative differences in performance on the Clock Draw Test 
might discriminate LBD and AD cases in the clinical environment. 
Groups working in San Diego have additionally attempted to classify LBV into a 
4 cortical' versus 'sub-cortical' framework. They suggest that LBV cases show a 
degree of 'sub-cortical' contribution to the cognitive deficits which is consistent 
with the more 'sub-cortical' distribution of neuropathology in LBV cases. 
The profile of neuropsychological deficits between AD, DLB, and PD suggests 
that DLB shares features of both AD (particularly mnemonic impairment) and PD 
(particularly visuo-spatial and attentional dysfunction), but is equally, qualitatively 
distinct from both. These observations echo findings by neuropathologists, 
neurochemists, and clinicians, which suggest that DLB both overlaps, and is 
distinct from, AD and Parkinson's disease. 
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1.6 Experimental aims and hypotheses. 
The primary aim of this body of work is to characterise neuropsychological. 
profiles in DLB and AD groups. The methodological limitations (described in 
detail in the preceding section), which have somewhat restricted comparison 
between many of the previous studies comparing cognitive impairment in DLB 
and AD, will be addressed by using larger cohorts of patients diagnosed using 
consensus criteria (McKeith et al, 1996). In addition, the experimental groups will 
be carefully matched for: pre-morbid IQ; overall severity of cognitive impairment; 
activities of daily living skills; and age. Computerised assessment procedures will 
be employed to enable accurate spatial and temporal control of stimuli and provide 
detailed measures of performance. 
9 Based on previous neuropsychological, neurochemical, neuropathological and 
clinical studies, it is predicted that both AD and DLB groups will both show 
global impairment compared to non-demented elderly controls. However, the 
profiles of cognitive impairment will differ between AD and DLB groups. The 
profile of cognitive impairment described in the AD and DLB groups will 
reflect the corresponding neurochemical and neuropathological changes in 
these two disorders. 
9 This study also aims to investigate the relationship between known clinical and 
neurochernical characteristics of DLB. This will include a comparison of 
hallucinating and non-hallucinating DLB cases, where distinct neurochemical 
differences have been observed (Perry et al, 1992). In addition an investigation 
of the relationship between fluctuating cognitive impairment and 
neuropsychological performance is planned. It is predicted that DLB patients 
with marked fluctuations will show a profile of cognitive impairment with 
particularly severe attentional deficits compared to DLB cases without marked 
fluctuations. 
The rate of cognitive decline in DLB compared to AD is somewhat disputed. 
Although several studies have reported more rapid decline in DLB cases, other 
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e The rate of cognitive decline in DLB compared to AD is somewhat disputed. 
Although several studies have reported more rapid decline in DLB cases, other 
authors have attributed this to adverse responses to neuroleptic medication and 
suggested equivalent rates of decline in AD and DLB. The final study will 
examine change in profile of cognitive impairment over a one year period in 
DLB, AD, and control groups. 
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Chapter 2: 
General Methods. 
2.1 General introduction. 
This chapter describes general details concerning study design, participant 
recruitment, clinical and preliminary psychometric assessment. Any deviations 
from these general methods, as well as the more detailed methods particular to 
each study, are described in the appropriate experimental chapters. 
2.2 Methods. 
2.2.1 Design. 
The experimental work described in this thesis is drawn from three studies 
investigating psychological function in DLB. Methodology for these studies is 
described in detail in chapters 3,6, and 9. 
1. The first study compares cognitive functioning in AD (n=8), DLB (n=6) and 
elderly controls (n= 10) using the Cambridge Neuropsychological Test 
Automated Battery (CANTAB). 
2. The second study compares cognitive function in a larger cohort of DLB 
(n=24), AD (n=46) and matched elderly controls (n=26) using the Cognitive 
Drug Research Computerised Assessment Battery (CDR). 
3. The third study the compares the rate and profile of cognitive decline at I year 
follow-up of DLB (n=9), AD (n= 16), and elderly controls (n=8) using the 
Cognitive Drug Research Computerised Assessment Battery (CDR). 
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2.2.2 Participants. 
2.2.2.1 Patient groups. 
Participants were recruited from the Newcastle Prospective Study of Memory 
Disorders. This case register consisted of consecutive referrals to Old Age 
Psychiatry services in hospitals in Newcastle and Gateshead, supplemented by 
consecutive referrals to a specialist clinic receiving regional referrals of patients 
diagnosed as DLB. All patients with an MMSE (Folstein et al, 1975) score of at 
least 8 were invited to participate in the Prospective Study, involving clinical 
assessment at annual intervals and, wherever possible, brain tissue donation for 
autopsy confirmation of the diagnosis and neurochemical analysis. 
Clinical diagnosis was established by the application of NINCDS-ADRDA criteria 
for the diagnosis of probable and possible AD (McKhann, 1984) and consensus 
criteria for the clinical diagnosis of probable and possible DLB (McKeith et al, 
1996a). These criteria were independently applied to the case-notes for each 
patient by three senior Psychogeriatricians (Prof IG McKeith, Dr CG Ballard and 
Dr J O'Brien) and following discussion a consensus diagnosis was agreed. 
2.2.2.2 Control group. 
Cognitively 'normal' elderly controls were recruited from two main sources. The 
majority of the control group were relatives (spouse or siblings) and / or carers of 
dementia patients included in the study. In addition a number of controls were 
recruited from the Newcastle Project for Health in Later Life, a large MRC funded 
epidemiological study of cognitive ftinction in the aged, based in Newcastle upon 
Tyne. Controls were screened for a recent history of major psychiatric disorder, 
neurological illness, alcoholism or drug abuse. Although recent minor reactive 
depression was reported in two controls, these cases were not excluded from the 
study. 
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2.2.3 General Procedures. 
2.2.3.1 Clinical assessment protocol. 
Patients who were included in the Newcastle Prospective Study of Memory 
Disorders underwent a standardised psychiatric history schedule using the History 
and Aetiology Schedule (HAS) of the Geriatric Mental State Examination (Dewey 
et al, 1992). The HAS contains detailed information regarding history, medication 
use, and mental state,, with detailed questions regarding fluctuation and 
disturbances of consciousness. A number of patients included in the studies were 
taking medication, however detailed appraisal of medication and performance is 
considered beyond the scope of this thesis. 
The Cornell Depression scale (Alexopoulos et al, 1988) was used to assess 
depression and was augmented by several extra items, such as the duration of the 
mood disturbance and its effect on social functioning, to allow the application of 
DSM-111-R criteria for depression. A diagnosis of depression was made using the 
DSM-III-R criteria (American Psychiatric Association, 1987), ignoring the caveat 
regarding exclusion if there is evidence of organic causation. Persistent depression 
was defined as mood disturbance lasting at least 6 months. Psychotic symptoms 
were evaluated using the Columbia University Scale for the Assessment of 
Psychosis in Dementia (CUSPAD) (Devanand et al, 1992). Definitions regarding 
the presence and classification of psychotic features were taken from the criteria 
of Bums et al (1990). 
A full physical examination was performed on all cases and included the 
Secondary Dementia Schedule (Dewey et al, 1992) and the assessment of 
parkinsonism with the modified Unified Parkinson's Disease Rating Scale 
(UPDRS) (Fahn et al, 1987). Seven parkinsonian features were rated (Ballard et 
al, 1997a) which included: reduced facial expression; resting tremor; action 
tremor; rising from chair; stooped posture; parkinsonian gait; and bradykinesia. 
Parkinsonism was also rated using the Hoehn and Yahr scale (Hoehn, 1967), with 
a rating of I or more taken as evidence of significant parkinsonism. 
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Consenting participants also underwent additional assessments. These included: 
apolipoprotein E genotyping; visual acuity tests; balance assessment; and 
magnetic resonance imaging. However, only clinical details deemed directly 
relevant to the measurement of Psychological dysfunction were reported. 
2.2.3.2 Standardised psychometric assessment procedures. 
Standard demographic variables such as age, years of education, and sex were 
recorded for all participants. In addition, estimates of pre-morbid IQ (National 
Adult reading Test; NART) (Nelson, 1982), and overall level of cognitive decline 
(CAMCOG; Cambridge Examination for Mental Disorders in the Elderly) (Roth 
et al, 1986), were obtained for all participants. Activities of daily living schedules 
were also used to match groups for impairment in day to day living skills (see 
Ballard et al, 1997b). 
The National Adult Reading Test (NART; Nelson, 1982) was employed to 
estimate pre-morbid intellectual functioning. The NART is based on the 
observation that reading ability and general intelligence level are significantly 
correlated. Furthermore,, the residual vocabulary ability of patients with dementia 
may be the most accurate measurable estimate of general pre-morbid intellectual 
ability, as this is relatively resistant to the dementing process (Nelson et al, 1978). 
The NART requires the participant to read phonetically irregular words which can 
only be read correctly if the participant has prior familiarity with them. 
All participants were asked to pronounce the following words: 
chord, ache, bouquet, psalm, capon, deny, nausea, debt, courteous, rarefy, 
equivocal, naive, catacomb, gaoled, thyme, heir, radix, assignate, hiatus, 
subtle, procreate, gist, gouge, superfluous, simile, banal, quadruped, cellist, 
facade, zealot, drachm, aeon, placebo, abstemious, d6tente, idyll, puerperal, 
aver, gauche, topiary, leviathan, beatify, prelate, sidereal, demesne, syncope, 
labile, campanile. 
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Pre-morbid intellectual ability was estimated from the number of words correctly 
pronounced according to Nelson et al (1982). 
The Cambridge Cognitive Examination (CAMCOG) is a subsection of the 
Cambridge Mental Disorders in the Elderly (CAMDEX) schedule (Roth et al, 
1986). The CAMCOG is a scale for the objective assessment of cognitive function 
in the elderly and in dementia. Subscales of the CAMCOG were described 
following Hooper et al (1993). The Hooper et al procedure omits several items 
previously included in the original schedule, and scores cognitive performance out 
of a total of 103. Questions omitted from the original CAMCOG were added as a 
final section to facilitate comparison with total CAMCOG scores derived 
according to Roth et al (1986). The CAMCOG subscales described include; 
I- Orientation (10 points) 
Day of the week; date; month; year; season; country; town; two streets nearby; 
floor of building; name of place at time of assessment. 
2. Language comprehension (9 points) 
Motor response: Please nod head; Touch right ear with left hand; Before 
looking at ceiling look at floor; Tap each shoulder twice with two fingers 
keeping eyes shut. 
Verbal response: Is this a hotel?; Are villages larger than towns?; Was there 
wireless before TV was invented?. 
Reading: Close your eyes; If you are older than 50 please close your eyes. 
3. Language expression (12 points) 
Namingpictures: Shoe; typewriter; scales; suitcase; barometer; lamp. 
Definitions: What do you do with a harnmer?; Where do people usually buy 
medicine?; What is a bridge?; What is an opinion?. 
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4. Visuo-spatial praxis (15 points) 
Copying and drawing: Copy of pentagon; spiral design; 3-D house; drawing 
from memory of a clock face with hands showing 10 past 11. 
Ideational: Take paper in right hand, fold paper in half, place paper on lap, 
write name and address on envelope and try and remember it (Mr John Brown, 
42 West Street, Bedford). 
Ideomotor: Show me how you wave goodbye, Cut with scissors, Brush teeth. 
5. Recent memory (Recall) (12 points) 
Recall: Pictures from language expression (shoe; typewriter; scales; suitcase; 
barometer; lamp); news in the past week; name and address written on 
envelope in visuo-spatial praxis section. 
6. Visual memory (recognition) (6 points) 
Recognition from choice of three: Pictures from language expression (shoe; 
typewriter; scales; suitcase; barometer; lamp). 
7. Remote memory (9 points) 
Recall: Date of First World War; Date of Second World War; Leader of 
Germans in Second World War; Leader of Russians. in Second World War; 
What was Mae West famous for?; Name of King who abdicated; Current King 
or Queen; Heir to the throne; Name of Prime Minister. 
8. Attention and calculation (8 points) 
Attention: Count backwards from 20; five serial subtractions of seven from 100 
(i. e. 93,86,79,71,64) 
Calculation: Add 10p and 5p; take 15p from fI 
9. Perception (10 points) 
Tactile: Pen, watch. 
Visual: Identify pictures of Queen; Pope; objects from unusual angles 
(spectacles; shoe; purse; cup and saucer; telephone; pipe) 
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I O. Abstract thinking (12 points) 
Similarities: Apple and banana; shirt and dress; table and chair; plant and 
animal 
Verbalfluency: Name as many animals as possible in I minute. 
I I. Additional items included in the original CAMCOG test. 
Modified scores for: Counting backwards; verbal fluency; writing name and 
address; folding papers. 
Additional questions: What does this person do (nurse)?, repeat after me "no 
ifs, ands or buts". 
2.3 Ethical approval. 
Ethical guidance and approval was obtained from local regional ethics 
committees. Written informed consent was obtained from all participants 
following procedures for obtaining consent from dementia patients. 
2.4 Statistical analysis. 
Details of procedures for statistical analysis are described in detail in the relevant 
chapters. Statistics were undertaken using the Minitab package (Minitab version 
10.2; 1994). Exact 'p' values are reported for the range 0.1 O<p>0.00 1. Following 
the Minitab package, any values of p<0.001 are reported as p<0.001. 
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Chapter 3: 
A COMDarison of cognitive deficits in AD, DLB, and 
elderly controls using the Cambridge neuropsychological 
test automated battery (CANTAB): Methods. 
3.1 Introduction. 
This chapter describes the methodology employed in a study to compare cognitive 
function in DLB, AD, and normal elderly controls using the Cambridge 
Neuropsychological Test Automated Battery (CANTAB). 
The CANTAB battery was developed by a research group working at the 
University of Cambridge to improve comparative assessment of cognition in 
humans and animals. CANTAB has been used extensively in humans to examine a 
number of neurological and psychiatric disorders including Alzheimer's disease 
(Sahakian et al, 1988; 1990; Sahgal et al, 1991); Parkinson's disease (Morris et al, 
1986; 1988; Sahakian et al, 1988; 1990; Downes et al, 1989; Owen et al, 1992, 
1993); multi system atrophy (Robbins et al, 1992; 1994a); Huntingdon's disease 
(Lange et al, 1995); schizophrenia (Charlesworth et al, 1993; Elliot et al, 1995); 
affective disorders (Abas et al, 1990; O'Brien et al, 1993; Moffoot et al, 1994); 
motor neurone disease (Chari et al, 1996); and senile dementia of the Lewy body 
type (Sahgal et al, 1992a; 1992b; 1992c; 1995: Galloway et al, 1992). 
3.2 Participants. 
All participants satisfied the following inclusion criteria: 
1) age above 65 
2) no current medication likely to influence test performance 
3) no concurrent major psychiatric disorder e. g. major depression, epilepsy, 
alcohol abuse. 
4) adequate colour vision (Ishihara, 1973) 
5) adequate visual acuity (able to read font 12 letters) 
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AD patients (n=8) met NINCDS-ADRDA criteria for the clinical diagnosis of 
probable AD (McKhann et al, 1984). DLB (n=6) cases met consensus criteria for 
the diagnosis of probable DLB (McKeith et al, 1996a). - Elderly controls (n= 10) 
were screened for cognitive impairment sufficient for a diagnosis of dementia. 
Participants were assessed at their place of residence. 
3.3 Materials and apparatus. 
CANTAB version 1.58 for IBM PC and compatibles was installed on a portable 
microcomputer (Carry 15320 series fitted with a 655XX VGA flat panel display 
driver) and presented on a portable LCD screen (Datalux, 195 min wide by 143 
mm high) with a touch sensitive screen (Microtouch) set up to use Com I port. 
For some tests, a non latching , 
hand operated switch fitted with a light spring for 
comfortable hand operation was connected to the parallel port of the computer. 
The abstract patterns used as stimuli in CANTAB were designed to minimise 
verbal encoding of the material and are described in detail elsewhere (see 
Sahakian et al, 1992; Roberts et al, 1993; Robbins et al, 1994b for reviews). 
3.4 Statistical Analysis. 
Data were analysed using the parametric analysis of variance (ANOVA), with or 
without transformation (proportional data - arcsine; latencies - logarithmic) 
according to Winer et al (199 1), and post hoc analyses were made using the 
Newman-Keuls pair-wise comparisons. Data failing to meet assumptions for the 
use of ANOVA were analysed using the non-parametric Kruskal-Wallis test, and 
means were compared using the non-parametric Mann-Witney U test. A minimum 
level of significance of u=0.05 was adopted. A trend towards significance is 
reported for p-values of between 0.1 and 0.05. 
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3.5 Psychometric assessment. 
All participants were tested on the National Adult Reading Test (NART) (Nelson, 
1982); the CAMCOG schedule (Roth et al, 1986); the Instrumental Activities of 
Daily Living (IADL) and the Activities of Daily Living (ADL) schedules (see 
Ballard et al, 1997b). These tests are described in more detail in the General 
Methods (Chapter 2). 
3.6 Computerised assessment: The CANTAB procedure. 
Care was taken to standardise the testing environment. The computer was always 
set up on a table of comfortable height, in a room in which the curtains were 
closed and strong overhead lighting was extinguished. Participants sat in a chair 
about 0.5m. from the touch screen. The computer, which was handled only by the 
experimenter, was placed a short distance away in front of the experimenter. 
Participants responded only via the touch screen and the hand switch where 
appropriate. A brief touch screen calibration procedure was undertaken at the 
beginning of each testing session. All participants attempted the entire CANTAB 
battery. 
The experimenter first explained the nature of each task, and all procedures and 
response requirements were demonstrated in a number of practice trials. A control 
check was incorporated to assure the participant had fully understood the 
requirements of each test, and where necessary instructions were repeated. Details 
of each of these tests can be obtained in the citations listed below. Testing usually 
required several visits to complete. Total testing time was approximately 4 hours, 
but varied according to the individual participant (1.5 hours minimum to 9 hours 
maximum). Standardised testing instructions supplied by Paul Fray Ltd were 
applied to all tasks. 
The CANTAB package consists of three separate batteries which measure visual 
memory, attention, and working memory and planning. A test of motor screening 
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is included at the beginning of each battery. Examples of test stimuli, and detailed 
descriptions of the tasks included in the CANTAB battery, are given elsewhere 
(Owen et al, 1993; Sahakian, 1988). 
3.6.1 Motor screening. 
This task is common to all three CANTAB batteries, and is a measure of motor 
response speed and accuracy. In this task a series of crosses appear on the screen 
in pseudo-random locations. The crosses alternatively flash green and pink. 
Initially a series of three demonstration crosses appear one at the time on the 
screen. At this stage the experimenter demonstrates to the participant by pointing 
to the crosses displayed sequentially on the screen. A pause is then introduced by 
the computer, and depression of the space bar is require to continue. The 
experimenter indicates to the participant that they must now touch the crosses as 
they appear on the screen. A further series of 10 crosses is sequentially displayed 
on the screen and the participant must point to them in turn. 
The motor screening test has a dual purpose. Firstly, it serves to familiarise 
participants with the touch screen. Secondly, measures of latency to respond and 
pointing accuracy are recorded. 
3.6.2 Visual memory battery. 
3.6.2.1 Pattern and spatial recognition. 
Pattern recognition. 
Twelve abstract line patterns were sequentially presented at the centre of the 
screen. These stimuli were enclosed by a 2.6 x 2.6 cm box outline, and were 
presented for three seconds each. The participant's task was to remember these 
patterns. Once the entire list had been presented, and 5 seconds after the final 
stimulus, 12 pairs of stimuli were sequentially presented side by side. One 
stimulus in each pair was novel, the other had occurred in the original list; the 
order of the presentation was the reverse of that earlier. The participant had to 
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point to the familiar stimulus. Feedback was provided by an Auditory tone, and by 
the appearance of a tick (for a correct response) or a cross (for an incorrect 
response). A second list of 12 stimuli, containing novel patterns, was presented 
soon after testing on the first list had finished. Accuracy (number correct) and 
latencies were recorded. 
Spatial recognition. 
In this task participants were sequentially presented a series of five white squares 
(2.0 x 2.0 cm) which appeared in pseudo-random locations on the screen for a 
duration of 3 seconds each. Participants are required to remember the location of 
the five sample stimuli. After a short delay (5 seconds), the recognition phases 
begins. The participant sees a series of pairs of squares, which includes one square 
presented in the location visited by a square in the presentation phase, and another 
square in a novel location. The participant is required to touch the square which is 
in the location occupied by a square in the presentation phase. Auditory and visual 
feedback is provided as described above for pattern recognition. All five locations 
visited in recognition phase are tested in the reverse of the presentation order. This 
cycle is repeated a total of 4 times, each time using a novel set of five locations. 
Accuracy (number correct) and latencies were recorded. 
3.6.2.2 Simultaneous and Delqyed Matching to sample (MTS). 
Matching to Sample (MTS) involved the opening of a3x3 cm red box, located at 
the top centre of the screen, to reveal a sample stimulus (one of a number of 
abstract rectangular dot patterns involving different arrangements of two 
components: four types of shape and four colours, measuring approximately 2 cm 
long by 0.7 cm high). This was followed by the opening of four boxes of the same 
size, which revealed four different choice stimuli in a row along the screen. One 
stimulus was always identical in shapes and colours to the sample stimulus, a 
second differed in shapes, but had the same colour components, the third differed 
in colours, but not shapes, and the fourth (a distracter) had different shapes and 
colours. The stimuli positions varied across trials and one (random) quadrant of 
the stimulus was common to all four stimuli. 
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In simultaneous matching, the sample stimulus remained on the screen whilst the 
choice stimuli appeared. Choice stimuli appeared 4.5 seconds after presentation of 
the sample stimulus. In delayed matching, the sample stimulus appeared for 4.5 
seconds, then disappeared, and the choice stimuli were presented 0,4 or 12 
seconds later. When the choice stimuli appeared, participants had to point to the 
one which resembled the sample. Auditory and visual feedback was provided by 
the machine. The stimuli remained in the event of an incorrect response, but with 
a cross superimposed on the incorrect stimuli until a correct response, signalled by 
a tone and a click, was made. 
Different delays (including the simultaneous condition) were programmed in a 
pseudo-random order, with 10 trials at each delay. The test always began with 
practice trials on the simultaneous condition, followed by 0 and 12 seconds delay 
conditions. After half (20) of the total (40) trials were completed, a break was 
included. Participants were given 2 minutes (or more if requested or required) to 
rest before the second half of testing was undertaken. 
Data pertaining to latency to respond, accuracy, position and type of error were 
recorded. In this task, three types of error are possible: responding to incorrect 
shapes but correct colours, incorrect colours but correct shapes, and incorrect 
shapes and colours (distracter stimulus). 
3.6.2.3 Conditional leaming: pattem-location paired associates. 
In this task, six white boxes (2.7 x3 cm) appeared in a circle around the screen. 
These opened for 3 seconds, and in a random manner to reveal one of a number of 
abstract colour stimuli; they could also be empty. A probe stimulus appeared at the 
centre of the circle of boxes after all the boxes had been opened, and the 
participant was required to point to (touch) the box where the probe stimulus had 
appeared. At first, only one stimulus was hidden in one of the six locations. If a 
correct response was made, a further replication of the test using a novel stimulus, 
was presented. An incorrect response resulted in the whole cycle of stimulus 
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presentation being repeated up to a maximum of 10 cycles in all. At this point the 
test would terminate. Otherwise, the stimulus set size was increased from I to 2,3, 
6, and finally 8 different stimuli (two extra boxes being added to the display on 
these occasions). A replication was included at set sizes 1,2, and 3, and error(s) 
resulted in a repeat of the cycle for up to 10 cycles. Performance was measured in 
terms of the total number of trials taken to complete the test, cumulated over all 
the sets and replications; the (maximum) score of 10 was added for each stage not 
attempted. 
3.6.3 Attentional battery. 
3.6.3.1 Circle discrimination. 
This task requires the participant to discriminate between two (0.6 and 1.8 cm 
diameter) circles of varying colours. The participant was initially instructed to 
touch the smaller of the two circles each time it appeared on the screen; after 20 
trials, and for a further 20, they were instructed to reverse the rule and touch the 
larger circle. The stimuli remained on until a response was made, when auditory 
and visual feedback was given. The number correct and latencies were recorded. 
3.6.3.2 Intra- and extra- dimensional (ID/ED) set shifting. 
This task assesses the ability of a participant to shift attentional set, either within a 
particular dimension (intra-dimensional shift; ID), or from one dimension to 
another (extra-dimensional shift; ED) when required. The protocol required the 
participant to learn, in a sequential manner, a set of visual discrimination tasks in 
which one of two stimuli were correct; feedback being provided by the machine. 
When touched, a correct box turned green and "correct" was presented above the 
central boxes, whereas when an incorrect box was touched, the box turned red and 
"incorrect" was displayed above the central boxes. The same feedback was shown 
for all subsequent trials at all nine stages. The feedback was displayed for 1.5 
seconds, and then both stimuli and feedback were cleared from the screen for I 
second before the subsequent trial. 
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A participant passes through each stage by achieving a criterion of learning (six 
successive correct responses) at each stage. If at any stage a participant fails to 
achieve six successive responses within the maximum of 50 trials for each stage, 
then the task is terminated. 
Two artificial dimensions are used in this task: purple filled shapes and abstract 
white line figures, and the test comprised nine stages presented in the same order. 
Initially, the participant was presented with two abstract white line figures 
presented in two of four boxes around the centre of the screen. The abstract white 
line figures were selected by the experimenter as the first dimension. 
i) Simple discrimination (sd) the participant was required to learn by trial and 
error, which of the two (different) line stimuli was 'correct'. The same stimuli 
were then represented in differing pseudo-randomly selected boxes. 
ii) In the second stage, the stimuli remained the same. However, participants must 
now respond to the previously incorrect stimulus, and ignore the previously 
correct stimulus; a simple discrimination reversal (sdR). 
iii) In the third stage, the second dimension (purple shapes) was introduced. One 
stimulus of each dimension was paired together to give a compound stimulus in 
each response box. At this stage the stimulus from each dimension were spatially 
separated within the response boxes. To respond correctly, participants had to 
continue responding to the stimulus that was correct for the previous stage; a 
compound discrimination (c_d). For this and all subsequent stages, stimuli of 
the different dimensions were paired in a pseudo random fashion with the 
constraint that the same pairings never occurred for more than three trials in a row. 
iv) Stimuli for the fourth stage and above were also compound (they involved 
stimuli from both dimensions). However, they were no longer spatially distinct, as 
the white line figure was superimposed on the purple shape. To respond correctly 
in the fourth stage, participants had to continue responding to the correct stimuli 
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from the previous two stages. This stage also involved compound discrimination 
(ed), but for superimposed figures. 
v) At the fifth stage, a compound discrimination reversal (cdR) occurred. The 
participant had to respond to the previously incorrect stimulus in the same 
dimension to obtain a correct response 
vi) To avoid previous experience confounding the results at the subsequent ID and 
ED shift stages, novel stimuli were introduced at the sixth stage. This stage was an 
intra-dimensional shift (IDS), which required the participant to discover which 
of the stimuli (in the same dimension as used in the previous stages) was now the 
4 correct' one. 
vii) This was succeeded by a further reversal at the seventh stage; an intra- 
dimensional reversal (IDR). 
viii) In stage eight, new stimuli were again introduced in both dimensions, but 
correct responses were only obtained when responding to the correct stimulus 
which was from the previously incorrect dimension; an extra-dimensional shift 
(EDS). 
ix) In the final stage, contingencies were reversed so that the previously incorrect 
stimulus of the new dimension became the 'correct' stimulus; an extra- 
dimensional reversal (EDR). 
Outcome measures included: the proportion of participants achieving criterion at 
each stage; the number of trials to criterion at each stage; and response latencies. 
3.6.3.3 Five choice serial reaction time. 
This task involved five sequential stages of increasing complexity. This task has 
three main purposes: firstly to train the participant to use the hand-switch; 
secondly to test the participants ability to acquire this motor skill; and thirdly, to 
114 
act as a simple and choice reaction time task. All stages involved the presentation 
of a (1.0 cm diameter) yellow dot within a 2.7 cm diameter circular outline. 
i) In the first stage, a single circle (diameter 2.7 cm) is permanently present in the 
centre of the screen and the smaller yellow dot appears for 0.25 seconds in the 
centre of the circle. The participant is required to accurately touch the screen 
inside the circular outline. Auditory and visual feedback informs the participant if 
their response was too quick (i. e. prior to the presentation of the yellow dot), or 
too slow (i. e. more than five seconds after the presentation of the yellow), or 
inaccurate (i. e. outside the circle), or if an appropriate response was made. Once 
the participant has successfully achieved five out of six correct response, or 
completed a maximum of 18 attempts, the choice reaction time is introduced. 
ii) In this stage, a series of five circles (diameter 3.5 cm) are presented in a circle 
around the centre of the screen. The procedure is similar to that in the first stage 
except the yellow dot may now appear in any one of the five circles, and the 
participant must point to the circle in which the yellow dot appeared. Auditory and 
visual feedback are provided as described above for the first stage. The participant 
must achieve a criterion of five out of six correct responses, or reach a maximum 
of 30 attempts before the third stage begins. 
iii) The third stage is attempted only if participants have achieved the criterion of 
five out of six correct responses in the first and second stages. This task introduces 
participants to the hand switch. A single circle appears in the centre of the screen 
as in stage one. The participant is required to depress the hand-switch until the 
yellow dot appears in the centre of the screen. The participant is required to 
release the hand-switch as soon as possible after the dot appears but is not 
required to touch the screen. Auditory and visual feedback indicate if the 
participant correctly released the hand switch, or took too long to release the 
switch (more than 5 seconds), or released the switch too early (prior to the dot 
appearing on the screen). 
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iv) The fourth stage is procedurally the same as the third stage, except that after 
releasing the hand switch the participant was required to point to the centre of the 
screen as in stage one. 
v) In the fifth and final stage five choice reaction time, 5-CRT), participants are 
required to hold down a the hand switch until the appearance, for 0.25 seconds, of 
the stimulus within one of five circular outlines which are arranged in a circle 
around the centre of the screen. Participants are then required to release the switch 
and touch the outline within which the dot had appeared as quickly as possible; 
auditory and visual feedback was provided, and a maximum of 40 trials, 
depending on performance, was given. The number correct, reaction time (interval 
between appearance of stimulus and release of switch) and movement time 
(interval between release of switch and response registration) were recorded. 
3.6.3.4 Visual search matching to sample. 
This task always directly followed the 5-CRT task described above, and so the 
participants were familiar with use of the hand switch. The stimuli used were 
similar to the type described for the MTS task. 
The VSMTS task undertaken is dependent on performance in the previous 
reaction time task. If criterion (five out of six correct responses in all tests 
completed and within a maximum of 18 trials for simple reaction time tasks and 
within 40 trials for choice reaction time tasks) was reached, then the VSMTS 
procedure was employed. If participants failed to reach criterion at any stage then 
the VSMTS (simple) procedure was employed. 
VSMTS: This method allowed participants to determine the pace of the task. 
Depression of the hand switch opened a central red box (3-0 x 2.7 cm), after a 
delay of I second, to reveal the sample stimulus and 2 seconds later choice stimuli 
(1,2,4, or 8 in number) appeared in the eight surrounding boxes. As for the MTS 
procedure, one choice stimulus was identical to the sample. The participant was 
required to hold down the hand switch and, when ready to make their choice, to 
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release it and point to the choice stimuli selected as quickly as possible. Auditory 
and visual feedback was provided. In the event of correct response, the trial was 
complete. If, however, an incorrect response was made, the participant had to 
continue selecting choice stimuli until the correct choice stimulus was selected 
and the trial completed. Practice trials involving four examples in order of 
increasing set six (1,2,4 or 8) were given before the 48 test trials (12 at each of 
the four set sizes, presented in a pseudo-random order). Number of correct 
responses, reaction and movement time (as in the 5-CRT) were recorded. 
VSMTS (simple): This task is similar to the procedure described above for 
VSMTS except for the following. 
i) The sample stimulus was displayed in a green rather than a red box for the 
benefit of the experimenter. 
ii) The hand-switch was depressed by the experimenter to reveal the sample 
stimulus. Thus, movement and reaction times are not distinguished in the VSMTS 
(simple) task, and a single choice time is recorded. 
iii) The participant was encouraged to maintain their hand in a constant location at 
the start of trials. 
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3.6.4 Working memory and planning battery. 
3.6.41j_5pgjqLMgR, 
This task is a computerised version of the Corsi Block Tapping test (Milner, 197 1) 
using the block layout and sequences of Smirni (1983). Spatial span assesses the 
participants spatial sequencing ability. Nine boxes (2.2 x 2.2 cm) were presented 
in the same pseudo random locations on the screen at the beginning of each trial. 
In the initial presentation phase, a number of boxes sequentially changed colour 
for a period of 3 seconds, with no delay between each box changing colour. The 
participant was required to remember the location and sequential order in which 
the boxes changed colour. Following an Auditory cue (tone) the participant was 
required to point to the boxes in the same sequence that they had changed colour. 
During this response sequence, each selected box changed colour for I second, 
and a feedback tone sounded. Whilst a box had changed colour during the 
response phase, the touchscreen was inactive, and the participant had to wait for 
the selected box to return to the original white colour before proceeding with the 
sequence. The initial set involved a sequence of 2 boxes. This was increased by 
one box each time a sequence was correctly recalled by the participant, up to a 
maximum of nine boxes. This continued until the participant failed three 
consecutive trials at any one level. Interference was minimised at the presentation 
phase by using different colours for adjacent sequences. The outcome measure 
was calculated as the final level at which the participant successfully recalled at 
least one sequence. 
3.6.4.2 Spatial working memory. 
The spatial working memory task determines the participants ability to 
manipulate, store and mentally segment spatial areas, as well as their ability to 
form efficient strategies. 
For each trial in the spatial working memory task, a number of boxes (2.3 x 2.0 
cm) were presented on the screen. Participants were required to search for blue 
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tokens which are hidden in the boxes and relocate them in a column at the side of 
the screen. A crucial rule, that a counter would never be found in a square that a 
counter had already been taken from, was carefully explained to participants. 
Participants searched the boxes by touching them in turn to reveal whether there 
was a "blue counter" hidden in the box. At any one time there was only one token 
hidden inside one of the boxes. Returning to an empty box already visited within a 
search is recorded as an error. Once found, the blue token had to be transferred to 
the column on the right hand side of the screen. The counter then appeared in the 
4 counter store' on the right side of the screen which displayed the number of 
counters collected to date. 
The participant then started a new search for another blue counter which might 
have been in any of the boxes which so far had not had a blue counter in it. The 
order of the search is self directed. As every box was used once in each trial to 
hide a blue token, the number of tokens to be collected corresponded to the 
number of boxes for each trial. A trial was complete when the number of blue 
tokens collected was the same as the number of boxes present and the counter 
store was full. The number of boxes (set size) was gradually increased from 3 to 4 
to 6, and finally to 8 boxes. There are four trials at each set size, and set size three 
was used as practice. The colour and position of the boxes is changed from trial to 
trial to discourage the use of stereotyped response strategies. 
Three types of error are evident in this task. A 'between search error' is recorded 
when a participant returns to a box in which a blue counter had already been 
found. A 'within search error' was recorded when the participant returns to a box 
opened and shown to be empty earlier in the search. A double error is when a 
participant returns to a box which was shown to be empty earlier in the search, and 
the box was one in which a blue counter had already been found. The number of 
empty boxes visited (excluding any errors) before a token was found was 
determined by the computer so that each participant received the same degree of 
feedback prior to finding the first blue counter. 
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To complete the task in the most efficient way, a search strategy using 
predetermined search sequences can be developed by the participant. One measure 
of the use of a search strategy is to record the number of times search sequences 
started from the same box for each trial in the more difficult 6 and 8 box 
problems. The total of these scores provides a measure of strategy, with high 
scores representing efficient search strategies (many searches starting with the 
same box), and low scores representing poor search strategies (many searches 
starting with a different box). 
3.6.4.3 Tower of London: "Stockings of Cambridge". 
This task assesses higher cognitive ftinctioning, in particular spatial planning and 
is based on the 'Tower of Hanoi' task (Shallice, 1982). 
Initially the participant was shown two displays containing three coloured (red, 
blue and green) balls (3 cm diameter), one display in the top half of the screen and 
the other in the bottom half of the screen. The upper and lower half of the screen 
were separated by a line from left to right across the screen. The coloured balls 
were described to the participant as hanging in 'socks' from a beam. There were 
three socks in both the upper and lower halves of the screen. The leftmost sock 
could hold three balls, the centre sock could hold two balls, and the rightmost sock 
could hold only one ball. 
On each trial the three balls were placed in predetermined position in both upper 
and lower displays. The position of the balls in the lower display relative to the 
position of the balls in the upper display determined the minimum number of 
moves to complete, and hence the difficulty, of that particular trial. The participant 
was required to move the red, green, and blue balls in the lower display so that 
they occupied the equivalent positions to those occupied by the red, green and 
blue balls in the upper half of the screen. 
A ball was moved by first touching it. A tone sounded and the rim of the ball 
started flashing, to indicate the ball was 'activated' and ready to move. A ball 
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could be 'deactivated' by touching it a second time'. The ball was moved to the 
desired location by touching that location. The rules of the TL task does not allow 
balls to be placed high in a pocket when there are no balls beneath it, or for a ball 
to be moved when there is another ball above it in the same pocket. These 'illegal' 
moves were carefully explained to the participant prior to and, where necessary, 
during testing. These moves were registered but ignored by the computer. 
Participants were instructed to carefully study the position of the balls and to start 
only when they were confident that they had planned a sequence of moves to solve 
each trial. Participants were instructed to solve the problem in the minimum 
number of moves possible. The original positions of the balls in the upper and 
lower halves of the screen determine the minimum number of moves required to 
complete a particular trial. The maximum number of moves for a given trial was 
twice the minimum number of moves. If a participant failed on three problems in a 
row, the computer terminated testing. There were no time limits for solving 
problems. 
At first it was only necessary to move one ball, but this increased to 'five move' 
problems. There were three practice problems at each of the one and two move 
stages, and then two problems at each of the three and three move stages. At this 
point a procedure controlling for motor performance is included, a so called 
'yoked' condition. The upper display moves one ball at a time, exactly repeating 
the moves made by the participant during the planning phase, the participant must 
follow the moves in the upper display by moving the corresponding balls in the 
lower display. The participant was unaware that the moves being made were the 
same moves they had previously made whilst attempting to solve the problem. 
1 Unfortunately a programming error meant that when 'activated' balls were at the bottom of sock 
they could not be deactivated. This problem was brought to the attention of the distributor, 
however, they were unable to rectify the problem, although the problem has been rectified in later 
versions on CANTAB. This problem was, however, consistent for all participants who completed 
the Tower of London task. 
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A second block of two 'two move' (which acted as practice trials) , two 'four 
move9, and four 'five move' problems were undertaken, and then followed by a 
further 'Yoked' motor control section. 
The time taken to complete each problem, and the number of moves taken are 
considered indices of the participant's planning ability. Selection and execution 
times in the 'yoked' motor control condition provided estimates of motor 
initiation and execution times. These were subtracted from the total time taken to 
solve a problem to eliminate the influence of motor confounds. 
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Chapter 4: 
A comparison of cognitive deficits in AD, DLB, and 
elderlv controls using the Cambridge Neuropsychological 
Test Automated Battery (CANTAB): Results. 
4.1 Non-com puterised assessment. 
4.1.1 Demographic features of experimental groups. 
Data pertaining to age, sex, whether the participant wore glasses, and the age at 
which participants left full-time education are documented in Table 4.1. 
Table 4.1: Demogrqphic data for experimental groups (±SEL4). 
Age left full-time 
N, Mean age Glasses education 
(M: F) [years] Yes No (±SEM) [years] 
Control 10 (3: 7) 73.2 (±2.03) 82 14.7 (±0.40) 
AD 8 (2: 6) 82.8 (±0.70) 7: 1 15.5 (±0.85) 
DLB 6 (4: 2) 70.8 (±2.65) 4: 2 14.2 (±0.17) 
Analysis indicated that groups were matched for the age at which full-time 
education was left. The AD group were significantly older than the DLB and 
control groups (F(2,21): --10.3 6, p=O. 00 1), although the control, and DLB groups 
were of similar ages. 
4.1.2 Non-computerised psychometric assessment. 
Mean scores for estimated pre-morbid IQ (NART IQ), global severity of dementia 
(total CAMCOG scores), and activities of daily living skills (ADL, IADL) are 
detailed in Table 4.2. Analyses indicated that groups were matched for estimated 
pre-morbid IQ (NART IQ), global severity of dementia (total CAMCOG scores), 
and on activities of daily living skills (ADL, IADL). 
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Table 4.2- Mean q(,. ores for non-computerised psychometric test data (±SEM). 
Mean NART Mean total Mean ADL Mean IADL 
IQ CAMCOG score score score 
(±SEM) (±SEM) (±SENI) (±SEM) 
Control 113 (±1.9) 101.1 (±0.53) N/A N/A 
(n 
AD 113 (±3.3) 67.3 (±3.69) 16.9 (±1.11) 18.5 (±1.67) 
DLB 107 (±4.0) 73.5 (±6.69) 17.8 (±0.86) 20.6 (±2.29) 
(n=6) 
'N/A' = Not Applicable. 
Scores for subsections of the CAMCOG schedule are presented in Table 4.3 and 
Figure 4.1. 
Table 4.3: Mean scores (±SEM) for CAMCOG subsections 
Control 
(n=10) 
AD 
n=8 
DLB 
n=6 
Orientation 10.0 (±0.00) 4.63 (±0.65) 7.7 (±0.84) 
Language Comprehension 8.7 (±0.15) 8.0 (±0.38) 8.5 (±0.22) 
Language Expression 11.5 (±0.22) 9.4 (±0.78) 10.2 (±1.14) 
Praxis 14.3 (±0.30) 13.1 (±0.48) 11.0 (±1.48) 
Recent Memory 10.5 (±0.22) 1.0 (±0.76) 5.2 (±1.25) 
Visual Memory (recognition) 5.9 (±0.10) 3.4 (±0.60) 4.3 (±0.62) 
Remote Memory 8.8 (±0.13) 4.0 (±0.73) 7.0 (±1.06) 
Attention and Calculation 8.0 (±0.00) 6.4 (±0.73) 4.2 (±0.79) 
Perception 9.9 (±0.10) 7.6 (±0.65) 7.3 (±0.67) 
Abstract Thinking 11.4 (±0.27) 7.5 (±0.93) 6.2 (±1.25) 
Additional Questions 0.9 (±0.01) 2.3 (±0.25) 2.0 (±0.37) 
CAMCOG Total Score 101.1 (±0.53) 67.3 (±3.69) 73.5 (±6.69) 
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Analysis of data from subsections of the CAMCOG schedule indicated that on the 
orientation subsection both dementia groups performed worse than controls, and 
in addition the AD group performed worse than the DLB group (F(2,21)=29.83, 
p<0.001). All groups performed equivalently on the language comprehension 
subsection (17<1). In the language expression subsection there was a trend towards 
a main effect of group (F(2,21)=2.82, p=0.082) but further pair-wise comparisons 
revealed no differences between groups on this measure. 
Analysis of data from the visuospatial praxis subsection, using one-way ANOVA 
(F(2,2 1)=4.9 3, p=O. 0 18), revealed the DLB group's performance to be worse than 
the control group's. The performance of the AD group was not statistically 
different from either DLB or control groups. Performance in the recent memory 
recall subsection of the CAMCOG was significantly worse in both dementia 
groups compared to control, in addition, the AD group performed significantly 
worse than the DLB group (F(2,21)=51.24, p<0.001). 
In the visual recognition memory subsection both dementia groups performed 
worse than controls (F(2,21)=9.56, p=0.001), but there were no statistically 
significant differences between dementia groups. The remote memory subsection 
revealed a similar pattern of performance with both dementia groups impaired 
with respect to controls (F(2,2 1)= 16.47, p<O. 00 1), but not with respect to each 
other. Analyses of data from the attention-calculation subsection of the CAMCOG 
revealed both dementia groups to be impaired with respect to controls, and in 
addition the DLB group performed worse than the AD group (F(2,21)=l 1.92ý 
P<0.001). 
Performance in the perception subsection was worse in both dementia groups 
compared to control s(F(2,2 )=9.3 4, p=0.001), however, the dementia groups did not 
differ with respect to each other. Similarly for the abstract subsection both 
dementia groups were impaired with respect to controls (F(2,21)=12.73, p<0.001), 
but not with respect to each other. 
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4.2 Computerised CANTAB assessment. 
4.2.1 Motor screening. 
Mean response latencies for the motor screening task are displayed in Figure 4.2. 
Analyses did not indicate any differences in motor response speed (F < 1) between 
experimental groups. 
Figure 4.2: Motor screeniu,: mean response latencies (+ SEM) for control (n = 10), 
AD (n = 8) and DLB (n = 6) jzroups. 
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Mean pointing accuracy for experimental groups in the motor screening task are 
displayed in Figure 4.3. Analysis indicated no differences in pointing accuracy 
between groups. 
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4.2.2 Visual memory battery. 
4.2.2.1 Pattern Recognition. 
Mean values for percent correct responses and mean reaction times for the pattern 
recognition task are presented in Table 4.4 and Figures 4.4 and 4.5. 
Table 4.4: Pattern recognition: Mean percent correct response (+SEM) nd 
response latencies (+SEM . 
Mean percent correct Mean response latency 
responses (mS) 
Control 80 (±2.0) 3196 (±365) 
(n= 10) 
AD 53 (±4.7) 7711 (±2777) 
(n = 8) 
DLB 65 (±2.8) 5493 (±1066) 
(n = 5) 
1 1 
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i reco gnition task: mean p ercent correct responses (+SEM) for 
control (n = 10) - AD (n = 8) and DLB (n = 5) groups. 
C4 80- 
60-- 
40 -- 
20-- 
0 
Control AD DLB 
* significant difference (p < 0.05) compared to controls; * significant difference (p < 0.05) 
between dementia groups 
Analysis indicated that both dementia groups obtained significantly fewer correct 
responses than controls, and in addition, the AD group performed worse than the 
DLB group (F(2,20) : -19.08, p<0.001). Further analysis of percent correct responses 
indicated the AD group were responding at chance levels (50% correct responses). 
Analysis of response latency data indicated that both dementia groups response 
latencies were longer than the control group 
(F(2,20) 
latencies for the AD and DLB groups were similar. 
4.76, p=0.02), but response 
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control 
(n = 10), AD (n 8) and DLB (n = 5) gro ps. 
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* significant difference (p < 0.05) compared to controls 
4.2.2.2 Spatial recognition. 
Mean percent correct response data and mean response latencies for the spatial 
recognition task are displayed in Table 4.5 and Figures 4.6 and 4.7. 
Table 4.5: Spatial recognition: Mean percent correct responses (+SEM) and 
response latencies (+ SEM . 
Mean percent correct Mean response latency 
responses (MS) 
Control 78 (±2.5) 3006 (±277) 
(n= 10) 
AD 58 (±4.7) 5101 (±434) 
(n = 8) 
DLB 64 (±3.7) 5618 (±724) 
(n = 5) 
Analysis indicated that both dementia groups made fewer correct responses then 
the control group 
(F(2,20)=: 8.96, p=0.002) , 
but the dementia groups did not differ 
from each other. Subsequent analysis indicated that the DLB group were 
performing at above chance (t=3.81, P=0.019), however, the AD groups 
performance was not significantly better than chance (t = 1.72, N. S. ). 
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Figure 4.6: Spatial recognition tq, -, k- mean percent correct responses (+SEM) for 
control (n = 10), AD (n = 8) and DLB (n = 5) groups. 
100- 
a. ) 
80 
60-- 
40- 
20-- 
9L4 
0- Control AD DLB 
* significant difference (p < 0.05) compared to controls 
Figure 4.7: Spatial recognition task: mean response latencies (+SEM) for control 
(n = 10), AD (n = 8) and DLB (n = 5) gro ps. 
* significant difference (p < 0.05) compared to controls 
Analysis indicated that both dementia groups responded more slowly than the 
control group 
(F(2,20) =: 10.95, p=0- 00 1) , 
but the dementia groups took an equivalent 
amount of time to respond. 
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4.2.2.3 Simultaneous and delayed matching to sample (DMTS - 
Mean group performances for simultaneous (SMTS) and delayed (DMTS) 
matching to sample are presented in Table 4.6 and Figures 4.8 and 4.9. 
Table 4.6: Simultaneous and delayed matching to sample: Mean percent correct 
responses (+SEM) at simultaneous and delayed (0,4 and 12 seconds) presentation 
of choice stimuli, and mean overall response latencies (+SEM). 
I Mean percent correct responses I 
Mean overall 
Simultaneous Os delay 4s delay 12s delay response latency 
(Ins) 
Control 83 (±3.3) 62 (±2.8) 57 (±4.6) 56 (±4.3) 4418 (±571) 
(n= 10) 
AD 81 (±4.7) 48 (±7.4) 42 (±3.2) 35 (±5.0) 6820 (±1058) 
(n = 7) 
DLB 54 (±5.6) 39 (±9.3) 33 (±4.8) 21 (±6.4) 8117 (±1742) 
(n=6) I I I I 
Mean values for percent correct responses from the SMTS task were analysed 
independently to the DMTS. Analysis of variance revealed a significant effect of 
group for SMTS (F(2,20)=4.48, p=0.025) such that the DLB group made less correct 
responses than both AD and control groups, but the AD and control groups 
performed equivalently. In DMTS, a significant main effect of both delay 
(F(2,38)= 5.4 1, p=0.008), and group 
(F(2,20) 
=13.85, p=0.0003) were 
described, but the 
group-by-delay interaction was not significant (F < 1). Further analysis revealed 
both patient groups made fewer correct responses than controls, furthermore the 
DLB group made significantly fewer correct responses than the AD group. 
Further analysis, using single sample t-tests, indicated performance at chance 
levels (25 % correct responses) in the DLB group for all delays (0,4, & 12 
seconds), however, the AD group's performance was significantly above chance 
for 0 (t = 3.04, p=0.023) and 4 second intervals (t = 5.29, p=0.00 18), although at 12 
seconds delay the AD group's performance was at chance levels. 
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latencies (+SEM) over all delays for control (n= 10), AD (n=7) and DLB (n=6) 
groups. 
* significant difference (p < 0.05) compared to controls 
The corresponding latency to respond analyses indicated that both patient groups 
responded slower than controls (F(2,20)=: 4.48, p=0.025) but were not different from 
each other. 
4.2.2.4 Conditional learninýz: Pattern location paired associates (CLP ). 
Mean set size achieved and the mean number of errors made for all trials in the 
paired associates learning are presented in Table 7 and Figures 4.10,4.11, and 
4.12. These data include a correction for participants who failed to reach the 
largest set size. For each stage that was not attempted, the maximum number of 
10 errors possible for each stage was added. 
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Table 4.7: Paired associates learning: mean set size achieved (+SEM) and mean 
number of errors L± SEM) - 
Mean set size achieved Mean number of errors 
(± SEM) (± SEM) 
Control 7.90 (±0.53) 33.83 (+5.75) 
(n= 10) 
AD 4.38 (±0.42) 65.75 (±4.38) 
(n = 8) 
DLB 3.83 (±0.48) 79.33 (±1.09) 
(n = 6)1 
Riwe 4.10: Paired associates learninvý: mean set size achieved (+ SEM) for 
control (n = 10), AD (n = 8) and DLB (n = 6) groups. 
* significant difference (p < 0.05) compared to controls 
Analysis indicated that both dementia groups achieved a lower set size than 
controls 
(F(2,2 
W, == 2 1.03, p<0.00 1) but did not differ with respect to each other. 
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d associates learniniz: mean number of errors (+SEM) made in 
all trials for control (n = 10), AD (n = 8) and DLB (n = 6) groups. 
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* significant difference (p < 0.05) compared to controls; * significant difference (p < 0.05) 
between dementia groups 
The dementia groups made significantly more errors than the control group, and in 
addition the DLB group made significantly more errors than the AD group 
(F(2,21)= 23.0, p<0.00 1). 
Figure 4.12: Paired associates learning: percent of participants in control (n= 0), 
AD (n = 8), and DLB (n = 6) achieving each set size. 
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Battery. 
4.2.3.1 Circle discrimination f CD . LI 
Mean percent correct responses and mean response latencies for the circle 
discrimination task are presented in Table 4.8 and Figures 4.13 and 4.14. 
Table 4.8: Circle discrimination: mean percent correct responses (±SEM) and 
mean response latencies (±SEM). 
Mean percent correct Mean response latency (mS) 
responses (±SEM) (ý±SEM) 
Control 100.0 (±0.00) 1231 (±202) 
(n=9) 
AD 98.8 (±0.95) 1501 (±174) 
(n=8) 
DLB 96.7 (±1.05) 1874 (±624) 
(n=6) 
Figure 4.13: Circle discrimination: mean percent correct responses (±SEM) fo 
control (n=9), AD (n=8) and DLB (n=6) groups. 
100 
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* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia groups 
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Analysis of variance revealed a significant effect of group for circle discrimination 
(F(2,2o)=7.9l, p=0.003) such that the DLB group were impaired with respect to both 
AD and control groups, but AD and control groups performed equivalently. 
Figure 4.14: Circle discrimination: mean response latencies (±SEM) for control 
(n=9), AD (n=8) and DLB (n=6) groups. 
Analysis of the latency to respond data indicated that there were no significant 
differences in the speed of response between groups. 
4.2.3.2 Intra- and extra- dimensional set shifting (ID/ED). 
Mean stage reached in the intra- and extra- dimensional set shifting task is 
displayed in Table 4.9. The percent achieving criteria for each group at each stage 
is presented in Figure 4.15. 
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Mean stage achieved 
(±SEM) 
Control 8.44 (zLO. 56) 
(n=9) 
AD 5.25 (±1.10) 
(n=8) 
DLB 2.80 (±1.59) 
(n=6) 
All participants achieved criterion in the circle discrimination task (see section 
4.1.3.6) indicating their ability to use a rule in making a simple discrimination 
with feedback, and their ability to change the rule under instruction. Non- 
parametric Kruskal-Wallis analysis indicated that both dementia groups achieved 
significantly fewer stages than the control groups (H=10.23, df=2, p=0.006), and 
additionally there was a trend towards less stages achieved by the DLB than the 
AD group (p=0.094). 
4.2.3.3 Five choice serial reaction time. 
Mean values for reaction, movement and total latencies of responses for level 5 of 
the reaction time task are presented in Table 4.10 and Figure 4.16. Three DLB and 
I AD participant failed to reach criterion on stage 2 of the reaction time task and 
hence the data presented are for the 9 control, 7 AD, and 3 DLB cases who 
completed all five levels. 
Analysis of the mean values for the reaction latency revealed a main effect of 
group (F(2,16)-7.60, p=0.005). Further analysis revealed the AD group to have a 
significantly longer reaction latency than both DLB and controls. The DLB and 
control groups had similar reaction latencies. 
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II 
able 4.10: Five choice serial reactiolfl'fiM task (level 5): Mean values (±SEM) 
Z) for reaction, movement and total response latencies for control (n=9), AD (n=7 
and DLB (n=3) groups. 
Mean reaction 
latency (mS) 
Mean movement 
latency (mS) 
Mean total latency 
to respond (mS) 
Control 428 (±38) 756 (±56) 1 1784 (±88) 
AD 878 (±180) 1175 (±200) 2053(±263) 
DLB 
1 
448 (±34) 1336 (±285) 1785 (±304) 
1 
Figure 4.16: Five choice serial reaction time task (level 5): Mean values for 
reaction, movement and total response latencies for control (n=9), AD (n=7) an 
DLB (n=3) groups. 
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* significant difference (p<0.05) compared to controls 
The analysis of movement latencies indicated that all groups took a similar 
amount of time between releasing the non-latching switch and touching the screen. 
For the total latency to respond, analysis indicated that both dementia groups took 
longer to respond than the control group. There was no. difference in the total 
response latency between AD and DLB groups. 
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4.2.3.4 Visual search matching to sample (VSMTS). 
Mean group performances for set sizes 1,2,4, and 8 are presented in Table 4.11 
and Figures 4.17 and 4.18. 
Table 4.11: Visual search matching to sam-ple: Mean percent correct responses 
(±SE ) at set sizes 1,2,4, and 8 and mean overall response latencies (±SEM). 
I Mean Dereent correct I 
Mean response 
Set size 1 Set size 2 Set size 4 Set size 8 latency (mS) 
Control 100 (±O. O) 100 (±O. O) 88 (±2.8) 78 (±5.6) 4189 (±649) 
(n--9) 
AD 100 (±O. O) 100 (±O. O) 90 (±5.6) 70 (±4.4) 5901 (±537) 
(n 
DLB 92 (±5.7) 86 (±5.1) 68 (±13.2) 40 (±8.5) 10265(±3125) 
(n=6) I I I 
The main group analysis of variance revealed a significant effect of group for 
VSMTS (F(2,19)=8.89, p=0.0022). Further analysis revealed that the DLB group 
made fewer correct responses than both AD and control groups, but the AD and 
control groups made equivalent numbers of correct responses. As might be 
expected, all three groups' VSMTS performance depended on set size 
(F(3,51)=85.67, p<0.001). The group-by-set size interaction was not significant. 
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The latency to respond analyses indicated a main effect of group. Upon further 
analysis it was revealed that both dementia groups responded more slowly than 
controls and, in addition, the DLB group responded slower then the AD group 
(F(2,19)=6.45, p=0.007). 
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4.2.4 Working memory and planning battery. 
Spatial span. 
Mean values for the maximum spatial span achieved by each group are presented 
in Table 4.12 and Figure 4.19. 
Table 4.12: Spatial span: mean sequence length (±SEM) achieved. 
Mean sequence length 
achieved (±SEM) 
Control 5.2 (±0.25) 
(n=9) 
AD 3.63 (±0.42) 
(n=8) 
DLB 2.50 (±0.34) 
(n=6) 
Figure 4.19: Spatial span: mean sequence length achieved (±SEM) for control 
(n= 10), AD (n=8) and DLB (n=6) groups. 
* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia groups 
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Analysis of variance indicated a main effect of group (F(2,22)ý 16.1, p<O - 
00 1) 
- 
Further analysis revealed that the spatial span for both dementia groups were 
significantly shorter than the control group. In addition spatial span for the DLB 
group was significantly shorter than the spatial span for the AD group. 
4.2.4.2 Spatial working memory. 
Data for the spatial working memory task is presented for set sizes 6 and 8 only. 
The strategy index, the total number of between, within and double errors, and the 
total time to complete levels 6 and 8 is presented in Table 4.13 and Figure 4.20. 
Table 4.13: Spatial working memory: mean strategy index (±SEM), mean total 
number of between, within and double errors (±SEM) and mean time to complete 
levels 6 and 8 (±SEM). 
Mean Mean total Mean total Mean total Mean total 
strategy between within double response 
index errors errors errors latency (S) 
Control 33.7 (±1.07) 32.9 (±6.3 9) 0.6 (±0.3 1) 1.1 (±0.46) 517(±251) 
(n= 10) 
AD 39.7 (±0.99) 68.6 (±3.66) 3.14 (±0.5 1) 10.4 1028 
(n=7) (±2.77) (±1378) 
DLB 38.3 (±1.26) 69.0 (±5.1 1) 6.5 (±3.61) 13.0 1592 
(n=6) I 1 1 (±7.15) (±3034) 
_j 
Analysis of variance revealed a main effect of group (F(2,2o)=8.88, p=0.002). 
Subsequent analysis indicated both dementia groups had a worse (higher) strategy 
index than controls, but the AD and DLB groups were not different from each 
other. 
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Figure 4.2 1: Spatial working memoly: mean number of between, within, and 
double errors at set sizes 6 and 8 for control (n= 10), AD (n=7) and DLB (n=6) 
groups. 
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Analysis of the number of between errors revealed a significant main effect of 
group (F(2,20): --14.49, p<0.001). Further analysis revealed both of the dementia 
groups to have made significantly more between errors than the control group. The 
number of between errors made by the AD and DLB groups was similar. 
Comparison of the mean number of within errors revealed a trend towards a main 
effect of group (F(2,20)=3.19, p=0.06). Further analysis revealed the DLB group 
made significantly more within errors than controls. All other comparisons were 
non significant. 
Analysis of the mean number of double errors revealed a significant main effect 
of group (F(2,2o)=3.45, p=0.05). Further analysis revealed both the DLB and AD 
groups made significantly more double errors than controls. The total number of 
double errors were similar for the AD and DLB groups. 
Figure 4.22: Spatial working memory: mean total response latencies (seconds) 
(±SEM) at set sizes 6 and 8 for control (n=10), AD (n=7) and DLB (n=: 6) groups_ 
significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia groups 
Analysis of the mean time taken to complete set sizes 6 and 8 revealed a main 
effect of group (F(2,20)=25.21, p<0.001). Further analysis indicated both dementia 
groups took longer to complete set sizes 6 and 8 of the spatial working memory 
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task than the control group. In addition the DLB group took longer to complete set 
sizes 6 and 8 then the AD group. 
4.2.4.3 Tower of London. 
Analysis was not undertaken on data from the Tower of London task, as only one 
DLB and three AD cases were able to complete the task. 
147 
Chapter 5: 
A comparison of cognitive deficits in AD, DLB, and 
elderly controls using the Cambridge Neuropsychological 
Test Automated Battery 0 (CANTAB): Discussion. 
5.1 Introduction. 
This study compared cognition in a cohort of DLB, AD and non-demented elderly 
controls. In the main, findings from this study replicated those from a series of 
studies by Sahgal and colleagues (Sahgal et al, 1992a; 1992b; 1992c; 1995; 
Galloway et al, 1992). 
Control, DLB and AD groups were matched for estimated pre-morbid IQ (NART), 
and the dementia groups were matched for overall level of cognitive impairment 
(CAMCOG), and measures of daily living skills (ADL, and IADL). Findings from 
subsections of the CAMCOG are not discussed in detail in this section, as a more 
substantial comparison is reported in chapters 7&8. The AD group were older 
than both the control and DLB groups. However, the control and DLB groups 
were of a similar age. 
The control group performed significantly better than both dementia groups on 
practically all indices of performance in the CANTAB battery, thus demonstrating 
the sensitivity of the CANTAB battery to the neuropsychological deficits 
associated with dementia, as well as the global nature of the cognitive impairment 
apparent in dementia. 
However, the comparison between the Alzheimer's disease and DLB groups is of 
primary importance for this study, and this is discussed in more detail in the 
following sections. 
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5.2 Individual CANTAB tests: comparison with previous studies 
and implications of findings. 
5.2.1 CANTAB motor screening. 
On the motor screening task both AD and DLB groups responded following 
similar latencies, although both took longer to respond than the control group. 
Pointing accuracy was equivalent for all groups. The similar response latencies 
and pointing accuracy on the motor screening task in the Alzheimer's disease and 
DLB groups suggests that differences observed on other CANTAB tests between 
the groups, were not due to difficulties in executing the motor components of the 
tasks. 
Galloway et al (1992) also found both SDLT and AD groups to have longer 
response latencies than the control group, although pointing accuracy in the SDLT 
group was less accurate than controls (but not the AD group). However, the 
magnitude of this difference was deemed too small (< 0.5 cm) to adversely affect 
performance on the CANTAB procedures, because the responses required were to 
stimuli which are relatively large compared to the observed difference in pointing 
ability. 
Although the motor screening test assesses the ability to respond to tasks requiring 
relatively simple motor response patterns, the DLB and AD groups may not have 
demonstrated equivalent motor abilities on tests which required more complex 
motor response patterns. Typically, DLB patients show neurochemical and 
neuroPathological changes in basal ganglia structures (Langlais et al, 1993; Perry, 
E. et al, 1993b), which are strongly implicated in the integration, sequencing and 
execution of complex motor programmes (Marsden, 1982). Further, previous 
studies have shown DLB patients have problems when complex grapho-motor 
responses are required (e. g. Gnanalinghain et al, 1997; Hansen et al, 1990), 
although it is difficult to dissociate the motor and cognitive components of these 
tasks. Thus, although findings from the motor screening task imply equivalent 
motor abilities in the dementia groups, extrapolation of these findings to tasks 
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requiring more complex motor response programmes should be made with 
caution. 
5.2.2 CANTAB visual memory battery. 
5.2.2.1 Pattem and spatial recognition. 
The pattern recognition task is a test of visual recognition memory and is sensitive 
to temporal lobe damage. The pattern recognition task discriminated the dementia 
groups, with the DLB recognising more patterns than the DLB group, who 
actually performed at chance levels. These data suggest less severe impairment of 
visual pattern recognition memory in the DLB group. 
In the study conducted by Galloway et al (1992), AD and SDLT groups showed 
equivalent impairment on the pattern recognition task. Galloway and colleagues 
suggested that the failure to dissociate DLB and AD groups on this task may have 
represented a floor effect for both dementia groups, although analysis supporting 
this assertion was not reported. 
Response latencies for the pattern recognition task were equivalently increased in 
the dementia groups compared to the control group, and is concordance with the 
Galloway et al (1992) study. This implies that differences in general responsivity 
were not responsible for the inferior accuracy of the AD group compared to the 
DLB group in the pattern recognition task. 
The spatial recognition task assesses the ability to retain spatial information. Both 
dementia groups showed equivalently impaired performance for percent correct 
responses. Further analysis indicated that the DLB group performed at above 
chance levels, whilst the AD group were experiencing floor effects. The floor 
effects seen in this test may have reduced the power of the test to discriminate 
dementia groups. Galloway (unpublished thesis) found that the AD and DLB 
groups responded with similar accuracy, although no analysis of possible floor 
effects was reported. 
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The ability to recognise visually presented abstract patterns is relatively more 
preserved in the DLB group and is in agreement with a number of studies finding 
less mnemonic impairment in DLB than Alzheimer's disease (e. g. Walker et al, 
1997; McKeith et al, 1992c). These findings imply less severe temporal lobe 
disruption in the DLB group. This assertion is in concordance with 
neuroPathological findings which suggest a smaller burden of pathology in the 
temporal lobe, and in particular hippocampal structures in DLB than in AD 
(Dickson et al, 199 1). 
5.2.2.2 Simultaneous and delqyed matching to sample (S/DMTS). 
The simultaneous and delayed matching to sample task quantifies the ability to 
recognise and select a stimulus from an array of 'choice' stimuli in a manner 
which allows performance to be analysed with respect to delay. 
At simultaneous matching the AD and control groups showed similar 
performance. However, the DLB group made fewer correct responses than both 
control and AD groups. Simultaneous matching to sample requires the participant 
to select one of four choice stimuli whilst the 'to be remembered' pattern remains 
visible to the participant. Thus, simultaneous matching has no mnemonic burden 
and acts as a measure of problems, such as visuo -perceptual or attentional 
dysfunction, in completing the task. These data showed that the DLB group were 
not as able as the control and AD groups to meet the fundamental requirements of 
the task. 
As expected from previous work, introduction of a delay between presentation of 
the 'to be remembered' and 'choice' stimuli demonstrated a main effect of delay. 
More interestingly, a main effect of group was also identified, such that the DLB 
group made fewer correct responses than the AD group, who in turn made fewer 
correct responses than the control group. Analysis indicated floor effects in the 
DLB group for all delays, and in the AD group for the longest delay (12 seconds) 
but not for shorter delays (0 &4 seconds). The poor performance of the DLB 
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group must be interpreted with reference to the similarly worse performance of the 
DLB group in the simultaneous matching task. Task-specific problems identified 
at simultaneous matching cannot be distinguished from the 'apparent' mnemonic 
deficits per se in the DLB group. 
As mentioned above, the AD group were not impaired with respect to the control 
group at simultaneous matching. The reduced ability of the AD, compared with 
the control group, to recognise and select the 'to be remembered' pattern with the 
introduction of increasing delays can therefore be attributed to mnemonic deficits. 
Response latencies in the matching to sample task were similarly increased for 
both dementia groups compared to the control group. Differences in performance 
in the DMTS task cannot therefore be attributed to a speed - accuracy trade off. 
Sahgal et al (I 992b) also found the DLB group performed worse than both AD 
and control groups in the delayed matching to sample task. Unlike the current 
study, performance at simultaneous matching to sample was similar for all three 
groups, although means were in a similar pattern to those recorded in the current 
study. Data for simultaneous matching to sample from the Sahgal et al (I 992b) 
study were subsequently revisited and a trend (0.1 >p>0.05) towards worse 
performance of the DLB compared to AD and control groups was observed. 
These data suggest the S/DMTS test is highly sensitive to cognitive decline in 
dementia, particularly in DLB. Caution is required, however, in the causal 
attribution of the particularly poor performance by the DLB group. The non- 
mnemonic problems associated with the DLB group's performance on this task 
can only be implied from the interpretation of findings from other tests. For 
example, pattern recognition was less impaired in DLB than AD groups (see 
Section 5.2.2.1), which is contrary to the 'apparent' worse mnemonic impairment 
of the DLB group recorded in the matching to sample task. 
The floor effects experienced by both dementia groups in this task indicate a 
decreased sensitivity of the task to discriminate between the dementia groups. Use 
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of the DMTS task in future investigations of dementia patients requires a review 
of task difficulty and the implementation of amendments to make the task easier. 
5.2.2.3 ConditionnI jearning: vattem-location paired associates. 
On the pattern-location paired associates learning task, the AD and DLB groups 
achieved set sizes smaller than the control group. However, there was no 
difference in the set size achieved between dementia groups. The total number of 
trials to completion (including correction for set sizes not attempted) made for all 
trials was greater in both dementia groups than controls. Furthermore, the DLB 
group made more errors overall than the AD group. The ability to retain pattern- 
location paired associates is similar for both dementia groups. However, the DLB 
group required more trials to learn these associations than the AD group. 
The mean response latencies for the dementia groups were longer than the control 
group. In addition, the DLB group took longer to respond than the AD group. The 
combination of longer response latencies and more trials to completion in the 
DLB compared to AD group, supports an impaired conditional learning ability in 
the DLB group. Findings from the current study follow a similar pattern to those 
reported by Galloway et al (1992). 
The conditional learning paradigm is similar to a test of object place memory 
employed by Smith et al (198 1), which was demonstrated to be sensitive to right- 
sided hippocampal damage. The conditional component of learning in the task is 
also similar to procedures used by Petrides (198 5) which are shown to be 
especially sensitive to frontal lobe damage. Thus, data from the conditional 
learning task imply relatively greater involvement of frontal and temporal lobe 
structures in DLB than AD. 
However, neuropathological (Dickson et al, 1991) and neuropsychological (see 
Section 5.2.2.1; Walker et al, 1997) findings suggest less medial temporal lobe 
involvement in DLB than AD. Furthermore, there may be greater frontal 
involvement in the poor performance of the DLB group on the conditional 
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learning paradigm, as dopamine is markedly depleted in the striatum in DLB 
(Langlais et al, 1993; Perry, E. et al, 1993b). The explanation for this is that the 
striatum forms an integral part of the intimate circuitry linking the striatum to 
frontal lobe structures, via parallel, segregated cortico-striatal loops that feed back 
via the pallidum, and thalamus to the frontal cortex (Alexander et al, 1986). 
Disruption of fronto-striatal circuitry may produce cognitive impairments which 
are similar to the effects of lesions to the respective targets in the frontal lobe 
(Owen et al, 1992). It is therefore tempting to speculate that the basis of the poor 
performance of the DLB group on the conditional learning task may be primarily 
related to dysfunction of frontal lobe structures and associated circuitry. 
5.2.3 CANTAB attentional battery. 
5.2.3.1 Circle discrimination. 
This simple discrimination task assesses the ability to follow a rule and to switch 
rules when requested, and acts as screening for the intra / extra-dimensional set 
shifting task. The DLB group made fewer correct responses than both the control 
and the AD groups who performed equivalently. Despite making more errors than 
both AD and control groups, the DLB group responded correctly in 97% of trials. 
Furthermore, all DLB cases achieved criterion for the subsequent intra / extra- 
dimensional set shifting task. 
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1-2--l-2 
-Intra -/exrLtra-d Lil men isional set-shifting. 
The intra / extra-dimensional (ID/ED) set shifting task assesses complex aspects 
of attentional ability; requiring the participant to selectively respond to certain 
stimuli following a rule, and to switch attentional set and follow a novel rule when 
required. The ID / ED set shifting task is analogous to the Wisconsin card sorting 
task which, has been shown to be sensitive to dorsolateral frontal lobe lesions 
(Milner, 1964). 
The intra / extra dimensional set shifting task did not discriminate between the 
dementia groups. However, both dementia groups achieved lower stages than 
controls. This pattern was similar to that reported by Sahgal et al (I 992a) except 
none of the SDLT cases in the Sahgal et al (I 992a) study progressed beyond the 
IDS stage, one of the DLB cases successfully completed the whole task in this 
study. Sahgal and colleagues suggest on the basis of these data, and in 
combination with findings from the visual search matching to sample task, that 
DLB cases have more severely degenerated fronto-striatal circuitry than the DLB 
group. This is supported by neuropathological and neurochemical abnormalities 
described in DLB (Perry, E. et al, 1990a: 1990b; Perry, E. et al, 1992). 
In view of the greater fronto-striatal involvement in DLB proposed by Sahgal and 
colleagues and the similar assertion made in this discussion (see Section 5.2.2.3), 
it would be predicted that the DLB group would perform less well than the AD 
group on the ID/ED set-shifting task. However, statistical analysis failed to 
discriminate the AD and DLB groups in either of the studies to date, although the 
mean set size achieved by each group was in the predicted order (Control > AD 
>DLB). A possible explanation for the failure to discriminate AD and DLB groups 
may be in the design of the tasks. Patients who fail to reach criterion at each stage 
are automatically excluded from analysis. Thus statistical analysis is restricted to 
less powerful, non-parametric procedures, which may be of particular interest 
when small experimental groups are compared. 
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5.2-3.3 Five cboi ce- -; eri I reaction time. 
Data from the five choice serial reaction time task indicated that the AD group had 
longer reaction latencies than both DLB and control groups, who responded 
following similar latencies. Movement latencies were similar for all groups. 
Comparison of total response latencies indicated that both dementia groups took 
longer to respond than controls, but there was no difference between dementia 
groups. 
Of particular note, however, is the finding that only three DLB patients achieved 
criterion at stage 2 of the task. Statistical analysis was restricted to just 3 DLB 
cases. Patients who failed to reach criterion at stage two of the task, by definition, 
responded more slowly and less accurately than those who achieved criterion. 
There is therefore a strong probability that DLB cases not reaching criterion 
represent those cases with slow reaction latencies and poor response accuracy. 
Hence the results described above are difficult to interpret, as exclusion of cases 
who found the task difficult in earlier stages (particularly in the DLB group) will 
selectively sample those cases able to competently perform the task. Thus the 
differences found on this task should not have too much weight placed upon them. 
5.2.3.3 Visual search matching to sample. 
The Visual Search Matching to Sample (VSMTS) procedure assesses focal 
attentional. abilities. In the VSMTS task, the DLB group made less correct 
responses at all set sizes than both AD and control groups, who performed 
equivalently throughout. The group by set size interaction term was not 
significant, indicating that increasing set size did not disproportionately affect any 
particular group. However, response latencies were greater for both dementia 
groups than controls. In addition the DLB group took longer to respond than the 
AD group. The DLB group were thus impaired compared to the AD group on both 
indices of performance in the VSMTS task. 
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The 'apparent' visual focal attention dysfunction in DLB compared to both control 
and AD groups, is confounded by the finding that the DLB group were impaired 
even at a set size 1. Set size one acts as a control for task specific problems with 
the task, such as visuo-Perceptual problems or failure to comprehend the task 
instructions. Thus the poor performance of the DLB group in this task may be 
mediated by specific difficulties with the VSMTS procedure, such as visuo- 
perceptual or motor problems, or a basic failure to sustain attention. 
Data from the current study partially replicate those of Saligal et al (I 992a), in that 
both studies found AD and control group performance were similar for all set 
sizes and the DLB group were impaired at set sizes 4 and 8. Nonetheless, the 
earlier study did not find any differences between groups at set sizes I and 2, 
which suggested the DLB group were able to perform the VSMTS task. Sahgal 
and colleagues suggested that qualitative differences exist between the DLB and 
AD groups in terms of focal attentional ability, and that this was due to damage to 
fronto-striatal circuitry. 
Although the current study also found impairments on the VSMTS task, the more 
impaired performance of the DLB group at the smallest set size means 
interpretation of the cognitive basis of poor performance of the DLB group at 
larger set sizes is equivocal. Notwithstanding the possible contribution of non- 
mnemonic problems to performance on the VSMTS task, the performance of the 
DLB group was qualitatively distinct from both AD and control groups. 
5.2.4 Working memory and planning battery. 
5.2.4.1 Spatial span. 
The spatial span task assesses spatial working memory, and is a computerised 
version of the Corsi block tapping test (Milner, 197 1). Both dementia groups 
achieved shorter spans than the control group, and, in addition, the spatial span for 
the DLB group was significantly shorter than for the AD group. This suggests that 
spatial span is relatively more preserved in AD than DLB. However, while Sahgal 
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et al (1995) found both dementia groups achieved a shorter spatial span than the 
control group, they also found no difference between AD and DLB groups. These 
findings are difficult to interpret and require replication with a larger cohort of 
Alzheimer's disease and DLB patients. 
5.2.4. Z3pgjqLýýýý 
On the spatial working memory task, which assesses spatial working memory and 
requires the application of efficient search strategies for effective completion, both 
dementia groups had equivalently higher (worse) strategy indices than controls. 
The number of between and double errors was significantly greater in both 
dementia groups compared to control, although the number of between errors 
made by the AD and DLB groups was similar. The DLB group made more within 
search errors than the AD and control groups who made a similar number of 
errors, although the number of within search errors was still relatively small. In 
addition, the DLB group took longer than both AD and control groups to complete 
the task. The DLB group took three times longer (almost 27 minutes) than the 
control group, and one and a half times as long as the AD group to complete the 
task. 
These findings, although similar to those reported by Sahgal et al (1995) do not 
exactly replicate their findings. Sahgal and colleagues found no differences 
between AD, DLB and control groups with respect to the strategy index employed 
in this study. A novel index, which focused on within search errors, dissociated 
dementia groups from the control group, but not from each other. The two strategy 
indices assessed similar aspects of spatial working memory ability, although the 
between search index measures the retention of spatial information over a longer 
delay, and is more susceptible to possible interference from intervening searches. 
The types of error made by the different groups reported by Sahgal and colleagues 
also differs from the present study. The earlier study suggested that the DLB group 
made more between search errors than the AD group, who also made more 
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between search errors than the control group. In addition the DLB group made 
more errors than both AD and control groups. 
These data further illustrate that both dementia groups show deficits in spatial 
working memory. The DLB patients performed significantly worse on one of three 
measures of performance accuracy than the DLB group, in addition the DLB 
group were considerably slower than the Alzheimer's disease group. 
5.2.4.3 Tower of London. 
The Tower of London task proved too difficult for the dementia groups with only 
one DLB and three AD cases completing the task. Analysis was not undertaken on 
these cases. 
5.3 CANTAB study: General discussion. 
This study compared the AD and DLB dementia groups on most tasks from the 
CANTAB battery and demonstrated distinct profiles of performance for the AD 
and DLB groups. On the majority of tasks where differences were observed 
between dementia groups, the performance of the DLB group was more impaired 
than that of the AD group (simultaneous and delayed matching to sample; 
conditional paired associates learning; circle discrimination; visual search 
matching to sample; spatial span; and spatial working memory). However, the 
DLB group was less impaired than the AD group on the pattern recognition task. 
In addition, the AD group took longer to release the switch in the five-choice 
serial reaction time task than the DLB group although data from this task should 
be interpreted with caution, as only three DLB cases completed the task. 
Equivalent performance of AD and DLB groups were observed on the motor 
screening, spatial recognition and intra / extra-dimensional set-shifting tasks. 
Comparison of cognitive function using the CANTAB battery has demonstrated a 
double-dissociation between AD and DLB groups. This strongly implies that DLB 
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and AD show distinct profiles of cognitive impairment, and that the differences 
between AD and DLB groups were not attributable to problems with matching 
Populations. Likewise, this pattern of deficits is highly unlikely to be attributable 
to the observed age differences between groups. Moreover, observed differences 
between groups, such as an inability to understand task instructions in one group, 
cannot be attributed to Problems which generalise to all tasks. This assertion is 
further supported by the finding that all groups showed similar language 
comprehension ability in the CAMCOG schedule. 
Nonetheless, certain tasks may be differentially susceptible to cognitive deficits 
not directly measured by the CANTAB battery. As the pattern recognition and 
matching to sample tasks both examine short term, non-verbal, visual recognition 
memory, it might be expected that both groups would perform similarly on these 
two tasks. However, the DLB group perform better on the pattern recognition task 
than the AD group, while the opposite was true for the simultaneous / delayed 
matching to sample task. This apparent discrepancy in findings from tasks which, 
purport to measure similar aspects of mnemonic function, can possibly be 
explained by considering specific attributes of the respective tasks. Firstly, the 
simultaneous / delayed matching to sample test duration is approximately 20 
minutes compared to 2/3 minutes required to complete the pattern recognition test. 
The longer duration of the simultaneous / delayed matching to sample task may 
adversely affect the DLB group, on the basis that the DLB group may be less able 
than the AD group to sustain attention as clouding of consciousness and 
fluctuations in alertness are common in DLB (McKeith et al, 1992c, 1996a). Such 
an inability to sustain attention for the necessary period required to complete the 
matching to sample task may represent the non-mnemonic impairment of 
performance identified at simultaneous matching to sample in the DLB group. 
Most of the previous studies investigating mnemonic perforinance in DLB have 
identified equivalent (Hansen et al, 1990) or better mnemonic performance in the 
DLB compared to AD groups (McKeith et al, 1992c; Connor et al, in press; 
Ballard et al, 1996b; Walker et al, 1997). Less severe impairment of visual 
recognition memory in DLB was identified using the pattern recognition task (see 
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Section 5.2.2.1). In view of these findings, the earlier assertion that the worse 
performance of the DLB group on the simultaneous and delayed matching to 
sample task is due to task-specific confounds is supported. Moreover, no aspect of 
cognition stands in isolation, and the interdependence of different cognitive 
processes has been highlighted. 
Performance on the spatial working memory and spatial span tasks (which also 
examines spatial working memory) was more severely impaired in the DLB group 
compared to the AD group. However, the DLB and AD groups performed 
equivalently on the spatial recognition task. Furthermore, the DLB group required 
more trials to learn visuo-spatial associations in the paired associates leaming 
task, although the DLB group were able to eventually remember similar numbers 
of paired associates to the AD group. These data strongly suggest that impaired 
visuo-spatial ability in the DLB group is not due to an inability to store and 
recognise spatial locations per se, but is due to difficulties in learning and 
manipulating 'on-line' visuo-spatial information. 
5.3.1 Summary. 
The results of this study reveal distinct patterns of impairment in carefully 
matched patients with DLB and AD. Visual pattern recognition memory appears 
to be relatively preserved in DLB, whilst visuo-spatial working, but not 
recognition, memory is more disrupted in the DLB group. In addition, matching to 
sample procedures with and without a mnemonic burden have demonstrated 
qualitatively distinct performance in the DLB group, although non-mnemonic 
deficits appear, at least, to contribute to the observed poor performance. 
The double-dissociation, between the neuropsychological performance of the 
dementia groups on subtests of the CANTAB battery, support previous studies 
suggesting that DLB cases represent a subgroup of dementia patients which may 
be distinguished from AD patients by neuropsychological assessment. 
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Chapter 6: 
A comparative study of co2nitive per ormance in 
AD, and elderly controls usini! the Cosmitive Drup, 
Research Computerised Assessment Batterv (CDR): 
Methods. 
6.1 Introduction. 
This chapter describes the methods for a comparative study of cognitive 
performance in a large cohort of DLB, AD, and elderly controls using the 
Cognitive Drug Research (CDR) Computerised Assessment Battery. 
The CDR battery of tests was originally designed to provide an instrument that 
could be used to detect alterations in the efficiency of cognitive functioning in 
various participant and patient groups. The aim was to provide sensitive, reliable 
and precise measures of the effect of phannaceutical compounds upon cognitive 
and motor function using tests of human performance. The CDR system has been 
widely used by groups throughout Europe and North America to study a wide 
variety of compounds and clinical populations. Examples of the research relevant 
to the present thesis include: the effects of scopolamine on human cognitive 
function (Wesnes et al, 1988a; 1988b); the reversal of the effect of scopolamine 
on cognitive performance (Wesnes et al, 1987; 1990a; 1990b; 1991); smoking and 
nicotine administration (Parrot et al, 1989; 1990; 1992); Alzheimer's disease 
(Mohr et al, 1996; Goa et al, 1997); and Huntingdon's disease (Mohr et al, 1996). 
6.2 Participants. 
See General Methods section (Chapter 2) for details of recruitment and 
standardised assessment of cases. 
Participants included 26 elderly controls, 46 AD patients (24 probable AD, 22 
possible AD) diagnosed according to NINCDS-ARDRA criteria 
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(McKhann et al, 1984), and 24 DLB patients (20 probable DLB, 4 possible DLB) 
diagnosed according to consensus criteria (McKeith et al, 1996a). All participants 
attempted the entire battery of tests, although some, more severely demented 
cases, were unable to complete the whole battery. The number of participants 
completing each CDR task is outlined in the relevant sections. 
6.3 Materials and apparatus. 
The CDR battery was installed on a portable microcomputer (Carry 15320 series) 
and presented on a portable LCD screen (Datalux, 195 mm wide by 143 mm. high) 
as previously described (see Section 3.3). Participant responses were recorded via 
modules containing two non-latching buttons, one marked 'NO' and the other 
'YES', connected to the games port of the computer. 
Data from each participant was stored on two floppy discs with coded participant 
identification details as well as on the hard drive of the portable microcomputer. 
The experimenter was not able to access these data. 
6.4 Procedures. 
6.4.1 Non-computerised psychometric assessment. 
The following psychometric tests were administered to all participants: the 
National Adult Reading Test (NART) (Nelson, 1982): the CAMCOG schedule 
(Roth et al, 1986); and the Cornell Depression Scale (Alexopoulos et al, 1988). 
These tests are described in detail in the General Methods section (Chapter 2). 
Patient groups also underwent a standardised psychiatric evaluation, as described 
in the General methods section. 
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6.4.2 Computerised assessment using the CDR battery 
A version of the CDR battery specially designed for use in an elderly or demented 
population was employed in this study, which included a selection of tasks from 
the CDR Computerised Cognitive Assessment System. The CDR battery was 
administered at the place of residence of the participant. Procedures outlined in the 
General Methods section were employed to minimise any changes in testing 
environment. 
A log book of performance was completed for each participant, which included 
details of any unusual occurrences during testing, such as: pausing tests if the 
participant became distracted, confused or distressed; the use of thumbs (rather 
than their index fingers) on the response module. The log was subsequently used 
in the interpretation of data points unrepresentative of a participant's performance. 
Prior to cognitive assessment, participants were introduced to the computer screen 
and response module. The computer automatically requests that the experimenter 
depress both buttons in turn on the response module to ensure the response 
module is functioning correctly before testing can begin. 
All participants received training on the use of the response module, and the 
following instructions were given: 
"You will be communicating with the computer by using the two buttons inftont of 
you. The left, black button is the 'NO' button and you shouldplace your left index 
finger on this button. The right, red button is the 'YES'button andyou should 
place your right indexfinger on this button" 
If the participant was unable to place their fingers (or thumbs) on the buttons due 
to physical disability, a note was made in the log book. In these exceptional 
circumstances the response module was operated by the experimenter and 
response latencies disregarded. Only one participant was unable to use the 
response module. Participants were trained in the use of the response module by 
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completing the choice reaction time (CRT) task (see Section 6.4.2.7), but without 
emphasising the need for rapid responding. All data from this practice CRT were 
disregarded. If after initial training, the participant was not able to utilise the 
response box correctly, the practice choice reaction time task was repeated. 
Appropriate use of the response buttons was monitored by the experimenter 
throughout the assessment session. 
When the participant was able to competently use the response buttons, the test 
session began. 
If the participant's attention wandered from the screen (with the exception of 
during the digit vigilance task; see Section 6.4.2.6), the task was paused by 
pressing the 'ENTER' key. When the participants attention was again focused on 
the screen, the task was resumed with the stimulus that was on the screen prior to 
pausing the task. This event was recorded in the log book. 
6.4.2.1 Word presentation. 
The following instructions were read to each participants: 
"A series of 12 words will appear on the screen, one at a time. Please read aloud, 
with me, each word as it appears on the screen. Try to remember the words as you 
will be asked to recognise them later on. " 
The word presentation was then initiated by the experimenter, and 12 words were 
serially presented on the monitor at the rate of I every 3 seconds. The words 
remained on the screen for 2.5 seconds and there was a pause of 0.5 seconds 
between words. 
The word list was composed of 5 AA words (frequency of 100 or over per 
million), 3A words (frequency of between 50 and 100 per million) and four words 
of relatively high frequency. The list was balanced to have approximately the 
same fairly high overall imaginability and consisted of seven I syllable words, 
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four 2 syllable words, and I three syllable word. Asking the participant to read 
each word aloud ensured the participant was attending to the stimuli. 
6.4.2.2 Immediate word recognition. 
This task measures the ability to store and retrieve verbal information, being a 
measure of episodic secondary verbal recognition memory. The immediate word 
recognition task directly followed the presentation of the 'to be remembered' 
words. The following instructions were read to each participant: 
"You will again see a list of words one at a time on the screen. For each word, if 
you think that it is one of those you havejust seen, you shouldpress the 'YES' 
button as quickly as you can, but ifyou do not remember seeing the wordjust 
now, you shouldpress the 'NO'button as quickly as you can " 
The experimenter stressed the importance of making the decision and response as 
quickly as possible, but not at the expense of making errors. The task was 
subsequently initiated by the experimenter and 24 words were presented. Twelve 
of the words presented were from the list presented in 'word presentation'. These 
were represented in a random order and interspersed with 12 novel distracter 
words. The list of 12 novel words were created in the same manner as described 
n, k above (Section 6.4.2.1). 
Although equal numbers of original and novel words were presented, participants 
were only informed that they would see 'some of the words originally presented'. 
This eliminated ongoing feedback about memory performance to reduce stress and 
improve participant compliance. Participants responded 'YES'/ 'NO', to indicate 
whether they remembered seeing each word in the original list. The words 
remained on the screen until the participant responded. 
Participants had to respond within a window of between 0.25 seconds and 30 
seconds for the response to be recorded. Responses made outside this window 
were disregarded and the word presented prior to the response was represented. 
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Following a response from the participant there was aI second pause prior to 
presentation of the subsequent word. 
6.4.2.3 Picture presentation. 
The following instructions were read to each participant: 
"A series of 14 pictures will appear on the screen, one at a time. Please look at 
each picture carefully as it appears and try and remember as many as you can. 
We will come back to them a little later on. " 
The picture presentation was then initiated by the experimenter. A series of 14 
pictures were presented on the monitor at the rate of I every 4 seconds for the 
participant to remember. Each picture remained on the screen for 3 seconds and 
was followed by aI second pause, prior to presentation of the next picture. 
The fourteen pictures consisted of one each of the following categories: animals; 
buildings; food; general transport; household items; interiors; jewellery; kitchen 
items; landscapes; outside items; road transport; sport; tools; toys. 
6.4.2.4 Face presentation. 
The following instructions were read to each participant: 
"A series of 14 pictures ofpeople'sfaces will appear on the screen, one at a time. 
Please look at eachface carefully as it appears and try and remember as many as 
you can. We will come back to them a little later on. " 
The face presentation was then initiated by the experimenter. A series of 14 faces 
were sequentially presented on the monitor at the rate of I every 4 seconds for the 
participant to remember. Each face remained on the screen for 3 seconds and was 
followed by a pause of I second prior to presentation of the next face. The faces 
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presented were balanced for sex, age group and backdrop (either a brick wall or an 
open landscape). 
6.4.2.5 Simple Reaction Time (SRT). 
This task measures reaction time and assesses the participant's ability to 
concentrate on the screen, and the speed of reaction to an expected event. 
The experimenter instructed the participant to place their right index finger on the 
'YES' response key, and remove their left finger from the 'NO' response key. All 
participants were then given the following instructions: 
"Every time you see the word TES'on the screen, you shouldpress the 'YES' 
button as quickly as possible " 
The experimenter stressed the importance of making the response as quickly as 
possible. The SRT task was then initiated by the experimenter pressing the 
'ENTER' key. A series of 20 stimuli ('YES') were presented on the screen with a 
random and varying inter-stimulus interval of between I second and 2.5 seconds. 
Subsequent trials were only presented following a response to the previous trial. 
The participant had to respond within the window of 0.1 seconds and 30 seconds 
for the data to be recorded. 
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6.4. 
This task assesses the ability to sustain an attentional focus and ignore distraction. 
The experimenter instructed the participant to place their right index finger on the 
'YES' response key, and remove their left finger from the 'NO' response key. All 
participants received the following instructions: 
"A number will appear on the right hand side of the screen and then remain 
there. " 
The experimenter then pressed the 'ENTER' key to initiate the presentation of the 
target digit. A target digit was pseudo-randomly selected and displayed on the 
right of the monitor screen for the whole duration of the task. The experimenter 
then gave the following instructions: 
"A series of numbers will appear, one at a time, in the middle of the screen. Every 
time the number in the middle is the same as the number on the right, press the 
'YES' button as quickly as possible. " 
Once the experimenter was certain the participant had understood the task 
requirements, the digit vigilance task proper was initiated by the experimenter 
pressing the 'ENTER' key. A series of 90 digits was serially presented in the 
centre of the screen at the rate of 80 per minute. Each digit remained on the screen 
for 0.7 seconds and there was a gap of 0.05 seconds between each digit. The 
participant was required to press the 'YES' button every time the digit in the series 
matched the target digit on the right hand side of the screen. There were 15 target 
digits to be detected in the rapidly changing digits. 
As this task measured sustained attentional capability, the task was not paused if 
the participant's attention wandered. If, however, it was apparent the part1cipant 
had failed to understand the task requirements, the task was terminated and re- 
started, following further instruction from the experimenter. 
6.4.2.7 Choice Reaction Time (CRT). 
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The choice reaction time task assesses the participant's alertness and ability to 
concentrate on the screen, as for the simple reaction time task. In addition, the 
choice reaction time task requires a further element of infon-nation processing to 
enable the participant to identify and select the correct response. 
All Participants received the following instructions: 
"Either the word TES'or the word 'NO'will appear on the screen. Every time 
you see the word TES'you shouldpress the 'YES' button as quickly as possible. 
Every time you see the word 'NO'you shouldpress the 'NO'button as quickly as 
possible. " 
The importance of responding as quickly as possible, but without making errors, 
was stressed. Once the experimenter was confident the participant had fully 
understood the instructions, the 'ENTER' key was pressed to initiate testing. 
Twenty stimuli (either the word 'YES' or the word 'NO') were presented on the 
screen with a random and varying inter-stimulus interval of between I second and 
2.5 seconds. The stimuli remained on the screen until the participant responded. 
The participant had to respond within the window of between 0.15 seconds and 30 
seconds for the response to be recorded. 
6.4.2.8 Spatial working memoly. 
This task assesses the ability to temporarily retain and manipulate spatial 
information. 
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The following instructions were given to all participants: 
"A Picture of a house will appear on the screen with nine windows. Four of the 
windows will be lit andfive will be dark. Please try to remember the position of 
the lit windows" 
The experimenter stressed the importance of making the decision and response as 
quickly as possible, but not at the expense of making errors. The experimenter 
initiated the spatial memory task. A picture of a house appeared, which remained 
on the screen for 10 seconds. Four of the nine windows in the house were lit. The 
participant was required to remember the position of the lit windows. Which four 
of the nine windows were lit was selected randomly, with the limitation that a 
combination of the four comer windows was impossible. The following 
instructions were then given: 
"You will see a series of houses appear on the screen one at a time. Each house 
will have just one window lit. If the window that is lit is one of the four that was lit 
in the original house you shouldpress the 'YES' button as quickly as you can, but 
if the window was not lit in the original house you shouldpress the 'NO'button as 
quickly as you can " 
This was followed by 18 presentations of the house with only one window lit, and 
the participant was required to indicate whether the lit window was one of the four 
windows lit in the original presentation. There was a gap of I second between the 
participant's response and presentation of the next house. The participant had to 
respond within a time frame of between 0.25 seconds and 30 seconds for the data 
to be valid. The participant recorded their response by pressing the 'YES' or 'NO' 
response button as appropriate. 
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6.4.2.9 Numeric working memoKy. 
The task assesses the ability to hold information 'on line' and to rapidly 
manipulate this information. 
The following instructions were given to all participants: 
"Please try to remember the three numbers that will now come on the screen one 
at a time. Say each number aloud to help you remember it. " 
The experimenter then pressed the 'ENTER' key twice to initiate the display of 
three pseudo randomly selected numbers. Each number was displayed for 1.15 
seconds with a gap of 0.5 seconds between each digit. The experimenter then 
asked the participant to recite the numbers to ensure they had been remembered. If 
the participant failed to correctly recite the three numbers, they were represented. 
Contingent upon the participant correctly reciting the three words, the following 
instructions were given: 
"Nowfor each number which appears on the screen, you shouldpress the 'YES' 
button if it is one of the numbers you are remembering, and you shouldpress the 
'NO'button if it is any other number. " 
The experimenter stressed the importance of making the decision and response as 
quickly as possible, but not at the expense of making errors. Once the 
experimenter was confident the participant had fully understood the instructions, 
and again verified that the participant could remember the three target numbers, 
the 'ENTER' key was pressed to initiate the next stage of the task. The participant 
was required to respond to 18 serially presented probe digits. The digits remained 
on the screen until the participant responded. The participant had to respond with 
a time frame of 0.25 seconds and 30 seconds for the data to be valid. There was a 
gap of 0.5 seconds between the participant's response and the presentation of the 
next number. The three target digits appeared 3 times each. The participant 
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recorded their response by pressing the 'YES' or 'NO' response button as 
appropriate. 
6.4.2.10 DelUed word recognition. 
This task measures the ability to store and retrieve verbal information, being a 
measure of cued secondary verbal memory. The delayed word recognition task 
was presented to the participant approximately thirty minutes after presentation of 
the 'to be remembered' words. The interval between word presentation and 
recognition phases depended on the time taken to complete intervening tasks and 
any breaks requested by the participant. 
The following instructions were given to each participant: 
"You will again see a list of words one at a time on the screen. For each word, if 
you think that it is one of those you havejust seen, you shouldpress the 'YES' 
button as quickly as you can, but ifyou do not remember seeing the wordjust 
now, you shouldpress the 'NO'button as quickly as you can " 
The procedure for the delayed word recognition task are the same as for 
immediate verbal recognition except that the 12 distracter words were drawn from 
a new list formulated as described previously (see Section 6.4.2.2). 
6.4.2.11 Delaved r)icture recojznition. 
This task assesses the ability to store and retrieve pictorial information from 
secondary memory. The delayed picture recognition task was presented to the 
participant approximately thirty five minutes after presentation of the 'to be 
remembered' pictures. The interval between picture presentation and recognition 
phases depended on the time taken to complete intervening tasks and any breaks 
requested by the participant. 
The following instructions were given to each participant: 
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"Now you are going to see some pictures one at a time on the screen. For each 
picture, ifyou think it is one of those you saw earlier and tried to remember, you 
shouldpress the 'YES' button as quickly as you can, but ifyou do not think that 
you saw it earlier, you shouldpress the 'NO'button as quickly as you can. " 
The experimenter stressed the importance of making the decision and response as 
quickly as possible, but not at the expense of making errors. Once the 
experimenter was confident the participant had fully understood the task, the 
'ENTER' key was pressed to initiate testing. Twenty eight pictures were presented 
containing the original 14 shown in picture presentation ( see Section 6.4.2.3) and 
14 novel exemplars, one from each of the categories previously described. The 
two pictures presented from the same category (picture pairings) were relatively 
distinct (e. g. in the animal category the pairing might be a dog and a horse). The 
pictures were ordered so that pairings were not shown one after the other. The 
pictures remained on the screen until the participant made a response and there 
was a gap of I second before the subsequent picture was presented. The window 
within which participants had to respond was 0.25 seconds to 30 seconds for the 
data to be valid. Participants responded 'YES' / 'NO', to indicate whether they 
remembered seeing each picture in the original list. 
The participant was only told that they would see some of the pictures originally 
presented. This eliminated ongoing feedback about memory performance to 
reduce stress and improve participant compliance. 
6.4.2.12 Delgyed face recognition. 
This task assesses the ability to store and retrieve pictorial representations of 
human faces from secondary memory. The delayed face recognition task was 
presented to the participant approximately forty minutes after presentation of the 
'to be remembered' faces. The interval between face presentation and recognition 
phases depended on the time taken to complete intervening tasks and any breaks 
requested by the participant. 
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The following instructions were given to each participant: 
"Now you are going to see some pictures offaces one at a time on the screen. For 
eachface, ifyou think it is one of those you saw earlier and tried to remember, 
you shouldpress the 'YESbutton as quickly as you can, but ifyou do not think 
that you saw it earlier, you shouldpress the 'NO' button as quickly as you can. 
The experimenter stressed the importance of making the decision and response as 
quickly as possible, but not at the expense of making errors. Once the 
experimenter was confident the participant had fully understood the task, the 
'ENTER' key was pressed to initiate testing. Twenty faces were presented 
containing the original 12 shown in face presentation ( see Section 6.4.2.4) and 12 
novel exemplars made up as previously described. The faces were paired for age, 
sex and backdrop, and were ordered so that pairings were not shown one after the 
other. The faces remained on the screen until the participant made a response and 
there was a gap of I second before the subsequent picture was presented. The 
window within which participants had to respond was 0.25 seconds to 30 seconds 
for the data to be valid. Participants responded 'YES' / 'NO', to indicate whether 
they saw each picture in the original list. 
6.4.2.13 Critical Flicker Fusion (CFF). 
This task is an indirect psychophysical measure of arousal and attention which 
determines the frequency at which a participants are able to distinguish a 
flickering light from a steady light. 
The task is sensitive to variables such as the distance between the participant and 
the CFF box and background illumination. However, attempts were made to 
minimise variations of these variables. The participant was seated approximately 
50 cm from the screen, and the special CFF box was mounted on top of the screen. 
The CFF box was attached to the parallel port of the computer and had two orange 
light emitting diodes on the front panel. 
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The CFF consists of two sections: an initial titration phase followed by the test 
phase. The initial titration phase establishes a preliminary frequency, using 
ascending and descending trials. 
The participant was instructed to place a single index finger on one of the buttons. 
Prior to the ascending titration phase, the following instructions were presented on 
the screen and read aloud by the experimenter: 
"In a moment the lights will start toflicker slowly and will start toflickerfaster 
andfaster until you can no longer see them flickering. Please press the button 
when you can no longer see the lights flickering. " 
There followed three ascending titration trials. Upon completion the following 
instructions were presented on the screen and read aloud by the experimenter: 
"In a moment the lights will come on steadily. After a short while the lights will 
start to flicker. Please press the button as soon as you see the lights flicker" 
There followed three descending titration trials. The mean frequency at which the 
participant was able to distinguish a flickering light from a steady light was 
established by averaging frequencies from all 6 titration trials. This preliminary 
frequency of the test phase was set at this value. Prior to commencing the test 
phase, the following instructions were presented on the screen and read aloud by 
the experimenter: 
"Both lights will come on for a short period One of the lights will be steady and 
the other will be flickering. Please press the response key which corresponds to 
the light which wasflickering. Ifyou are unsure about which light wasflickering 
just guess. " 
The participant was instructed to place both index fingers on the corresponding 
response buttons. The test phase was then initiated by the experimenter. The two 
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lights then came on, one of which was a steady light, and the other was flickering 
at the frequency determined in the titration phase. Whether the flickering light was 
on the left or the right or the left hand side was determined randomly. The 
frequency of the flickering light increased by I Hz if the participant responded 
correctly three times in a row. The frequency decreased by I Hz if the participant 
made one incorrect response. There was a gap of 2 seconds between the response 
of the participant and the subsequent trial. 
There were 15 trials to establish the final critical flicker fusion frequency. 
Reaction time was not recorded for this task, but a response had to be made within 
the time window of 0.1 seconds to 30 seconds for the response to be recorded. 
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6.4 les of CDR tests: main and secondgly outcome measures. 
Table 6.1 - The CT)R battery: tasks and the associated cognitive states and 
Processes assessed 
Task Cnnitive States and Processes Assessed 
Attention 
Simple reaction 0 Alertness, power of concentration, primary stage of 
time information processing, motor speed. 
Choice reaction 0 Alertness, power of concentration, primary stage of 
time information processing, motor speed, stimulus 
discrimination, response organisation. 
Digit vigilance 0 Intensive vigilance, ability to ignore distraction. 
Critical Flicker 0 Correlated with alertness and attention, though not 
Fusion Frequency itself a direct measure of either. 
(CFF) 
Working memory 
Digit scanning 0 Sub-vocal rehearsal of digit sequences. 
(numeric working Articulatory loop sub-system of working memory. 
memory) 
Spatial working Ability to temporarily retain spatial information. 
memory Visuo-Spatial sub-loop of working memory. 
Secondary memory 
Word recognition 0 Ability (speed and sensitivity) to discriminate novel 
from previously presented words. 
0 Episodic secondary verbal recognition. 
Picture recognition 0 Ability to discriminate novel from previously 
presented pictorial information. 
0 Episodic secondary non-verbal visual recognition. 
Face recognition Ability to discriminate novel from previously 
presented faces. 
Episodic secondary face recognition. 
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Table 6.2- The CT)R battery: primM and secondaly outcome measures 
Task Primary Measure Secondary 
Measure 
Immediate word Recognition sensitivity (SI) 
recognition Recognition speed (mS) 
Simple reaction time Speed (mS) 
Digit vigilance Speed (mS) False alarms 
Percentage of targets detected 
Choice reaction time Speed (mS) Accuracy (%) 
Spatial working Scanning sensitivity (SI) 
memory Scanning speed (mS) 
Numeric working Scanning sensitivity (SI) 
memory Scanning speed (mS) 
Delayed word Recognition sensitivity (SI) 
recognition Recognition speed (mS) 
Picture recognition Recognition sensitivity (Sl) 
Recognition speed (mS) 
Face recognition Recognition sensitivity (Sl) 
Recognition speed (mS) 
Critical flicker fusion CFF threshold (Hz) 
Primary variables are variables that, if affected, reflect upon the overall efficiency 
of the performance of the task. Secondary variables are those which, if affected, 
will not in themselves reflect on the actual ability to perform the task, but will be 
important in modulating the interpretation of any changes in the primary variables. 
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6.5 Statistical procedures. 
Data were analysed using the parametric analysis of variance (ANOVA), with or 
without transformation (proportional data - arcsine; latencies - logarithmic) 
according to Winer et al (199 1), and post hoc analyses were made using the 
Newman-Keuls pair-wise comparison. A minimum level of significance of 
4=0.05 was adopted. A trend towards significance is reported for p-values of 
between 0.1 and 0.05. 
A signal detection theory index of sensitivity is used for several tasks (see Table 
6.2). This non-parametric index (SI) is calculated from formulae presented by 
Frey & Colliver (1973) and combines the accuracy scores from the original and 
novel information. The index ranges from I (total sensitivity) to - 1, with zero 
representing an absence of sensitivity that is equivalent to chance performance. 
The sensitivity index was chosen for several reasons. Firstly, the index combines 
into a single measure the ability to recognise previously presented information and 
the ability to discriminate this from novel information. Secondly, the index 
prevents erroneous conclusions about performance based on changes to only one 
measure. Thirdly, this methodology reduces the total number of variables to be 
analysed which helps the overall statistical power. 
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Chapter 7: 
A- comparative study of cognitive performance in DLB, 
AD, and elderlv controls usiniz the Cosmitive Dru2 
Research Computerised Assessment Battery (CDR): 
Results. 
7.1 Intra-group comparison of probable versus possible diagnoses 
for AD and DLB. 
To establish whether probable and possible cases within the AD and DLB groups 
could be considered as similar, comparisons of demographic variables and 
neuropsychological deficits were made. Two-sample t-tests were used to compare 
probable and possible AD cases, and probable and possible DLB cases. 
Demographic features and primary outcome measures from the psychometric 
analyses (age, NART IQ, total CAMCOG score, and all primary outcome 
measures from the CDR assessment battery) were considered. A summary of 
findings is presented in Tables 7.1 and 7.2. 
The possible and probable AD categories were matched for age, estimated pre- 
morbid IQ, and overall level of cognitive impairment using the CAMCOG. 
Analysis of the main outcome measures for the CDR battery indicated there were 
no differences in performance between possible and probable AD groups. 
Analysis indicated no differences between possible and probable DLB diagnostic 
categories for age and on measures of estimated pre-morbid IQ (NART) and 
overall degree of cognitive impairment (CAMCOG). Analysis of performance on 
all the main outcome measures for the CDR assessment battery indicated no 
significant differences between possible and probable diagnostic groups. Trends 
towards significance were, however, demonstrated for several measures of 
response latencies. There was a trend towards significantly longer reaction times 
for the probable than the possible DLB groups on immediate word recognition 
(t=-2.03, p=0.08), delayed word recognition (t---2.09, p=0.08), delayed picture 
recognition (t=-2.06, p=0.09), and delayed face recognition (t=-1.99, p=0.08). 
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T ive analysis of possible and probable diagnostic categories for 
A iM outcome measures of neuropsychological perfonnance 
ýým 
- 
Possible AD Probable AD 2-sample 
(n=22) (n=24) t-test 
Age 78.2 (±1.84) 81.8 (±0.35) N. S.. 
NART pre-morbid IQ 109.0 (±1.64) 112.3 (±1.67) N. S.. 
CAMCOG total score 65.9 (±3.16) 60.83 (±3.54) N. S.. 
Immediate word recognition 
Sensitivity index 0.40 (±0.06) 0.32 (±0.37) N. S.. 
Reaction latency (rnS) 3265 (±410) 3664 (±526) N. S.. 
Simple reaction time (rnS) 680 (±85) 674 (±63) N. S.. 
Number vigilance 
Accuracy (% targets detected) 79.1 (±5.86) 89.7 (±3.21) N. S.. 
Reaction latency (mS) 622 (±27) 622 (±21) N. S.. 
Choice reaction time 
Response latency (rnS) 802 (±63) 727 (±32) N. S.. 
Accuracy (% correct) 94.0 (±1.61) 95 (±1.55) N. S. 
Cognitive reaction time (rnS) 193 (±49) 126 (±26) N. S. 
Spatial memory 
Sensitivity index 0.15 (±0.07) 0.14 (±0.07) N. S. 
Reaction latency (rnS) 2789 (±239) 3546 (±595) N. S. 
Memory scanning 
Sensitivity index 0.77 (±0.06) 0.69 (±0.08) N. S. 
Reaction latency (rnS) 1891 (±281) 2231 (±361) N. S. 
Delayed word recognition 
Sensitivity index 0.31 (±0.08) 0.24 (±0.08) N. S. 
Reaction latency (rnS) 2461 (±312) 2521 (±511) N. S. 
Delayed picture recognition 
Sensitivity index 0.39 (±0.07) 0.37 (±0.06) N. S. 
Reaction latency (rnS) 2672 (±395) 2723 (±268) N. S. 
Delayed face recognition 
Sensitivity index 0.36 (±0.07) 0.28 (±0.06) N. S. 
Reaction latency (rnS) 2218 (±231) 2603 (±286) N. S. 
Critical flicker frequency (Hz) 33.5 (±0.96) 34.2 (±1.58) N*S. 
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T ive analysis of possible and probable DLB cases on age and 
pri lgi: y outcome measures (±SEM) of neuropsychological performance. 
Possible DLB Probable DLB 2-sample 
(n=4) (n=20) t-test 
Age 80.0 (±2.38) 77.1 (±1.78) N. S. 
NART pre-morbid IQ 108.5 (±1.71) 109.2 (±1.77) N. S. 
CAMCOG total score 73.8 (±7.41) 59.35 (±4.13) N. S. 
Immediate word recognition 
Sensitivity index 0.47 (±0.13) 0.38 (±0.13) N. S. 
Reaction latency (rnS) 1845 (±292) 3382 (±528) (t---2.03, p=0.08) 
Simple reaction time (mS) 1017 (±314) 1131 (±164) N. S. 
Number vigilance 
Accuracy (% targets detected) 73.3 (±18.9) 57.3 (±7.85) N. S. 
Reaction latency (mS) 607 (±37) 656 (±31) N. S. 
Choice reaction time 
Response latency (mS) 904 (±204) 1803 (±350) N. S. 
Accuracy (% correct) 95.0 (±3.54) 88.2 (±4.24) N. S. 
Cognitive reaction time (mS) 33 (±22) 652 (±255) (t=-2.29, p=0.07) 
Spatial memory 
Sensitivity index 0.15 (±0.14) 0.06 (±0.08) N. S. 
Reaction latency (mS) 3707(±1303) 3523(±527) N. S. 
Memory scanning 
Sensitivity index 0.84 (±0.08) 0.66 (±0.08) N. S. 
Reaction latency (mS) 2533(±1251) 2846(±477) N. S. 
Delayed word recognition 
Sensitivity index 0.49 (±0.19) 0.41 (±0.06) N. S. 
Reaction latency (mS) 1624 (±366) 2991 (±486) (t=-2.09, p=0.08) 
Delayed picture recognition 
Sensitivity index 0.38 (±0.13) 0.35 (±0.08) N. S. 
Reaction latency (mS) 1735 (±382) 3524(±522) (t---2.06, p=0.09) 
Delayed face recognition 
Sensitivity index 0.28 (±0.16) 0.30 (±0.09) N. S. 
Reaction latency (rnS) 1634 (±253) 3153 (±648) (t=-1.99, p=0.08) 
Critical flicker frequency 33.5 (±0.96) 34.2 (±1.58) N. S. 
(Hz) 
I 
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In summary, there were no statistically significant differences between the 
probable and possible diagnostic categories on any measures undertaken. All 
subsequent analyses compare generic AD and DLB groups, and do not distinguish 
Possible and probable diagnostic cases. 
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7.2 Comparison of cognitive function in AD, DLB and elderly 
controls using the CDR assessment battery. 
7.2.1 Demographic features of experimental groups. 
Data pertaining to age, sex, handidness, whether the participant wore glasses and 
age of education are documented in Table 7.3. 
Table 7.3: Demogrqphic data for control, AD and DLB grollps. 
N Mean Age Handedness Glasses Mean years 
(M: F) (years) right / left Yes No of education 
(±SEM) (±SEM) 
Control 26 (8: 18) 74.5 (±1.51) 26: 0 24 2 15.0 (±0.37) 
AD 46 (18: 28) 80.1 (±1.08) 45: 1 43: 3 15.3 (±0.38) 
DLB 24 (13: 11) 77.5 (±1.53) 23: 1 22: 2 14.2 (±0.10) 
Analysis of variance indicated that the AD group were significantly older than 
controls (F(2,93)=4.72, p=0.01), however, there was no age difference between AD 
and DLB groups, or between DLB and control groups. All groups were matched 
for the age at which ftill time education was left. 
7.2.2 Non-computerised psychometric assessment. 
Mean scores for estimated pre-morbid IQ (NART), global severity of dementia 
(total CAMCOG scores), and activities of daily living skills (ADL, IADL) are 
detailed in Table 7.4. 
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Table 7.4- Mean -. -Rcores for psychometric test data for control, AD and DLB 
9EQU-P -S. 
Mean NART Mean total Mean ADL Mean IADL 
IQ CAMCOG score score score 
(±SEM) (±SEM) (±SEM) (±SEM) 
Control 114.9 (±1.3) 99.4 (±0.86) N/A N/A 
(n--26) 
AD 110.4 (±1.2) 62.8 (±2.27) 17.3 (±0.45) 21.4 (±0.92) 
(n--46) 
DLB 109.2 (±1.4) 62.4 (±4.00) 16.2 (±0.77) 22.13 (±1.19) 
(n=24) I I I I I 
N/A = not available 
The dementia groups were matched for estimated pre-morbid IQ using the NART, 
however, both dementia groups had lower estimated pre-morbid IQs than the 
control group (F(2,93)=4.45, p=0.01). Similarly, the dementia groups were matched 
for overall level of cognitive impairment, but as would be expected both AD and 
DLB groups showed significantly greater global impairment of cognitive function 
than the control group (F(2,93)=59.66, p<0.001). Comparison of daily living skills 
revealed dementia groups were matched for both ADL and IADL measures. 
Mean scores for subsections of the CAMCOG schedule are presented in Table 7.5 
and Figure 7.1. 
Analyses of data from subsections of the CAMCOG schedule indicated that on the 
orientation subsection both dementia groups performed worse than controls 
(F(2,93)=35.7, p<0.001), but AD and DLB groups performed equivalently. A 
similar pattern of performance was observed for the language comprehension 
subsection (F(2,93)=7.0, p=0.001), and language expression subsection 
(F(2,93)=l 1.42, p<0.001). 
Analysis of data from the visuo-spatial praxis subsection revealed that the DLB 
group performed worse than both control and AD groups, furthermore the 
performance of the AD group was worse than controls (F(2,93)=30.59, p<0.001). 
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Table 7.5- Mean Prnres (±SEM) for control, AD and DLB groups on subsections 
of the CAMCOG schedule. 
Control 
(n=26) 
AD 
(n=46) 
DLB 
(n=24) 
Orientation 10.0 (±0.04) 5.6 (±0.35) 5.6 (±0.62) 
Language Comprehension 8.8 (±0.08) 7.7 (±0.21) 7.4 (±0.40) 
Language Expression 11.7 (±0.12) 9.3 (±0.33) 9.2 (±0.60) 
Praxis 14.7 (±0.13) 11.3 (±0.37) 9.1 (±0.76) 
Recent Memory 9.8 (±0.33) 1.8 (±0.37) 4.1 (±0.64) 
Visual Memory (recognition) 5.8 (±0.08) 3.1 (±0.31) 4.1 (±0.37) 
Remote Memory 8.8 (±0.08) 4.6 (±0.37) 5.5 (±0.56) 
Attention and Calculation 8.1 (±o. og) 5.7 (±0.39) 4.6 (±0.56) 
Perception 9.5 (±o. 19) 7.1 (±0.27) 6.7 (±0.36) 
Abstract Thinking 10.7 (±0.27) 5.4 (±0.48) 4.8 (±0.65) 
CAMCOG Total Score 9.4 (±0.86) 62.8 (±2.27) 62.4 (±4.00) 
Performance in the recent memory recall subsection of the CAMCOG was 
significantly worse in both dementia groups compared to control, in addition the 
AD group performed significantly worse than the DLB group (F(2,93)=85.69, p< 
0.001). In the visual recognition memory subsection both dementia groups 
performed worse than controls, however, the AD group performed worse than the 
DLB group (F(2,93)ý 19.84, p<0.001). 
In the remote memory subsection both dementia groups were impaired with 
respect to controls (F(2,93) =30.79, p<0.001), but not with respect to each other. 
Analyses of data from the attention-calculation subsection of the CAMCOG 
revealed both dementia groups to be impaired with respect to controls (F(2, 
93)ý 15.24, p<O. 00 1), but AD and DLB groups were not impaired with respect to 
each other. Performance in the perception subsection was worse in both dementia 
groups than the control group (F(2,93)=23.54, p<0.001), however, the dementia 
groups did not differ with respect to each other. Similarly for the abstract 
subsection both dementia groups were impaired with respect to controls 
(F(2,93)=35.67, p<0.001), but not with respect to each other. 
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7.3 Computerised (CDR) cognitive assessment. 
7.3.1 Attentional function 
7.3.. I. l Simple reaction time (SRT) 
Mean reaction time data from the simple reaction time task is presented in Table 
7.6 and Figure 7.2. 
Table 7.6: Simple reaction times (mS) for control, AD and DLB groups. 
Mean simple reaction 
time (mS) (±SEM) 
Control 377 (±15) 
(n=26) 
AD 676 (±51) 
(n=45) 
DLB 1112 (±144) 
(n=24) 
Figure 7.2: Simple reaction time task: mean reaction times (mS) (±SEM) for 
control (n=26), AD (n=45) and DLB (n=24) groLips. 
I (f\ 
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1ne (p<0.05) compared to controls; * significant difference (p<0.05) between significant differe c 
dementia groups 
Analysis revealed both dementia groups to react more slowly on the simple 
reaction time task, in addition the DLB group reacted more slowly than the AD 
group (F(2,92)=28.00, p<0.001). Further analysis indicated no significant 
correlation between simple reaction times and clinical measures (Unified 
Parkinson's Disease Rating Scale; UPDRS) of motor slowing (r---0.24) (UPDRS 
Bradykinesia score) or overall severity of Parkinsonian motor symptoms (r---0.01) 
(UPDRS Total score) for the DLB group. 
7.3.1.2 Choice reaction time (CRT). 
Data concerning accuracy and response latency for the choice reaction time task 
are presented in Table 7.7 and Figures 7.3. 
Table 7.7: Choice reaction time: mean reaction times (mS) and accuracy (! /o 
correct) for control, AD and DLB groups. 
Mean choice Mean accuracy of 
reaction time (mS) responses (% correct) 
(±SEM) (±SEM) 
Control 534 (±12) 95.8% (±0.72) 
(n=26) 
AD 760 (±33) 94.6% (±i. i) 
(n=45) 
DLB 1647 (±298) 89.4% (±3.57) 
1 11 ý 
Analysis indicated that both dementia groups responded more slowly than controls 
on the choice reaction time task, and in addition the DLB group responded more 
slowly than the AD group (F(2,91)=30.32, p<0.001). All groups responded with 
similar accuracy. Further analysis indicated no significant correlation between 
choice reaction time performance and clinical measures of motor slowing 
(accuracy: r=O. 15; speed: r---0.325) (UPDRS Bradykinesia score) or overall 
severity of Parkinsonian motor symptoms (accuracy: r---O. -O. 20; speed: r---0.27) 
(UPDRS Total score) for the DLB group. 
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EigqjL71ý-Choice reaction time task: mean reaction time (m. S) (±SEM) fo 
control (n=26), AD (n=45) and DLB (n=23) groups. 
* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia groups 
7.1.3.3 Cognitive reaction time. 
Cognitive reaction time provides a measure of speed of cognitive processing and 
were calculated by deducting simple reaction times from corresponding choice 
reaction times. Mean cognitive reaction times are presented in Table 7.8 and 
Figure 7.4. 
Table 7.8: Cognitive reaction times (mS) for control, AD and DLB groups. 
Mean cognitive reaction 
time (mS) (±SEM) 
Control 157 (±12) 
(n=26) 
AD 156 (±26) 
(n=45) 
DLB 544 (±216) 
(n=23) 
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unitive reaction time (mS) (±SEM) for control (n=26), AD 
(n=45) and DLB (n=23) groqps. 
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* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia groups 
Some of the cognitive reaction times were negative values. All negative values 
were assigned a value of 0 mS. Analysis indicated that cognitive reaction times for 
the DLB group were significantly greater than both control and AD, and in 
addition the cognitive reaction times for the control group were longer than the 
AD group (F(2,92)=25.98, p<0.001). 
7.1.3.4 Number vigilance. 
Data pertaining to the number vigilance task are described in Table 7.9 and 
Figures 7.5,7.6 and 7.7. 
Both dementia groups detected significantly fewer target digits than controls, and 
furthermore, the DLB group detected fewer target digits than the AD group 
(F(2,93) ..:: 16.30, p<0.001). Further analysis 
indicated no significant correlation 
between the number of target digits correctly identified and clinical measures 
(Unified Parkinson's Disease Rating Scale; UPDRS) of motor slowing (r---0.25) 
UPDRS Bradykinesia score) or overall severity of Parkinsonian motor symptoms 
(r=-0.25) (UPDRS Total score) for the DLB group. 
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Control AD DLB 
Table 7.9: Number vigilance: mean accuracy scores, response latencies and 
number of false alarms for control, AD and DLB groupS. 
Mean percentage of Mean latency to Mean number of 
target digits correctly respond to target false alarms 
detected (%) (±SEM) digits(mS) (±SEM) (±SEM) 
Control 99.0% (±0.48) 498 (±i 1) 0.35 (±0.15) 
(n=26) 
AD 82.9% (±3.70) 609 (±21) 3.39 (±1.12) 
(n=46) 
DLB 60.0% (±7.19) 648 (±27) 7.21 (±2.30) 
(n=24) I I I 
Figure 7.5: Number vigilance: mean percent of target digits detected (±SEM) fo 
control (n=26), AD (n=46) and DLB (n=24) groups. 
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* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) 
between dementia groups 
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tar g, -t digits (±SEM) for control (n=26), AD (n=46) and DLB (n=24 ) groups. 
* significant difference (p<0.05) compared to controls 
Figure 7.7: Number vigilance: mean number of false alarm responses (±SEM) fo 
control (n=26), AD (n=46) and DLB (n=24) groups. 
* significant difference (p<0.05) compared to controls 
Response latencies are described for responses to correctly detected target digits 
only. Mean response times for all groups were within the requisite 1.25-second 
response window. Both dementia groups responded more slowly than the control 
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group (F(2,93)ý 15.97, p<O. 00 1), however, there was no difference in response 
latency between AD and DLB groups. 
Analysis of variance revealed a main effect of group (F(2,93)=4.93, p=0.009). The 
mean number of false alarms was greater for the DLB group than controls, 
however all other pair-wise comparisons were non-significant. 
7.1.3.5 Critical flicker fusion frequency. 
Mean critical flicker fusion frequencies are described in Table 7.10 and Figure 
7.8. 
Table 7.10: Mean critical flicker ftision frequencies for control, AD and DLB 
groups. 
Mean critical flicker 
fusion frequency (Hz) 
(±SEM) 
Control 37.8 (±0.71) 
(n--25) 
AD 33.9 (±0.96) 
(n=44) 
DLB 31.1 (±1.24) 
(n=2 1) 
Analysis of variance indicated that critical flicker fusion frequencies obtained for 
both dementia groups were less that obtained by the control group (F(2,89)=8.37, 
p<O. 00 1). Comparison of AD and DLB groups revealed no significance difference 
in critical flicker fusion frequency. 
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Figure 7.8: Mean critical flicker fusion frequencies (±SEM) for control (n=25), 
AD (n=: 44) and DLB (n=23) groups. 
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* significant difference (p<0.05) compared to controls 
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7.3.2 Secondary memory. 
7.3-2.1 Immediate word recognition. 
Mean word recognition sensitivity indices and reaction times are presented in Table 7.11 
and Figures 7.9 and 7.10. 
Table 7.11: Immediate word recognition: mean word recognition sensitivity index and 
response latencies for control, AD and DLB groups. 
Mean word recognition Mean response 
sensitivity index latency (mS) 
(±SEM) (±SEM) 
Control 0.89 (±0.021) 902 (±28) 
(n=26) 
AD 0.36 (±0.047) 3482 (±340) 
(n=46) 
DLB 0.39 (±0.064) 3126 (±456) 
(n=240, 
Figure 7.9: Immediate word recognition: mean sensitivily index for control (n=26), AD 
(n=46) and DLB (n=24) groups. 
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* significant difference (p<0.05) compared to controls 
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Analyses of variance indicated that both dementia groups were less able to recognise 
previously seen words and discriminate these from words not previously seen than the 
control group (F(2,93)=33.58, p<0.001), but dementia groups performed equivalently. 
Figure 7.10: Immediate word recognition: mean reaction latencies (mS) (±SEM) for 
control (n=26), AD (n=46) and DLB (n=24) groups. 
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* significant difference (p<0.05) compared to controls 
Analysis of reaction latencies for the immediate word recognition task indicated that 
both dementia groups responded significantly slower than controls (F(2,93)=40.15, 
p<O. 00 1), but AD and DLB groups' response latencies were similar. 
7.3.2.2 Delgyed word recognition. 
Mean delayed word recognition sensitivity indices and reaction times are presented in 
Table 7.12 and Figures 7.11 and 7.12. 
Both dementia groups were less able to recognise previously seen words and 
discriminate these from words not previously seen than the control group, moreover, the 
AD group performed significantly worse than the DLB group (F(2,92)=37-50, p<0.001). 
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Table 7.12: Delayed word recognition: mean word recognition sensitiviiy index and 
response latencies for control, AD and DLB groups. 
Mean word recognition Mean response 
sensitivity index latency (mS) 
(±SEM) (±SEM) 
Control 0.84 (±0.025) 908 (±35) 
(n=26) 
AD 0.27 (±0.047) 2493 (±306) 
(n=45) 
DLB 0.42 (±0.057) 2763 (±421) 
(n=24) 
Figure 7.11: Delayed word recognition: mean sensitivily index for control (n=26), AD 
(n=45) and DLB (n=24) groups. 
* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia group 
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-d word recognition: mean reaction latencies (mS) (±SEM) fo 
control (n=26), AD (n=45) and DLB (n=24) groups. 
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* significant difference (p<0.05) compared to controls 
Analysis of reaction latencies for the delayed word recognition task indicated that both 
dementia groups responded significantly slower than controls (F(2,92)=33.1 1, p<0.001), 
but AD and DLB groups' response latencies were similar. 
7.3.2.3 Delqyed picture recognition. 
Mean delayed picture recognition sensitivity indices and reaction times are presented in 
Table 7.13 and Figures 7.13 and 7.14. 
Table 7.13: Delayed picture recognition: mean picture recognition sensitivity index and 
response latencies for control, AD and DLB groups. 
Mean picture recognition Mean response 
sensitivity index latency (mS) 
(±SEM) (±SEM) 
Control 0.87 (±0.025) 978 (±35) 
AD 0.38 (±0.044) 2700 (±229) 
DLB 0.35 (±0.067) 3001 (±452) 
(n=24) 
200 
Control AD DLB 
Figure 7.13: Delqyed picture recognition: mean sensitivi1y index for control (n=26), AD 
(n=44) and DLB (n=24) groups. 
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* significant difference (p<0.05) compared to controls 
Analysis of recognition sensitivity indices indicated both dementia groups were less able 
than the control group to recognise previously seen pictures and distinguish these from 
novel exemplars (F(2,91)=32.12, p<0.001). The AD and DLB groups had similar 
recognition sensitivity indices on the delayed picture recognition task. 
Figure 7.14: Delqyed picture recognition: mean response latencies (mS) (±SEM) fo 
control (n=26), AD (n=44) and DLB (n=24) groups. 
* significant difference (p<0.05) compared to controls 
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Response latencies for the delayed picture recognition task were significantly greater for 
both dementia groups than controls (F(2,91)=38.61, p<0.001), although response latencies 
for AD and DLB groups were similar. 
7.3-2.4 Delqyed face recognition. 
Mean delayed face recognition sensitivity indices and reaction times are presented in 
Table 7.14 and Figures 7.15 and 7.16. 
Table 7.14: Delgyed face recognition: mean face recognition sensitiviiy index and 
response latencies for control, AD and DLB groups. 
Mean face recognition Mean response 
sensitivity index (±SEM) latency (mS) (±SEM) 
Control 0.67 (±0.043) 978 (±35) 
(n=26) 
AD 0.30 (±0.044) 2451 (±263) 
(n=44) 
DLB 0.30 (±0.074) 2877 (±544) 
Figure 7.15: Delayed face recognition: mean sensitivily index for control (n=26), AD 
(n=44) and DLB (n=22) groups. 
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* significant difference (p<0.05) compared to controls 
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Control AD DLB 
Both dementia groups were less able than the control group to recognise previously seen 
faces and distinguish these from novel exemplars (F(2,89)= 15.84, p<O. 00 1), but AD and 
DLB groups performed similarly on the delayed face recognition task. 
_ 
pd face recognition: mean response latencies (mS) (±SEM) fo 
control (n--26). AD (n=44) and DLB (n=22) groups. 
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* significant difference (p<0.05) compared to controls 
Both dementia groups took significantly longer to respond in the delayed face 
recognition task than the control group (F(2,89)=25.96, p<0.001), but AD and DLB 
groups responded with equivalent latencies. 
203 
7.3.3 Working memory. 
7.3.3.1 Spatial working memory. 
Mean spatial working memory sensitivity indices and response latencies are presented in 
Table 7.15 and Figures 7.17 and 7.18. 
Table 7.15: Spatial working memoKy: mean spatial recognition sensitivity index and 
response latencies for control, AD and DLB groups. 
Mean spatial recognition Mean response 
sensitivity index latency (mS) 
(±SEM) (±SEM) 
Control 0.75 (±0.068) 1276 (±70) 
(n=26) 
AD 0.14 (±0.047) 3655 (±443) 
(n=45) 
DLB 0.07 (±0.069) 3557 (±478) 
Figure 7.17: Spatial working memoKy: Mean spatial recognition sensitivily index for 
control (n=26), AD (n=45) and DLB (n=22) groups. 
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* significant difference (p<0.05) compared to controls 
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Both dementia groups were less able than the control group to recognise previously 
presented spatial locations and distinguish these from novel exemplars (F (2, go)=3 5.02, 
p<O. 00 1), but AD and DLB groups performed similarly on the spatial working memory 
task. Further post hoc analysis comparing the performance of each dementia groups 
performance to chance performance (sensitivity index of 0) indicated that although the 
AD group was performing above chance level (t=3.02, p=0.002), the DLB group was 
not performing above chance levels (t=1.06, n. s. ). 
Figure 7.18: Spatial working memory: mean reaction latencies (mS) (±SEM) for control 
(n=26), AD (n=45) and DLB (n=22) groups. 
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* significant difference (p<0.05) compared to controls 
Analysis indicated that response latencies for both dementia groups on the spatial 
working memory task were significantly greater than reaction latencies for the control 
group (F(2, go)=28.77, p<0.001), but the response latencies for AD and DLB groups were 
similar. 
7.3.3.2 Memoly scanning (numeric Working memoly). 
Mean memory scanning sensitivity indices and corresponding response latencies are 
presented in Table 7.16 and Figures 7.19 and 7.20. 
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Table 7.16: Memory scanning: mean memojy scanning sensitivAy indices and respons 
latencies for control, AD and DLB groups. 
Mean spatial recognition Mean response 
sensitivity index latency (mS) 
(±SEM) (±SEM) 
Control 0.91 (±0.020) 805 (±32) 
(n=26) 
AD 0.74 (±0.047) 2072 (±232) 
(n=45) 
DLB 0.69 (±0.067) 2789 (±438) 
(n=22) 
Figure 7.19: Memory scanning: mean memoly scanning sensitivily indices for control 
(n=26), AD (n=45) and DLB (n=22) groups. 
* significant difference (p<0.05) compared to controls 
Comparison of sensitivity indices for the memory scanning task indicated that both 
dementia groups were less able to discriminate the target and non-target numbers than 
controls (F(2,90)=4.42, p=0.0 15), but there was no difference between AD and DLB 
groups. 
206 
Figure 7.20: Memojy scanning: mean reaction latencies (mS) (±SEM) for control 
(n==26), AD (n=45) and DLB (n=22) groups. 
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* significant difference (p<0.05) compared to controls 
Analysis of response latencies for the memory scanning task indicated that both 
dementia groups responded more slowly than controls (F(2,90)=26.69, p<0.001). 
Response latencies for the AD and DLB groups was not significantly different. 
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7.4 Comparative analysis of cognitive function in hallucinating 
and non-hallucinating DLB groups, AD and controls. 
7.4.1 Introduction 
Perry et al (1990; 1994) have demonstrated that neocortical ChAT is more 
profoundly reduced for DLB cases with hallucinations (80% reduction) compared 
to DLB cases without hallucinations (50% reduction). An analysis was undertaken 
comparing DLB cases with and without persistent visual hallucinations to elderly 
controls and the AD group. McShane et al (1995; 1996) have demonstrated that 
patients with persistent rather than fleeting visual hallucinations are more likely to 
have Lewy body pathology, and that persistent hallucinations are less likely to be 
associated with poor eyesight. The dementia with Lewy body cases were hence 
divided into two subgroups based on the clinical identification of persistent visual 
hallucinations (VH) into a group with persistent visual hallucinations (DLB+VH) 
and a group without persistent visual hallucinations (DLB-VH). 
The DLB+VH and the DLB-VH groups were compared to control and AD groups 
using single factor analysis of variance on transformed data as appropriate (Winer 
et al, 1991). Data analysed included demographic features as well as the primary 
outcome measures from the psychometric analyses (NART pre-morbid IQ, total 
CAMCOG score for overall cognitive impairment, and primary outcome measures 
from the CDR assessment battery). In the following presentation of statistical 
findings, figures are not drawn to illustrate findings when differences exist only 
between the control and three dementia groups. Where findings indicate 
significant differences between dementia groups these findings are illustrated in 
more detail. 
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7.4.2 Comparison of demographic features and non-computerised 
psychometric assessment in control, AD, DLB-VH, and DLB+VH groups. 
Details of group means for age, mean estimated pre-morbid IQ (NART) and 
overall severity of cognitive impairment are described in Table 7.17. All four 
groups were matched for age and estimated pre-morbid IQ (NART). As expected, 
the control group showed less severe overall cognitive impairment as measured by 
the CAMCOG schedule than all dementia groups (F(3,92)=38.55, p<0.001), 
although there were no differences in degree of overall cognitive impairment 
between the dementia groups. 
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7.4.3 Attentional function. 
Performance indices for tests of the computerised tests of attentional function are 
detailed in Table 7.18 and Figures 7.20,7.21, and 7.22. 
7.4.3.1 Simple reaction time (SRT). 
Analysis indicated that all three dementia groups took longer to respond than 
controls on the simple reaction time task (F(3,91)=20.12, p<0.001). In addition the 
DLB+VH group took longer to respond than both the AD and DLB-VH groups, 
although response latencies for the AD and DLB-VH groups were not 
significantly different. 
Figure 7.21: Simple reaction time: mean response latencies (±SEM) for controls 
(n=26), AD (n=45), DLB-VH (n=10), and DLB+VH (n=14) groups. 
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7.4.3.2 Choice reaction time (CRT). 
Accuracy of responses in the choice reaction time task was similar for all groups 
(see Table 7.18). Response latencies for the reaction time task were significantly 
greater for all dementia groups than the control group. Furthermore, both DLB- 
VH and DLB+VH groups responded significantly slower than the AD group 
(F(3, qo)=20.42, p<0.001), although the response latencies did not differ for the two 
DLB groups. 
Figure 7.22: Choice reaction time: mean response latencies (±SEM) for controls 
(n=26), AD (n=45), DLB-VH (n=10), and DLB+VH (n=13) groups. 
significant difference (p<0.05) compared to controls 
significant difference (p<0.05) compared to AD 
7.4.3.3 Cognitive reaction time 
Analysis indicated a main effect of group for cognitive reaction times 
(F(3,9o)=2.75, p=0.05), however, subsequent analyses indicated no significant 
differences between groups. 
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7.4.3.4 Di2it viiailance task. 
The percentage of targets digits detected in the number vigilance task was greater 
in the control group than all of the dementia groups (F(3,91)=18.78, p<0.001). In 
addition, the percentage of target digits detected was less in the DLB+VH group 
than in the DLB-VH and AD group, although the DLB-VH and AD group 
performed equivalently. 
Figure 7.23: Digit vigilance task: meanDercent of target digits detected (±SEM) 
for control (n=26), AD (n=45), DLB-VH (n= 10), and DLB+VH (n= 14) groups. 
significant difference (p<0.05) compared to controls 
significant difference (p<0.05) compared to AD 
significant difference (p<0.05) compared to DLB-VH 
Response latencies for the number vigilance task were greater in all of the 
dementia groups than the control group (F(3,91) --- ý 10.57, p<0.001), however, there 
were no differences in response latencies between dementia groups. All group 
means for response latencies were within the 1250 mS response window for the 
digit vigilance task (see Table 7.18). 
7.3.4.5 Critical flicker fusion. 
Analysis indicated no group differences on the critical flicker fusion task. 
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7.4.4 Secondary memory. 
Data pertaining to group performance in the CDR secondary memory tests is 
detailed in Table 7.19, and Figures 7.24,7.25, and 7.26. 
7.4.4.1 Immediate word recognition- 
In the immediate word recognition task all dementia groups were less able than 
controls to discriminate between previously seen words and novel distracter words 
(F(3,92)=22.06, p<0.001). There were, however, no differences in recognition 
sensitivity indices between the AD, DLB-VH and DLB+VH groups. A similar 
pattern of performance was observed for responses latencies in the immediate 
word recognition task, all patient groups took longer to respond than controls 
(F(3,92)=27.09, p<0.001) but there were no differences between dementia groups. 
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7.4.4.2 Delayed word recognition. 
Analysis of sensitivity indices for the delayed word recognition task revealed the 
control group's discrimination between previously seen words and novel 
exemplars was significantly better than all of the dementia groups (F(3,91)=24.87, 
p<0.001), however there were no differences between the dementia groups. 
Response latencies for the control group were significantly greater for all 
dementia groups than controls (F(3,91)=24.67, p=0.001). Furthermore, the 
DLB+VH group took longer to respond than the DLB-VH group. All other 
comparisons were non- significant. 
Figure 7.24: Delayed word recognition: mean response latencies (±SEM) for 
control (n=26), AD (n=45), DLB-VH (n=10), and DLB+VH (n=14) groups. 
significant difference (p<0.05) compared to controls 
significant difference (p<0.05) compared to DLB-VH 
217 
7.4.4.3 Delaved nicture recoianition. 
The sensitivity index for the control group was significantly greater than for all 
dementia groups (F(3,90)=22.72, p<O. 00 1), however pair-wise comparisons 
indicated no significant difference between dementia groups. Response latencies 
for the control group were shorter than the response latencies for all three 
dementia groups (F(3,90)=30.15, p<0.001). In addition, the DLB+VH group took 
longer to respond than the DLB-VH group. All other comparisons between 
dementia groups failed to reach significance. 
Fiaure 7.25: Delaved Dicture recoanition: mean reSDonse latencies (±SEM) for 
control (n=26), AD (n=44), DLB-VH (n=10), and DLB+VH (n=14) groups. 
significant difference (p<0.05) compared to controls 
significant difference (p<0.05) compared to DLB-VH 
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7.4.4.4 Delayed face recognition. 
On the delayed face recognition task, all dementia group's sensitivity indices were 
less than controls (F(3,88)=l 1-80, p<0.001), although there were no differences 
between the dementia groups. Analysis of response latencies indicated a similar 
pattern to that seen for delayed word and picture recognition. The DLB+VH 
group took significantly longer to respond than the DLB-VH group, but all other 
comparisons between dementia groups were non-significant. 
Figure 7.26: Delayed face recognition: mean response latencies (±SEM) for 
control (n=26), AD (n=44), DLB-VH (n=10), and DLB+VH (n=12) groups. 
significant difference (p<0.05) compared to controls 
significant difference (p<0.05) compared to DLB-VH 
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7.4.5 Working memory. 
Data pertaining to group performance in the CDR working memory tasks are 
presented in Table 7.20. 
7.4.5.1 Spatial working memory. 
The control group was better able than all three dementia groups to discriminate 
previously seen locations from novel exemplars (F(3,89)=27.29, p<0.001). In 
addition, the DLB+VH group had a significantly lower mean spatial memory 
sensitivity index than the DLB-VH and AD group. The sensitivity indices for the 
DLB-VH and AD groups were similar (see Figure 7.26). 
Figure 7.26: Spatial working memory: mean sensitivity indices (±SEM) for 
controls (n=26), AD (n=45), DLB-VH (n=10), and DLB+VH (n=12) groups. 
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Sensitivity indices for each of the dementia groups were compared to chance 
performance (sensitivity index = 0.0) using single sample t-tests. Performance 
significantly above chance was observed for both the AD (t=3.03, p=0.004) and 
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DLB-VH (t=2.67, p=0.03) groups, however, the DLB+VH group did not perform at 
above chance levels. 
Analysis of the response latencies for indicated that all dementia groups responded 
significantly slower than controls (F(3,89)=16.46, p<0.001), however, all three dementia 
groups responded following similar latencies. 
7.4.5.2 Numeric workinia memor 
Comparison of group sensitivity indices failed to discriminate between any of the 
groups. Analysis of response latencies indicated that all dementia groups responded 
slower than controls (F(3,89): --": 16.46, p<0.001), however response latencies for all three 
dementia groups were similar. 
7.5 Additional comparisons of groups based on clinical symptoms. 
Additional comparisons were intended between dementia cases with and without major 
depression, however, a paucity of cases with clinically diagnosed major depression (AD 
n=4; DLB n=3) precluded such a comparison on statistical grounds. 
Furthermore, intended investigations to establish the relationship between clinically 
identifiable fluctuating cognitive impairment and cognitive function in DLB cases also 
proved statistically non-viable. The clinical identification of fluctuating impairment was 
made in all but one of the DLB cases in the cohort for this study. 
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Chapter 8: 
A comparative study of cognitive per ormance in 
AD, and elderly controls using the Cognitive Drull 
Research Computerised Assessment Battery (CDR): 
Discussion 
8.1 Introduction. 
This body of work is the largest prospective comparison of DLB, AD and control 
groups to date. Intra-group comparison of probable and possible diagnostic 
categories indicated no differences in cognitive performance in either AD or DLB 
groups. Subsequent comparative analysis of controls with pooled (i. e. both 
probable and possible categories) AD and DLB groups demonstrated impairment 
in the dementia groups in all areas of cognitive function examined. 
The AD and DLB groups, who were carefully matched for global severity of 
cognitive impairment, showed distinct profiles of differences in performance on 
several measures of cognitive function. The DLB group showed particularly poor 
attentional function and relatively, preserved delayed verbal recognition memory 
compared to the AD group. Such a double dissociation of AD and DLB groups on 
tests of attentional and mnemonic function further support DLB as a form of 
dementia with a profile of cognitive impairment distinct from AD. 
Similar performance in the two dementia groups was observed on a number of 
measures. Although impaired on both tests of working memory compared to 
controls, numeric working memory was relatively preserved in both dementia 
groups compared to visuo-spatial working memory. Further, immediate word 
recognition, as well as secondary pictorial and face recognition memory, were 
markedly impaired in both dementia groups, though the analysis failed to 
distinguish between them. 
A comparison of controls, AD and DLB groups with persistent visual 
hallucinations (DLB+VH) and without (DLB-VH) persistent visual hallucinations 
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found both DLB groups to be distinct from the AD group. Furthermore, the 
DLB+VH group showed a distinct profile of impairment from the DLB-VH group. 
The number of hallucinating AD patients was too small (n=4) to allow useful 
comparison with non-hallucinating AD patients. 
Many, but not all, of the differences described between DLB and AD groups may 
be associated with the presence of visual hallucinations in the DLB group. The 
DLB+VH group showed particularly poor attentional function, demonstrated by 
poor performance on the simple reaction time and digit vigilance tasks. Although 
similar sensitivity indices were seen for all dementia groups on all delayed 
secondary memory tasks, the DLB+VH group showed longer response latencies. 
The DLB+VH group performed at chance level and worse than both the AD and 
DLB-VH groups on the spatial working memory task. All groups showed similar 
performance on the numeric working memory task. 
These data suggest that hallucinations and poor cognitive function co-exist and 
might be produced by a common underlying mechanism such as particularly 
reduced cholinergic function in the DLB+VH group. The DLB group without 
persistent visual hallucinations also showed a profile of cognitive impairment 
distinct from the AD group, but a statistically significant difference was found 
only on a single task (choice reaction time). 
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8.2 The comparative neuropsychology of DLB and AD 
8.2.1 Attentional deficits in AD and DLB. 
8.2.1.1 Simple and choice reaction times. 
Many studies investigating 'intensive' aspects of attention (alertness and power of 
concentration) have employed reaction times as an index of available processing 
resources. Although it is possible to have relatively specific or restricted deficits in 
selective attention, any disruption of the intensive components will inevitably 
exert more widespread detrimental effects upon information-processing. 
Simple reaction time, as its name implies, invokes relatively elementary 
information-processing skills, and is also procedurally comparatively simple. 
Performance on the simple reaction time task is contingent on a number of factors, 
including: motor response speed (neural conduction velocity, and effector and 
muscular response); exteroceptor operations; and the central stimulus-response 
integration. The stimulus-response integration requires attentional components, 
such as the ability to develop and maintain an appropriate state of readiness to 
respond to the stimulus. In simple reaction time tasks the stimuli and response are 
the same on every trial, so identification and encoding of the response are not 
required. The participant can, therefore, pre-programme the response, which only 
needs to be initiated when the imperative stimulus is registered. Choice reaction 
time also involves all of the underlying components of simple reaction time, but 
requires additional central processing. The participant must, additionally, 
discriminate stimuli and make contingent responses. This prevents pre- 
programming of responses possible in simple reaction time. Cognitive models of 
uncued simple and choice reaction time are shown in Figure 8.1. 
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Figure 8.1: Cognitive processing involved in uncued simple and choice reaction 
time tasks adamed from Jahanshahi et al (1992a). 
I Simple Reaction Time I 
Imperative Stimulus 
Stimulus Registration 
Response pre- [6ý Response Initiation 
Response 
I Choice Reaction Time I 
Imperative Stimulus 
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Mapping 
I Response Selection I 
Response Programming 
I Response Initiation I 
Response 
Simple reaction times were markedly slower in both dementia groups than 
controls. In addition, the DLB group responded more slowly than the Alzheimer's 
disease group. A similar pattern of performance was observed in the choice 
reaction time task in which response latencies were in the order: control < AD < 
DLB. All groups responded with similar accuracy on the choice reaction time task. 
The relationship between the simple and choice response latencies and clinical 
measures of motor impairment in the DLB and AD groups were investigated using 
correlational analysis. There were no significant correlations between clinical 
measures of motor impairment (bradykinesia score and overall Unified 
Parkinson's Disease Rating Scale score) and measures of performance on the 
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reaction time tasks (response latencies SRT + CRT) or accuracy (choice reaction 
time). Previous studies have demonstrated that the short ballistic finger 
movements that constitute responses in the CDR reaction time tasks are easily pre- 
programmed (Klapp, 1975; Bloxharn et al, 1984). Thus, the increased response 
latencies in the DLB group, particularly on the simple reaction time task, is 
unlikely to reflect an inability to pre-programme the simple motor response 
required. 
Studies investigating simple and choice reaction time in PD patents have generally 
described simple reaction times of around 500 milli-seconds, although numerous 
studies have failed to discriminate PD and control groups on measures of simple 
and choice reaction time (Jahanshahi et al, 1992a; 1992b; Pate et al, 1994). The 
response latencies of the non-demented PD patients (-500 milli-seconds), with 
similar motor difficulties to the DLB group, are noticeably shorter than those 
observed for the DLB group (-1150 milli-seconds) investigated in this study. This 
provides further support for the assertion that motor disability is unable to account 
for the markedly increased response latencies of the DLB group in the simple and 
choice reaction time tasks. 
The lack of association between reaction times and clinical measures of motor 
impairment in DLB, and the longer simple reaction times observed in the DLB 
group compared to previous studies investigating PD patients with similar motor 
difficulties, suggest that the particularly poor performance of the DLB group be a 
consequence of disruption of intensive aspects of attentional function. This would 
appear to be a predominant feature of the cognitive impairment associated with 
DLB. 
8.2.1.2 Cosmitive reaction time. 
The measure of cognitive reaction time described in this study represents the mean 
differences between simple and choice reaction times. Cognitive reaction time is a 
means of studying the information-processing requirements distinguishing these 
tasks, whilst controlling for perceptuo-motor dysfunction. Based on the cognitive 
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model proposed by Jahanshahi et al (I 992a), cognitive reaction time is comprised 
of the time taken between registration of a stimulus and its identification, the 
mapping of stimuli to the appropriate responses, and the selection and 
programming of the contingent response. 
Cognitive reaction time was not increased in the AD group compared to controls. 
However, there is a marked increase in the cognitive reaction time of the DLB 
group. This suggests that 'central processing' speed in the DLB group is slower 
than in the AD and control groups. Slowing of central processing speed may 
reflect difficulties in any one of the individual cognitive processes which 
distinguish simple and choice reaction time. Equally, the slowed cognitive 
reaction time may reflect a general slowing of processing speed (bradyphrenia), 
which is apparent for all of the components of cognitive reaction time. 
Bradyphrenia is a generic term describing slowing of thought processes and 
describes similar slowing of information-processing to the increased cognitive 
reaction times described in this study. Numerous studies have demonstrated 
bradyphrenia in PD (e. g. Cummings, 1986; Pate et al, 1994), although these 
findings are not equivocal (e. g. Bloxham et al, 1987). Wesnes (1996) found 
cognitive reaction time in AD to be similar to controls in a large comparative 
study. Data from the current study support similar cognitive reaction times in AD 
and control groups. Furthermore, Wesnes et al (1996) demonstrated no increase in 
cognitive reaction time in normal young controls who were administered doses of 
scopolamine sufficient to induce a broad range of cognitive impairment in other 
cognitive domains. It is therefore possible that the slowed cognitive reaction time 
in the DLB group is not principally related to cholinergic dysfunction, and may be 
due to the other fundamental neurochemical abnormality in DLB, namely 
depletion of doparninergic nigro-striatal cells. 
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8.2.1.3 Sustained attention in DLB. 
The digit vigilance task in the CDR battery is similar to the Continuous 
Performance test originally developed by Rosvold et al (1956). This test requires 
the participant to sustain intensive attentional resources on a task over a relatively 
short period of time. The DLB group showed marked impairments compared to 
AD and control groups; the DLB patients being unable to sustain intensive 
attentional resources for the duration of this relatively brief vigilance test. 
This is the first study to directly assess sustained attention in DLB. Previous work 
(e. g. McKeith et al, 1992c, 1996a) has identified fluctuation and idiopathic 
clouding of consciousness as a prominent feature of DLB. This has been included 
in diagnostic criteria as a feature supportive of a diagnosis of DLB. The DLB 
group's problems in sustaining attention may represent a neuropsychological 
quantification of the gross fluctuations and idiopathic clouding of consciousness 
observed in DLB. 
To elucidate the causality of observed deficits on the digit vigilance task, the 
possibility that motor impairments contribute to the poor performance must be 
considered. To correctly identify target digits in the digit vigilance task, 
participants must respond within 1.25 seconds of the target digit presentation. 
Thus, slow responses might contribute to the poor digit vigilance performance in 
the DLB group. This notion might be supported by the observation that the 
number of false alarm responses was significantly greater in the DLB than control 
group. However, the number of false alarms made by the DLB and AD groups was 
not statistically different. 
Examination of false alarms made by the DLB group revealed that 31% of the 
false alarms were made between two correctly detected target digits and cannot be 
attributed to slow responses. The remaining 69% of the false alarms made by the 
DLB group were not made between successive, correctly detected target digits. It 
is possible that these false alarms were due to slow motor responses, to the 
preceding target digits, which were outside the 1.25 second response window. 
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However, the CDR system allows calculation of the time elapsed between 
presentation of the last target digit and each false alarm. For false alanns not 
occurring between two successive correctly detected target digits, the mean time 
elapsed between the presentation of the previous target digit and the false alarms 
was 4.62 (±4.74) seconds. This is considerably greater than the 1.25 second 
response window and, therefore the increased number of false alarms observed in 
the DLB group does not appear to reflect an inability to make a response within 
the requisite time. 
During testing, the experimenter remarked that some DLB cases made repeated 
stereotypical pressing responses during the digit vigilance task following response 
to a target digit. This observation, although not quantitative, suggests the basis of 
the observed increased false alarm rate in the DLB group was stereotypical 
response patterns rather than slow motor responses. 
Poor performance on the digit vigilance task might conceivably be due to 
problems in understanding and retaining task instructions throughout the duration 
of the task. However, the DLB group showed similar language comprehension 
skills to the AD group on the CAMCOG schedule, and were able to complete 
other CDR tasks of similar or greater complexity with equivalent or better 
performance than the AD group. Furthermore, during testing the experimenter 
frequently observed DLB patients missing, but subsequently correctly identifying, 
target digits throughout the course of the digit vigilance task. These observations 
imply that problems in understanding and retaining the task instructions are 
unlikely to be major confounds of performance on the digit vigilance task. 
Both neuropsychological and clinical observations strongly suggest, therefore, that 
DLB patients have great difficulty sustaining attentional resources. Previous 
studies have investigated the neurochernical basis of sustained attention. 
Numerous studies on the effect of the administration of scopolamine have 
demonstrated linear dose-dependent deficits in the ability to sustain attention 
(Broks et al, 1988; Parrott, 1986; Wesnes et al, 1983a). These deficits have been 
shown to be due to the central, rather than peripheral, effects of scopolamine. 
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Administration of methoscopolamine, which has similar peripheral attributes to 
scopolamine but is unable to cross the blood brain barrier, failed to reproduce the 
deficits associated with centrally acting scopolamine. Furthermore, nicotine has 
been shown to improve sustained attention in scopolamine induced cognitive 
impairment (Wesnes et al, 1984). Nicotine has also been shown to improve 
vigilance performance in AD patients (Sahakian et al, 1989). 
The involvement of the cholinergic system in attentional function is well 
documented (Broks et al, 1988; Parrott, 1986; Wesnes et al, 1983a). The 
combination of particularly compromised cholinergic function and poor sustained 
attention performance are consistent with the assertion that disruption of 
cholinergic nuclei and pathways contributes significantly to the reduced ability to 
sustain visual attention in the DLB group. 
8.2.2 Secondary memory in AD and DLB. 
The disruption of memory function in dementia has been extensively 
demonstrated by the present study. The marked impairment of secondary verbal 
and pictorial recognition memory further characterises this mnemonic impairment 
as a prominent feature in AD and DLB. Secondary memory tests assess the ability 
to retain information over a period of time without constant rehearsal of this 
information. 
Both AD and DLB groups showed a similar degree of impairment on recognition 
sensitivity indices and measures of response latencies for immediate word 
recognition as well as delayed picture and face recognition tasks. The DLB group, 
however, discriminated previously seen words from novel exemplars more 
successfully than the AD group in the delayed word recognition task, without a 
concomitant increase in the latency to respond. 
The DLB group also demonstrated less impairment than the AD group on the 
recent memory and visual recognition memory subsections of the CAMCOG 
schedule. Although there is undoubtedly marked mnemonic impairment in the 
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DLB group, performance on several tasks assessing memory function suggest the 
mnemonic impairment in DLB to be less severe than in AD. 
Equivalent or better mnemonic function in DLB than AD has been reported by 
numerous researchers using a variety of tasks. McKeith et al (I 992c) found SDLT 
cases were less impaired on a test of free recall. F6rstl et al (1993) found 
equivalent impairment of AD and LBV cases on a global score of memory from 
the CAMCOG schedule. Hansen et al (1990) showed equivalent performance of 
matched AD and LBV groups on tests of semantic and episodic secondary 
memory. The same group of researchers showed more severe mnemonic 
impairment in a group of 23 AD cases than in 23 matched LBV cases on some 
memory subscales of the Mattis Dementia Rating scale (DRS). Samuel et al 
(1995) also compared cognitive function in LBV and AD using the Mattis DRS, 
but failed to replicate the less severe mnemonic deficit in DLB. Sahgal and 
colleagues reported equivalent performance of SDLT and AD groups on a test of 
pattern recognition memory, and more impaired performance of the SDLT group 
on a matching to sample procedure, although, as previously discussed, 
performance on the matching to sample task may reflect non-specific difficulties 
in the DLB group with matching to sample procedures. 
Ballard et al (I 996b) compared AD and SDLT groups using the CAMCOG 
schedule and demonstrated similar performance on most tests of mnemonic 
ftinction, although the DLB group were less impaired on the recent memory 
subscale. Walker et al (1997) found LBD patients were less impaired on the recent 
memory recall subsection of the CAMCOG. 
Mnemonic function does not, however, operate in isolation from other aspects of 
cognitive function. Intact attention is an essential prerequisite for the efficient 
execution of all information-processing operations. The role of attentional 
dysfunction in the genesis of mnemonic impairment in AD, and particularly DLB, 
is an important consideration when comparing these groups. This study has 
described attentional impairment in both dementia groups, though the DLB group 
show particularly reduced attentional capabilities. Although observed secondary 
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memory impairments are associated with both attentional and mnemonic deficits 
in both AD and DLB groups, the relative contribution of these cognitive domains 
may be different in DLB and Alzheimer's disease. It is possible that attentional 
deficits are more consequential in the genesis of the mnemonic impairment seen in 
DLB. 
The demonstration, by numerous authors, that mnemonic impairment is less 
severe in DLB than AD is consistent with the neuropathology of these disorders. 
The memory deficits associated with AD have been strongly linked to 
neuropathological burden in the medial temporal lobe. In particular, the 
hippocampus, entorrhinal cortex and parrahippocampal gyrus (Braak at al, 1991) 
are thought to underlie memory consolidation. Studies investigating pathological 
burden in these areas in AD and DLB have demonstrated that ubiquitin- 
immunoreactive dystrophic neurites are often present in the CA2/CA3 region of 
the hippocampus in DLB (Dickson et al, 1991). However, the senile plaque and 
neurofibrillary tangle burden is less in DLB than AD. The hippocampus and 
related structures are generally thought to be less damaged in DLB than in AD 
(Salmon et al, 1996). 
It is therefore possible that differences in hiPpocampal pathological burden 
underlie the relative preservation of secondary memory function in DLB compared 
to AD, described in this and other studies. Nevertheless, the problems of isolating 
circumscribed brain areas in patients with diffuse damage, and the uncertain 
causal link between neuropathological burden and functional abilities are 
recognised. 
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8.2.3 Working memory in AD and DLB. 
The term working memory is used here to describe the storage and manipulation 
of small amounts of information for relatively short periods. In the present 
context, working memory is interchangeable with the term 'short-term memory'. 
The term is used in a more restricted fashion than it might be employed in other 
disciplines, for many of whom it can refer to the retention of information over 
periods of minutes, hours, days, or even weeks; which would be categorised as 
secondary memory in the present study. 
The current study investigated two aspects of working memory, specifically 
numeric and spatial working memory. The AD and DLB groups were impaired on 
both measures of performance (sensitivity index and speed) on both tests of 
working memory, though, the dementia groups did not show different 
performance on either task. On the spatial working memory task, the DLB group 
did not Perform above chance levels, suggesting possible floor effects in this 
group. Floor effects may have reduced the sensitivity of the spatial working 
memory test to discriminate AD and DLB groups. 
Few previous studies have directly assessed working memory in DLB patients. 
Hansen et al. 1990 reported LBV cases had reduced digit-span compared to AD 
cases. The digit-span subtest requires participants to repeat a random series of 
digits in the same (digit-span forward) or the reverse (digit-span backwards) order 
of presentation. However, digit-span forwards and digit-span reverse have 
different working memory loads. Digit-span forwards requires little manipulation 
of information, whereas digit-span reverse requires substantial working memory 
effort to rearrange the digits. If DLB cases do, indeed, have lowered working 
memory resources compared to controls, as is suggested by Hansen et al (1990), it 
might be expected that DLB cases would show a specific deficit in digit-span 
backwards compared to the AD group. Hansen et al (1990) do not distinguish 
digit-span forwards and backwards. However, Gnanalingham et al (1997) 
described performance on the digit-span forwards and backwards, and found 
neither measure discriminated AD and LBD groups. These data are in 
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concordance with findings from the current study, which suggest numeric working 
memory is equivalently impaired in the two dementia groups. 
The visuo-spatial praxis section of the CAMCOG has discriminated AD and DLB 
groups in both the current and previous studies (Walker et al, 1997). The visuo- 
spatial praxis subsection undoubtedly involves aspects of spatial working memory. 
However, other aspects of cognitive, and especially motor, function confound a 
direct comparison with performance on the CDR spatial working memory task. 
Comparison of numeric and spatial working memory performance suggests that 
numeric working memory may be relatively preserved in both dementia groups, 
compared to spatial working memory. The confounding effect of task difficulty on 
this comparison can be eliminated by directly relating AD and DLB to control 
group performance. In the numeric working memory task, the AD and DLB 
group's recognition sensitivity indices were 81% and 76% of control values 
respectively. In the spatial working memory task, the AD and DLB group's 
sensitivity indices were 19% and 9% of control values respectively. Response 
latencies were increased in both numeric working memory (AD=257% and 
DLB=346% of control group) and spatial working memory (AD=286% and 
DLB=279% of control group). 
These data support the notion that numeric working memory ability is relatively 
preserved compared to spatial working memory ability in both AD and DLB. Both 
tasks are similar in terms of the responses required: the number of pieces of 
information to be remembered (3 digits and 4 spatial locations); and the number 
(nine) of possible locations / numbers from which 'to be remembered' information 
must be selected. In view of these findings, AD and DL13 groups have greater 
difficulty on tasks assessing spatial compared to numeric information. In addition, 
these findings further the considerable evidence for the separation of visual and 
verbal working memory systems (Baddeley, 1991). 
In summary, findings from the current and previous studies suggest that working 
memory declines in dementia. Spatial working memory appears to be more 
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sensitive than numeric working memory to the changes associated with AD and 
DLB. Neither spatial or numeric working memory discriminated between AD and 
DLB groups although this is possibly due to floor effects, especially in the spatial 
working memory task. 
8.2.4 Summary. 
A double dissociation has been described between AD and DLB dementia groups 
on tests assessing attentional and secondary word recognition memory. This 
further confirms the neuropsychological distinction of these dementing disorders. 
This study is the first to assess sustained attention and speed of information 
processing in these groups. The importance of including the assessment of 
attentional function in neuropsychological and pharmaceutical studies of dementia 
patients has been demonstrated. The assessment of attentional function has 
previously received limited regard in dementia (Hart et al, 1994). The study also 
highlights the need to assess diverse aspects of cognition in dementia patients to 
avoid misinterpretation of aspects of cognitive dysfunction studied in isolation. 
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8.3 Visual hallucinations and cognitive function in dementia with 
Lewy bodies. 
Visual hallucinations (fleeting and persistent) are observed in the majority (93%) 
(Ballard et al, 1997b) of DLB cases and are an important diagnostic consideration 
(McKeith et al, 1992c; 1996a). Persistent visual hallucinations, starting within 
three years of the onset of dementia, are strongly associated with cortical Lewy 
bodies (McShane et al, 1995). In addition, neurochernical analysis has 
demonstrated that hallucinating DLB cases show more profoundly (80% 
reduction) depleted choline acetyltransferase levels compared to non-hallucinating 
DLB cases (50% reduction). Non-hallucinating DLB cases show a similar 
reduction in choline acetyltransferase activity to that observed in AD (Perry et al, 
1990a: 1990b). 
This study compared neuropsychological deficits in hallucinating (DLB+VH) and 
non-hallucinating (DLB-VH) DLB cases with Alzheimer's disease, who were 
matched for global severity of cognitive impairment. A strong association between 
the presence of persistent visual hallucinations and the profile of cognitive 
impairment in the DLB group was observed. The DLB+VH group showed worse 
performance on two tasks assessing attentional function (simple reaction time and 
digit vigilance) than the DLB-VH group, whose performance was similar to the 
AD group. On the spatial working memory task, the DLB+VH group performed at 
chance levels, and had a significantly lower sensitivity index than the DLB-VH 
and AD groups who performed equivalently. Similar response latencies were 
observed for both DLB groups on the choice reaction time task. Response 
latencies were significantly longer than those recorded for the AD group. 
Measures of secondary memory failed to discriminate the dementia groups when 
sensitivity indices were compared. Comparison of response latencies, however, 
revealed the DLB+VH group took longer to respond on the delayed word, picture 
and face recognition tasks than the DLB-VH group and AD group, who responded 
following similar latencies. 
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The four groups were not significantly different on several indices of performance, 
namely: choice reaction time accuracy; numeric working memory; and cognitive 
reaction time. 
Thus, the DLB-VH group had a profile of cognitive impairment similar to the AD. 
Nonetheless, choice reaction time response latencies discriminated the AD and the 
DLB-VH group. The DLB+VH group showed a profile of cognitive impairment 
which was markedly different from both AD and DLB-VH groups. The 
neurochemical basis of these differences are discussed in more detail in the 
General Discussion (see Chapter 12). 
The current study compared 10 non-hallucinating and 14 hallucinating DLB cases, 
which represents a prevalence rate of 60% for persistent visual hallucinations in 
the DLB group under investigation. The prevalence rate of visual hallucinations 
reported in Newcastle has previously been reported as 80% (McKeith et al, 
1992c). More recently, Ballard et al (1997b) also reported that 80% of DLB cases 
experienced persistent visual hallucinations. The prevalence of persistent visual 
hallucinations in the DLB cohort reported in this study appears somewhat less 
(60%) than the population from which the participants were recruited. 
Several possible explanations for this possible selection bias exist. Firstly, the 
DLB+VH group demonstrated worse performance than the DLB-VH group on all, 
but one, measure of performance. Thus, hallucinating DLB cases may be less able 
to usefully complete neuropsychological. investigation, as a consequence of the 
more severe cognitive impairment associated with the presence of persistent visual 
hallucinations. Secondly, hallucinating DLB cases are, by definition, 
behaviourally disturbed. The behavioural and emotional stress associated with 
visual hallucinations may have precluded some DLB+VH cases from completing 
the neuropsychological evaluation. 
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8.3.1 Summary. 
This is the first study to examine the relationship between the presence of 
persistent visual hallucinations and cognitive function. Distinct profiles of 
cognitive impain-nent have been described in matched DLB+VH, DLB-VH, and 
AD groups. The neuropsychological implications of differing patterns of 
neurochemical and neuropathological changes in these groups is addressed in 
detail in the General Discussion (see Chapter 12). 
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Chapter 9: 
A comparative study of cognitive decline over one year i 
DLB., AD, and elderly controls using the Coimitive Drug 
Research Computerised Assessment Battery (CDR): Methods. 
9.1 Introduction. 
This chapter describes the methods for a comparative study of cognitive decline in a 
cohort of DLB, AD, and elderly controls using the Cognitive Drug Research 
Computerised Assessment Battery (CDR). All participants included in the I year 
follow-up analysis were part of the initial cohort described in Chapter 6. 
9.2 Participants. 
See general methods (Chapter 2) for details of recruitment and standardised assessment 
of cases. 
All participants in the initial cross sectional cohort were considered for follow-up 
cognitive testing. The cases reported are those, which, have undergone repeat cognitive 
testing at one year. A number of participants from the original cohort did not undergo a 
follow-up assessment due to death, physical ill health, or because they had become too 
demented or refused to partake in further testing. Furthermore, 27 participants who 
underwent assessment in the original cross-sectional study have not (to date) been 
approached for follow-up assessment as 12 months have not elapsed since baseline 
assessment. 
Participants who underwent a follow-up cognitive assessment included 18 elderly 
controls, 20 AD patients, and 10 DLB patients. A number of these cases did not 
complete the entire test battery. The number of participants completing each CDR task 
is outlined in the appropriate sections. 
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9.3 Procedures. 
9.3.1 Non-computerised psychometric assessment. 
Non-computerised psychometric assessment (NART, CAMCOG) were carried out at 
baseline only and are as previously described (see Section 6.4.1. ). 
9.3.2 Computerised assessment using the CDR hattery. 
At I year follow-up, all participants were tested using a parallel form of the CDR battery 
used at baseline assessment. The parallel CDR battery used novel stimuli for all tests 
except the simple and choice reaction time tasks. The follow-up assessment using the 
CDR battery was otherwise as previously described (see Section 6.4.2). 
9.4 Statistical procedures. 
Indices of performance in the follow-up CDR assessment were as previously described 
(see Section 6.5). 
Group means for baseline matching measures (age, estimated pre-morbid IQ, overall 
CAMCOG score) were compared using one-way analysis of variance and Newman- 
Keuls post-hoc pair-wise comparisons. 
Group means for baseline and follow-up scores on the primary outcome measures of the 
CDR assessment were compared using two-way analysis of variance with repeated 
measures in one factor. Diagnostic group ( control, AD, & DLB) was the between 
subjects factor, and CDR assessments at baseline and one year were the repeated 
measure. Newman-Keuls post-hoc pair-wise comparisons were applied when significant 
effects were described. Analysis of means were employed when significant interaction 
terms were found. Percentage decline compared to baseline scores over the one year 
period are also described. 
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Chapter 10: 
A comparative study of cotmitive decline over one vear in 
DLB, AD, and elderly controls usin2 the CoLynitive Drui! 
Research Computerised Assessment Battery (CDR): 
Results 
10.1 Comparison of baseline demographic features and non- 
computerised psychometric assessment in control, AD and DLB 
groups. 
Details of group means, and a summary of statistical analyses, for age, mean 
estimated pre-morbid IQ (NART), and overall severity of cognitive impairment 
(CAMCOG total score) are presented in Table 10.1. These assessments were used 
for matching procedures only and were not repeated at the one year follow-up 
assessment. 
Table 10.1: Comparative analysis of age (±SEM), estimated pre-morbid IQ 
(NART) (±SEM) and overall severily of dementia (CAMCOG total score) 
(±SEM) at baseline for control, AD and DLB gropps. 
Control AD DLB One-way ANOVA 
(n= 18) (n=20) (n=10) 
Age 74.8 (±1.84) 79.3 (±1.48) 78.4 (±2.15) N. S 
NART 115.7 (±1.5) 111.6 (±1.3) 109.7 (±1.3) F(2,45)=2.84, p=0.07 
pre-morbid 
IQ 
CAMCOG 102.3 (±0.83) 66.8 (±2.88) 59.6 (±4.61) F(2,45)=16.54, p<0.001 
totalscore 
All diagnostic groups were matched for age. Analysis indicated that for estimated 
pre-morbid IQ (NART) a trend towards a main effect of group was observed. 
Which further analysis indicated to be due to the control group having higher 
estimated pre-morbid mean IQ than the DLB group. The AD and control group 
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did not differ for estimated pre-morbid IQ. The control group showed less overall 
cognitive impairment than both dementia groups (F(2,45)=16.54, p<0.001), though 
the dementia groups did not differ with respect to each other. 
The mean duration between baseline and follow-up assessments is presented in 
Table 10.2. Analysis indicated there were no differences between groups for the 
time elapsed between baseline and follow-up assessments. 
Table 10.2: Comparative analysis of mean time elapsed (dqys) (±SEM) between 
baseline and follow-up assessments for control, AD and DLB groups. 
Control AD DLB One-way 
(n= 18) (n=20) (n=10) ANOVA 
Time elapsed between 
baseline and follow-up 378 (±8) 379 (±6) 371 (±4) N. S 
assessment (days) 
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10.2 Computerised (CDR) cognitive assessment. 
All outcome measures and statistical analyses for this longitudinal investigation 
are reported in tabular form. To further illustrate findings, data is also presented in 
figures where significant between group, between visit, or interaction terms are 
described. 
10.2.1 Attentional function. 
10.2.1.1 Simple reaction time. 
Group means for response latencies at baseline and I year follow-up as well as the 
percentage change between baseline and I year follow-up are presented in Table 
10.3 and in Figure 10.1. A summary of statistical analysis using two-way ANOVA 
and Newman-Keuls post-hoc pair-wise comparisons is presented in Table 10.4. 
Table 10.3: Simple reaction time: mean response latencies (±SEM) at baseline and 
I year follow-up for control, AD, and DLB groups.. 
Control AD DLB 
Simple reaction time (mS) 
n 18 19 8 
Baseline 379 (±18) 670 (±71) 1294 (±243) 
Follow-up 400 (±21) 751 (±88) 2022 (±382) 
% change +6% +12% +56% 
Table 10.4: Simple reaction time task: summgly of ANOVA for response 
Inten ci f-. q 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,42)::::::::: 50.3, p<0.001 Control < AD < DLB 
visit F(1,42)=6.0, p=O. 0 19 Baseline < Follow-up 
Diagnostic group x Visit N. S. I -I 
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Analysis indicated a main effect of group (F(2,42)=50.3, p<0.001). Subsequent pair- 
wise comparisons showed group means for simple reaction times were in the 
order: control < AD < DLB. In addition, a main effect of visit was found 
(F(1,42)=6.0, p=0.0 19), which was shown to be due to reaction times for follow-up 
assessments being longer than reaction times for the baseline assessment. The 
interaction term (diagnostic group x visit) was not significant, indicating there was 
no disproportionate decline in any of the groups between baseline and 1 year 
follow-up visits. 
Figure 10.1: Simple reaction time task: mean response latencies (mS) (±SEM) fo 
control (n= 18), AD (n= 19) and DLB (n=8) groups at baseline and I year follow- 
up assessment. 
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Control AD DLB 
* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia groups 
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10.2.1.2 Choice reaction time. 
Group means for response latencies and accuracy at baseline and I year follow-up 
as well as the percentage change between baseline and I year follow-up are 
presented in Table 10.5 and Figure 10.2. A summary of statistical analysis using 
two-way ANOVA and Newman-Keuls post-hoc pair-wise comparisons is 
presented in Tables 10.6 and 10.7. 
Analysis indicated a main effect of group (F(2,4o)=44.0, p<0.001). Subsequent 
analysis indicated group means for choice reaction time response latencies were in 
the order: control < AD < DLB. A main effect of visit was found (F(1,4o)=7.2, 
p=0.01 1), which was shown to be due to response latencies for follow-up 
assessments being longer than response latencies at baseline. The interaction term 
(diagnostic group x visit) was not significant, indicating no disproportionate 
change in response latencies for the choice reaction time task in any of the groups 
between baseline and I year follow-up visits. 
Table 10.5: Choice reaction time: mean response latencies (±SEM) and accuracy 
(±SEM) at baseline and I year follow-up for control, AD, and DLB groups. 
Control AD DLB 
Choice reaction time task 
n 18 18 5 
Response latency (mS) 
Baseline 524 (±14) 768 (±44) 1766 (±441) 
Follow-up 567 (±45) 1024 (±135) 2148 (±382) 
% change +8% +33% +22% 
Accuracy (% correct) 
Baseline 96.1 (±0.86) 91.7 (±2.36) 91.0 (±1.87) 
Follow-up 98.1 (±0.59) 94.4 (±1.51) 84.0 (±6.60) 
% change +2% +3% -8% 
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Table 10.6: Choice reaction time: summary of ANOVA for response latencies. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,40)=44.0, p<0.001 Control < AD < DLB 
Visit F(1,4o)=7.2, p=O. 0 11 Baseline < follow-up 
Diagnostic group x Visit N. S. 
Figure 10.2: Choice reaction time task: mean response latencies (mS) (±SEM) for 
control (n= 18), AD (n= 18) and DLB (n=5) groups at baseline and I year follow- 
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* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia groups 
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Table 10.7: Choice reaction time: summM of ANOVA for response accuracy. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
DLB < control 
Diagnostic group F(2,4o)=6.9, p=0.003 DLB =- AD 
Control =-AD 
Visit N. S. 
Diagnostic group x Visit N. S. 
Analysis indicated a main effect of group (F(2,40)=6.9, p=0.003). Subsequent 
analysis indicated the DLB group were responding less accurately than the control 
group. All other comparisons were non-significant. There were no differences 
between response accuracies at baseline and at I year follow-up. The interaction 
term (diagnostic group x visit) was not significant, indicating there was no 
disproportionate decline in response accuracy for the choice reaction time task in 
any of the groups between baseline and I year follow-up. 
10.2.1.3 Cognitive reaction time. 
Mean changes between baseline and I year follow-up assessment for cognitive 
reaction times are presented in Table 10.8. Statistical analysis (see Table 10.9) of 
cognitive reaction time data indicated no significant findings for between group, 
and between visit, comparisons, or for the group x visit interaction term. 
Table 10.8: Cognitive reaction time: mean values (±SEM) at baseline and I year 
follow-up for control, AD, and DLB groups. 
Control AD DLB 
Cognitive reaction time (mS) 
n 18 19 6 
Baseline 145 (±12) 183 (±46) 765 (±504) 
Follow-up 167 (±37) 283 (±92) 645 (±160) 
% change 0/ +15 o +55% 16% 
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Table 10.9: Cognitive reaction time: summM of ANOVA for response latencies. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group N. S. 
Visit N. S. 
Diagnostic group x Visit N. S. 
10.2.1.4 Dijzit vigilance. 
Group means in the digit vigilance task primary outcome measures at baseline and 
I year follow-up, as well as the percentage change between baseline and I year 
follow-up are presented in Table 10.10 and Figures 10.3 and 10.4. A summary of 
statistical analysis using two-way ANOVA and Newman-Keuls post-hoc pair-wise 
comparisons is presented in Tables 10.11 and 10.12. 
Table 10.10: Digit vigilance: percent of target digits correctly identified (±SEM) 
and response latencies (±SEM) at baseline and 1 year follow-up for control, AD, 
and DLB groups. 
Control AD DLB 
Digit vigilance 
n 18 19 9 
Target digits identified 
(% correct) 
Baseline 98.9 (±0.60) 87.4 (+-4.17) 41.5 (±9.80) 
Follow-up 97.0 (±1.96) 82.8 (±5.21) 20.7 (±8.57) 
% change -2% -5% -50% 
Response latency (mS) 
Baseline 496 (±15) 627 (±22) 698 (±44) 
Follow-up 516 (±14) 621 (±30) 525 (±100) 
% change +4% - 1% -25% 
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Table 10.11: Digit vigilance: summajy of ANOVA for percent of target digits 
correctly identified. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,43)=65.2, p<0.001 Control > AD > DLB 
Visit F(1,43)=9-9, p=0.003 Baseline > follow-up 
Diagnostic group x Visit F(2,43)=4.5, p=O. 0 17 
1 
Figure 1 
. 
3: Digit vigilance: mean percent of target digits correctly identified (%) 
(±SEM) for control (n= 18), AD (n= 19) and DLB (n=9) groups at-baseline and I 
year follow-up. 
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* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia groups 
Analysis indicated a main effect of group (F(2,43)=65.2, p<0.001). Subsequent pair- 
wise comparisons indicated that group means for the percent of target digits 
correctly identified were in the order: control < AD < DLB. A main effect of visit 
was also demonstrated (F(1,43)=9-95 p=0.003), which was shown to be due to the 
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percent of target digits correctly identified at baseline being greater than at I year 
follow-up. 
The interaction term (diagnostic group x visit) was significant (F(1,43)=4.5, 
p=O. 0 17), indicating disproportionate change in the percent of target digits 
correctly identified by experimental groups between baseline and I year follow-up 
visits. Post-hoc, analysis of means indicated that the percent of target digits 
correctly detected by the control and AD groups at baseline and follow-up did not 
differ. However, the DLB group correctly detected fewer target digits at follow-up 
than at baseline (F(1,43)ý18.013, p<0.001). 
Table 1.0.12: Digit vigilance task: summM of ANOVA for response latencies. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
DLB > Control 
Diagnostic group F(2,43)= 10.3, p<0.001 AD > Control 
DLB AD 
Visit N. S. 
Diagnostic group x Visit N. S. 
Response latencies are described for responses to correctly detected target digits 
only. Mean response times for all groups were within the requisite 1.25 second 
response window. Comparison of response latencies for the digit vigilance task 
indicated a main effect of group (F(2,43)= 10.3, p<0.001), which further analysis 
indicated was due to both dementia groups responding more slowly than controls, 
though AD and DLB groups had similar response latencies. There were no 
differences between response latencies at baseline and at 1 year follow-up. The 
interaction term (diagnostic group x visit) was not significant. 
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Figure 10.4: Digit vigilance: mean response latencies (mS) (±SEM) for control 
(n= 18), AD (n= 19) and DLB (n=9) groups at baseline and I year follow-up. 
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* significant difference (p<0.05) compared to controls 
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10.2.2 Secondary memory. 
10.2.2.1 Immediate word recognition. 
Group means for primary indices of performance in the immediate word recognition 
task at baseline and I year follow-up, as well as the percentage change between baseline 
and I year follow-up, are presented in Table 10.13 and Figures 10.5 and 10.6. A 
summary of statistical analysis, using two-way ANOVA and Newman-Keuls post-hoc 
pair-wise comparisons, is presented in Tables 10.14 and 10.15. 
Table 10.13: Immediate word recognition: sensitivily indices (±SEM) and response 
latencies (±SEM) at baseline and I year follow-up for control, AD, and DLB groups. 
Control AD DLB 
Immediate word recognition 
n 18 21 10 
Sensitivity index 
Baseline 0.89 (±0.02) 0.37 (W. 06) 0.32 (±o. og) 
Follow-up 0.87 (±0.03) 0.41 (±0.05) 0.21 (±0.05) 
% change -2% + 11% -34% 
Response latency (mS) 
Baseline 876 (±32) 3518 (±528) 3979 (±949) 
Follow-up 985 (±114) 3330 (±567) 5432 (±874) 
% change +12% -5% -36% 
Table 10.14: Immediate word recoRnition: summga of ANOVA for recognition 
sensitivily index. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,46)=65.4, p<0.001 Control > AD > DLB 
visit N. S. 
Diagnostic group x Visit N. S. 
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Figure 10.5: Immediate word recognition: mean sensitiviiy indices (±SEM) for control 
(n== 18), AD (n=2 1) and DLB (n= 10) groups at baseline and I year follow-up. 
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* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia groups 
Analysis of sensitivity indices for the immediate word recognition task indicated a main 
effect of group (F(2,46)=65.4, p<0.001). Group means for immediate word recognition 
sensitivity indices were in the order: control > AD > DLB. There were no differences in 
sensitivity indices between baseline and I year follow-up visits. The interaction term 
(diagnostic group x visit) was non- significant. 
Table 10.15: Immediate word recognition: summM of ANOVA for response latencies. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,46)=51.4, p<0.001 Control < AD < DLB 
Visit N. S. 
Diagnostic group x Visit N. S. 
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Comparison of response latencies for the immediate word recognition task indicated a 
main effect of group (F(2,46)---,::: 5l. 4, p<0.001). Response latencies were in the order: 
control < AD < DLB. There were no differences between response latencies at baseline 
and at I year follow-up. The interaction term (diagnostic group x visit) was not 
significant. 
Figure 10.6: Immediate word recognition: mean response latencies (mS) (±SEM) for 
control (n= 18), AD (n=2 1) and DLB (n= 10) groups at baseline and I year follow-up. 
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dementia groups 
10.2.2.2 Delqyed word recognition- 
Group means for primary indices of performance in the delayed word recognition task at 
baseline and I year follow-up, as well as the percentage change between baseline and I 
year follow-up, are presented in Table 10.16 and Figures 10.7 and 10.8. A summary of 
statistical analysis, using two-way ANOVA and Newman. -Keuls post-hoc pair-wise 
comparisons, is presented in Tables 10.17 and 10.18. 
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Table 10.16: DelM ed word recognition: sensitivil y indices (±SEM) and response 
latencies (±SEM) at baseline and I year follow-up for control, AD, and DLB groups. 
Control AD DLB 
Delayed word recognition 
n 18 20 8 
Sensitivity index 
Baseline 0.83 (±0.03) 0.24 (±0.08) 0.30 (±0.12) 
Follow-up 0.81 (±0.04) 0.26 (±0.07) 0.19 (±0.10) 
% change -2% +8% -32% 
Response latency (mS) 
Baseline 864 (±34) 2051 (±197) 3383 (±1069) 
Follow-up 944 (±81) 2671 (±441) 4614 (±757) 
% change +9% -32% -37% 
Table 10.17: Delgyed word recognition: summM of ANOVA for recognition sensitiviiy 
index. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,43): --54.5, p<0.001 Control > (AD -= DLB) 
Visit N. S. 
Diagnostic group x Visit N. S. 
In the delayed word recognition task, analysis of recognition sensitivity indices indicated 
a main effect of group (F(2,43)=54.5, p<0.001). Both dementia groups scored lower 
sensitivity indices than the control group, but were similar to each other. There were no 
differences in sensitivity indices between baseline and I year follow-up visits. The 
interaction term (diagnostic group x visit) was not significant. 
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control 
(n= 18), AD (n=20) and DLB (n=8) groups at baseline and I year follow-qp. 
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Table 10.18: Delayed word recognition: summary of ANOVA for response latencies.. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,43)=45.7, p<0.001 Control < AD < DLB 
Visit F(1,43)=6.9, p=O. 0 11 Baseline < Control 
Diagnostic group x Visit N. S. I -I 
Comparison of response latencies for the delayed word recognition task indicated a 
main effect of group (F(2,43)=45.7, p<0.001). Response latencies were in the order: 
control < AD < DLB. Response latencies at baseline were shorter than response 
latencies at I year follow-up (F(2,43)=6.9, p=0.01 1). The interaction term (diagnostic 
group x visit) was not significant. 
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Figure 10.8: Delqyed word recognition: mean res ponse latencies (mS ) (±SEM) for 
control (n= 18), AD (n=20) and DLB (n=8) group s at baseline and Iy ear follow-up. 
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* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia groups 
10.2.2.3 Delayed -picture recognition. 
Group means for the primary indices of performance in the delayed picture recognition 
task at baseline and I year follow-up, and the percentage change between baseline and I 
year follow-up, are presented in Table 10.19 and Figures 10.9 and 10.10. A summary of 
statistical analysis, using two-way ANOVA and Newman-Keuls post-hoc pair-wise 
comparisons, is presented in Tables 10.20 and 10.2 1. 
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Table 10.19: Dela yed picture recog nition: sensitivity indices ( ±SEM) and response 
latencies (±SEM) at baseline and I _ year follow-up for control , AD, and DLB groups. 
Control AD DLB 
Delayed picture recognition 
n 18 20 9 
Sensitivity index 
Baseline 0.89 (±0.03) 0.39 (±o. o5) 0.21 (±o. 1o) 
Follow-up 0.85 (±0.05) 0.39 (±0.04) 0.20 (±0.08) 
% change -4% 0% -5% 
Response latency (mS) 
Baseline 962 (±39) 2486 (±210) 3414 (±941) 
Follow-up 1078 (±102) 4328 (±720) 6553 (±858) 
% change +12% -74% -92% 
Table 10.20: Delqyed picture recognition: summqa of ANOVA for recognition 
sensitivily index. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,44)=58.7, p<0.001 Control > AD > DLB 
Visit N. S. 
Diagnostic group x Visit N. S. 
Analysis of recognition sensitivity indices for the delayed picture recognition task 
indicated a main effect of group (F(2,44)=58.7, p<0.001). Mean sensitivity indices were in 
the following order: control > AD > DLB. There were no differences in sensitivity 
indices between baseline and I year follow-up visits. The interaction term (diagnostic 
group x visit) was non-significant. 
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Figure 10.9: Delay ed picture recog nition: mean sensitivity indices (±SEM) for control 
Ln= 18), AD (n=20 ) and DLB (n=9 ) groups at baseline and I year follow-qp. 
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Table 10.21: Delayed picture recognition: summaly of ANOVA for response latencies. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,44)=68.7, p<0.001 Control < AD < DLB 
Visit F(1,44)=24.3, p<O. 00 1 Baseline < Control 
Diagnostic group x Visit F(2,44)=6.0, p=0.005 
Comparison of response latencies for the delayed picture recognition task indicated a 
main effect of group (F(2,44)=68.7, p<0.001). Response latencies were in the order: 
control < AD < DLB. Response latencies at baseline were shorter than response 
latencies at I year follow-up (F(1,44)=24.3, p<0.001). 
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Analysis of response latencies for the group x visit interaction indicated 
disproportionate changes between visits in the different groups (F(2,44)==6.0, p==0.005). 
Post-hoc analysis of means indicated that response latencies were significantly increased 
at follow-up compared to baseline for both AD (F(1,44)=7.0, p=0.01 1) and DLB 
(F(1,44)=29.2, p<0.001) groups. 
Figure 10.10: Delqyed picture recognition: mean res-ponse latencies (mS) (±SEM) fo 
control (n= 18), AD (n=20) and DLB (n=9) groups at baseline and I year follow-up. 
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10.2.2.4 Delqyed face recognition. 
Group means for the primary indices of performance in the delayed face recognition task 
at baseline and I year follow-up, and the percentage change between baseline and 1 year 
follow-up, are presented in Table 10.22 and Figures 10.11 and 10.12. A summary of 
statistical analysis, using two-way ANOVA and Newman-Keuls post-hoc pair-wise 
comparisons, is presented in Tables 10.23 and 10.24. 
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Table 10.22: Delqyed face recognition: sensitivily indices (±SEM) and response 
latencies (±SEM) at baseline and I year follow-up for control, AD, and DLB groups. 
Control AD DLB 
Delayed face recognition 
n 18 20 8 
Sensitivity index 
Baseline 0.69 (±0.05) 0.30 (±0.06) 0.25 (±o. i o) 
Follow-up 0.69 (±0.06) 0.14 (±0.08) 0.14 (±0.14) 
% change _0% -53% -44% 
Response latency (mS) 
Baseline 1012 (±44) 2419 (±251) 3710 (±1277) 
Follow-up 1065 (±99) 3365 (±587) 5489 (±910) 
% change +5% +39% +48% 
Table 10.23: Delgyed face recognition: summga of ANOVA for recognition sensitivity 
index. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,43)=25.9, P<0.001 Control > (AD =- DLB) 
visit N. S. 
Diagnostic group x Visit N. S. 
Analysis of recognition sensitivity indices for the delayed face recognition task indicated 
a main effect of group (F(2,43)=25.9, p<0.001). Recognition indices were smaller for the 
control than both dementia groups, although the DLB and AD groups had similar 
sensitivity indices. There were no differences in delayed face recognition sensitivity 
indices between baseline and 1 year follow-up visits. The interaction term (diagnostic 
group x visit) was non-significant. 
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Figure 10.11: Delqyed face recognition: mean sensitivi1y indices (±SEM) for control 
(n== 18), AD (n=20) and DLB (n=8) groups at baseline and I year follow-up. 
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* significant difference (p<0.05) compared to controls 
Table 10.24: Del! qyed face recognition: summary of ANOVA for response latencies. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,43)=52.2, p<0.001 Control < AD < DLB 
visit F(1,43)=8.4, p=0.006 Baseline < Control 
Diagnostic group x Visit F(2,43)=3.3, p=0.044 I-I 
In the delayed face recognition task, comparison of response latencies indicated a main 
effect of group (F(2,43)=52.2, p<0.001). Response latencies were in the order: control < 
AD < DLB. Response latencies at baseline were shorter than response latencies at I year 
follow-up (F(1,43)=8.4, p=0.006). 
Analysis of response latencies for the group x visit interaction indicated 
disproportionate changes between visits in the different groups (F(2,43)=3.3, p=0.044). 
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Post-hoc analysis of means indicated that response latencies were significantly increased 
at follow-up compared to baseline for the DLB (F(1,43)-=l 1-9ý p=0.002) group, however, 
response latencies were similar at baseline and follow-up for the AD group. 
Figure 10.12: Del! qyed face recognition: mean response latencies (mS) (±SEM) for 
control (n= 18), AD (n=20) and DLB (n=8) groups at baseline and I year follow-qp. 
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* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia groups 
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10.2.3 Working memory. 
10.2.3.1 Spatial working emory. 
Group means for the primary indices of performance in the spatial working memory task 
at baseline and I year follow-up, and the percentage change between baseline and I year 
follow-up, are presented in Table 10.25 and Figures 10.13 and 10.14. A summary of 
statistical analysis, using two-way ANOVA and Newman-Keuls post-hoc pair-wise 
comparisons, is presented in Tables 10.26 and 10.27. 
Table 10.25: Spatial working memo ry: sensitivily indices (±SEM) and response 
latencies (±SEM) at baseline and Iy ear follow-up for control, AD , and DLB groups. 
Control AD DLB 
Spatial working memory 
n 18 18 5 
Sensitivity index 
Baseline 0.76 (±0.08) 0.17 (±o. o8) -0.03 (±0.15) 
Follow-up 0.60 (±0.08) 0.35 (±0.08) 0.29 (±0.12) 
% change -21% +100% +1066% 
Response latency (ms) 
Baseline 1420 (±253) 2630 (±310) 4518 (±1403) 
Follow-up 1751 (±416) 2861 (±484) 4044 (±894) 
% change +23% +9% + 10% 
Table 10.26: Spatial working memoly: summaKy of ANOVA for recognition sensitivily 
index. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,39)ý--10.7, p=0.002 Control > (AD =- DLB) 
visit N. S. 
Diagnostic group x Visit F(2,39)=3.7, p=0.034 
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Fi gure 10.13: S patial working memojy: Mean sensitivity indices (±SEM) for control 
(n = 18) , AD (n= 18) and 
DLB (n=5) groups at baseline and I year follow-up. 
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* significant difference (p<0.05) compared to controls 
Analysis of sensitivity indices for the spatial working memory task indicated a main 
effect of group (F(2,3 9)=: 10.7, p=0.002). The dementia groups performed equivalently, but 
significantly worse than the control group. 
There was no overall difference in performance between baseline and I year follow-up 
visits. However, the interaction term (diagnostic group x visit) indicated 
disproportionate changes in groups between visits for the spatial working memory task 
(F(2,39)=3.7, p=0.034). Post-hoc, analysis of means indicated that recognition sensitivity 
indices were improved at follow-up compared to baseline for both AD (F(1,39)=2.99, 
p=0.088) and DLB groups (F(1,39)=99.6, p=0.004). 
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Table 10.27: Spatial working memory: summM of ANOVA for response latencies. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,39): --12.2, p<0.001 _ Control < AD < DLB 
Visit N. S. 
Diagnostic group x Visit N. S. 
Figure 10.14: Spatial working memoK y: mean response latencies (mS ) (±SEM) for 
control (n= 18 ), AD (n= 18) and DLB (n=5) groups at baseline and Iy ear follow-up. 
7000 - 
6000 - 
5000 - 
4000 - 
3000- 
2000- 
T 
1000-- 
0- 
7; >4 >4 
Control AD DLB 
* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia groups 
Comparison of response latencies for the spatial working memory task indicated a main 
effect of group (F(2,39)"::::: l2.2, p<0.001). Response latencies were in the order: control < 
AD < DLB. Comparison of response latencies at baseline and I year follow-up indicated 
no differences between baseline and 1 year follow-up. Analysis of response latencies for 
the group x visit interaction indicated no significant interaction. 
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10.2.3.2 Memory scanning (numeric working memojy). 
Group means for the primary indices of performance in the numeric working memory 
task at baseline and I year follow-up, and the percentage change between baseline and I 
year follow-up, are presented in Table 10.28 and Figures 10.15 and 10.16. A summary 
of statistical analysis, using two-way ANOVA and Newman-Keuls post-hoc pair-wise 
comparisons, is presented in Tables 10.29 and 10.30. 
Table 10.28: Memoa scanning: sensitivily indices L±SEM) and response latencies 
(±SEM) at baseline and I year follow-up for control, AD, and DLB groups. 
Control AD DLB 
Memory scanning 
n 18 18 6 
Sensitivity index 
Baseline 0.90 (±0.03) 0.86 (±0.06) 0.52 (±o. i i) 
Follow-up 0.96 (±0.02) 0.76 (±0.08) 0.36 (±o. og) 
% change +6% -12% -31% 
Response latency (ms) 
Baseline 787 (±32) 1501 (±126) 3766 (±858) 
Follow-up 831 (±76) 1941 (±468) 4917 (±849) 
% change +6% +29% + 30% 
Table 10.29: Memory scanning: summga of ANOVA for recognition sensitivily index. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,39)=27.1, p<0.00 I (Control -= AD) > DLB 
Visit N. S. 
Diagnostic group x Visit N. S. 
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AD (n=1 8) and DLB (n=6) groups at baseline and I year follow-up. 
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* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) compared to 
other dementia group 
Analysis of sensitivity indices for the memory scanning task indicated a main effect of 
group (F(2,39)=27.1, p<O. 00 1). The DLB group performed worse than both the AD and 
control groups, who performed equivalently. There were no differences between 
baseline and I year follow-up visits. The interaction term (diagnostic group x visit) was 
not significant. 
Table 10.30: Memojy scanning: summqa of ANOVA for response latencies. 
Source of variance ANOVA summary Newman-Keuls analysis 
(p<0.05) 
Diagnostic group F(2,39)=57.0, p<0.001 Control < AD < DLB 
Visit F(1,39)=3.6, p=0.064 
Diagnostic group x Visit N. S. 
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Figure 10.16: Memory scanning: mean response latencies (mS) (±SEM) for control 
(n= 18), AD (n= 18) and DLB (n=6) groups at baseline and I year follow-up. 
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* significant difference (p<0.05) compared to controls; * significant difference (p<0.05) between 
dementia groups 
Comparison of response latencies for the memory scanning task indicated a main effect 
of group (F(2,39)=57.0, p<0.001). Response latencies were in the order: control < AD < 
DLB. Comparison of response latencies at baseline and I year follow-up indicated a 
trend towards longer response latencies at I year follow-up (F(1,39)=3.6, p=0.064). 
However further pair-wise comparisons revealed the difference was not significant. 
Analysis of response latencies for the group x visit interaction indicated no significant 
interaction. 
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Chapter 11: 
A comparative study of cognitive decline over one year in 
DLB, AD, and elderly controls usinLy the CoLynitive Druiz 
Research Computerised Assessment Battery (CDR): 
Discussion 
11.1 Introduction. 
Direct and indirect evidence suggests a difference in the rate of cognitive decline 
in AD and DLB cases, although further investigation is certainly required. Direct 
evidence suggesting a more rapid rate of decline in DLB comes from studies in 
which the duration of illness (time between onset and death) has been shown to be 
shorter in DLB than AD (McKeith et al, 1992b). In addition, a more rapid rate of 
cognitive decline in DLB than AD, over a1 year period, has been identified 
(Ballard et al, 1996b). However, not all studies confirm a shorter duration of 
illness in DLB than AD (e. g. Fbrstl et al, 1993) and, in addition, there is some 
evidence that administration of neuroleptic medication may have contributed to 
shorter duration of illness (McKeith et al, 1992b). 
Indirect evidence of a more rapid rate of cognitive decline in DLB has been 
inferred from a number of studies investigating clinical predictors of cognitive 
decline in AD. Alzheimer's disease patients with extrapyramidal symptoms and 
hallucinations have been shown to have a shorter duration of illness and faster rate 
of cognitive decline than AD cases without these symptoms (Mortimer et al, 1992; 
Chui et al. 1994; Miller et al, 1991). Many of the AD patients with extrapyramidal 
symptoms and hallucinations are likely to have been misdiagnosed DLB cases 
who were included in these studies (Chui et al, 1994). 
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11.2 The comparative decline in cognitive function over one year 
in AD and DLB. 
The current body of work aimed to compare rate of cognitive decline in AD and 
DLB using procedures sensitive to decline and with proven test-retest reliability 
(Simpson et al, 1991). On the basis of the findings described above, it was 
predicted that the rate of cognitive decline in DLB would be greater than in AD. 
This study did not, however, aim to report the cross-sectional comparison of 
groups, as this has already been described with a larger cohort in Chapters 6,7, 
and 8. Notwithstanding, the smaller control and dementia groups showed profiles 
of cognitive impairment similar to those reported for the larger cohort previously 
described in Chapter 7. 
The CDR test battery was sensitive to decline at one year follow-up on a number 
of indices of performance: simple reaction time; choice reaction time (but not 
accuracy); digit vigilance accuracy; and response latencies for delayed word, 
picture and face recognition tasks. A significant improvement between baseline 
and follow-up assessments on the spatial working memory task was found for 
both dementia groups, although both dementia groups were impaired compared to 
controls at baseline and follow-up. 
Analysis of interaction terms revealed disproportionate changes in group 
performance between visits. The DLB group declined more than the AD and 
control groups in terms of accuracy on the number vigilance task, and showed a 
significantly greater increase in response latency for the delayed face recognition 
task. Both dementia groups declined compared to controls on response latencies 
for the delayed picture recognition task. 
These data demonstrate that the CDR battery was sensitive to changes (both 
decline and improvement) in performance between baseline and I year follow-up. 
Overall, both AD and DLB dementia groups showed decline over the 1 year 
period between assessments, although the decline was restricted to certain aspects 
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of cognitive function. Furthermore5 these findings support more rapid cognitive 
decline in DLB than in AD. In particular, the ability to sustain attention (measured 
by the digit vigilance task) declined faster in the DLB group. These data are novel 
as previous studies comparing cognitive decline in AD and DLB groups have 
failed to adequately assess attentional function and in particular vigilance. 
Findings from the secondary memory tasks highlight the need to assess speed as 
well as accuracy when examining mnemonic function. Although performance on 
these tasks as measured by the ability to discriminate novel and previously seen 
exemplars failed to discriminate between visits, the response latencies increased 
between visits for both AD and DLB groups compared to controls on the delayed 
picture recognition task. Furthermore, DLB cases showed disproportionate 
slowing of response latencies in the delayed face recognition task. These data 
suggest changes in response strategy in these secondary visual recognition 
memory tasks between baseline and one year follow-up visits, such that speed of 
responding is reduced to improve accuracy of responding. 
The finding that spatial working memory sensitivity indices actually improved 
between baseline and follow-up in both dementia groups without a concomitant 
increase in response latencies is somewhat surprising. As, by definition, dementia 
is progressive and degenerative, it is unlikely that the improved performance in 
the dementia groups on the spatial working memory task was due to underlying 
neurochemical or neuropathological changes associated with dementia 
progression. It is, however, conceivable that improved performance may have 
been due to a practice effect between visits. Nonetheless, the long delay (I year) 
between assessments and the poor mnemonic function associated with both of the 
dementia groups would argue against this interpretation. 
The observed improvement in spatial working memory performance may be 
attributable to alterations in strategy which attempt to compensate for the marked 
problems completing such tasks in dementia groups. The change in response 
strategy did not, however, involve a speed-accuracy trade-off as response latencies 
were similar for all groups at baseline and follow-up assessments. Nonetheless, 
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previous studies have reported differences in measures of spatial working memory 
strategy in dementia groups which are not associated with changes in responsivity 
(Sahgal et al, 1995). 
11.3 Methodological considerations 
A number of methodological considerations are salient to this, and other studies 
measuring decline in dementia groups. 
The comparisons detailed in this study may have been subject to a degree of 
sampling bias. Firstly, only patients who were still alive; cognitively not too 
impaired; and not adversely behaviourally disturbed, were included for detailed 
follow-up assessment. Thus, individuals excluded from follow-up assessment may 
well include cases with rapid cognitive deterioration. In consequence, data from 
the current study may underestimate the degree of cognitive decline in the total 
cohort investigated in the original cross-sectional study. 
Secondly, not all of the participants who attempted follow-up assessment were 
able to complete a full assessment. For example, only half (n=5) of the DLB group 
were able to complete the spatial working memory task at follow-up assessment. 
Individuals who were unable to complete the task were thus excluded from this 
task. Exclusion of patients unable to complete this task would therefore distort the 
sample towards individuals with less deteriorated spatial working memory 
The influence of sampling factors on the observed profiles of cognitive decline 
cannot be disregarded, and suggest these data must be applied to a clinical 
population with some caution. Notwithstanding, the data described are for 
repeated measures comparisons and suggest qualitatively distinct profiles of 
cognitive decline in DLB and AD within the cohort able to complete follow-up 
assessments. 
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11.4 Summary. 
The investigation of cognitive decline in dementia is, to some extent, limited by 
the progressive nature of cognitive impairment in dementia. Sampling biases 
associated with a cognitively deteriorating population somewhat restrict the 
extrapolation of findings to more general dementia populations. These 
methodological limitations are, nonetheless, common to all studies comparing 
rates of cognitive decline in dementia 
Notwithstanding, these data have further demonstrated distinct profiles of 
cognitive decline over one year in DLB and AD in the cohort of patients able to 
complete both baseline and follow-up assessments. This study supports and 
extends previous findings suggesting a more rapid rate of decline in DLB than 
AD. The more rapid decline in cognitive abilities the DLB group is not apparent in 
all aspects of cognition. Specific aspects of cognitive performance, most notably 
sustained attention, appear to decline more rapidly in DLB than AD. 
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Chapter 12: 
General Discussion 
12.1 Introduction 
The body of work described in this study includes the largest prospective 
comparative study to date of cognition in DLB with a well characterised and 
investigated clinical cohort. This study has successfully replicated previous 
work suggesting poor visuospatial function and relatively preserved recognition 
memory in DLB. Furthermore, fundamental aspects of attentional function 
have been assessed for the first time and were shown to differ between DLB 
and AD. 
Concurrent rigorous clinical evaluation has facilitated the comparison of DLB 
groups with distinct clinical symptoms. The cognitive impairment described in 
DLB cases with persistent visual hallucinations is distinguishable from the 
cognitive impairment described in both AD and DLB cases without persistent 
visual hallucinations. Much of the neuroPsychological distinction described 
(see Section 7.3) between AD and DLB groups appears to be associated with 
the occurrence of persistent visual hallucinations in the DLB group. 
In addition, a comparative longitudinal study of cognitive decline in DLB and 
AD over a 12 month period is reported. While these data confirm previous 
work suggesting a more rapid rate of decline in DLB, the use of a broad range 
of sensitive tests has identified this to be restricted to specific areas of 
cognition. Sustained attention, and speed of making recognition memory 
decisions appear particularly susceptible to decline in DLB and this confirms 
the central role of attentional dysfunction. 
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12.2 General methodological considerations 
12.2.1 Patient diagnosis and recruitment. 
When comparing neuropsychological profiles in different types of dementia, it is 
preferable that cohorts studied are representative of the clinical population from 
which they are drawn. Systematic misdiagnosis of dementia patients can lead to 
spurious conclusions from neuropsychological and other investigations comparing 
different types of dementia. 
12.2.1.1 The clinical diagnosis of dementia with LeM bodies and Alzheimer's 
disease. 
Until relatively recently, DLB cases have generally been ascribed a diagnosis of 
AD or, less often VaD (McKeith et al, 1994b). The recent publication of 
consensus clinical criteria for the clinical diagnosis of DLB (McKeith et al, 1996a) 
and their ongoing neuropathological validation should further improve the 
sensitivity and specificity of operationalised criteria for the clinical diagnosis of 
DLB. 
All patients in the studies reported in this thesis were recruited from the Medical 
Research Council Prospective Study of Memory Disorders. The primary aim of 
this study is to validate clinical diagnostic criteria for DLB. As neuropathological 
investigations remain the gold standard for subtype diagnosis, autopsy evaluation 
has a pivotal role in the MRC study. Publication of this thesis could not, however, 
await autopsy confirmation of clinical diagnoses of cases included, although 
eventual autopsy findings are intended to be employed for analysis at a later date. 
Nonetheless, data from the first forty-six cases from the MRC study to have 
received autopsy validation are available (Ballard et al, 1997b), which includes 
only one of the cases included in this thesis. Consensus clinical diagnoses made by 
three senior psychogeriatricians were compared with neuropathological diagnoses 
(McKeith et al, 1996a) to provide measures of specificity (% of clinically 
identified cases pathologically confirmed) and sensitivity (% of pathological 
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identified cases which met clinical criteria). The procedures for clinical and 
neuropathological diagnosis are standardised and the subsequent findings are 
intended to be indicative of the specificity and sensitivity of diagnoses made by 
this research group. 
Specificity values indicate how likely clinically identified cases are to have the 
assigned diagnosis at post mortem. Sensitivity values indicate the number of cases 
with pathological features who also meet clinical criteria. High specificity and 
sensitivity rates are the most desirable if a cohort under investigation is to be 
maximally representative of a population. 
Twenty two of 24 clinically identified probable DLB cases also met pathological 
criteria (92% specificity), whilst three pathologically confirmed probable DLB 
cases failed to meet clinical criteria (88% specificity). One DLB case was 
misdiagnosed as VaD and two DLB cases were misdiagnosed as AD cases. All 
DLB cases fell into the probable diagnostic category, hence data is not available 
for criteria for the diagnosis of possible DLB. 
Eight out of ten clinically identified probable AD cases were pathologically 
confirmed (80% specificity), and 14 out of 15 pathologically identified probable 
AD cases met clinical criteria (93% sensitivity). One probable AD case was 
misdiagnosed as DLB, and one probable AD case also had significant vascular 
pathology and met criteria for the diagnosis of VaD. Clinically identified possible 
AD was pathologically confirmed in 6 out of 9 cases (67% specificity). 
The index of primary importance for this thesis is specificity, as it is essential that 
groups are made up of the diagnostic categories. Low diagnostic specificity would 
mean numerous misdiagnoses would be included in each diagnostic group. The 
specificity ratios for probable DLB (92%), probable AD (80%) and possible AD 
(67%) suggest the majority of cases in these diagnostic categories were correctly 
diagnosed. 
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If these data are applied to the main comparative study which used the CDR 
procedures, it can be estimated that 18 out of 20 probable DLB cases will actually 
show pathology supporting the clinical diagnosis. Furthermore 18 out of the 22 
clinically diagnosed probable AD cases and 16 out of the 24 clinically diagnosed 
possible AD cases will show corresponding pathology. 
Sensitivity provides an indication of how many patients who meet 
neuropathological criteria also meet clinical criteria and as such, provides a idea of 
how representative a clinically identified group is of the total neuropathologically 
diagnosed population. The relatively high sensitivity in both probable DLB (88%) 
and AD (93%) suggest the majority of probable AD and DLB cases would be 
identified by application of these clinical criteria. These values are comparable 
with those found in AD using NINCDS-ARDRA criteria (e. g. Kukull et al, 1990). 
Although the misclassification of cases might well have occurred, these data 
suggest the problem to be of equivalent magnitude to other studies prospectively 
comparing AD and DLB. Data from the MRC prospective study can, therefore be 
confidently extrapolated to the neuropathologically defined AD and DLB 
diagnostic categories. 
12.2.1.2 Selectivijy of assessment tools - are the neuropsychological findings 
genuinely representative of the -population from which cases were drawn? 
A further level of selection of dementia patients occurs when participants are 
requested to complete neuropsychological assessment, since increasingly severe 
cognitive impairment impacts on the ability of some patients to complete 
neuropsycho logical testing. Even with appropriately designed testing procedures 
and skilled experimenters, it is inevitable that the cognitive impairment associated 
with severe and end stage dementia precludes some dementia patients from 
understanding the most simplified testing procedures. Furthermore, in patients 
able to complete assessment, 'floor' effects may reduce the power of 
neuropsychological. tests to discriminate experimental groups. The selectivity of 
CANTAB and CDR assessment procedures are outlined in this section and 
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discussed in terms of their application in a demented population. As all controls 
approached were able to complete full neuropsychological assessment, they will 
not be considered further in this section. 
The decision whether to approach a referred patient for neuropsychological 
assessment was based on a number of factors. Previous recent neuropsychological 
test performance was a major consideration which was discussed with senior 
psychogeriatricians and an experienced psychiatric nursing sister. Suitability for 
detailed neuropsychological assessment was initially discussed in terms of chronic 
factors unlikely to be resolved such as: severity of dementia; marked behavioural 
disturbance; impaired sensory capabilities; and physical disability (e. g. severe 
arthritis) preventing the necessary responses (see Appendix V). 
In addition, a number of patients, who were not excluded from neuroPsychological 
assessment, did not partake in neuropsychological assessment for reasons not 
necessarily related to their ability to complete neuropsychological assessment. 
These included: objections or refusals to partake in cognitive assessment, 
withdrawal from main MRC study, research overload, and death. 
If a patient was considered appropriate for neuropsychological assessment, acute 
problems which might affect compliance and performance were considered. These 
might include: a recent move into residential nursing care, a recent change in 
medication, infection or other acute physical illness. Assessments were 
subsequently attempted only upon resolution of acute difficulties ensuring care 
was taken to minimise inappropriate testing. 
Patients deemed as 'borderline' were generally approached and tested when the 
approach was thought not likely to negatively affect them. The experimenter made 
over 40 visits to attempt testing with 'borderline' cases to find 30 patients unable 
to usefully complete neuropsychological. assessment. It is likely, therefore, that all 
referred patients capable of completing neuropsychological testing were included. 
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All patients were able to at least attempt the CAMCOG schedule. However, 
differences in exclusion rates associated with the different computerised batteries 
used in the cross-sectional studies were evident. 
CANTAB: A total of 137 patients were consecutively referred for the CANTAB 
study from the MRC study. Fourteen (10%) were appropriate for CANTAB 
assessment and 123 (90%) were excluded, the most common reason being severity 
of dementia (80 cases). For all dementia cases consecutively referred from the 
MRC study, 58% were too demented to comprehend and complete CANTAB 
assessment. 
The relatively high (90%) exclusion rate of consecutively referred cases from the 
CANTAB study reflects, in part, the procedural complexity, duration, and nature 
of the tests. Many of the tests which comprise the CANTAB battery are based on 
experimental procedures which generally have numerous complex trials (e. g. 40 
trials in simultaneous and delayed matching to sample task) to maximise task 
sensitivity. In addition, stimuli in many of the CANTAB battery tests (e. g. pattern 
recognition, and matching to sample procedures) are complex and small requiring 
good visual acuity to complete the tasks which is reflected in the number (10) of 
cases excluded from neuropsychological testing due to sensory difficulties. 
Nonetheless, all participants who completed the CANTAB study were required to 
read a line of size twelve font prior to testing to confirm adequate visual abilities. 
Although the CANTAB battery is a sophisticated and sensitive battery of 
neuropsychological tests, the complexity of these may restrict the applicability of 
the system to relatively mildly demented populations. The data reported using the 
CANTAB battery are therefore representative of cognitive changes only in the 
early stages of dementia in AD and DLB. 
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CDR: A total of 104 patients were referred for the CDR cross-sectional study, of 
whom 34 patients (33%) were unable to complete CDR assessment and 70 
patients (67%) were capable of completing CDR assessment. The major reason for 
non-inclusion in the study was severity of dementia: of the 104 cases 
consecutively referred from the MRC study, I I% (I I cases) were too severely 
demented to complete CDR assessment. Four patients were unable to partake in 
assessment as physical disabilities (3 severe arthritis, I severe parkinsonian 
tremor) prevented the use of the response box. In addition, 'floor' effects were 
observed on the spatial working memory task, which may have reduced the ability 
of this task to discriminate dementia groups. 
The CDR battery used was specifically designed (Simpson et al, 199 1) for use 
with a demented population and this is reflected in the high (70%) inclusion rate 
of consecutively referred cases. A number of specific modifications are included: 
1. The experimenter was also able to briefly pause testing without the loss of data 
if participants became fatigued and / or became distracted. 
2. Negative feedback on performance can highlight cognitive deficits to dementia 
patients and hence reduce participant compliance, and such feedback has been 
kept to a minimum. In addition to the removal of ongoing performance 
feedback, tasks requiring recall testing were avoided, as the participant is too 
clearly aware of the poor quality of performance. 
3. The size of words and digits were increased to minimise the impact of visual 
deficits on cognitive test performance. 
4. The number of trials for each task was reduced compared to the CDR battery 
used in healthy volunteer populations. 
The findings from the CDR study appear to be representative of mild to moderate 
dementia patients, however, severely demented patients were unable to complete 
the battery. 
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In summary, high sensitivity and particularly specificity rates for the differential 
diagnosis of dementia in the cohort from which the participants in this study were 
recruited, imply that the DLB and AD groups include patients who at autopsy are 
likely to receive confirmation of their clinical diagnosis. The inclusion of mis- 
classified dementia patients is inevitable although this would be likely to add 
4noise' to group comparisons rather than creating or magnifying group differences. 
The cohort of patients assessed using the CANTAB battery of tests appears 
representative of relatively mildly demented population. The CDR battery, which 
is specifically adapted for use with a dementia population, is representative of a 
broader range of dementia patients. Neither system was capable of assessing 
severely demented cases, however, when patients become severely demented 
differential diagnosis has usually been made and the administration and 
interpretation of psychometric assessments becomes severely restricted (Lezak, 
1983). 
12.2.2 Retrospective validity of matching methodology. 
Matching procedures were employed to minimise the effect of any systematic 
sampling differences between groups. All groups were matched for measures of 
activities of daily living and global severity of cognitive impairment using the 
CAMCOG schedule. Groups were not consistently matched for age, although as 
previously discussed (see Chapter 8) this is highly unlikely to account for the 
observed differences between groups. 
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Matching t-or severily of global cognitive impairment using the 
CAMCOG schedule 
Although the CAMCOG schedule provides a relatively comprehensive assessment 
of cognitive impairment in dementia (Roth et al, 1986), the attentional subsection 
of the CAMCOG schedule failed to discriminate between AD and DLB despite 
the marked differences in attention described in both CANTAB and CDR studies. 
The failure of CAMCOG to discriminate AD and DLB- groups probably reflects 
the cognitive processes purported to be assessed by questions in the 'attentional' 
subsection which all involve numeric calculations (counting backwards from 20, 
subtracting 7 from 100 five times, adding I Op and 5p, and taking 15p from f 1). 
These questions undoubtedly involve attentional resources, however, they are all 
primarily tests of numeric working memory which has been shown to be 
equivalently impaired in AD and DLB (see Section 7.3.3.2). This highlights the 
problems associated with the assessment of attentional function, and in particular 
vigilance, using traditional psychometric tests. 
The identification of a particularly severe reduction in the attentional abilities of 
DLB patients confirms the earlier assertion (see Section 1.5) that mnemonically 
based tools for measuring the severity of global impairment in dementia may 
underestimate the degree of overall cognitive impairment in DLB patients. 
Nonetheless, the CAMCOG provided further evidence of a discrimination 
between neuropsycholgical profiles in AD and DLB. A double dissociation was 
observed between more impaired recall and recognition memory in AD than 
DLB, and a better performance of AD patients on the visuo-spatial praxis section. 
These parallel the findings of the computerised assessment procedures and 
confirm the value of the CAMCOG schedule in profiling most aspects of 
cognitive performance in dementia. In addition, these findings replicate a recent 
study comparing cognitive impairment in LBD and AD using the CAMCOG 
schedule (Walker et al, 1997). 
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12.2.2.2 Matching for estimated pre-morbid intellectual ability using the NART. 
Matching groups for pre-morbid IQ using the NART schedule aims to prevent 
spurious group distinctions due to differences in pre-morbid intellectual 
capabilities. The NART has been frequently employed to match dementia and 
control groups (for review see O'Carroll, 1995b), however, there is increasing 
evidence that NART performance is not impervious to the effects of dementia 
(Fromm et al, 1991; O'Carroll et al, 1995). These authors have reported 
significant correlations between severity of dementia in AD (as measured by 
MMSE scores) and estimated pre-morbid IQ (as measured by NART 
performance). The ability to pronounce irregular words appears to remain intact 
only in the mild stages of dementia. (Fromm et al, 1991, Patterson et al, 1994). 
Comparison of pre-morbid intellectual ability between dementia groups and 
controls from the cross-sectional studies reported in this thesis support these 
findings. For example, in the CANTAB study, which included predominantly 
mildly demented patients, no differences were described between dementia groups 
and the control group for estimated pre-morbid intellectual ability. In the study 
using CDR assessment procedures, a broader range of mild to moderately 
demented patients were included and although both dementia groups were 
matched for NART performance, the control group performed significantly better 
than both dementia groups and at a similar level to that described for all groups in 
the CANTAB study. The introduction of the more severely demented patients in 
the CDR study may have resulted in the lowered estimated pre-morbid IQ in the 
dementia groups. Notwithstanding the evidence suggesting dementia patients 
retain the ability to pronounce irregular words only in the mild stages of dementia, 
the primary comparison in this study was between AD and DLB dementia groups 
and NART performance of these groups was similar. 
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12.3 A neurochemical model of the cognitive deficits in DLB 
12.3.1 Introduction 
This section will examine the relationship between neuropsychological deficits, 
neurochernical dysfunction, and neuropathological damage in DLB. A composite 
model relating known neurochemical, neuropathological, and neuropsychological 
features of DLB and AD with lesion and drug studies in both animals and humans 
will be proposed. 
12.3.2 Neurochemical pathology and cognitive impairment in DLB. 
12.3.2.1 Introduction 
Absolute levels of cholinergic activity are more severely reduced in DLB than AD 
(Dickson et al, 1987; Perry, E. et al, 1990b; 1994). Archicortical cholinergic 
depletion has been shown to be more severe in AD than DLB (Perry, E. et al, 
1994) which contrasts with the more severe cholinergic depletion in many 
neocortical areas in DLB (Perry, E. et al, 1990b, Langlais et al, 1993). Cholinergic 
receptors remain relatively preserved in DLB compared to AD, this is true for both 
muscarinic M, (Perry, E. et al, 1990b) and nicotinic receptors (Perry, E. et al, 
1995a). The reduced neocortical cholinergic activity in DLB does not appear to be 
due to loss of receptor sites, but may be due to pathological processes which 
contribute to the degeneration of cholinergic neurones in the nucleus basalis of 
Meynert, a rich supplier of acetylcholine innervation to the neocortex (Perry, E. et 
al, 1994). 
Furthermore, acetylcholine depletion appears to be particularly severe in DLB 
patients with visual hallucinations. An 80% reduction of neocortical ChAT has 
been reported in hallucinating cases compared to a 50% reduction in non- 
hallucinating cases (Perry, E. et al, 1994). The cholinergic depletion in non- 
hallucinating cases was similar to the reduction seen in AD cases from the same 
series of patients. The presence of hallucinations may also be related to findings 
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suggesting the ratio of serotonergic hyperactivity (although absolute levels are 
reduced) and relative cholinergic hypoactivity are associated with visual 
hallucinations (Perry, E. et al, 1993a) which is consistent with the 
psychopharmacological effects of drugs acting on these systems. 
Reductions in subcortical doparninergic activities differentiate AD and DLB 
particularly in the neostriaturn (caudate nucleus) where doparnine depletion 
(which reflects neuronal depletion in the substantia nigra) may be as much as 60% 
(Perry, E. et al, 1990a, Langlais et al, 1993). Neocortical monoamine activities do 
not, however, discriminate DLB, AD and controls (Langlais et al, 1993). 
A proposed relationship between cholinergic depletion and neuropsycho logical 
dysfunction can be based on findings from studies of cholinergic function and 
separate studies (including findings reported in this thesis) of cognitive function in 
AD and DLB, as well as studies comparing of AD with DLB groups with different 
levels of cholinergic dysfunction (DLB+VH and DLB-VH). 
The correlation of cholinergic and cognitive impairment in AD, DLB-VH and 
DLB+VH groups is based on the assumption that cholinergic depletion at post 
mortem reflects the cholinergic dysfimction at the time patients completed 
cognitive assessments. This assumption is based on a number of findings. Firstly, 
the presence of visual hallucinations are a more prominent feature at all stages in 
DLB than AD (e. g. McKeith et al, 1992c; 1996a). Secondly, pharmacological 
agents which compromise cholinergic function such as scopolamine and atropine 
induce hallucinations (Perry, E. et al, 1996). Thirdly, the type of visual 
hallucinations reported in DLB are mainly of circumscribed visual images of 
familiar objects, faces or animals (Ballard et al, 1996a) and are consistent with the 
ability of acetylcholine receptor antagonists to induce similar types of visual 
hallucinations (Perry, E. et al, 1995b). In contrast, serotenergic enhancing agents 
such as LSD produce altered sensory perception including a degree of 'cross 
writing' or synaesthesia - hearing colours for example, and an often disturbing 
sense of depersonalisation (Perry, E. et al, 1995b). Thus, the neurochemical basis 
of the increased incidence of visual hallucinations in living DLB patients appears 
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to be related to the concomitant cholinergic depletion rather than the apparent 
serotonergic hyperactivity. On this basis, it is assumed that the level of cholinergic 
depletion reflects that seen at post mortem, such that there is similar cholinergic 
depletion in the AD and DLB-VH groups, however cholinergic depletion is 
greatest in the DLB+VH group. 
12.3.2.2 Cholinergic depletion and cognitive impairment in DLB and Alzheimer's 
disease. 
If the level of cholinergic depletion is pivotal to the cognitive deficits seen in DLB 
then, profiles of cognitive impairment should reflect the level of cholinergic 
depletion in DLB+VH, DLB-VH and AD groups. The demonstration that DLB- 
VH and AD groups have similar reductions (-50%) in cholinergic activity coupled 
with DLB+VH patients from the same series showing a greater cholinergic deficit 
(-80% reduction) could imply that profiles of cognitive impairment in the DLB- 
VH and AD groups would be similar. Furthermore, the profile of cognitive 
impairment in the DLB+VH group would be distinct from both DLB-VH and AD 
groups in a manner which would account for the neuropsychological distinctions 
identified between pooled AD and DLB groups. 
The findings reported in the comparison of DLB+VH, DLB-VH and AD groups 
reported in this thesis (see Section 7.4) support this prediction. The DLB-VH and 
AD groups performed similarly on all tests in the CDR battery apart from the 
choice reaction time test. Choice reaction times reported for the DLB-VH group 
were increased compared to the AD group, but were equivalent to those described 
for the DLB+VH group. 
Performance of the DLB+VH group was, however, quite distinct from both DLB- 
VH and AD groups. The DLB+VH group showed more impaired performance 
than both AD and DLB-VH groups on the simple reaction time task, and the 
sustained attention task, which mirrors the distinctions between DLB and AD 
groups. In addition, the DLB+VH group performed at Chance levels on the spatial 
working memory task which further analysis indicated was worse than both AD 
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and DLB-VH group. The DLB-VH and AD groups performed equivalently on the 
spatial working memory task. This finding is not necessarily at odds with findings 
from comparison of pooled AD and DLB groups, where it has been argued that 
floor effects contributed to the failure to discriminate pooled AD and DLB groups 
on the spatial working memory task. It is conceivable that subtle changes in 
variance of each groups performance, which may be particularly relevant where 
floor effects are demonstrated, lead to the discrimination between AD and 
DLB+VH as well as between DLB-VH and DLB+VH on the spatial working 
memory task. 
All of the secondary memory tasks failed to discriminate DLB+VH, DLB-VH and 
AD groups, in contrast to the previously reported less impaired delayed word 
recognition in the DLB group (see Section 7.3.2). The failure of the delayed word 
recognition task to dissociate between DLB+VH, DLB-VH and AD groups may 
reflect the reduced statistical power associated with splitting the DLB group. 
Nonetheless, response latencies in all secondary memory tasks were greater in the 
DLB+VH group than in both AD and DLB-VH groups who responded following 
similar latencies. 
These neuropsychological data provide support for the proposal that level of 
cholinergic depletion is pivotal in the genesis of the cognitive deficits associated 
with DLB. It has been demonstrated that comparison of DLB and AD groups 
reveal a pattern of cognitive impairment that is associated with the level of 
cholinergic depletion in the DLB group. The cholinergic model proposed cannot, 
however, account for all of the observed differences in cognitive function (choice 
and cognitive reaction times and response latencies in the secondary memory 
tasks) between DLB groups with and without visual hallucinations. Explanations 
are proposed for these differences in the subsequent paragraphs. 
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12.3.2.3 Neostriatal doparnine depletion and choice reaction times in DLB and 
Alzheimer's disease. 
Increased choice reaction times were found in the DLB group compared to AD, 
independent of the presence of visual hallucinations and associated degree of 
cholinergic depletion. This implies that differences in neurochernical pathology 
not associated with cholinergic depletion might account for these differences in 
choice reaction times. The other major distinction in neurotransmitter function 
between AD and DLB groups is the degree of doparnine depletion in subcortical 
structures and in particular the neostriatum (Perry, E. et al, 1993b; Langlais et al, 
1993). However, no differences in dopamine depletion have been described 
between hallucinating and non-hallucinating DLB groups. 
A possible neurochernical substrate for the observed longer choice reaction times 
is the doparninergic depletion seen in DLB. Support for this is derived from 
studies showing a selective increase in choice but not simple reaction times when 
doparninergic antagonists (Haloperidol) are administered to healthy young 
controls, and the selective decrease in choice but not simple reaction times when 
pro-doparninergic agents are administered to healthy young controls (Wesnes et al, 
in preparation). 
A similar doparninergic based explanation has also been proposed for the 
increased cognitive reaction time seen in DLB compared to AD and control 
groups (see Section 8.2.1.2). Evidence from a large study comparing the cognitive 
impairment profile of AD patients with scopolamine induced impairment 
demonstrated that a selective increase in simple reaction times accounted for all of 
the increase in choice reaction times in both groups (Wesnes, 1996; Wesnes et al, 
1996). Thus cognitive reaction time is not affected at any stage of AD or following 
various doses of scopolamine administration. These findings strongly suggest that 
increased cognitive reaction time in DLB patients is not related to muscarinic 
dysfunction. 
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On the basis of this finding, doparnine dysfunction was previously proposed as the 
neurochernical substrate of the increased cognitive reaction time observed in the 
DLB compared to AD and control groups (see Section 8.2.1.2). It is therefore 
logical to predict similarly increased cognitive reaction times would be observed 
in both DLB+VH and DLB-VH groups. However, this pattern of results was not 
apparent, although means were clearly (see Section 7.4.3) in the right direction. 
Reduced statistical power associated with the smaller DLB+VH and DLB-VH 
groups, as well as the large variability of recorded cognitive reaction times, may 
account for the failure to discriminate between DLB+VH, DLB-VH, and AD 
groups. Although the mean cognitive reaction time for the DLB-VH group (699 
milli-seconds) was slightly longer than reported for the pooled DLB group (519 
milli-seconds), comparison with the same AD and control groups failed to identify 
the increased cognitive reaction time described for the pooled DLB group. The 
relationship between cognitive reaction time and dopamine requires further 
investigation in a larger cohort of DLB+VH, DLB-VH, and AD cases. 
12.3.2.4 The putative impact of a reduced abilily to sustain attentional resources 
on task performance. 
Response latencies for all secondary memory tasks were significantly longer in the 
DLB+VH then the AD and DLB-VH groups, although there were no between 
group differences for sensitivity indices. These data suggest a specific slowing of 
decision making in the delayed secondary memory tasks which was not apparent 
in the earlier immediate word recognition task. These findings are difficult to 
explain in terms of the neurochernical model proposed as other comparisons did 
not describe differences in response latencies on delayed secondary recognition 
memory tasks between dementia groups. Nor do the increased response latencies 
generalise to all secondary recognition memory tasks as they were not apparent in 
the earlier word recognition task. 
A possible explanation for the observed increase in response latencies in the 
DLB+VH group is a susceptibility to fatigue effects in the DLB+VH group. This 
supposition would be consistent with task ordering, as the increased secondary 
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recognition memory response latencies were observed only on the final three tests. 
Furthermore, a particularly reduced capability of the DLB+VH group to sustain 
attentional resources has been demonstrated (see Section 7.3.1). 
12.3.2.5 SummM. 
In summary, relative cholinergic depletion has been proposed as the basis of the 
majority of the neuropsychological distinctions between pooled DLB and AD 
groups. Comparison of DLB groups with different levels of cholinergic depletion 
suggest this assumption to be valid. A number of findings appeared to weaken this 
model, however, these have been explored and explained in terms of differential 
dopamine depletion, reduced statistical power associated with division of the DLB 
group, and fatigue effects. 
12.3.3 Evidence suggesting differential involvement of nucleus basalis of 
Meynert-cortical and septo-hippocampal cholinergic projections in AD and 
DLB 
As recently as 1983, antibodies to ChAT were developed enabling for the first 
time the accurate description of the organisation of cholinergic innervation in the 
brain. Even more recently, the immunotoxin 192 IgG-Saporin has been developed 
which has been employed in a growing number of studies investigating basal 
forebrain cholinergic lesions. IgG-Saporin is a powerful and, importantly, 
selective lesioning tool which has lead to the functional discrimination of nucleus 
basalis of Meynert and septo-hippocampal cholinergic pathways in the basal 
forebrain (Wiley et al, 1991). The septo-hippocampal projection is associated 
primarily with mnemonic function (e. g. Steckler et al, 1995) whilst cortical 
projections from the nucleus basalis of Meynert are thought to contribute to visual 
attentional function, but not to mnemonic function per se (e. g. Everitt et al, 1997). 
It is possible that DLB is associated with particularly disrupted nucleus basalis of 
Meynert projections, whilst AD is associated with relatively severe septo- 
hippocampal disruption. The basis of this distinction is based on neurochernical, 
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neuropathological, and most importantly neuropsychological studies of DLB and 
AD. 
All tests in the CDR battery employed in this study have been shown to have a 
linear dose-dependant relationship between performance and the administration of 
increasing doses of scopolamine (Wesnes, 1994). Scopolamine is an 
indiscriminate muscarinic antagonist and therefore affects all cholinergic 
synapses. The results described in this study (see Chapter 7), and others, suggest 
relative mnemonic preservation in DLB compared to AD, and relative attentional 
preservation in AD compared to DLB. The finding that DLB cases, which show a 
greater neocortical depletion of cholinergic function, have relatively preserved 
mnemonic processing suggests the septo-hippocampal projection may not be as 
disrupted as in AD, whilst the relatively poor attentional function suggests the 
nucleus basalis of Meynert-cortical projection (which has been recently shown to 
be important in visual attentional function; Everitt et al, 1997) may be more 
severely disrupted in DLB than AD. 
This assertion is consistent with known neurochemical and neuropathological 
alterations observed in AD and DLB. Archicortical (including hippocampal) 
cholinergic depletion has been shown to be more severe in AD than DLB (Perry, 
E. et al, 1994), and conversely cholinergic function is more disrupted in 
neocortical areas in DLB than AD (Perry, E. et al, 1990a; 1990b; 1993a). These 
findings are consistent with the pathological burden in the hippocampus (Dickson 
et al, 1991) and cell loss in the nucleus basalis of Meynert (Perry, E. et al, 1990b). 
Preliminary neurochemical, neuropathological, and neuropsychological findings 
appear consistent in suggesting the differential involvement of nucleus basalis of 
Meynert and septo-hippocampal cholinergic projections in the genesis of cognitive 
impairment in AD and DLB. Nonetheless, studies describing differences in 
neocortical and cortical cholinergic function in DLB and AD (Perry, E. et al, 
1990a; 1994) involved small cohorts of highly selected patients and await 
replication. Furthermore, the relationship between pathological burden and 
functional disruption is not clear, indeed, synaptic loss might be a better indicator 
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of functional disruption than pathological burden per se (Terry et al, 1994). 
Further investigations might explore this area by comparing nucleus basalis of 
Meynert and medial septum neuropathology and neurochemistry in DLB and AD 
groups. The relative involvement of septo-hippocampal and nucleus basalis of 
Meynert-neocortical projections may help account for the observed pattern of 
neuropsychological deficits in AD and DLB. 
12.4 Future directions. 
The proposal that cholinergic deficits underlie many of the neuropsychological 
deficits observed in DLB patients, combined with the relative preservation of 
cholinergic receptor populations, suggests these patients may respond to 
cholinornimetic therapy. Indeed, some investigations have already suggested this 
may be the case (e. g. Eagger et al, 1996). Trials of putative pharmacological 
treatments for DLB must include adequate assessment of attentional abilities and, 
in particular, the ability to sustain attentional resources. Solely mnemonically 
based cognitive assessments may underestimate potential improvements in 
cognition in the DLB group to cholinergic enhancement. 
The distinction between DLB+VH and DLB-VH outlined in this theses requires 
ftirther investigation. It is conceivable that the profile of cognitive deficits 
identified in DLB+VH cases might be symptom rather than disease specific. This 
question might be addressed by the comparative neuropsychological and 
neurochernical investigation of hallucinating and non-hallucinating AD cases. 
Unfortunately, such a comparison was not possible in this study due to the small 
number of AD cases with visual hallucinations included in the cohort. 
In addition, several areas of cognitive function remain relatively 
under-investigated. Visuospatial abilities have been shown to differentiate DLB 
and AD cases (e. g. Gnanalingharn et al, 1997) and data from the current study 
suggest a particularly severe impairment of spatial working memory in 
hallucinating DLB cases. Work is currently underway in Newcastle to develop a 
battery of tasks which assess aspects of spatial working memory, visual working 
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memory and spatial planning. The Newcastle frontal assessment battery 
(NewFAB) has been developed specifically for use with a demented population 
using similar adaptations to those previously described for the dementia version of 
the CDR battery. In addition, complex motor response patterns are not required (as 
in Hansen et al, 1990; Gnanalingham et al, 1997; Walker et al, 1997), which will 
facilitate the dissociation of visuospatial deficits from problems making complex 
motor responses. 
12.5 Summary and Conclusions: Neuropsychology and the 
nosological status of DLB. 
That neuropsychological impairment is a central feature of DLB is not disputed. 
Of interest is whether the type of cognitive decline observed in DLB has a 
characteristic profile and course which distinguish it from other forms of 
dementia, and in particular AD. Much of the early controversy surrounding the 
nosological and neuropsychological status of DLB arose through the use of 
disparate selection criteria and small cohorts. The body of work presented in this 
thesis has attempted to address these shortcomings. This is the first 
neuropsychological study to employ the recently described consensus criteria for 
the clinical diagnosis of DLB (McKeith et al, 1996a) in a large prospectively 
investigated cohort. 
Findings from this thesis suggest that DLB patients share with AD patients a 
global impairment of cognitive function compared to elderly controls. There is 
considerable overlap between the neuropsychological deficits observed in DLB 
and AD. This is not, however, surprising as the brains of both AD and DLB 
patients show diffuse neurodegenerative changes and similar findings have been 
previously reported by a number of groups (Gnanalingham et al, 1997; Walker et 
al, 1997; Sahgal, 1996; Hansen 1990). 
Marked differences in the profile and course of cognitive impairment in DLB have 
been described in comprehensively matched DLB and AD groups in this body of 
work. The impact of attentional dysfunction and in particular the ability to sustain 
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attention has not previously been addressed in AD and DLB, but appears to be a 
strong discriminator of these two dementing disorders. The impact of fundamental 
attentional. deficits cannot be considered in isolation and are likely to affect many 
aspects of cognitive performance. These attentional impairments may represent 
the first quantified demonstration of the so called 'fluctuations' and 'idiopathic 
clouding of consciousness' seen in these patients. Previous failures to identify the 
marked attentional deficits in DLB are likely to reflect the non-attentional nature 
of the 'attentional' tasks employed by many previous researchers. 
In addition, the course of change in DLB appears to be distinct from that seen in 
AD. This body of work has described decline in the cognitive function in AD and 
DLB groups over aI year period. Of particular interest is the increased rate of 
decline of attentional function observed in DLB compared to AD patients. This 
finding supports previous studies which have identified a more rapid rate of 
decline in DLB, and suggests that decrement in the ability to sustain attentional 
resources may underlie the faster rate of decline. Furthermore, the central role of 
attentional dysfunction in the profile of cognitive impairment and decline 
associated with DLB has been reaffirmed. 
The reported comparison of hallucinating and non-hallucinating DLB cases adds 
further intricacies to the noslogical debate. Hallucinating DLB (DLB+VH) cases 
show a markedly different profile of cognitive impairment to both non- 
hallucinating DLB (DLB-VH) and AD groups. The non-hallucinating DLB group 
were only distinguished from the AD group on one measure of performance: 
choice reaction time. Thus the profile of cognitive impairment in non- 
hallucinating DLB cases could not readily be described as distinct from that seen 
in AD. This raises the possibility that non-hallucinating DLB cases may form a 
distinct subgroup of DLB patients, and are similar to AD cases on the basis of 
neuropsychological findings. 
Hallucinations are not, however, a necessary prerequisite for the diagnosis of 
DLB, indeed neuropathological studies have often described cortical Lewy bodies 
in non-hallucinating DLB cases at autopsy. Furthermore, to receive a clinical 
296 
diagnosis of DLB, non-hallucinating DLB cases must have shown both 
spontaneous motor features of parkinsonism and fluctuations. These features 
would distinguish them from AD cases as parkinsonism and fluctuations are also 
associated with the presence of Lewy body pathology at autopsy. 
Although non-hallucinating DLB cases are not markedly distinct in terms of 
neuropsychological. impairment from AD cases, clinical and neuropatho logical 
features support their continued distinction from AD. The possibility of a 
subgroup of hallucinating DLB cases with distinct neurochernical and 
neuropsychological features awaits the necessary neuropathological investigation 
anticipated in this group at autopsy. 
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Appendix 1: 
The Nottingham criteria for the clinical diagnosis of LBD (Byrne et al, 19911. 
1. Probable LBD 
Either 
(1) gradual onset of DSM-III-R dementia with prominent attentional deficits or early 
unexplained apparent confusional states 
(ii) classical Parkinson's disease with subsequent dementia as above 
(iii) simultaneous onset of both dementia (as described) and parkinsonism with three or 
more of tremor, rigidity, postural change, bradykinesia and gait abnormality 
2. Possible DLB 
Either dementia (as described) with acute onset and rapid progression la plateaux, 
frequently associated with psychiatric symptoms or dementia (as described) with 
subsequent parkinsonism with one or two of tremor, rigidity, postural change, 
bradykinesia and gait abnormality 
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Appendix 11: 
Newcastle criteria for the clinical diagnosis of senile dementia of the Lewy 
body type (SDLT) (McKeith et al (1992c). 
Fluctuating cognitive impairment affecting both memory and higher cortical 
functions (e. g. language, visuospatial ability, praxis or reasoning skills). The 
fluctuation is marked with the occurrence of both episodic confusion and lucid 
intervals and is evident either on repeated tests of cognitive function or by 
variable performance on daily living skills. 
2. At least one of the following: 
(a) visual and / or auditory hallucinations which are usually accompanied by 
secondary paranoid delusions 
(b) mild spontaneous extrapyramidal features or neuroleptic sensitivity 
syndrome (i. e. exaggerated adverse responses to standard doses of 
neuroleptics) 
(c) repeated unexplained falls and / or transient clouding or loss of 
consciousness. 
3. Despite the fluctuating pattern the clinical features persist for weeks or months 
(unlike delirium) and progress, often rapidly, to severe dementia 
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Appendix III: 
Consensus guidelines for the clinical diaimosis of dementia with Lewy bodies 
(DLB) (McKeith et al, 1996a) 
1. The central feature required for a diagnosis of DLB is progressive cognitive 
decline of sufficient magnitude to interfere with normal social or occupational 
function. Prominent or persistent memory impairment may not occur in the 
early stages. Deficits on tests of attention and of frontal-cortical skills and 
visuo-spatial ability may be especially prominent. 
1 2. Two of the following core features are essential for a diagnosis of probable 
DLB, one is essential for possible DLB. 
a) Fluctuating cognition with pronounced variations 
in attention and alertness. 
b) Recurrent visual hallucinations which are typically 
well formed and detailed. 
c) Spontaneous motor features of Parkinsonism. 
13. Features supportive of the diagnosis are 
a) Repeated falls 
b) Syncope 
c) Transient losses of consciousness 
d) Systematised delusions 
e) Neuroleptic sensitivity 
f) Hallucinations in other modalities 
14. A diagnosis of DLB is less likely in the presence of 
a) Stroke disease evident in focal neurological signs 
or on brain imaging. 
b) Evidence on physical examination and 
investigation of any physical illness, or other brain 
disorder, sufficient to account for the clinical 
picture. 
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Appendix IV: 
Summary of Neuropsychological Test Procedures and Main Cognitive 
Functions Measured. 
Blessed Information MemoKy and Concentration Test (IMC, Blessed 1968) 
The IMC was first published in 1968 as part of the Blessed dementia rating scale. 
The IMC is one of the only scales which has been correlated with 
neuropathological parameters of severity in AD. The IMC consists of three 
subsections (information, memory and concentration), although each section does 
not receive an equal weighting. The Blessed IMC is particularly sensitive to 
mnemonic dysfunction. The information section (total 13 points) of the IMC 
examines how well the subject is orientated in time and place. The memory 
section (total 14 points) is further divided into three sections, the first assesses 
personal memories (5 points), the second assesses non-personal memories (4 
points) and the third assesses five minute recall of a name and address (5 points). 
The concentration subsection (6 points)of the IMC requires the subject to recite 
the months of the year backwards, and to count from 1-20 forwards and 
backwards. 
Boston Naming Test (Ka-plan et al, 1978) 
The full version of this test consists of 85 large pen and ink drawings of items 
which range in familiarity. When a subject is unable to correctly name a drawing, 
the examiner provides a stimulus clue, and if the subject is still unable to correctly 
name the object a phonetic clue is offered. This test was initially developed to 
investigate naming deficits, but is also sensitive to perceptual fragmentation as is 
often seen following right-sided frontal lobe damage. 
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Buschke-Fuld Selective Remindiw Test (Buschke et al, 1974 
This test aims to differentiate between disorders of retention, storage, and retrieval 
by using selective reminding. In selective reminding the subject attempts to recall 
as many words as possible in any order from a list of words just presented to them. 
Subsequent to each trial, the examiner repeats all of the words the patient omitted 
in that trial. reminding and recall continues until the patient has correctly recited 
the whole list. 
Cambridiae Cop-nitive Function Examination (CAMCOG. Roth et al. 1986 
The CAMCOG is part of a standardised psychiatric assessment schedule 
CAMDEX and is designed specifically for use in an elderly population with a 
diagnosis of dementia. CAMCOG assesses a broader range of cognitive functions 
than other standardised schedules. Sixty items yield eight subsection scores and a 
total score of 107. The subsections of the CAMCOG include orientation, 
language, memory, attention, visuospatial praxis, calculation, perception, and 
abstract thinking. In comparison with the Mattis Dementia Rating Scale (DRS), 
CAMCOG is more sensitive to language or visuospatial dysfunction, but contains 
less very easy items and subsequently prove less sensitive in more advanced 
dementia cases. 
CoDv-a-Cross Test (Goodglass & Ka-plan, 197 
The Copy-a-Cross test requires subjects to copy a line drawing of a Greek cross, 
and the drawings are scored on an ordinal scale of I (good) to 5 (poor), and is an 
indicator of visuospatial/ constructional abilities. This provides an index of visuo- 
graphic abilities, and is sensitive to visual inattention as well as preservation of 
spatial relationships. 
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Letter and Category Fluency (Benton et al. 1968 
In the Letter Fluency Test, participants are required to generate as many words as 
possible (excluding proper names and different forms of the same word) 
beginning with the letters "I"', "A" , and "S". In the Category Fluency test, 
participants are required to generate as many different kinds of animals, fruits, or 
vegetables as possible. Participants are allowed one minute for each letter or 
category. The tests measure the speed and ease of verbal production of material. 
The category sub-test requires a more intact level of semantic functioning than the 
letters for normal scores to be obtained. 
Mattis Dementia Rating Scale (DRS, Mattis et al. 1976 
The DRS assesses a fairly broad range of cognitive functions, and contains 
sufficient less demanding items to be valid and reliable in more severely demented 
cases. The first four sections - attention (37 points), initiation/perseveration (37 
points), construction (6 points) and conceptualisation (39 points) - contain 
screening tests which if passed mean the rest of the section need not be 
administered. The final memory section (25 points) is administered to all subjects. 
The total score possible score for the DRS is 144 points. The DRS provides 
comprehensive assessment of broad cognitive functions, but little assessment 
localised functions such as language. 
Mini-Mental State Examination (MMSE. Folstein et al. 1975 
The MMSE is the most widely applied and studied screening test for dementia, 
and is widely applied in clinical practice and research alike. The MMSE is very 
vulnerable to the effects of age, education, and socio-economic status. The MMSE 
may be subdivided into 6 sections - orientation (10 points), registration (3 points), 
attention (5 points), recall (3 points), language (8 points) and copying (1 point). 
The MMSE is of practical value in detecting dementia and measuring the progress 
323 
of the disease, but is of limited use in measuring focal cognitive deficits or 
progression in severely demented patients. 
Visual Re-production Test (Russell. 1975 
The Russell adaptation of the Visual Reproduction Test provides an index of 
memory for geometric forms by asking participants to reproduce a complex 
geometric figure. In the three trials which contain increasingly complex figures, 
participants are firstly required to reproduce the figure immediately following a 10 
second presentation period. Participants are subsequently required to simply copy 
the figures with the stimulus present. This aims to assess and eliminate any visuo- 
perceptual / praxis dysfunction which would contaminate the memory 
performance. The reproductions are assessed for the number of components 
present from the original stimulus drawings and presented as a percentage of the 
total score in the copy condition. 
Wechsler Adult IntelliLyence Scale - Revised (WAIS-R: Wechsler. 1981 
Arithmetic Sub-test (WAIS-R 
The arithmetic sub-test assesses an individuals ability to perform a range of 
calculations. The sub-test contains 14 items, but items I and 2 are omitted unless 
the subject fails items 2 and 4, testing is continued until the subject fails four 
consecutive items or completes all fourteen. The items have time limits ranging 
from 15s to 120s for the final question ("Four men can finish a job in eight hours, 
how many men would it take to complete the job in half an hour? "). For the final 
four questions, bonus points are awarded for rapid responses. Difficulties in 
immediate memory, concentration, or conceptual manipulation and tracking can 
prevent even mathematically skilled individuals from performing well on this test. 
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Block Design Sub-test (WAIS-R) 
The block design sub-test is a construction test in which the subject is presented 
with either four or nine (depending on the item) red and white blocks. The task is 
to replicate two block constructions made by the examiner, and to replicate a 
further seven designs printed in smaller scale. The order of presentation differs 
from the order of difficulty. The four-block designs have a time limit of I minute 
and the nine block designs have a time limit of 2 minutes. In addition, bonus 
points may be earned for the rapid completion of items 3-9. Block design is 
generally recognised as a valuable measure of visuospatial functioning, although it 
is sensitive to dyspraxia. 
Digit Span Sub-test (WAIS-R 
The Digit Span sub-test comprises two different tests, namely the digits forwards 
and digits backwards, both tests assess auditory attentional function and working 
memory. The tests consist of seven pairs of random number sequences that the 
examiner reads aloud at the rate of one per second, the participant is required to 
repeat the numbers back to the examiner in either the forward or the reverse order 
to which they were read out. The tests continue until the subject fails a pair of 
sequences, or is able to complete the longest sequence of eight letters in either 
direction. Combining the two scores is commonplace and useful in participants up 
to middle age. Older subjects, however, tend to show a decrement in digit 
backwards, whilst digit forwards remains relatively stable. The discrimination 
between digits forward and backwards is thought to be due to different loads being 
placed on working memory. 
Similarities Sub-test (WAIS-R 
The similarities sub-test is a test of verbal concept formation. The test requires the 
subject to explain what a pair of words have in common. Word pairs range in 
difficulty from easy ("banana-orange") to difficult ("praise-punishment"). The test 
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begins with the first item and is discontinued after four successive failures or 
when the subject completes the task. Scores are an a two point scale with one 
point awarded for a specific concrete likeness, and two points awarded for an 
abstract generalisation. The similarities sub-test is fairly independent of mnemonic 
ability, and especially in old subjects becomes the best test of verbal ability in the 
WAIS-R. The similarities sub-test is relatively independent of educational, socio- 
economic, and other background experiences. 
VocabulM Sub-test (WAIS-R) 
The vocabulary sub-test consists of 35 words arranged in order of difficulty. The 
examiner reads the question "What does mean? ". Administration usually 
starts with the fourth word on the list (the first three are assessed only if the 
response to the fourth word is unsatisfactory) and continues until the subject fails 
five words consecutively or the list is exhausted. The subject gains one or two 
points for each acceptable definition depending on the accuracy, precision and 
aptness of their response. The final score reflects the participants ability to recall 
vocabulary and the effectiveness of their speaking vocabulary. Vocabulary has 
been identified as the single best measure of both verbal and general mental 
ability, and is sensitive to the patient's socio-economic and cultural origins, but 
relatively insensitive to schooling. 
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Appendix V: 
Selectivity of computerised assessment Procedures for cross-sectional 
comparative studies of AD and DLB 
Patients were consecutive referrals from the MRC Prospective Study of memory 
disorders based in Newcastle upon Tyne. Referrals to the MRC were made by 
collaborating psychogeriatricians and neurologists in the Tyne & Wear district. 
Summaly of reasons for patient exclusion from the CANTAB cross-sectional 
study. 
Reason for non-inclusion in the stud Number of patients 
excluded 
Di d i e pr or to assessment 5 
............ . ...................... -- - -- ----------------- ------ ------------- -- ---- ------- Too demented to complete assessment 80 
Refused approach 4 
Dysphasia 2 
Sensory difficulties (e. g. poor eyesight) 10 
.............. .................. ................... . ................... ................... . ..................... . ... . ........ . ........................ ........ . ................... . ..... .............. Unable to contact patient .................... ...... ..... ...... ................. ........ ......... ... . 4 
Physical illness 7 
Inappropriate due to research overload 4 
Withdrawn from MRC study 3 
.................. . Objections to cognitive testing ...... . ............ . ..................... ........................................ 4 
Total number of patients referred 137 
Total patients referred who were excluded 123(90%) 
Total number of assessments completed 14(10%) 
J 
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Summary of reasons for patient exclusion from the CDR cross-sectional studv 
.......... . .... . ............. - --------- -............ 
Reason for non-inclusion in the stud_ 
Died prior to assessmen-1 t 
Too demented to complete asse ssment 
................................................ . -- - -------- .... . ................ . ........................... ............ . ..... . ............. . .... . ............... -- . ......... ........... Refused approach 
Dysphasia 
Sensory difficulties (e. g. poor eyesight) 
Unable to contact Patient 
- --- ------- - -------------------- ----- ........ ............... --- --- ----------- Physical illness 
Inappropriate due to research overload' I 
............ Withdrawn from MRC study 
Objections to cognitive testing 
................. ............. 
Total number of patients referred 
Total patients referred who were excluded 
Total number of assessments completed 
Number of patients 
excluded 
104 
34(33%) 
70(67%) 
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